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Inflammation of any organ frequently resolves by remodelling of the tissue. Normal tissue function is
restored. However, inflammation can lead to scarring, dysfunction and even failure of function of the
tissues. The kidney, in particular the glomerulus, is a focus for inflammation by many, currently
obscure mechanisms. Inflammation here is not exceptional, and failed resolution leads to organ failure
and death. However, in humans and animals complete resolution of apparently severe inflammatory
injury of the glomerulus can occur. Mesangial cells (MC) are a major cell-type in the healthy
glomerulus. They respond to inflammation by proliferation and laying-down scar tissue. In animal
models, deletion of excess MC by a cell death process called apoptosis is crucial for resolution and
restoration of the normal tissue. Coincident with the occurrence of MC apoptosis is the presence of
inflammatory macrophages (M<])), in the mesangial areas of the glomerulus. Motivated by a clear role
for M(j) in deleting excess cells in developmental remodelling, I sought to determine whether
inflammatory M(J) as found in the diseased glomerulus could induce apoptotic death in of cultured MC.
By developing an in vitro assay of proliferating MC with M(J) as a model of glomerular
inflammation, M<J), either activated by cytokines, or taken directly from diseased glomeruli, induced
apoptotic death of MC. Thus, Mtj) were able to control MC populations. Roles for Mc() derived nitric
oxide and tumour necrosis factor (TNF) in mediating these effects on MC were clearly shown. Further,
when M(|) ingested opsonised particles (to model immune complex activation), hydrogen peroxide
release was also found to induce MC apoptosis.
Excessive M(J) killing of MC is also deleterious to healing of the glomerulus, since excessive
MC loss also leads to scarring. Negative feedback in M0 killing was sought. Since M(j) ingestion of
apoptotic cells leads to transforming growth factor beta release, I hypothesised that once M(|) had
induced MC apoptosis and ingested the dead cells, they might deactivate. Co-culture was modified
whereby activated M<|) ingested pre-formed apoptotic cells whilst in the process of killing healthy MC.
These M(f> were rendered incapable of inducing TNF dependent MC apoptosis, indicating a novel
negative feedback loop in the inflammatory response. TNF receptor 1 signalling pathways of apoptosis
in MC were investigated. Following stable transfection, an important role for interferon regulatory
factor-1 was shown.
This thesis has contributed to the understanding of the inflammatory process both in the
glomerulus and in a wider context. It has demonstrated that inflammatory M(]) induce apoptosis of MC,
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Inflammation is a tissue response to injury characterised by rubor, color, tumor, do/or (redness,
heat, swelling and pain). The injured tissue has responded by increased vascular flow, increased
vascular permeability, and has attracted inflammatory leucocytes to leave the capillaries and enter
the tissue. Many types of injury allow (particularly to epithelial surfaces) pathogenic organisms to
enter, therefore requiring a swift response by the innate immune system. The most efficient cell
types at clearing invading organisms are the neutrophil and the inflammatory macrophage. These
two cell types are the first to appear at a site of local injury; usually the neutrophil precedes the
macrophage. Diapedesis, the movement of leucocytes across the endothelial barrier, and the
extravascular, cytokine-rich environment trigger differentiation. The monocyte differentiates into a
macrophage phenotype (Figure 1-1). Neutrophils entering the injured tissue, upregulate adhesion
molecules and may produce oxygen radicals or proteases, thereby becoming activated.
Figure 1-1: Human monocytes (X400) purified from fresh buffy coat show characteristic morphology
by haematoxylin and eosin stain (Panel A). In the presence of autologous serum they differentiate into
macrophages (X400) (panel B). Note characteristic 'crystals' in the nucleus of monocytes, and the
characteristic 'fried egg' morphology of macrophages with greater diameter and cytoplasm.
Increased blood flow and permeability allow increased transfer of plasma borne proteins of the
innate immune system to enter the injured tissue (such as C-reactive protein). Vascular damage
results in activation of the coagulation cascade and release of a granules from platelets. Amongst
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other mediators, a multitude of growth factors (found in serum) are released locally by platelet
degranulation and initiate de-differentiation and proliferation of local resident tissue cells. In all
tissues, are mesenchymal cells that de-differentiate into myofibroblasts. In health, these cells are
major contributors to the normal extracellular matrix comprising laminins and collagens
(principally type IV). In response to injury and growth factors, myofibroblasts proliferate and are
responsible for laying down abnormal matrix or scar tissue. Once proliferating, these cells generate
their own growth factors which, by autocrine mechanisms, perpetuate proliferation and the
myofibroblast phenotype. The matrix generated now contains an excess of collagen I, which is not
normally synthesised by these cells in health. The generation and degradation of matrix is dynamic
during the inflammatory response as the very cells that lay down matrix also break it down using
enzymes called metalloproteinases. This family of enzymes is also active during inflammation. It is
not true to say therefore that any scar tissue laid down will be permanent.
Neutrophils that are activated at the site of inflammation produce many proteases that can
breakdown extracellular matrix. They also undergo a 'respiratory burst', swiftly generating
abundant oxygen radicals (Figure 1-2) and hydrogen peroxide. Lipopolysaccharide (LPS) and
cytokines such as tumour necrosis factor alpha (TNF-a) can result in induction of the oxygen
radical burst of neutrophils, but many stimuli can activate them in this stereotyped fashion. There
is much evidence in models of inflammation that neutrophils can inflict 'bystander' or 'friendly
fire' damage on the tissue concerned (Johnson, Guggenheim et al., 1988; Johnson, Alpers et al.,
1988; Albina et al., 1990; Mateo et al., 1994; Worthen et al., 1987; Savill et al., 1989). Indeed the
induction of many sterile inflammatory responses does not occur without neutrophil mediated local
damage (Santos & Tipping 1994; Henson & Johnson 1987; Sandoval et al., 1996). Excessive local
damage mediated by neutrophils would cause perpetuation of the inflammatory response leading to
further influx of leucocytes. Monocyte-derived M<|> entering the site of inflammation appear to take
on an activated phenotype (Albina et al., 1995; Nessel et al., 1999; Meszaros et al., 2000; Erwig
et al., 1999). These cells when activated can produce a variety of free radicals and cytokines. In
addition, they are another potent source of growth factors. Macrophages, so called because of their
appetite for phagocytosing particles have long been thought of as the 'hoover' in the inflammatory
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Figure 1-2 Flow diagram indicating the key steps in the generation of reactive oxygen intermediates.
Key enzymes and co-factors are marked. Also, key regulatory enzymes such as catalase are also shown.
Generation of 02 is essential for nitric oxide generation by the NOS family of enzymes from L-arginine. The
pathway of NO metabolism is also shown.
1.2 APOPTOSIS - A FORM OF CELL DEATH
Apoptosis is a term used to describe programmed or physiological cell death. It appears that all
cells can undergo apoptotic cell death. This form of death is sometimes induced by noxious
stimuli, sometimes induced by specific ligand receptor interactions either at the cell surface or
intracellularly, sometimes by deprivation of vital survival signals initiated at the plasma
membrane, and sometimes occurs as a default process, when the cell becomes damaged, unable to
repair itself, or if it becomes effete (Duke & Cohen 1986; Williams et al., 1990; Clarke et al., 1993;
Soengas et al., 1999; Talhouk et al., 1992; Itoh et al., 1991; Smith et al., 1994). Many non-
haematopoeic cells require survival signals from adhesion to extracellular matrix. In the event that
these cells become non-adherent (such as columnar epithelial cells at the apex of villi in the gut),
the cell defaults into apoptotic cell death (Frisch & Francis 1994; Bates et al., 1994; Ruoslati &
Reed 1994).
It is important to distinguish apoptosis from non-programmed cell death where cells are so
abruptly damaged that they 'fall apart' without being able to initiate the cellular program or
organised death (Duvall & Wyllie 1986; Kerr et al., 1972). In the case of non-programmed cell
death, intracellular contents are randomly released into the extracellular space. One can envisage
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that necrotic death of inflammatory cells such as eosinophils and neutrophils will lead to
uncontrolled release of granules spilling proteases that degrade normal tissue architecture. By
contrast programmed cell death leads to maintenance of the plasma membrane and intracellular
organelles. The Golgi is disrupted but compacted into vesicles and importantly, DNA is
characteristically cleaved into small sections by apoptosis-specific endonucleases. This cleavage
can be seen as a characteristic ladder if DNA from apoptotic cells is electrophoresed (Wyllie et al.,
1980). Significantly, apoptotic cells are specifically phagocytosed by phagocytes of the monocyte
lineage and also semi-professional phagocytes such as fibroblasts (Savill et al., 1989; Savill et al.,
1992). Most cells when de-differentiated can phagocytose apoptotic cells. The mechanisms of
phagocytic clearance of apoptotic cells are distinct from phagocytosis of other particles including
necrotic debris and unlike phagocytosis of many particles do not induce an inflammatory response
in the phagocytosing cell (Meagher et al., 1992).
Apoptosis as opposed to necrosis is defined both morphologically and functionally. The distinction
between these forms of cell death for inflammatory cells such as neutrophils is obvious since
necrotic death might lead to enhancement of tissue destruction through release of intracellular
contents and by further exciting local inflammatory responses (Stern et al., 1996). However, in the
case of resident tissue cells the functional distinction is less clear cut since most cells do not
contain vesicular enzymes capable of tissue destruction. More importantly, possibly, is the effect
uptake of apoptotic cells as opposed to necrotic cell debris has on the phagocytosing cell. This
issue is pursued in this thesis.
Apoptosis was defined morphologically in 1972 (Kerr et al., 1972). This remains the gold standard,
though there are now biochemical markers that are variably reliable depending on the cell type
under investigation. Morphologically, the features are highly stereotyped across species and cell
type. Indeed there is evidence that plant eukaryotic cells undergo apoptosis! Features include cell
shrinkage, cytoplasmic condensation and vacuolation, condensation of nuclear heterochromatin,
abutting the nuclear membrane, then distinction of nuclear material into homogeneous spheres. In
some cell types there is dramatic cytoplasmic blebbing. When viewed in real time the blebbing
looks like the cell is 'boiling away'. Some of these buds contain nuclear material and are termed
apoptotic bodies. These bodies are also swiftly phagocytosed, non-phlogistically, by macrophages.
Functionally, apoptotic death can be distinguished from necrotic cell death by maintenance of
function of the plasma membrane. The necrotic cell membrane can be breached by all manner of
molecules and is unable to maintain ion gradients. This is manifested by leakage of dyes into
necrotic cells that are excluded from apoptotic and live cells. Commonly, trypan blue and the
fluorescent nucleic acid-binding dye, propidium iodide (PI), can assist in assessing the integrity of
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the plasma membrane. Another fluorescent molecule the binds avidly to DNA only, Hoescht
33342, is freely permeable to the plasma membrane of healthy cells but is pumped out actively
(Sun et al., 1992) (see Figure 3-5). In apoptotic cells, this pump does not function, permitting
accumulation and nuclear labelling of DNA in the apoptotic cells. The cell membrane, though
intact is manifestly different from the healthy plasma membrane in many ways. For example, many
cell surface receptors and ligands are shed, the actin cytoskeleton immediately below the plasma
membrane is disrupted and the composition of the external lipid bilayer changes due to down
regulation of scramblases which exchange phosphatidylserine in the inner leaflet for
phopshatidylcholine in the outer leaflet (Fadok et al., 1992). Furthermore, as a part of the apoptotic
process, certain intracellular contents such as nuclear proteins that are not normally displayed,
become localised to the external plasma membrane (Casciola-Rosen et al., 1996). Many of these
biochemical changes have been exploited as biological tools to define apoptosis. One commonly
used tool is the appearance of phosphatidyl serine in the external leaflet of the lipid bilayer which
can be specifically recognised by Annexin V (Figure 1-3).
1.3 EFFECTOR MECHANISMS IN THE APOPTOTIC PROCESS.
Whilst apoptosis can be defined by morphological and biochemical processes it is clear that many
stimuli can result in a final common outcome for the cell. Much effort has been devoted to
unravelling the effector mechanisms in this final common pathway. What has become clear is that
for many types of apoptotic death an intracellular cascade of aspartic acid proteases (the caspases)




is important in directing the manifestations of cell death. The key pro-enzymes were first
delineated from mutant studies of the developing worm C. elegans. This worm characteristically
loses 131 of the original 1090 somatic cells by apoptosis during development. CED-3, a caspase
was discovered from these mutant studies and shares great homology with enzymes in mammalian
cells and in many cases are functionally intact when transferred to mammalian cells (Yuan, &
Horvitz 1990; Yuan et al., 1993). In mammalian cells this caspase pathway, which is analogous to
the coagulation and complement cascades, has many amplification steps. Whilst the nucleus is
dispensable (Jacobson et al., 1994), for many types of apoptotic cell death the mitochondria have
proved vital in the amplification process of the cascade (Mignotte & Vayssiere 1998; Yang et al.,
1997; Susin et al., 1999). It is worth emphasising that whilst this pathway is undoubtedly very
important, there do appear to be examples of apoptotic death where caspases are not necessary.
Indeed in vivo some cells do not express key members of this pathway (Horvitz personal
communication; Bennett personal communication; Doerfler et al., 200;, Carmody & Cotter 2000;
Kuida et al., 1998; Kuida et al., 1996; Woo et al., 1999). It is perhaps not surprising that such an
evolutionarily conserved event (apoptosis) has many levels of mechanistic redundancy. However,
knockout studies in worms and mice have emphasised a key role for the caspase cascade (Figure
1.4) (Kuida et al., 1998; Kuida et al., 1996; Woo et al., 1999).
Cytolysis of tumour cells by soluble cytokine tumour necrosis factor was recognised in 1983
(Drysdale et al., 1983). However, confirmation that this ligand could swiftly induce apoptotic death
of certain tumour cells through specific ligand-receptor interactions was not described until 1991
(Tartaglia et al., 1991). This indicated that signalling events at the cell surface could link into
effector mechanisms operating intracellularly. A receptor named Fas (Apo-1), homologous to the
TNF receptor 1, whose activity was shown to also result in cell death (Itoh et al., 1991), was co-
precipitated with one such caspase named FLICE (subsequently caspase 8) (Muzio et al., 1996).
This provided a direct link between cell surface receptor ligation and the death-signalling cascade.
Subsequently, TNFR1 and more recently many other homologous 'death' receptors have been
shown to activate the caspase pathway through cleavage (hence activation) of caspase 8 (Hsu et al.,
1996). It should be noted that these death receptors also cleave other caspases (eg caspase 2) in
certain cell types (Cohen 1997). Furthermore activation of other signalling pathways such as
DAXX (Yang, Khosravi-Far, et al., 1997) and Jun kinases (Latinis & Koretzky 1996), extracellular
signal-regulated kinases (Goillot et al., 1997) and acid sphingomyelinase-ceramide (Cifone et al.,
1995) pathways are likely to be important in induction of apoptosis in some cell types following
death receptor ligation (Figure 1.4). At the effector end of the caspase cascade, caspase-specific
final effectors such as the caspase activated DNase (CAD) have been clearly demonstrated. Other
targets for proteolysis include kinases such as FAK, MEKK1, structural proteins such as laminins,
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Figure 1-4: Diagram of a cell giving an interpretation of current data in the literature regarding
pathways involved in apoptosis following death receptor trimerization at the cell surface. The key players
and their interactions are indicated though aspects of this pathway might be refuted by some and it is by no
means comprehensive. For a more detailed overview refer to Schulze-Osthoff et al., 1998; Mignotte et al.,
1998.
Recent attention has been paid to the role of cytochrome C released from mitochondria in
augmenting the caspase cascade. Cytochrome C (cyt. C) has traditionally been associated with the
electron transport chain in the inner lipid bilayer of mitochondria, crucial in ATP generation. There
is good evidence that caspase 9 binds to, and is cleaved to the active form by a factor called APAF-
1 when cyt. C is released from mitochondria. This 'apoptosome' is able to cleave caspase 3 which is
thought to be the final common effector in caspase dependent apoptotic death (or at least a
component of the final common pathway) (Susin et al., 1999; Susin et al., 1999; Mignotte et al.,
1998; Li et al., 1997). Release of cyt. C from mitochondria is modulated by numerous factors
including members of the B-Cell Lymphoma-2 (Bcl-2) family of pore-forming proteins (Yang,
Liu, et al., 1997). It appears that many survival signals derived from cell-surface integrins and
8
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growth factors such as insulin-like growth factors impinge on mitochondrial release of cyt C,
thereby 'plugging in' to the caspase cascade, possibly by regulating phosphorylation and therefore
activity of Bcl-2 family members such as Bid.
This model of regulation of the apoptotic process cannot be the whole story since attenuation of the
function of caspase 3 either in knockout mice or in antisense/dominant negative studies does not
necessarily block induction of apoptosis (Kuida et al., 1998; Kuida et al., 1996; Honarpour et al.,
2000). Indeed in caspase 3, caspase 9 and APAF knockout mice the principal defect is impaired
neuron deletion. Other organs developed normally. However, when such caspase 3 knockout mice
were challenged with agonistic anti Fas antibodies, the hepatocytes were protected from apoptosis
for 72h. Notably in these mice, lymphocyte development appeared normal, though when
thymocytes were challenged with apoptotic stimuli, knockout thymocytes were variably resistant
(Doerfler et ah, 2000). These knockout animals indicate that there are either caspase-independent
mechanisms of apoptosis or that other caspases can take over the function of deleted family
members.
It is evident that many cells exposed to noxious stimuli phosphorylate and thereby activate a
nuclear factor p53 (Ko et ah, 1997). This family of nuclear factors is induced both functionally and
quantitatively prior to morphologically detectable apoptosis. Over-expression of some of the p53
isotypes results in induction of apoptosis. p53-mediated apoptosis has been closely associated with
DNA damage due to radiation (UV, gamma) and noxious stimuli such as nitric oxide and oxygen
radicals (Messma et ah, 1994; Albina et ah, 1993; Clarke et ah, 1993). Induction of p53 is
associated with cell cycle arrest, frequently at the G,/S border (Baker et ah, 1990; Harper et ah,
1993). However, it has become apparent that other forms of apoptotic death such as
developmentally regulated cell deletion may involve p53 (Almog & Rotter 1997). Indeed, many
stimuli that activate p53 also seem to induce caspase 3 cleavage (Zhao et ah, 2000; Soengas et ah,
1999) and others have indicated a p53-dependent activation of caspase 8 via Fas at the plasma
membrane (Bennett et ah, 1998) (Figure 1-5). For example, nitric oxide induces p53 activity, but
also results in caspase 8 and caspase 1 cleavage (Bennett et ah, 1998, Zhou et ah, 2000). The
mechanisms by which p53 enables apoptosis have remained obscure, but recently it has become
clear that p53 controls Bax activity, which in turn regulates caspase 3 activity (Miyashita et ah,
1994; Cregan et ah, 1999). One mechanism, therefore, by which p53 can induce apoptosis is by
cleaving key caspase family members. Investigations of toxic stress-induced apoptosis have shown
that not all cells require p53 to undergo apoptosis. Many of the cells that die in response to DNA-
damaging stimuli undergo apoptosis independently of p53 require induction and translocation to
the nucleus of another nuclear protein, interferon regulatory factor-1 (Tamura, Ishihara, et ah,
9
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1995; Tanaka et al., 1994; Clarke et al., 1993; Bellarmy et al., 1997). First noted as an interferon
induced gene (Tanaka & Taniguchi 1992), this nuclear factor is also induced synergistically by
interferon-y in association with TNF-a in addition to other factors including DNA damage.
Transgenic overexpression in B-lymphocytes lead to developmental deletion, of those cells
(Yamada et al., 1991). In murine knockout studies lymph node architecture is disrupted with






Figure 1-5: Diagram of a cell with nucleus indicating mechanisms potentially responsible for
mediating apoptosis of cells following removal of survival signals from the plasma membrane or following
DNA damaging insults such as gamma or UV irradiation.
1.4 MESANGIAL CELL AS A MYOFIBROBLAST; ITS ROLE IN REMODELLING
The principal function of the kidney is concerned with extracellular homeostasis, that is fluid and
electrolyte control in the extracellular space. The kidneys achieve this by relatively non-specific
ultrafiltration of protein deplete fluid from the plasma component of blood through many sieve-like
structures, called glomeruli. There are between 2xl04 and 5x10s glomeruli per kidney depending
10
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on the species. This functional unit comprises capillaries with specialised endothelium, a
specialised basement membrane upon which lie the endothelial cells on one side and specialised
epithelial cells, the podocytes. Holding this structure of many capillaries surrounded by podocytes
together is the mesangium, containing mesenchymal cells that produce extracellular matrix and
function in addition to structural support to regulate capillary blood flow. Surrounding this central
structure (looking like the surface of the brain) is a smooth spherical skin of parietal epithelium
which at one pole becomes the proximal tubule or the 'drain' of the glomerulus. The normal
glomerulus is a tightly regulated structure with a fixed number of mesangial cells and little cell
turnover. Filtered fluid is enriched for waste and has useful, beneficial compounds selectively re¬
absorbed by tubular cells that constitute the tubular structure carrying away the filtered fluid. The










Figure 1-6: Diagram of a nephron in the kidney, indicating the glomerulus
Inflammation involving either the glomerular or tubular structures is very common and is a
manifestation of many poorly understood diseases. Glomerulonephritis, inflammation of the
kidney specifically directed at either some or all glomeruli (Figure 1-6). During inflammation of
the glomerulus there is a stereotyped response to many different stimuli. The responses include
increased and altered matrix production by mesangial cells, induction of proliferation of mesangial
cells (one of the most common findings in human biopsies from kidneys with disease is an increase
in mesangial cellularity and matrix expansion). Other responses include changes (ultrastructural) to
the basement membrane that render it permeable to albumin and other plasma proteins and loss of,
11
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or damage to, endothelial cells. When MC respond to inflammatory stimuli they produce a-smooth
muscle actin (and other proteins of the contractile apparatus), and in models of glomerular disease
(Thy 1.1 nephritis) they show distinct migratory and contractile tendencies (Johnson et al., 1991;
Floege et al., 1991; Haseley et al., 1999).
This differentiation of MC to myofibroblast like cells and the consequences of this differentiation
on the tissue, however, is reiterated in many types of inflammation throughout the body (Figure 1-
7).
Figure 1-7: Fluorescent photomicrograph of human mesangial cells in tissue culture (X400) labelled
specifically with anti-a-smooth muscle actin antibody followed by FITC conjugated secondary antibody (see
methods). Note filamentous actin cytoskeleton of mesangial cells.
Myofibroblasts are de-differentiated cells that express a-smooth muscle actin and are both
migratory and contractile (smooth muscle cell phenotype) and they lay down extracellular matrix
containing Collagen I (fibroblast phenotype). Whilst the skin fibroblast during injury might be
thought of as the archetypal myofibroblast (Schurch et al., 1992), many other tissues have cells in
the interstitium that, when provoked, de-differentiate into this phenotype. Such sites include
atherosclerotic plaques (Bennett 1999), the septae of liver lobules during inflammation (Iredale et
al., 1998), lungs during the inflammatory response (Brewster et al., 1990; Polunovsky et al., 1993),
gut (Jobson, et al., 1998; Shuppan et al., 2000) and the kidney (interstitial fibroblasts and
mesangial cells). Further, there is evidence that epithelial cells can trans-differentiate into
12
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myofibroblasts. As inflammation in diverse sites is characterised by infiltrating bone-marrow-
derived cells, proliferating resident cells, myofibroblasts, and laying down of abnormal matrix it
seems reasonable to consider glomerular inflammation in that light.
In self-resolving models of glomerulonephritis, Baker and colleagues (Baker et al., 1994), and
Shimizu and co-workers (Shimizu et ah, 1995) have both demonstrated that resolution of
glomerular hypercellularity (and therefore disease) is brought about by loss of excessive mesangial
cells by apoptosis. Return to the normal cell complement is therefore brought about by apoptosis.
Concomitantly, there is loss of excessive matrix. Therefore, like skin wounding (Desmouliere et
ah, 1995), and resolving hepatic inflammatory scarring (Iredale et ah, 1998), co-ordinate loss of
myofibroblasts brings about resolution of disease.
In models of progressive disease, there is good evidence that excessive mesangial cell loss is also
brought about largely by apoptosis. Firstly, in a study of progressive anti-GBM nephritis in the
WKY (Wistar-Kyoto) rat, apoptosis occurs in proliferating (PCNA +ve) MC. The incidence of
apoptotic cells is high compared with the resolving Thy 1.1 nephritis and correlated with
infiltration of leucocytes. However, the rate of apoptosis increases further in the fibrotic later
stages of the disease (Shimizu et ah, 1996). Similar findings were reported using the same
nephrotoxic nephritis model, but in the Sprague Dawley rat (Sugiyama et ah, 1997). However,
NTN induced by El Nahas' group using the WKY rat, found that maximum apoptosis of resident
cells occurred earlier in the disease and correlated more closely with leucocyte infiltration (Yang et
ah, 2000) (Figure 1-8). In the latter study, all the cell loss could be accounted for if clearance time
of apoptotic cells was 3.5h. In human glomerulonephritis there are many reports of increased MC
apoptosis in both progressive and resolving diseases (Harrison 1988; Baker et ah, 1994; Shimizu et




Figure 1-8: Time course of resident cell number per glomerular cross section compared with
macrophage number and number of apoptotic cells seen per 50 glomerular cross sections in progressive
nephrotoxic nephritis in the Wistar Kyoto rat. Note high levels of apoptosis and corresponding high
glomerular macrophage influx. Data derived provided by GL Thomas (Yang et al., 2000).
It appears therefore that in glomerular disease the myofibroblast-like mesangial cell regulates scar
formation and healing in the wounded tissue. Factors that alter that process appear to impinge on
resolution or progression of the disease process.
1.5 MACROPHAGE EFFECTORS AND RESIDENT CELL APOPTOSIS IN TISSUE
REMODELLING
Tissue remodelling is the ability of a tissue to change co-ordinately form or shape. This is obvious
during embryogenesis when many tissues change form dramatically. During this remodelling there
are co-ordinated waves of apoptosis and cell division as well as differentiation of cells (Johnson
1994; Sorensen et al., 1998; Gassier et al., 1998; Araki et al., 1999). Developmental remodelling
occurs no more obviously than during development of digits from limb buds. In this instance as the
digits develop co-ordinated apoptosis results in the progressive loss of inter-digital webbing. In
fact, involution of tissue is characterised by apoptosis. For example, involution of ductules in the
breast after lactation (Kerr et al., 1972; Maclaren et al., 2001). In seminal work during the mid-
1990s, Lang and colleagues discovered that during remodelling of the neonatal eye in rodents, a
leash of vessels in the vitreous humor disappears due to apoptosis of endothelial cells and the other
cells of the vascular structure. Curiously, for this phenomenon to occur, macrophages were
required. It seemed that the M(|) dock onto the vascular cells and induce cell death prior to
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phagocytosis. This observation was reproduced using a variety of interventions (Lang & Bishop
1993; Lang 1997; DiezRoux et al., 1997). In animals without M<(), the deletion of the vascular
structures can be induced by reconstituting the eye with M<|).
Tissue remodelling also occurs in inflammation. The inflammatory process, characterised by
infiltrating leucocytes and increased capillary permeability, is also characterised by proliferation of
local resident cells, which lay down Collagen I rich extracellular matrix. One such cell type which
predominates in this setting is the myofibroblast (see above). Considering skin wounding, during
the healing process, the transition from granulation tissue (containing fibroblasts, endothelial cells,
vascular structures and pericytes) to scar is mediated by apoptosis of wound (myo)fibroblasts and
other cell types (Desmouliere et al., 1995). This process appears to be co-ordinated. Histological
examination of healing wounds reveals that up to 10% of all myofibroblasts can be apoptotic in
tissue sections. Curiously, in these studies it was noted that M<)> containing phagolysosomes were
always seen in close apposition to the apoptotic cells, indicating M<J) to be the major cell in
clearance of apoptotic cells. Indeed, observations of resolving inflammation in the lung, liver and
kidney indicate that myofibroblast apoptosis is a characteristic of the resolution phase (Polunovsky
et al., 1993; Iredale et al., 1998; Baker et al., 1994). This wave of apoptosis results in deletion of
excessive cells that are producing abnormal (Collagen I-containing) matrix that ultimately if not
resorbed will become scar tissue. Thus deletion of these myofibroblast cells is crucial to the
restoration of normal tissue architecture. There is evidence in models of inflammation that
disturbances in the balance of cell loss results in persistent inflammation or inappropriate scarring
which may ultimately lead to loss of function. For example in skin wounding the hypertrophic and
keloid scars show a persistence of granulation tissue which remains hypercellular i.e. there appears
to be a failure of apoptosis of myofibroblasts (Rockwell et al., 1994; Erlich et al., 1989). In studies
where proliferation is promoted and apoptosis decreased (Shankland 2000; Guervara et al., 1999)
the disease process and outcome is worse. Arguably in leukocytoclastic vasculitis there is an
excess of apoptotic neutrophils that are not cleared from the tissue. Perhaps this is the cause of
persistent inflammation. Recently, in models of multisystem inflammation as seen in Systemic
Lupus Erythematosis there is evidence of failed clearance of apoptotic cells triggering further
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Figure 1-9: Time course of total cell number per glomerular cross section compared with macrophage
number and apoptotic cells seen per 50 glomerular cross sections in resolving Thy 1.1 mesangioproliferative
glomerulonephritis. Note presence of macrophages mirrors appearance of apoptotic mesangial cells. Data
derived from experiments by Baker and colleagues (Baker et al.,1994).
At inflamed sites there are abundant macrophages, lymphocytes and neutrophils. M<\> are described
in apposition to apoptotic resident cells, often containing phagocytosed apoptotic cells
(Desmouliere et al., 1997; Grigg et al., 1991). However, a link between the presence of M(|> and
mechanisms of induction of apoptosis of resident cells during inflammatory remodelling has not
been made. The work of Baker and others (Baker et al., 1994) showed a striking correlation
between the presence of M(|) and apoptosis of mesangial cells (glomerular myofibroblasts) during a
self resolving (healing) model of inflammation in the kidney (Figure 1-9). Further, it has long been
reported that M(|) possess the 'machinery' to limit tumour growth by induction of apoptosis of
tumour cells utilising a variety of mechanisms. Albina's group reported roles for nitric oxide, and
TNFa in deletion of tumour cells in co-culture in vitro, and a role for macrophages in tumour
immune defence has been shown in various models of tumour growth and regression (Hagari et al.,
1995).
It is conceptually plausible that since M(|) are able to regulate tumour growth and regulate deletion
of unwanted structures during development. This function might be re-iterated during the




An extrapolation of this idea would be that too many M<() or rather too many activated 'killer' M<)>
at an inflammatory site would disrupt the balance between the tendency of myofibroblasts to
proliferate, deposit matrix or to be induced to die by apoptosis. Thus if it were true that M<() in
inflammation were regulators of resident populations the outcome of tissue repair would lie with
processes regulating M<J) activation (and deactivation) and localisation.
Further evidence in the kidney for a role of M<(> in regulating resident cell populations comes from
studies contemporaneous with this Thesis. Firstly, Hughes and Johnson (Hughes et al., 1999), in a
model of ureteric obstruction confirmed an accumulation of cortical M<j) adjacent to proliferating
interstitial myofibroblasts and proliferating tubular cells, as reported by Diamond (Diamond et al.,
1995). Using gld/gld (FasL deficient) mice, they showed that M<)) may play a role in inducing distal
tubular cell apoptosis. Also, in a model of anti glomerular basement membrane glomerulonephritis
in mice (with concomitant interstitial nephritis), tubular epithelial cell apoptosis occurred with M<f>
in close apposition. However, in MCP-1 -/- mice (monocyte chemoattractant protein-1), fewer
interstitial M<j) were recruited and a corresponding reduction in tubular cell apoptosis was seen,
suggesting M(j) were responsible for tubular cell apoptosis (Tesch et al., 1999). In vitro they
demonstrated that supernatants from activated M()) resulted in apoptosis of proliferating tubular
cells.
1.6 MACROPHAGES IN GLOMERULAR INFLAMMATION
So far, I have referred to the presence of M(|) in the Thy 1.1 model of resolving nephritis in the rat,
but a striking feature of glomerular inflammation is the preponderance of M<|) in many types of
disease (Figure 1-10). There is an equally striking paucity of lymphocytes to be found in the
glomerulus, compared with the tubulo-interstitial compartment of the kidney and many other sites
of inflammation. A well-established model of nephritis is the nephrotoxic nephritis model. This
disease is initiated by planted antigen in the form of foreign antibody against glomerular basement
membrane. However, priming animals with the foreign immunoglobulin results in a host antibody
and cell-mediated response to the anti-GBM antibody and augmentation of glomerular disease,
once the anti-GBM is planted in the glomerulus. In many ways this model mirrors events in human
diseases such as anti-GBM disease, and other forms of rapidly progressive glomerulonephritis. In
rabbit, sheep rat and mouse the model is characterised by abundant intra-glomerular, mesangial-
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infiltrating M<|> (Holdsworth et al., 1985; Tesch et al., 1999; Erwig et al., 2000). Interestingly,
rapidly progressive GN in humans is also characterised by infiltration with M(|> (Nolasco et al.,
1987; Cockwell et al., 1998; Cunningham et al., 1999). Indeed, in crescentic GN in humans and
animals, intraglomerular M<\> can contribute 50% of all cells. In other disease models such as active
Heymann nephritis, a model of human membranous GN, there are also abundant M(|) (Cattell et al.,
1991). It seems that many forms of inflammation in the glomerulus are characterised by
predominantly M(|) infiltration. Interestingly, Tipping irradiated rabbits with the telescoped form of
nephrotoxic nephritis and was able to reduce M(|) infiltration, TNF-a production and ameliorate
disease, implicating M<j> as being important in disease progression (Tipping et al., 1991). Similar
experiments in the active Heymann nephritis did not ameliorate disease. These bone marrow
depletion experiments are open to interpretation due to the crude techniques employed in
depletion, but they do point to M(j) as key players in glomerular disease.
Figure 1-10: Photomicrograph (xlOOO) of an acutely inflamed glomerulus showing ED-1 positive M(|)
(black) in immune complex glomerulonephritis at 4h after onset of disease (left hand panel). Telescoped rat
nephrotoxic nephritis at day 7 stained for the macrophage marker ED-1 (brown stain) counterstained with
haematoxylin. Intense mesangial infiltration of macrophages can be seen in both diseases (provided by J.
Hughes and G.L. Thomas).
1.7 DIFFERENT PATTERNS OF GLOMERULAR INFLAMMATION
From studies of the inflammatory response, two distinct patterns of inflammation emerge. Firstly
there is a rapid inflammatory response to a local insult such as skin wounding or mesangiolysis in
the kidney, or possibly to immune complex deposition in the mesangium (as characterised by post
infectious glomerulonephritis in humans. This inflammatory response is innate in that the immune
system was already poised to rapidly respond in this way and is characterised by initial neutrophil
influx (within minutes), which is followed some hours later by M<\> influx. It is undoubtedly true
that during localisation to the site of inflammation neutrophils are activated and undergo a
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respiratory burst (Johnson et al., 1987; Johnson et al., 1988; Rehan et al., 1984). Studies would
suggest that inhibition of this burst prevents local tissue injury (Rehan et al; 1984; Mosely et al.,
1999). In diseases such as post-infectious nephritis, the inflamed mesangium has similar numbers
of Mc|) and neutrophils. Studies by Cattell (Cattell et al., 1993), Rees (Rees, personal
communication), and Johnson (Johnson et al., 1995) on M(f> in the Thy 1.1 model of GN indicate
that the macrophages are activated, that they produce nitric oxide abundantly and that a proportion
are positive for staining for myeloperoxidase indicating that they undergo a respiratory burst.
Further, the heterologous (non-telescoped) nephrotoxic nephritis model, which usually resolves
spontaneously, again, has neutrophils and M(j) co-existing in the glomerulus. Detailed studies
(Waddington et al., 1996) indicate that M<)) and neutrophils in this setting are activated, since both
produce nitric oxide. Many diseases of the glomerulus feature immune complexes in the
glomerular basement membrane and/or mesangium. It is evident from the Con A and anti-GBM
models of nephritis where immune complexes bind to the glomerular basement membrane and fix
complement, that the inflammatory response is potently activated and typified by a neutrophil/
macrophage inflammatory influx with renal damage. This inflammation is dependent on FcyR and
complement receptor (CR1, CR3) signalling (Couser et al., 1995; Hughes et al., 1999; Wakayama
et al., 2000; Gomez-Guerrero et al., 2000; Launay et al., 2000).
A yeast cell wall extract, zymosan, is a potent activator of immune cells cultured in vitro and is
believed to act through ligation of mannose receptors. Macrophages secrete complement factors in
vitro and rapidly opsonize the particles enabling a CR3 dependent phagocytic pathway
subsequently (Bodmer & Dean 1983; Bodmer & Dean 1983a; Ezekowitz et al., 1984; Ezekowitz et
al., 1985). However, when zymosan is opsonised with either IgG or serum, it binds
immunoglobulins and complement forming immune complexes on the cell surface. Its activation of
M<|) upon phagocytosis has been shown to be dependent on Fey polymerisation, CR1 and CR3
ligation (Klebanoff et al., 1985; Porteu et al., 1986; Gresham et al., 1988; Klegeris & McGeer
1994). This opsonised particle can therefore be used as a model for immune complex activation.
In other models of nephritis there appears to be a switch in the inflammatory response, i.e. a
different pattern of inflammation. This is demonstrated no better than in the telescoped model of
nephrotoxic nephritis. After several days of injury mediated by the innate immune response, there
is a much greater influx of M(|), a notable absence of neutrophils and the presence of T-
lymphocytes with an activated phenotype suggesting cognate activation (Diaz Gallo et al., 1992;
Cunningham et al., 1999). Much evidence exists to suggest that these M(j) are activated under the
influence of lymphocytes, rather than local stimuli such as immune complexes hypoxia or other
chemokines. In these circumstances there is little evidence of respiratory burst in the M<}). Early
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studies (1980's) on rabbits and more recent work with mouse models of immune complex
nephrotoxic nephritis have shown unequivocally that T cell transfer experiments could recapitulate
the M(|)-rich glomerular disease purely by adoptive transfer (Chandra 1988). This work and the idea
of T-cell dependent M<() activation has more recently been supported by experiments using animals
knocked-out for different T cell sub-sets (Rosenkranz et al., 2000).
1.8 DEATH RECEPTORS AND SIGNALLING PATHWAYS IN GLOMERULAR
INFLAMMATION
Fas and its natural ligand were found to be important regulators of lymphocyte development since
naturally occurring mutations of these genes in mice (and humans) result in a syndrome
comprising striking similarities to Systemic Lupus Erythematosis (SLE). These animals and
humans have lymphadenopathy and a preponderance of CD4-ve, CD8-ve lymphocytes that are
believed to be deleted during development in normal animals. This observation lead to the
demonstration that ligation and activation of the Fas receptor was indeed important in lymphocyte
deletion. These animals have anti dsDNA antibodies, a hallmark of SLE and many develop
glomerulonephritis with characteristic immune complex deposition in the basement membrane.
More widespread interest in Fas as a molecule signalling cell death came when it was realised that
agonistic anti-Fas antibodies could induce rapid apoptosis in many cells in culture (particularly
tumour cells). Intra-peritoneal administration of moderate doses of this antibody resulted in
massive hepatocyte apoptosis and secondary necrosis, and ultimately death of the animal
(Ogasawara et al., 1993).
Spanish researchers showed weak induction of apoptosis of cultured human MC that had been
primed with IFN-y, upon application of large doses of agonistic antibody (Gonzalez-Cuadrado et
al., 1996). They supported this work with in vivo induction of massive mesangiolysis of glomeruli
after administration of agonistic anti-Fas antibodies (Gonzalez-Cuadrado et al., 1997). Whilst this
renal pathology was not reported in the earlier administrations of antibody (hepatic cell death
only), this study implicated Fas/FasL interactions in glomerular injury or glomerular remodelling;
it was possible that glomerular scarring in the Fas/FasL deficient mice was due to failed (or
excessive) deletion of mesangial cells. Importantly, it was noted that whilst the T-lymphocyte had
been described as the archetypal bearer of FasL, M(|) also expressed cell surface FasL. Indeed
evidence amassed for a potential role for M(()-FasL in induction of apoptosis of other cell types,
including neutrophils, lymphocytes and pancreatic islets of Langerhans (3 cells (Badley 1997;
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Brown & Savill 1999; Kiener et al., 1997; Signore et al., 1998). These observations could lead one
to speculate about the role of M(|)-FasL in regulating mesangial cells in vivo.
The role of FasL became more complicated following observations in vivo and in vitro. Firstly,
when FasL was injected into, or over-expressed in tissues in animals, rather that induce local cell
death, the area became infiltrated by neutrophils, suggesting that soluble FasL was acting as a
chemokine (Ottonello et al., 1999; O'Connell 2000). Molecular biological studies deduced that in
addition to the caspase-dependent apoptotic signalling pathway, other signalling pathways existed
(Cifone et al., 1995; Um et al., 1996; Yin et al., 1999). Furthermore, there appeared to be a
multitude of 'adaptor proteins' able to link into the death inducing signalling complex (DISC)
(Figure 1-11), and modulate it or regulate Fas directly. The biological implication from these
studies was that regulation of apoptosis by Fas was complicated. It did not follow that activation of
Fas necessarily resulted in death of the cell. Indeed, the in vivo data have confirmed that suspicion,
and there are studies indicating other cellular consequences upon Fas activation (trimerisation)
including proliferation (Alderson et al., 1994). The role of Fas in the kidney has become more
controversial since tubular cell biologists have demonstrated both Fas and FasL on tubular cells in
vitro and implicated these molecules in cell fratricide though little data exists to confirm this
hypothesis in vitro or in vivo (Schelling et al., 1998; Koide et al., 1999). However, the idea that
only inflammatory cells exhibit FasL has had to be re-addressed in the light of many cell types
including endothelia being shown to express membrane bound FasL.
Tumour necrosis factor receptor 1 (TNFR1), the archetypal death receptor, upon trimerization
activates pro-inflammatory genes by signalling through the (nuclear factor kappa B) NFkB
pathway. Paradoxically the same receptor can induce cell death upon signalling through the
caspase 8 pathway, This receptor, like Fas, also seemed to be regulated by many adapter proteins
(Baker & Reddy 1996; Chan & Lenardo 2000), including concomitant intracellular signalling
through TNFR2 trimerization (which lacks a death domain). For many cell types, studies of
activation of the NFkB signalling pathway upon TNFR1 trimerization protected the cell from
undergoing apoptosis (Figure 1-4). This observation was made apparent in studies where
translocation of NFkB species to the nucleus (where they act) was blocked using IkB (inhibitor of
kB proteins) over-expression or dominant negative transfection of cells. In these cells,
trimerization of TNFR1 lead to rapid apoptosis in cells that were otherwise resistant (Sugiyama et
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Figure 1-11: Diagram indicating different factors and pathways responsible for preventing apoptosis
following ligation of death receptors. Note, plasma membrane density, plasma membrane phosphatases such
as FAP-1, and the proportion of splice variants of FADD or TRADD regulate the ability of the death receptor
to recruit caspase 8. Cleavage of the latter is blocked by inhibitors such as FLIP family and IAP family
members. IAPs also inhibit cleavage of other caspases. Importantly regulation of the mitochondrial
amplification step by survival factors such as BCL-2 plays a key role. Finally pathways such as NFkB
pathway promote survival in the presence of pro-apoptotic signalling.
In addition to NFkB, TNFR1 activates another nuclear factor Interferon Regulatory Factor 1 (IRF-
1). This factor, originally described as one of the genes up-regulated by interferons, is also
modulated by TNFR1 ligation. Interferon gamma (IFN-y) and TNF-a synergistically activate this
protein in a variety of cell types, where it appears essential in the pro-inflammatory response (eg
iNOS induction requires IRF-1) (Martin et al., 1994; Kamijo et al., 1994). Importantly, IRF-1
induction is NFkB dependent (Ohmori et al., 1997; Pine 1997). Studies both in vivo and in vitro,
suggest this factor has a role in cell cycle arrest and possibly apoptosis in a similar fashion to p53
(Burke et al., 1999; Kano et al., 1999; Kirchoff et al., 1999). However, its precise relationship to
the caspase cascade is unclear. IRF-1 knockout mice show reduced CD8 T cell populations, yet
transgenic over-expression of IRF-1 in B lymphocytes leads to B cell deletion (Yamada et al.,
1991). Indeed, ex vivo studies of activated splenocytes and thymocytes implicated IRF-1 to be a
key player in induction of apoptosis of splenocytes after exposure to agents that induce DNA
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damage (y irradiation and chemotherapeutic agents) (Tamura et al., 1995). Thus IRF-1 which is in
part regulated by TNFR1 signalling through NFkB is responsible for controlling DNA repair (Prost
et al., 1998) and apoptosis in cells following noxious stimuli such as irradiation, in some cell types.
It appears that both in vitro and in vivo, the synergistic effect of IFN-y and TNF-a in bringing
about apoptosis is being recognised in tissue inflammation (Kirchhoff et al., 1993; Burke et al.,
1999; Kano et al., 1999; Ohta et al., 2000; Suk et al., 2001). One can speculate that IRF-1 might be
the common denominator in the intracellular signalling events required to bring about cell death.
An ever increasing family of death receptors is developing. Macrophages possess on their cell
surface ligands for many of these receptors. Recently work from two groups (Browning et al.,
1996; Zhai et al., 1998) on the role lymphotoxin (3 receptor and another death receptor HVEM
(herpes virus entry mediator; its sole function when it was originally discovered) in tumour cell
killing by apoptosis suggested a possible role for macrophages in such killing since they express
on their cell surface the ligands LIGHT (homology with lymphotoxin) (Zhai et al., 1998), and
lymphotoxin LTa^. These trimeric ligands can bind to trimeric death receptors, which then either
activate the NFkB pathway or alternatively induce apoptosis. LT-a^- is an exclusively membrane
bound ligand is trimeric and binds to the LT(3R. Further, they produce a membrane bound and
soluble ligand called LIGHT which activates the LT[3R. The receptor-ligand interactions are more
complicated since LIGHT can ligate and activate HVEM. The cartoon shown (Figure 1-12)
illustrates the death receptors that might potentially be important in macrophage mesangial cell
interactions.
Interestingly the work on tumour cells indicated that IFN-y was important in mediating the switch
in LT(3R and HVEM receptor function from pro-inflammatory to death inducing (Zhai et al., 1998;
Browning et al., 1996). Indeed there is evidence that IFN-y may play a general role in switching







Figure 1-12: Cartoon indicating possible receptor-ligand interactions between some death ligands found
on macrophages and lymphocytes and the target receptor on effector cells. Note that the ligands must be
trimeric for them to trimerise and activate successfully the receptor. Further, some ligands can be cleaved
from the membrane by metalloproteinases and successfully bind to the receptor on the target cell surface.
1.9 OXYGEN RADICALS IN CELL DEATH
Much work has focussed on bystander damage by oxygen radicals in the inflammatory response,
particularly in the context of neutrophil rich acute inflammation such as pneumonia, and vasculitis.
There is good evidence that re-perfusion injury to organs is largely mediated by reactive oxygen
intermediate (ROI) release. Indeed studies of the early events (neutrophil dependent) in different
forms of glomerulonephritis have clearly implicated ROI (including hydrogen peroxide) in the
early endothelial damage that is seen. Further work on the role of neutrophils as disease-mediators
in vasculitis have again implicated neutrophil-derived ROI in local small vessel damage (Harper et
al., 2001)
Relatively little attention has been paid to oxygen radicals as a potential disease mediator when
released from M(j). Albina's group suggested that wound M(|) in rats have only a vestigial
respiratory burst (Nessel et al., 1999). However, Cook and co-workers (Cook et al., 1989), and
24
Chapter 1 Introduction
Holdsworth's group (Boyce et al., 1986) indicated that M<|) in rabbit models of nephrotoxic
nephritis appeared to express key enzymes of the respiratory burst. Johnson, confirmed similar
findings in M<|> present in inflamed glomeruli of Thyl.l nephritis (Johnson et al., 1995). Cultured
human MC are susceptible to apoptosis in the face of exogenous hydrogen peroxide (Sugiyama et
al., 1996), though it is widely accepted that high levels of peroxide can induce necrosis in cells
rather than apoptosis.
There is another, more subtle, role of the oxidative burst. Whilst some cell-types release large
amounts of toxic radicals that induce peroxidation of lipids and proteins, in other cell-types,
ligation of death receptors leads to a swift low level oxidative burst. This phenomenon has received
relatively little attention compared with the caspase cascade. However, in some cells, inhibition of
this respiratory burst with reducing agents such as glutathione effectively blocks TNFR1 and Fas
mediated apoptosis (Um et al., 1996; Spanaus et al., 1998; Sidoti-de Fraisse et al., 1998). In the
latter study of TNFR1 -mediated apoptosis of HELA (uterine malignant epithelial) cells, inhibition
of the oxidative burst after TNFR1 ligation prevented about 50% of induction of apoptosis of the
cell population. Application of ZVAD (peptide), the pan-caspase inhibitor, blocked the other 50%.
It has been postulated that the oxidative burst merely reflects cytochrome C release from
mitochondrial stores. However, if this were simply a side effect of cyt. C release, inhibition by
reducing agents would not be expected to block the apoptotic process. Thus, oxidative burst has a
potential role in induction of bystander leucocyte-mediated apoptosis and as an intracellular
regulator of death receptor signalling.
1.10 NITRIC OXIDE IN CELL DEATH
Nitric oxide is generated by nitric oxide synthases. There are three forms: nNOS (NOS-1) is
constitutively present in neuronal tissue and its low level activity is dependent on intracellular
calcium fluxes. iNOS (NOS-2) is inducible in response to a variety of pro-inflammatory signals,
and was first described in macrophages. It is rapidly induced and when present usually results in
high concentrations of NO generation. It avidly binds calcium, therefore functions independently
of intracellular calcium fluxes (Figure 1-13). eNOS (NOS-3) is found in the endothelium
constitutively and its generation of low levels of NO is again calcium dependent. All three
enzymes share homology with cytochrome P450 family since one subunit contains binding sites
for NADPH, FAD and FMN, giving them a functional electron transport chain as seen in
mitochondria. The other subunit contains a haem-group and requires calcium binding for
stabilisation. Tetrahydrobiopterin is also required to stabilise the haem-moeity (Figure 1-13).
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NO production is a stress response and can lead to either tissue injury because of its radical
chemistry, or be cyto-protective, protecting cells from damage by destroying pathogenic micro¬
organisms first (e.g.neutrophils and macrophages). Nitric oxide and particularly its superoxide
derivative peroxynitrite have been reported to cause DNA damage in bacteria for example in the




Figure 1-13: Cartoon of iNOS showing the binding sites for the cofactors NADPH, FAD, FMN. The
electron transport chain is shown . The haem-group is denoted by Fe3+ and both BH4 and calcium are shown
binding to this part of the molecule. L-arginine plus molecular oxygen are required. The intermediate,
hydroxy-arginine is shown prior to generation of L-citrulline plus nitric oxide.
One can consider NO generation as part of the defence arsenal, since, in addition, it is required in
host defence to certain tumours such as gastric epithelia, breast tissue, brain, to suppress growth
(Edwards et al., 1996; Gal et al., 1997; Hajri et al., 1998,; Nishikawa et al., 1998). Such a defence
mechanism, however, has limitations since it is also linked to septic shock. Bacterial endotoxins
26
Chapter 1 Introduction
induce the iNOS, which in turn produces high levels of NO, damaging pathogenic DNA and
inhibiting respiration (inhibits metabolic energy production needed for cell division). The free
radicals, however, do not discriminate pathogenic DNA from host DNA and indiscriminate
induction of iNOS in the body therefore induces cell and tissue damage, sometimes leading to a
fatal development (septic shock) in the course of bacterial infections (Parratt 1997).
Nitric oxide is a free radical molecule and one of its major effects is the activation of cytoplasmic,
soluble guanyl cyclase (Callsen et al., 1998). This enzyme catalyses the conversion of GTP to
cyclic GMP. Cyclic GMP is a signalling molecule (similar to cAMP) by virtue of activating
protein kinases. Nitric oxide binds to the haem group of the cyclase. Other protein targets are
metallo- enzymes, where NO binds to Fe-S clusters. Aconitase is inactivated by NO, as is complex
IV, the cytochrome oxidase in the inner membrane of mitochondria. Thus NO has an inhibitory
effect on oxidative phosphorylation by blocking the electron transport chain and controlling the
levels of citrate in the Krebs cycle essentially blocking the oxidative degradation of acetyl-CoA
(Drapier 1997).
NO in lower concentrations is a short-lived chemical transmitter, which is freely diffusible across
membranes. The molecule possesses a small dipole moment because of the similar
electronegativity of oxygen and nitrogen, making it essentially hydrophobic. Its reactivity is due to
the unpaired electron in the outer valence orbital of its oxygen constituent. NO is almost un-
reactive compared to other oxygen radicals. Indeed, NO decays within seconds after its synthesis if
left unbound in solution because it reacts with either molecular oxygen or superoxide.
NO strongly interacts with molecular oxygen to form dinitrotrioxide (N203), or with superoxide 02"
to form peroxynitrite (ONOO-). NO also binds to sulfhydryl groups (SH) and unsaturated fatty
acids. The reaction with superoxide can be diminished by superoxide dismutase (SOD) which
removes 02 to form hydrogen peroxide (H2Oz). NO can be 'stored' by covalent interaction to
glutathione to form S-nitroso-glutathione. Both H202 and S-nitroso glutathione can have a
stimulatory effect on guanine cyclase. Superoxide dismutase thereby prevents the loss of nitric
oxide to peroxynitrite forming hydrogen peroxide instead and increasing the cyclase stimulatory
capacity of the cell.
NO can be regenerated from ONOO- by the enzyme nitrate reductase. The enzyme exists in two
isoforms, a mitochondrial type and an endoplasmic reticulum resident protein. Both receive their
electrons needed for nitrite reduction to NO from either NADH or NADPH, and interact with
flavoproteins (FAD prosthetic groups) and cytochromes (cyt. C oxidase in mitochondrial
membrane; cytochrome P450 in ER membrane).
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Nitrite reductase therefore not only prolongs the effective 'life time' of NO, but also reduces the
concentration of highly reactive, secondary metabolites. Peroxynitrite, hydrogen peroxide, and
dinitrotrioxide all have been linked to apoptotic cell death through protein nitration and DNA
damage. The latter is a consequence of DNA stand breakage and guanine nitration. Inhibitors of
nitric oxide synthase and antioxidants are known to have cell-protective properties because they
limit the formation of highly reactive nitrogen containing radicals (Sandau et al., 1997).
1.11 CELL CYCLE AND APOPTOSIS
Shankland has drawn attention to the role of cell cycle and cell cycle regulatory proteins in disease
regulation in the kidney (Shankland 2000). It was notable in the earlier studies of Thy 1.1 nephritis
(Baker et al., 1994) that the presence of apoptotic bodies in glomerular cross sections also
correlated with the presence of mitotic cells in the same glomerulus, i.e. the more proliferation, the
more apoptosis. This might suggest that cells that are proliferating are more susceptible to
apoptosis. This hypothesis appears to be borne out in several studies of cell cycle. Indeed, when
p53 is induced in cells it appears to induce cell cycle arrest at the G,/S border most frequently,
though there are reports of cell-cycle arrest at the G2/M checkpoint (Allday et al., 1995; Aloni-
Grinstein et al., 1995; Enoch et al., 1995; O'Connor et al., 1997; Deptala et al., 1999). It is thought
that these checkpoints allow time for DNA repair, to prevent the possibility of mutated daughter
cells. If repair is unsuccessful, apoptosis ensues. Thus, cellular decisions about cycle also influence
apoptosis. Whilst it is evident that cells do not need to be cycling for apoptosis to be induced
(Ogasawara et al., 1993) it is plausible that cycling cells are more susceptible to apoptosis than
cells that are not cycling. Indeed, this appears to be the case. (Duttaroy et al., 1997; Kato et al.,
1997). IRF-1 induction also appears to induce cell cycle arrest (Tanaka et al., 1996; Kano et al.,
1999; Lieberman & Hoffman 1998; Tada et al., 1998; Prost et al., 1998). Following arrest of cell
cycle, again apoptosis may ensue. However, there has been little attention to this nuclear factor as a
regulator of cell cycle and apoptosis. Understanding some of the molecular processes controlling
the cell cycle is providing links with factors controlling apoptosis. For example, at the G2M point
in the cycle, one of the anti-apoptotic, survival proteins Bcl-2 becomes phosphorylated. This
protein is involved in pore formation in the mitochondrial outer membrane. This step results in
deactivation. The cell no longer has the protective function of Bcl-2 during any cellular insults or
pro-apoptotic stimuli. The stress induced kinase pathway involving ASK1 and JNK1 was found to
be active and responsible for BCL-2 phospholylation in lymphocytes. Following successful mitosis
Bcl-2 is re-activated by de-phosphorylation (Yamamoto et al., 2000).
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1.12 DEACTIVATION OF MACROPHAGES
Macrophages can express many cytokines and toxic radicals that can inflict damage on
neighbouring tissue or cells. These cytokines and radicals can induce apoptosis of neighbouring
cells in models of tumour growth. However, not all M(j) have the killer phenotype. Indeed many
cells of the M(j) lineage do not exhibit pro-inflammatory cytokines, such as Kupffer cells and
oligodendrocytes. Moreover, it appears that even in an inflammatory tissue, macrophages may
have more than one phenotype. Macrophages can be characterised by TGFfl production,
hyaluronidase or class II MHC expression. It is likely that M<|) expressing high levels of these
cytokines or matrix proteoglycans might be involved in tissue repair. M<|) expressing high levels of
MHC molecules may be involved in antigen presentation. In immunohistochemical studies of
glomerulonephritis, it is apparent that only a proportion of the M<|> in the inflamed glomerulus
express in iNOS in human IgA nephritis (Furusu et al., 1998), in keeping with these hypotheses.
Why however, macrophages exposed to a similar inflammatory milieu, should have dissimilar
phenotypes is unclear since it is generally accepted that macrophages in inflammatory sites derived
from blood borne monocytes which differentiate following initial cytokine exposure (Riches 1995;
Fournier et al., 1995; Erwig et al., 1998). It is plausible that this reflects slightly different
chemokine and cytokine exposure. However, it might suggest that with time, macrophage
phenotype in the inflammatory milieu is changing. Kluth and colleagues (Kluth & Rees 1999),
have demonstrated that the disease progression of a rat model of telescoped nephrotoxic nephritis
can be modulated by infusing gene targeted macrophages into the inflamed kidneys. For example,
macrophages over-expressing TGF-p that enter the mesangium, result in less protein leakage from
the glomeruli, than normal monocyte derived macrophages entering the mesangium in vivo. Thus,
in this instance, M<|) over-expression of TGF-P is beneficial. There is good evidence that the
cytokine TGF-p in some diseases can result in excessive scarring of remodelling tissues, whereas
in others it is important to normal healing and tissue resolution (Kitamura et al., 1995; Sime et al.,
1997). It may be that the balance of activated killer M<j) and the healing, matrix-generating M(j) is
important in successful remodelling of inflamed tissues.
Reiter (Reiter et al., 1999) made the interesting observation that activated mouse bone marrow-
derived macrophages, following ingestion of apoptotic tumour cells were less able to kill other
tumour cells. Voll had previously (Voll et al., 1997) suggested that human M<(> produce less TNF-a
and more IL-10 following ingestion of apoptotic lymphocytes. It is possible therefore that activated
macrophages can alter their phenotype by phagocytosis of apoptotic cells. This work has been
more thoroughly investigated by Fadok and colleagues (Fadok et al., 1998; McDonald et al., 1999).
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They implicate TGF-(5 as one candidate autocrine signal to deactivate the M(j). It is released by M(j)
that ingest apoptotic cells and is able to down-regulate TNF-a release from those M()).
1.13 IN VITRO CELL CULTURES - A MODEL FOR IN VIVO CELLULAR
INTERACTIONS?
In order to tease out precise cellular interactions, their regulation and cell signalling pathways, it is
necessary to turn to cell cultures, since it has become clear that cells interact with many cell types
in vivo, and cytokines act at many different levels of the inflammatory process. For example,
regulation of local blood flow might obscure an important biological event if a cellular interaction
of interest also modulates vascular wall tone. To dissect out cellular mechanisms in vitro assays
offer a simple method to investigate specific interactions. Mesangial cells grow readily in culture
in a de-differentiated, myofibroblast phenotype as do many specialised mesenchymal cells such as
vascular smooth muscle cells from blood vessels, fibroblasts in skin and interstitia, and stellate
cells in the liver. Fortunately, in disease mesangial cells adopt this phenotype. The validity of using
primary mesangial cells in culture has been reviewed comprehensively by Floege (Floege et al.,
1994). For many years M(j) have been obtained for in vitro studies from bone marrow precursors,
inflamed peritoneum and blood monocytes. These cells have been well validated, and compared in
terms of cell surface receptor profile, cytokine production and in functional studies. Work of
Riches amongst others has indicated that M<() both in vitro and in vivo may be 'relatively
undetermined' and their local environment induces phenotypic changes that are may be irreversible
(Riches 1995; Erwig et ah, 1999). It appears that bone marrow M<|> are partially undetermined
whereas elicited peritoneal M<() are different and are more determined. Cytokine exposure can
induce in bone marrow cells a phenotype similar to elicited peritoneal cells. However, work from
Albina's group on wound M(|) indicates that they might have a distinct phenotype from elicited
peritoneal cells. Thus whilst in vitro M<f> cultures can be induced to mimic in vivo M(|) populations
it is clear that the in vivo environment is important to M(|) phenotype and function. It is clear that
M<]) populations exist at the inflamed site and that in vitro observations of M<() function require
supplementation with carefully planned in vivo or ex vivo studies.
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1.14 AIMS OF THIS STUDY
• To determine whether macrophages are able to regulate populations of mesangial cells in an in
vitro model of glomerular inflammation.
• To determine the phenotype of macrophages that are able to perform such functions.
• To delineate mechanisms employed by both macrophages and mesangial cells to bring about
the macrophage-mediated regulation of mesangial cells.
• To investigate factors involved in susceptibility of mesangial cells to macrophage killing.








2.1 PURIFICATION OF HUMAN LEUCOCYTES FROM WHOLE BLOOD
2.1.1 Separation of leucocytes from whole blood
Blood was drawn from a peripheral arm vein of a healthy donor, on no medication, using an 18 gauge
butterfly needle. 40ml of blood was mixed by gentle inversion with 4ml of sodium citrate (3.8%). Care
was taken not to aerate the blood, during collection and to avoid red cell lysis during letting lest
platelets or neutrophils should become activated. 160 ml of blood typically yielded 250 x 106
granulocytes which were usually more than 95% neutrophils (PMN) and 150 x 106 PBMC which were
often 75% lymphocytes, 25% monocytes.
Aliquots of 44ml of citrated blood were centrifuged at 350g for 20min (no brake) in 50ml tubes
(Falcon). Care was taken to avoid an aerosol of blood being generated at this stage. Plasma was gently
removed using a transfer pipette, to avoid disturbing the buffy coat. The plasma was used to generate
platelet rich plasma derived serum (PRPDS) or platelet poor plasma (PPP) (Chapter 2.1.3)
The remaining cells including buffy coat were resuspended, by inversion, in warmed (37°C) normal
saline with dextran MW500,000 (6% stock solution made up in normal saline) to give a final
concentration of 0.6% if the haematocrit was < 0.55 and 0.72% if the haematocrit was > 0.55). The
final volume was 50mls. Dextran induces aggregation of red cells thereby inducing rapid red cell
precipitation. The tubes were left without disturbing for 20-30min whilst the red cell aggregates settled.
The upper layer of saline was now depleted of red cells and was harvested into fresh 50ml tubes using
a transfer pipette. Care was taken not to disturb the sedimented red cells whilst collecting all the
supernatant. The supernatant was now leucocyte enriched and was ready for further purification to
yield pure cell types. It was pelletted at 350g for 6min (low brake).
2.1.2 Separation of granulocytes from mononuclear cells (PBMC) by Percoll discontinuous
gradient
The Percoll discontinuous gradient separates granulocytes from PBMC relying on buoyancy of the
different cell types, and further purifies by separation of remaining erythrocytes.
To generate a gradient, Percoll at 4°C and diluted with lOx PBS at 4°C to generate a 90% solution in
PBS (not DPBS). After thorough mixing, three solutions were prepared in PBS (expressed as
percentages of the 90% solution); 81% (recently modified to 79%), 70% (recently modified to 68%),
and 55%. Each solution was thoroughly mixed. To a 15ml polystyrene tube (Falcon) 2.5ml of the 81%
solution was added, followed by 2.5ml of the 70% solution which was carefully layered on top, by very
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slow, steady pipetting (either transfer pipette or plastic Pasteur pipette). The leucocytes from one 44ml
of citrated blood were resuspended in 2.5ml of the 55% Percoll solution. One gradient is sufficient for
separation of leucocytes from 2 tubes or 88ml of citrated blood. Very gently (one drop at a time
initially), 2.5mls of leucocytes in 55% Percoll were layered on the top of the gradient. When
completed, the gradient was centrifuged at 720g for 20min (no brake).
The gradient now contained three layers: at the apex of the tube, a pellet of red cells. In the interface
between the 81% and 70% Percoll were the granulocytes and between the 55% and 70% were the
PBMC. To collect these, the first 0.5-1.5ml of gradient was discarded. The PBMC layer was aspirated
into a clean 50ml tube. The gradient between the two layers was discarded and, using a fresh pipette,
the granulocyte layer was collected into a different 50ml tube. Cells were washed x2 in 50ml of PBS,
with intervening centrifugation at 220g for 6min (low brake).
2.1.3 Preparation of Platelet rich plasma-derived serum and platelet poor plasma
10ml of citrated plasma was incubated with 200pl of 13% CaCl2 solution in a glass vial, for 15min at
37°C to generate PRPDS. For PPP (platelet-poor plasma), platelets were pelleted in citrated plasma by
centrifugation at 350g for 20min. The supernatant was then decanted and stored.
2.2 GENERATION OF MESANGIAL CELLS
2.2.1 Preparation of human mesangial cells (HMC)
MC were prepared as outgrowths from purified glomeruli. After several passages in culture, (usually
three) other cell types such as epithelial, endothelial cells and macrophages were lost leaving pure
mesangial cells as assessed by immunofluorescence (Methods 2.12, Methods 2.2.7, Figure 1-7). Of
note, the human kidneys utilised were from 50+ year old patients. The glomerular outgrowths often
proliferated rapidly in culture but cells divisions became limited often by the tenth passage. It is
interesting to note that a group in Germany has a human MC clone from a foetal kidney that is
immortalised and has grown for more than 100 passages (personal communication Dr. B. Banas).
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2.2.2 Collection of human glomeruli
Human kidney cortex was collected from patients after nephrectomy for renal cell carcinoma
(epithelial). Every care was taken to take pieces of cortex from the unaffected area of the kidney. The
cortex was transported on ice in Hanks buffer (HBSS w/o).
In a tissue culture hood, the renal capsule was removed and the cortex chopped into small pieces using
a scalpel. Three Endocotts sieves were assembled in series, with 150pm sieve on top, followed by a
210pm, followed, at the bottom by a 106pm sieve. The sieve system was placed in a sterile bacterial
grade culture dish to collect effluent. Hanks solution (HBSS w/o) was passed through the system to
wet the meshes. The kidney cortex was then placed in the top sieve and gently pressed through using
the inverted end of a 50ml syringe plunger. Hanks solution was poured into the top sieve to wash
through the mashed tissue; the process being repeated until the entire cortex has passed through the
first sieve. Repeated flushing with Hanks solution was continued with aspiration of the petri dish until
the effluent ran clear.
The glomeruli now rested in the 106pm sieve, and were collected by gently washing the mesh at an
angle with Hanks solution, so that the glomeruli collected in the lip of the sieve. Aspiration around the
lip of the mesh with the same pipette, where the glomeruli had come to rest ensured complete
collection. The glomeruli were then washed by centrifugation at 150g for 2min. x 2.
2.2.3 Growth of human mesangial cells from glomeruli
The purified glomeruli were subjected to a gentle collagenase digest to remove the collagenous
capsule. Collagenase was prepared in O.lmg/ml (Sigma) in Hanks with Ca2+ and Mg2+ The glomeruli
were resuspended in lOmls of the collagenase and incubated for l-5min at 37°C. They were regularly
viewed by microscopy (xlOO) to look for loss of the glomerular capsule (seen as increased fluffiness of
the surface of the glomerulus). Medium containing 10% FCS was added to inactivate the collagenase
and the glomeruli were then centrifuged at 150g for 2min. After aspiration of medium, they were
resuspended in RPMI medium containing L-glutamine, penicillin, streptomycin (500U/ml) and 16%
FCS. The density was 1000 glomeruli/ml. This suspension was placed in T25 or T75 flasks and
incubated without disturbance for one week. Additional medium was gently added after 4 days if
necessary.
After one-two weeks the glomeruli became adherent to the plastic and cells were seen growing out.
Regular replacement with fresh medium ensured proliferation of these cells. Once the plastic was
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confluent with cells they were passaged. Medium was aspirated away and the cells washed with PBS.
lx trypsin-EDTA (TE) was added (here 1ml per T75), and incubated at 37°C for 5min. Vigorous
agitation was sometimes required to loosen these cells. Floating cells were collected into fresh medium
(minimum 10ml) and cells and re-plated after a 1:2 split. Cells were passaged in the same fashion for
two further passages.
At this stage the medium was changed to the less nutrient rich DMEM/F12 (containing glutamax) with
penicillin/streptomycin and now 10% FCS. This change was made whilst the cells are adherent and
growing well.
The proliferative burst of these cells was limited to approximately 10 passages. In addition they were
very sensitive to a variety of factors and stopped dividing if conditions were not optimal.
To maintain optimal conditions, the cells were fed with fresh medium every 3-4 days. At passage, cells
were split on a 1:2 basis. Often 1:3 splits were not deleterious but this was not uniformly so. Greater
splits inevitably resulted in failure of the cells to grow. In addition, if the cells were allowed to become
confluent they appeared to stop dividing (contact inhibition). Further passaging of cells would not
result in further proliferation. It was imperative therefore that human mesangial cells were closely
monitored and treated
2.2.4 Preparation of rat mesangial cells.
The advantage of using rat mesangial cells over human cells was that, after 3-5 passages, they grew
clonally in culture and were much more hardy than human mesangial cells. These clonal cells were not
limited by passaging more than 20 times but, for the purpose of these studies all experiments were been
performed on cells no greater than 16 passages. Indeed the rat cells were all derived from young
animals (8-12wks). The rat cells can grow for more than 100 passages (Personal communication Dr. M
Kitamura, Imperial College).
To demonstrate the validity of some of the findings with the clonal cells, polyclonal, early passage,
cells were also tested and appeared to corroborate observations using the clonal cells.
The principal clone used in this study was a gift from Dr. M. Kitamura, and its phenotypic
characteristics have been verified (Kitamura et al., 1995). This clone was derived from a Sprague-
Dawley rat, in a similar fashion to that described below (i.e. from the outgrowths of whole glomeruli).
36
Chapter 2 Methods
2.2.5 Purification of glomeruli
The method for the purification of glomeruli from rat kidneys was similar to that for human glomeruli.
Whole rat kidneys were isolated from an 8-12 week Wistar rat. The capsule was removed and the
whole kidneys chopped with a scalpel.
The kidneys were then pressed through a sieve system as described for human mesangial cells.
However, due to the glomerular size differences the sieves were 106pm, 150pm followed by 53pm.
Pure glomeruli were collected from the 53pm mesh after flushing with large volumes of Hanks
solution.
2.2.6 Growth of rat mesangial cells from whole glomeruli
Glomeruli from rats did not require collagenase digestion to allow cellular outgrowth. Washed,
purified glomeruli were resuspended in RPMI with L-glutamine, penicillin/streptomycin and 16% FCS
and cultured in T25 flasks (usually one flask per kidney) in 5mls of medium. Medium was carefully
replaced after 4 days, and after one week the glomeruli were adherent with obvious cellular
outgrowths. After 3-4 weeks, flasks were near-confluent and passaged as described for HMC. After 3
passages (50% splits), the medium was changed to DMEM/F12 with 10% FCS.
2.2.7 Characterisation of mesangial cells
Glomeruli contain mesangial epithelial and endothelial cells. In addition, they contain resident
macrophages and podocytes. There is potential for all of these cells to grow in the in vitro
environment, though the conditions used favour the hardier cell-type, the mesangial cell.
For the purposes of these studies, previous investigators have thoroughly characterised the HMC
outgrowths (Savill et al., 1992). By the third passage, the cells do not express cytokeratin (epithelial
cell marker), nor do they express VWF (endothelial cell marker) or leucocyte common antigen (CD45).
The cells however are positive for a-smooth muscle actin, and desmin. For my own satisfaction I
characterised one of the cell preparations looking for cytokeratin and a-SMA (Figure 1 -7)
Since the rat mesangial cells had not been previously grown in the department, rat cell outgrowths
were characterised using anti-a-SMA (Sigma), anti-CD90 (Thy 1.1) (Serotec), anti-cytokeratin
(Sigma), and anti-ED-1, a macrophage marker (Serotec).
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Cells were grown (P4) to 70% confluence. They were washed and fixed with ice-cold methanol for 5
min, before air-drying. Once dry, non-specific binding was blocked using PBS containing 10% new
born calf serum (NBCS) with 0.01% NaN3 (preservative). After 30min at room temperature specific
antibody or isotype matched negative control was added (diluted in PBS/10%NBCS blocking
solution). Overnight incubation at 4°C achieved most favourable results. After, washing x3 with PBS
(containing 0.05% Tween 20) and a further washing x3 with PBS alone, the appropriate FITC-
conjugated anti-immunoglobulin was applied. After lh at room temperature, the secondary antibody
was removed by washing x 3 with PBS and the well covered with a fluorescent (glycerol based)
mountant (Chapter 2.7.1). Characterisation of cells by immunofluorescence can be seen (Figure 2-1)
2.2.8 Passaging of cells
Once established in culture all primary proliferating cells (principally mesangial cells) were grown in a
combined medium: Dulbecco's modified Eagle medium with F12. (DMEM/12) This contains glutamax
(a stable replacement for L-glutamine: Life Technologies). To this medium was added Penicillin
(500U/ml), Streptomycin (500U/ml), and 10% FBS (Life Technologies). The added ingredients were
routinely filtered through a 0.45(im filter. Medium was stored at 4°C when not in use.
Cells were grown routinely in Costar flasks (T25, T75, or T162). They were maintained at 37°C with
5% carbon dioxide atmosphere (Binder). They were routinely screened for Mycoplasma infection by
Hoechst 33342 fluorescent microscopy.
The exact timing of passage of cells was specific to the cell type cultured. Typically, however cells
were split when they were 80-95% confluent. In a pre-cleaned tissue culture hood (Neutrocon followed
by 70% ethanol with water), medium was aspirated using an autoclaved glass pasteur pipette. The cell
monolayer was washed with 2-10mls of sterile, autoclaved PBS to remove calcium and serum. An
aliquot of sterile lx trypsin-EDTA (trypsin 50 units/ml and EDTA 5mM) solution (0.5ml for T25, 1ml
for T75, 2ml for T162) was placed into the flask using a transfer pipette. Cells were covered with the
TE and replaced in the 37°C incubator for 2-5min, until cells were evenly detached. Following a gentle
tap of the flask to loosen all cells, an appropriate volume of fresh medium containing 10% FCS was
added and the cells suspended by gentle pipetting with a transfer pipette. The resuspension volume was
> lOx the volume of TE applied to ensure full inactivation of trypsin. An aliquot of the suspension was
placed into a new flask containing fresh medium (typically mesangial cells were split 1:2 or 1:3 apart
from clonal immortalised rat mesangial cells which were split 1:10). The flask was immediately placed
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in the 37°C incubator in order that the cells could adhere. All waste medium was treated with bleach
for >24h prior to disposal. Used flasks and transfer pipettes were autoclaved.
B
C
Figure 2-1: Fluorescent photomicrograph (X 400) of rat mesangial cells P4 fixed in wells with ice-cold
methanol visualised by phase contrast microscopy (A), or labelled with (B) anti-a-smooth muscle antibody or
(C) anti-Thyl.l antibody, followed by secondary FITC-conjugated anti IgG. IgG2a and lgGx control antibody
gave no specific binding (not shown). Cells were prepared and labelled according to Chapter 2.12
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2.2.9 Preparation of steroid (oestrogen) depleted FCS
Mesangial cells transfected with the interferon regulatory factor 1 producing vector were grown in
medium containing oestrogen-depleted FCS, This was because the IRF-1 protein was fused to part of
the oestrogen receptor that is responsible for translocation to the nucleus. In the presence of oestrogens,
transfected cells would translocated the IRF1 to the nucleus where it is active. To control this cells
were grown in medium containing depleted FCS. This was achieved as follows (ref. Green & Leake
Steroid Hormones- a practical approach. Dextran coated charcoal was prepared by incubating for 16h
at 4°C, 0.25% Charcoal (Norit A-Sigma) with 0.0025% dextran T-70 (Pharmacia) in a buffer of 0.25M
sucrose, 1.5mM MgCl2, lOmM Hepes pH 7.4.
To an aliquot of FCS and equal volume of the dextran coated charcoal suspension was taken and the
charcoal pelleted by centrifugation (500g, lOmin). The supernatant was decanted and replaced by an
equal volume of FCS and agitated for 12h at 4°C. FCS was then separated by centrifugation, followed
by 50pm filtration.
2.3 GENERATION OF MACROPHAGES
2.3.1 Collection of bone marrow from rats.
A 200g Wistar rat (male) was killed by cervical dislocation. The animal's coat was cleaned with 0.5%
chlorhexidine. Using autoclaved surgical instruments, skin was removed from the lower abdomen
bilaterally without disturbing the peritoneal cavity. This involved lateral incisions between the skin and
first muscle layer. The lower limb muscle was then exposed by cutting the skin medially along the
length of each limb. By blunt dissection, skin covering the legs was removed. Next the lower limbs
were separated from the animal by cutting through the pelvic muscles and the pelvic bones. Sometimes
it was possible to dislocate the femoral head thereby preventing the need for cutting the pelvis. The
extracted limbs were immediately placed on ice in a container, immersed in 100% ethanol.
In a pre-cleaned tissue culture hood, on a sterile petri dish, the limbs of the rat were dissected with
autoclaved scissors and scalpel to remove all muscle, but leave both femur and tibia intact. The foot
was removed above the ankle bones. Each limb was washed with sterile PBS or Hanks solution. 2x
10ml of full DMEM/F12 was transferred to sterile universal containers. Using an 21 gauge needle
(green) and 10ml syringe, 10ml of medium was drawn into the syringe. The proximal end of the rat
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femur and distal end of the tibia were removed using the scalpel. The needle was inserted into the bone
marrow cavity and the bones were held in a clean universal container by use of sterile forceps. By
applying gentle pressure to the syringe, the marrow cells were flushed out into the container. Due to
large numbers of red cells in the marrow, a red cell lysis was typically performed (see Chapter 2.3.9)
Following this, cell number was assessed by microscopical counting using a haemocytometer. One
limb typically yielded 200 x 106 bone marrow cells.
2.3.2 Collection of bone marrow from mice.
A 25g male mouse (several strains used) was killed by cervical dislocation. The whole mouse was
placed in a sealed container, on ice, containing 100% ethanol and transported to a sterile pre-cleaned
tissue culture hood. The whole mouse was placed in a sterile petri dish and dissected in a similar way
to that described for the rat. However, only the femurs were removed. The tibias were cut close to the
knee joint and left in situ. Once extracted, the whole femurs were dissected using scissors and a scalpel
to remove muscle. The femurs were washed with sterile PBS/Hanks solution.
lOmls of full DMEM/F12 medium transferred to a universal container. 5ml of medium was drawn into
a syringe and connected to a 25 gauge needle (orange). Using the scalpel blade and holding the femur
close to the proximal end, the proximal 2mm of bone was removed. The bone was now held using
sterile forceps over a clean universal container and the needle inserted into the shaft of the bone from
its proximal end. By applying gentle pressure medium was passed into the marrow cavity to flush out
the marrow cells. All 5ml was flushed through the bone. The process was repeated for the other bone.
Cell number was assessed by microscopical counting using a haemocytometer. Few red cells
contaminate mouse bone marrow, therefore red cell lysis was not carried out. Typically one mouse
yields 40-60 x 106 cells by this method.
2.3.3 Differentiation of bone marrow (rat and mouse) to macrophages
Cells were cultured for 7 days in wells made from Teflon. This non-adherent environment was
necessary for the following reasons. The majority of experiments required precise ratios of two cell
types in co-culture. This was only possible by aliquoting the precise number of cells into wells
immediately prior to the experiment. Cells that have been cultured and differentiated in plastic
flasks/wells are notoriously difficult to remove. My personal experience is that no matter whether cells
41
Chapter 2 Methods
are removed using TE, ice cold 50mM EDTA there remains a population of adherent cells that are
therefore not reliably included in experiments. Furthermore, 50mM EDTA and cell scraping techniques
result in many necrotic cells when re-plated. I found Teflon matured cells to be similar to adherent-
matured cells in terms of histology, NO and TNFa generation in response to LPS stimulation ().
Anecdotally, 24h after plating into plastic wells, the Teflon matured cells are less efficient at
phagocytosing apoptotic cells than those which have been matured in plastic wells.
Teflon wells were generated as described in (Chapter 2.3.8). Bone marrow cells were cultured in full
DMEM/F12 with 10% L929 conditioned medium (Chapter 2.5.1) at a density of 5 x 106 per ml (10 x
106 per ml for rat cells). On day 2 and day 4, half the medium was removed and replaced with an equal
volume of fresh medium. On day 6, cytospins with Diff Quik staining were used to confirm the
presence of macrophages.
In some experiments it was necessary to differentiate bone marrow directly in culture plates (Falcon).
To generate an approximate covering of 70% of the plastic on day 7 or 8 of culture bone marrow was
plated at 4 x 105 cells per 1.5cm2 (one well of 24-well plate), in 800|il of full DMEM/F12 with 10% L-
929 conditioned medium. An equal volume of additional medium containing L-929 conditioned
medium was added at 48h, and after washing further medium was added (1ml per 5 x 105bone marrow
cells) on day 4.
This method gave variable cell-density at day 7 and seemed to depend on a variety of factors including
the precise batch of L-929 conditioned medium, and animal to animal variation.
2.3.4 Isolation of rat glomerular macrophages
Sprague-Dawley rats (200g) were humanely killed by C02 anaesthesia followed by cervical dislocation
(Schedule 1). 16h prior to sacrifice they were placed in metabolic cages for collection of urine.
Immediately upon sacrifice, cardiac puncture was made for collection of serum. An abdominal midline
incision was made using forceps and scissors through chlorhexidine (0.5%) cleaned skin. Kidneys were
sequentially removed by cutting the vessels and the capsule removed. Small biopsies of cortex were
taken for histological purposes, into neutral buffered formaldehyde (4%) or methyl Camoy's fixative
(Appendix 1) on dry ice. The remaining renal tissue was transported in Paris buffer on ice for sieving.
Paris buffer (Appendix 1) had been prepared on the previous evening and chilled to 4°C.
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Whole kidneys were chopped using a scalpel and placed in the clean sterile upper most sieve that had
been moistened with buffer. The three sieves were arranged with the 250pm uppermost, the 150pm in
the middle and the 63pm at the bottom. The kidney pieces were gently pressed through the top sieve
using the plunger of a 10ml sterile syringe, and flushed repeatedly with buffer at 4°C
The 250pm sieve was removed and any tissue in the middle sieve was pressed though, again with
regular flushing with buffer. Finally, the glomeruli remained in the surface of the bottom sieve and
were collected into cold buffer by washing them with buffer into the lip of the sieve and collecting with
a sterile pipette.
Glomeruli were centrifuged at 4°C (250rpm for 2min. no brake) to remove any debris and then
resuspended in 10ml of full Hanks solution (HBSS with Ca++ and Mg++). Glomeruli were centrifuged
again, then resuspended in 5ml of enzyme mixture at 37°C (this contains collagenase (type I)
l.Omg/ml, trypsin (type III) 0.5mg/ml, and DNase at 1500U/ml dissolved in full Hanks solution). The
glomeruli were placed on a rocker at 37°C for 20 min. The cell suspension was then centrifuged
(500rpm for 5min. 4°C no brake), and the cells washed x2 with Hanks w/o by centrifugation, aspiration
of supernatant and resuspension. After the final aspiration, the cells were resuspended in sterile EDTA
solution (2mM in Hanks w/o) at 4°C and placed on the rocker for 20min. at 4°C.
Pelletted cells (500rpm lOmin. 4°C no brake) were resuspended in a further 5ml of collagenase
solution (l.Omg/ml) and rocked at 37°C for 20 min. Now, on ice, cells were aspirated into a 10ml
syringe through a 20 gauge (yellow) needle and ejected from the syringe through a 24 gauge (blue)
needle. This process was repeated x3. Cells were now centrifuged (1500rpm, 5min. 4°C) and
resuspended in full DMEM/F12 at 4°C.
The percentage of M<j) in the single cell preparation had previously been determined by flow cytometry
(EDI immunofluorescence) for normal glomeruli and diseased glomeruli (day 2, 4, and 7 of the
disease). It was possible therefore to place a known number of M<|> into wells by knowing the total cell
concentration as assessed by haemocytometry.
2.3.5 Isolation of monocytes from peripheral blood mononuclear cells (PBMC) by lymphocyte
depletion
Purification of PBMC by Percoll gradient was carried out as described (Chapter 2.1.2). The monocytic
layer of the gradient was washed twice in PBS to remove the percoll and contaminating platelets. Cells
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were counted by microscopically using a haemocytometer and populations of cells analysed,
principally looking for the exclusion of granulocytes (this assessment was made by flow cytometry
(FSC/SSC) (Figure 2-3) or by cytospin with Diff-quik staining). Pure monocytes were derived using
the MACS magnetic bead monocyte cell isolation system from (Miltenyi Biotec).
Figure 2-2: Flow cytometry-derived forward (FS) and log10 side scatter (LSS) histogram of leucocytes
purified from a Percoll discontinuous gradient before (A) and after (B) lymphocyte depletion. A-lymphocytes, B-
monocytes, C-granulocytes and D-platelets. Note absence selectively of the lymphocyte population after
depletion.
Cells were resuspended by agitation in a PBS buffer containing 0.5% BSA (filter sterilised) at a
concentration of 107 cells per 60(il of buffer. To this, human IgG was added. The cell suspension was
incubated at 6°C for 5 min. A hapten-conjugated antibody cocktail containing anti- CD3, CD7, CD 19,
CD45RA, CD56 and anti- IgE antibodies was applied to the sample and incubated at 6°C for 15 min.
Unbound antibody was removed by washing x2 in buffer (20x original resuspension volume) and re-
pelletting cells at 220g for 5 min.
Cells were then resuspended in buffer (as above). Further non-specific blocking was achieved using
human IgG. To the suspension, hapten-conjugated magnetic micro beads were added and incubated at
6°C for 30 min. The whole suspension was then passed through a column of magnetic iron. The details
of the composition are withheld by the manufacturers. Lymphocytes and eosinophils remained within
the column. The eluted solution contained purified monocytes, which were confirmed by flow
cytometry (Figure 2-2) or cytospin.
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2.3.6 Isolation of monocytes from peripheral blood mononuclear cells (PBMC) by elutriation
Leucocytes were prepared as described (Chapter 2.1.1) from either 176ml or 264ml of citrated blood.











Figure 2-3: Diagram indicating the apparatus required for elutriation of leucocytes. The rotor arm seen in
cross-section is placed within a Beckman centrifuge. Enriched leucocytes are introduced into the sample chamber
through the injection valve. By operating the bypass valve they are transported to the elutriation chamber within
the rotor arm which is at 2500 rpm. At steady state with buffer flow through the system the leucocytes order
themselves according to buoyancy. By increasing the flow rate different leucocyte populations leave the chamber
separately and are collected in the effluent.
The rotor arm was assembled by initially dismantling and cleaning with ethanol and cotton buds if
necessary, followed by re-assembly according to the manufacturer's instructions. O-rings were
lubricated with silicone grease and the retaining bolts loosened by half a turn before inserting rotor into
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to centrifuge. The rotor arm was then connected to the pump (see Figure 2-3) and pressure monitoring
system. The whole circuit through which cells will pass was sterilised by passing 500mls 70% ethanol
through the pump followed by 2 litres of sterile water. It was imperative that all air bubbles were
removed from the system. Therefore all air locks were flushed and the rotor was accelerated (to
2500rpm) and decelerated several times to dislodge bubbles in the tubing and elutriation chamber,
while sterile water was flushed through the system. Hanks (HBSS w/o) was then passed through the
system and the pump was calibrated in order that the flow rate (dial) on the pump could be correlated
exactly with ml/min of HBSS flowing through the chamber. This calibration was carried out with the
centrifuge operating at 2500rpm. It required collection of fluid exiting the elutriator into a measuring
cylinder. The pump was calibrated for flow rates of 16, 18, 20, 22, 24, 26 ml/min.
Once calibrated, with the elutriator was left in 'steady-state' at 2500rpm, with HBSS w/o flowing at the
lowest setting (usually about 1.3 on pump or <10ml/min). Once the leucocytes were prepared, they
were resuspended in 5ml of PPP (platelet poor plasma Chapter 2.1.3). PPP was added to the HBSS
(final concentration 0.1%). The leucocytes were placed in the introduction chamber slowly so that
speed of introduction did not exceed 15ml/min. This was carried out whilst the flow of HBSS was set
to bypass the introduction chamber. Cells were then flushed through into elutriator rotor arm by
switching the flow of HBSS through the introduction chamber). At the lowest flow rate (about
lOml/min.) the cells were seen to collect in the elutriation chamber within the spinning rotor arm. Once
all the leucocytes were in the elutriation chamber, the flow rate was increased to 18ml/min. The
effluent was collected until no more cells left the elutriation chamber. Cells in the effluent were
analysed immediately (by cytospin) and would be expected to consist of red cells and lymphocytes.
The flow rate was increased to 22ml/min. Further cells now left the elutriation chamber and were
collected. Cytospin confirmed these cells to be pure monocytes (Figure 1.1). The remaining cells were
collected by increasing the flow rate to 24 and 26 ml/min. and contained pure granulocytes. The
monocyte fraction was pelletted (350g for 6min low brake) and resuspended in Iscove's modified
DMEM with 10% autologous serum (PRPDS).
2.3.7 Differentiation of human macrophages from peripheral blood monocytes
Monocytes were collected from peripheral blood of healthy donors as above. Monocytes were cultured
in Iscove's modified DME medium (containing penicillin and streptomycin 500U/ml of each) with
10% autologous serum (PRPDS). Medium was replenished every two days during the first four days by
removing half the medium and replacing it with fresh medium including PRPDS. Cells were cultured
46
Chapter 2 Methods
either in Teflon wells (Chapter 2.3.8) or in tissue culture plastic wells (Falcon). In the former case, the
monocytes and macrophages remained non-adherent. They differentiated into M(|) and were considered
mature after 7 days in culture. Culturing in Teflon resulted in complete absence of giant cells which
variably comprised up to 50% of M(|) after 7d culture in plastic wells. Furthermore, cell number was
much easier to control in experiments carried out after M<|) had been cultured in Teflon.
2.3.8 Preparation of Teflon wells
Teflon membrane was cut to 12 x 12cm2 pieces and autoclaved. In a tissue culture hood, wearing
gloves, the square was placed over the top of a sterile 50ml tube (Falcon). Using the inverted end of a
clean 15ml tube (Falcon) the membrane was gently pressed into the 50ml tube to create a recess which
could hold 15ml medium. This was ensured by holding the membrane close to the neck of the 50ml
tube as the membrane was pressed in with the smaller tube. When completed, the neck was secured
with an elastic band. 70% ethanol was placed in the well for 5min. After discarding, the well was
shaken vigorously to remove as much ethanol as possible. Wells were air dried for 15min minimum
before cell suspension was added. If the folds of Teflon (near the neck) remained wet, cell suspension
could be subsequently lost out of the well by capillarity. Tubes containing wells were covered with the
original 50ml screw-on lid and placed in a clean rack in the incubator.
2.3.9 Red cell lysis
Preparation of rat bone marrow (and occasionally other cell types) resulted in significant red cell
contamination. To remove red cells, hypotonic lysis was performed. Two sterile solutions were
prepared; 1.6% PBS and 0.2% PBS (Normal PBS is 0.9%). Pelletted cells were resuspended in a
volume of 0.2% PBS for 15s followed by addition of an equal volume of 1.6% PBS. The resultant




2.4 PREPARATION OF APOPTOTIC CELLS FOR INGESTION BY M<t>
2.4.1 Induction of apoptosis of rat mesangial cells
Rat MC were induced into apoptosis by ultraviolet irradiation. Sub-confluent monolayers in T75 flasks
(Costar) were exposed to UV irradiation (312nm, 8W, 3min) followed by incubation for 16h. Non
adherent (apoptotic) cells were removed by agitation and collected in the supernatant. After
centrifugation, apoptotic cells were further purified by washing with PBS xl and centrifugation (190g,
5min). Apoptosis was confirmed by histology, selective uptake of Hoechst 33342 (lpg/ml), but
exclusion of propidium iodide (l(ig/ml). Typically, fewer than 10% of cells were PI positive and fewer
that 5% did not exclude trypan blue (0.2%).
2.4.2 Percoll density gradient purification of human neutrophils
Neutrophils were collected from the lower layer of the Percoll discontinuous gradient as described in
Methods 2.1.2. The cells were washed x 2 in sterile PBS to remove platelets and Percoll. Each wash
comprised placing cells in 50 ml PBS in a Falcon tube followed by centrifugation (220g, 5min). Cell
pellets were gently agitated to loosen before re-suspending in medium.
2.4.3 Preparation of murine peritoneal neutrophils
Murine peritoneal neutrophils were prepared by injection of 1ml of 3% autoclaved-sterile Brewers
thioglycollate in PBS into C57/bl6 mice. After 16, the mice were killed by cervical dislocation and the
peritoneal cavity flushed briskly by injection of 10ml of sterile saline. The fluid was then withdrawn
after then creation of a sterile pocket between the anterior abdominal wall skin and the facial planes
overlying the peritoneum. The peritoneum was then breached using a sharp scalpel and the peritoneal
fluid withdrawn using a syringe as it collected in the pocked described. This fluid was then centrifuged
and the cells resuspended in DMEM/F12 with 10% FCS. The cells were typically more than 80%
neutrophils by microscopy of cytospins. Cells were cultured in wells of 6-well plates.
2.4.4 Induction of apoptosis of neutrophils
Human peripheral blood neutrophils (PMN) were isolated from the buffy coat of freshly drawn blood
as described (Chapter 2.4.2). The purity (>95%) and quiescence of cells were verified by flow
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cytometry. Apoptosis was brought about by ageing in upright T25 or T75 flasks (Costar) for 6h if the
neutrophils were resuspended in PBS with calcium and magnesium ions, at a density of 4xl06/ml. In
some experiments PMN were aged in DMEM/F12 containing 10%FCS. In these experiments, ageing
in the incubator was carried out for 16h. Alternatively apoptosis was induced by UV irradiation
(312nm, 8W 10 min) in DMEM/F12 and 10% FCS (heat inactivated). Cells were utilised after 2.5h.
Apoptosis, both constitutive and induced was typically seen in 40-60% of cells, as assessed by
histology (Figure 2-4). Necrosis was excluded by 0.2% trypan blue staining (typically <1%).
Aged granulocytes: CD 16 high
1 cell removed
:ZSk-.
Figure 2-4: Apoptotic neutrophils (arrows) on cytospin before (A) and after (B) Dyna bead anti CD 16
purification. Note contaminating eosinophil. (C) Evidence of separation of CD 16 positive and negative
neutrophils by flow cytometry following Dyna bead purification.
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2.4.5 CD16 enrichment of apoptotic neutrophils
Neutophils were assessed for apoptosis, after approximately 16h incubation in medium with 10% FCS
or after 6-8h incubation in PBS with Ca++ and Mg++. Assessment was made by preparation of cyto-
spins slides followed by Diff-Quik staining. Characteristic morphology was used as the criterion, and
although not routinely performed, this definition has been verified against Annexin-V binding to
phosphatidyl serine on the surface of apoptotic neutrophils as seen by flow cytometry (Brown & Savill
1999) (see Figure 1-3).
24h prior to culture anti-mouse IgG antibody coated magnetic beads were prepared by incubating the
beads with the anti-CD 16, 3G8 antibody. These beads (Dyna M450) are maintained at 4°C in a sterile
suspension at 4 x 108/ml. 500|il of beads suspension were incubated with lOmls of 3G8 supernatant for
24h at 4°C. Prior to collection of apoptotic neutrophils, the beads were separated from the culture
supernatant using a powerful magnet to keep them in the 10ml polystyrene tube, allowing the spent
supernatant to be aspirated away. Beads were washed x 1 in 10ml PBS, then resuspended in 1ml of
PBS. Half of the beads, 100 x 106 are sufficient to bind 100 x 106 live neutrophils. Therefore, in
cultures where apoptosis was approaching 50%, half of the beads were incubated with the neutrophils
in 10ml PBS for 30min at 4°C.
After this time, beads were separated from the supernatant using a magnet at 4°C. The supernatant
contained enriched apoptotic cells. The supernatant was transferred to the remaining beads and rolled
again for 40min at 4°C. After separation of the beads the supernatant contained highly enriched
apoptotic cells which was confirmed by microscopy. The apoptotic neutrophil population of cells
before and after CD 16 purification can be seen (Figure 2-4) The cells were assessed for necrosis by
trypan blue staining (see Chapter 2.7.6). Fewer than 5% of cells were trypan blue positive. Most
frequently, this was less than 1%.
2.4.6 Preparation of murine thymocytes
Freshly killed 6 week old (20g) C57/B16 mice were killed by cervical dislocation. After cleaning with
ethanol, the anterior rib cage was surgically lifted to reveal the prominent white lobes of the thymus.
This was carefully dissected and washed in fresh medium. The thymus was then pressed through a
wetted 50|im sieve the plunger from a 5ml syringe. The single cell preparation was washed though the
sieve using 10ml of fresh medium and collected. This suspension was centrifuged (250g, 5min) and the
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cells resuspended at 2x 106 cells/ml in RPMI supplemented with glutamine and 2-mercaptoethanol in
addition to 10% FCS and antibiotics. The cells were transferred to wells of a six well plate (2mls per
well).
2.4.7 Induction of apoptosis of thymocytes
Cells were either exposed to a 5min burst of UV irradiation (312nm, 8W) followed by 2.5h culture, or
dexamethasone (1|J.M) followed by culture for 6h. Typically >50% of induced cells were apoptotic
(Annexin V binding (Boeringher Mannheim)) and permeable to Hoescht 33342 (lpg/ml)) whilst <5%
of those were positive for the uptake of propidium iodide (Figure 2-5).
Q.
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Figure 2-5: Induction of apoptosis of murine thymocytes by 1 jiM dexamethasone or UV irradiation. (A)
Flow cytometric histogram plot of FSC against SSC indicating a distinct homogeneous population of cells (Rl)
(B) Rl-gated cells indicating blue fluorescence (Y axis) and red fluorescence (X axis) prior to administration of
Hoechst 33342 and PI. (C) Thymocytes cultured overnight exposed to Hoechst and PI. Note a small (16%)
population of Hoechst positive, PI negative cells. (D) After overnight culture with lpM dexamethasone 85% of
cells were Hoechst positive, PI negative.
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2.5 HYBRIDOMA/ CELL SUPERNATANT HARVESTING
2.5.1 Production of supernatant containing murine M-CSF (CSF-1)
Murine fibrosarcoma cell, L-929 spontaneously secrete into culture supernatant macrophage colony
stimulating factor (M-CSF or CSF-1). These malignant cells grow well in DMEM/F12 medium
supplemented with 10%FCS. Cells were grown in T162 flasks in 50ml medium. After 7 days they were
split 1:20 and replated. The supernatant was harvested, centrifuged to remove cellular debris (250g,
5min), in 50ml Falcon tubes. Medium was then filtered (0.5|im) prior to storage at -80°C.
2.5.2 Production of supernatant containing mouse anti-human CD16 antibody
The hybridoma 3G8 releases murine anti CD 16 IgG into supernatants. Cells were grown in DMEM
with pyruvate, L-glutamine, and 10% FCS supplementation. Cells were grown in T162 flasks for 7
days in 50ml medium. After this duration, cells were separated from the medium by centrifugation
(250g, 5min) and split 1:10. Supernatant was then passed through a 10|im filter prior to storage at
-80°C. Activity was confirmed by ELISA after 6months, which was not decreased after lyr.
2.6 CO-CULTURE
2.6.1 Rodent co-culture with bone marrow-derived macrophages
Bone marrow-derived macrophages (BMDM<))) from rats or mice were cultured for seven days in
Teflon wells as described (Chapter 2.3.8) and purity assessed by cytospin. From the single cell
suspension, M(j) were counted using a haemocytometer and then placed in wells of Falcon 96-well
plates such that 50-70% of the well base was covered with cells. This was achieved by first placing
200ml of fresh full medium into the well, then adding a 10(il aliquot of single cell suspension
containing approximately 20,000 cells. Within 2h the cells became fully adherent.
MC could now be added to the M<|). It became apparent that the ratio of one cell to the other was very
important to the outcome. The proliferating cells, the mesangial cells, had a tendency to overgrow
during preliminary experiments. This overgrowth blunted the impact of M(j) on mesangial cells (see
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Chapter 3). By trial, it became apparent that the best ratio to achieve a near confluent monolayer was a
ratio of 1.5-2.0 M(|) per MC. This resulted on average macrophages and mesangial cells in close
apposition with adequate mixing of the cell types. Furthermore, the experiments were made easier by
adding macrophages prior to mesangial cells rather than the other way round due since it was easier to
determine the precise number of MC at the start of the experiment. However, plating mesangial cells
prior to macrophages or plating the cells simultaneously had no effect on the results.
Once ready in T75 or T25 flasks (Costar) mesangial cells were trypsinised as described for routine
passaging. The non-adherent cells were resuspended in full medium and counted by haemocytometry.
13,000 cells were added to the wells of the 96-well plates containing macrophages. After 2-4h, once
cells had become fully spread out and adherent, wells were washed with full medium to remove any
non-adherent cells/debris prior to experimentation. Since growth factors are abundant in glomerular
inflammation, platelet degranulation is an associated feature, and since cultured MC proliferate readily
(another feature of glomerular inflammation) in the presence of serum growth factors, it was decided
that experiments should be performed in the presence of 10% FCS. Some experiments were however
performed in the presence of 1% FCS. As the concentrations of extra-vascular plasma proteins and
platelet-derived growth factors will vary at different stages of inflammation it was decided to contrast
the experiments in 10% FCS with those in 1% FCS.
2.6.2 Distinguishing rat mesangial cells from macrophages.
In order to distinguish macrophages from mesangial cells by microscopy, it was decided to use a
fluorescent inert dye. Initial experiments showed that either cell type would take up the label without
any apparent deleterious effects. The dye CellTracker green, (synonymous CMFDA) (Molecular
Probes) is lipid soluble and interacts with cellular proteins. It also binds avidly to serum proteins. In
preliminary experiments it appeared to have no effect on growth of MC nor was it transferred to
unlabelled cells. Also in co-culture experiments there was no difference in outcome when the
macrophages were labelled with the dye instead of the mesangial cells. To aid morphological
distinction of apoptotic mesangial cells (red condensed nuclear material contrasts well against green
cytoplasm), it was decided to label the mesangial cells with this green fluorescent dye.
To label cells, a 70-80% confluent flask of cells was aspirated to remove medium, washed xl with 5ml
of sterile medium containing no serum. This was aspirated and replaced with 5ml of serum-free
medium containing 5|fl of CMFDA at lmg/ml (in DMSO). Cells were incubated for lh, at which time
the medium was aspirated away and replaced with medium containing 10% FCS (full medium) to mop
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up any unbound CMFDA. If cells were to be added to co-culture immediately then cells were
trypsinised and resuspended in full medium which mopped-up free dye. Contamination of unlabelled
cells with dye was never a problem. The co-culture as seen by fluorescence microscopy is illustrated in
Figure 3-1.
2.6.3 Rat co-culture with glomerular macrophages
Glomerular single cell supernatant containing 1 x 105 glomerular M()) was placed in wells of 24-well
plates (Costar), in full DMEM/F12. After incubation for 2h, wells were washed by piping, aspiration
and replacing medium (1ml of fresh full medium per well). Non adherent cells were removed. In
separate experiments (immunohistochemistry) this procedure resulted in the cells remaining containing
>90% M(|>. Rat MC (6 x 104), pre-labelled with CMFDA, were added to wells. In addition, adjacent
wells without M<j) were seeded with MC as a control. Wells were returned to the incubator and were
not washed again. In some experiments L-NMMA or D-NMMA (100p.M) was added. No other
cytokines were added at any stage however. Experiments were stopped at 8h, 16h, and 24h (Chapter
2.6.8.).
2.6.4 Human co-culture
Monocyte-derived macrophages (MDM) were differentiated from peripheral blood monocytes, in
Teflon wells, for seven days as described (Chapter 2.3.7). Their maturation and purity was confirmed
by cytospin with Diff-Quik staining (Figure 1-1). They were plated into wells of 96-well plates to
cover 50-60% of the area. This equated to 2 x 104 cells per well. The M(J) were plated in Iscove's
modified DMEM containing 10% autologous human serum (this is the same medium used for
differentiation of cells). Cells were usually left overnight in wells, and the following morning medium
was aspirated and replaced with 200|ll of full DMEM/F12 per well.
Human MC are larger than rat cells but tend to proliferate less rapidly. By trial, it was found that 0.8 x
104 to 1.0 x 104 achieved 80-90% coverage of the well surface once the mesangial cells had spread out
and close apposition of the two cell types was achieved. The exact number depended on the kidney
whence the mesangial cells were derived as some cells appeared a little larger than others. The ratio
was 2.0-2.5 M(J) for each human MC.
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After 4h (not less) wells were washed by agitation of the medium using a plastic Pasteur pipette,
followed by aspiration and replacement with 200pl of full DMEM/F12 per well.
2.6.5 Distinguishing human mesangial cells from macrophages
Human MC were pre-labelled with the CMFDA in an identical fashion to the rat mesangial cells
(Chapter 2.6.2). If cells were cultured in T25 flasks as opposed to T75 flasks, the concentration of
CMFDA in serum-free medium remained the same but the volume was reduced from 5ml to 2ml. In
addition, 0.5ml of lx trypsin-EDTA was used to detach the cells.
2.6.6 Activation of the co-culture with cytokines
Provisional experiments of rat co-culture in the presence of IFN-y showed little effect on mesangial
cells. Given that activating cytokines such as TNF-a and CD40 ligand are known to be present during
inflammation and are able to activate M(j) in the presence of IFN-y, it was decided to prime the M(j) for
16h prior to co-culture with IFN-y (rat recombinant) at lOOU/ml (Lake et al., 1994). Once the co-
culture was established it was activated with IFN-y (lOOU/ml) plus TNF-a (lOOU/ml). Alternatively,
CD40L was used in place of TNF-a. IFN-y priming followed by lipopolysaccharide (LPS) activation
has also been widely used to activate M<|) (Lake et al., 1994), and tends to mimic the IFN-y/TNF-a
activating regime (Lake et al., 1994; Erwig et al., 1998) (Figure 2-7). Given that during inflammation
resident cells are just as likely as inflammatory leucocytes to encounter cytokines, it was decided to
add cytokines to the whole co-culture instead of activating the M(|> prior to co-culture. This ensured that
both cell types would be exposed to the stimuli. For initial experiments M<j) were primed for 16h with
IFN-y in order to differentiate the M(|>. However, it was found that whether M<|) were primed for 16h or
not had no bearing on the ability of M<}> to induce apoptotic death of MC or suppress mitosis.
Therefore, the M<))-priming procedure was not used for the majority of experiments.
2.6.7 Activation of the co-culture with opsonised particles
A feature of glomerular inflammation is the deposition of immune complexes containing antigen,
immunoglobulin G, sometimes immunoglobulin M, often complement factor 3bi and sometimes Clq.
There has been much debate in the literature about the role of such complexes in initiating or
propagating pro-inflammatory responses in glomerular disease (see Chapter 1.9). In provisional
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experiments, I attempted to mimic immune complexes by mixing rat IgG with rat- sheep anti-rat IgG,
or human IgG with goat anti-human IgG to prepare insoluble complexes. Unfortunately these
complexes did not precipitate well and failed to activate macrophages. In addition I opsonised red
blood cells with anti-human erythrocyte antibodies. Such opsonised erythrocytes were poorly ingested
by macrophages but again failed to induce NOS 2 or cause macrophage mediated cell death in co-
culture. Finally, it was decided to opsonise zymosan (yeast wall) particles (Sigma) passively with
pooled, non-heat inactivated serum. These opsonised particles are known to bind M(j) via Fcyl, Fcylll
receptors, complement receptor 3 (CR3) and activate macrophages through these receptor-mediated
signalling pathways.
Pooled sera from greater than 10 donors was used (human serum was PRPDS from healthy donors,
rodent serum was from S.A.P.U.). Every effort was made to avoid LPS contamination. Therefore,
serum was pre-absorbed with Polymyxin-B-conjugated polystyrene beads in glycerol (Sigma). These
beads bind LPS. Serum was mixed with an equal volume of beads suspension and rotated at 4°C
overnight. Beads were readily separated by centrifugation.
Zymosan was prepared at 5mg/ml in filter-sterile low-endotoxin PBS (Sigma), and washed x3 by
repeated centrifugation (500g for 2 min) and resuspension in fresh PBS. Particles were then
resuspended in pooled serum at 5mg/ml and incubated with regular agitation at 37°C for 5 min. The
particles were washed x2 in PBS after centrifugation and resuspended again in PBS at a final
concentration of 5mg/ml.
The co-culture, once established, was activated by the addition of the 50pg of particles per well. This
ensured even coverage of the bottom of the well in order that all cells were exposed to the particles.
2.6.8 Termination of co-culture
For co-culture experiments that were to be assayed morphologically by fluorescence microscopy the
wells were fixed with 38% formaldehyde solution (BDH) in a linear flow cabinet, by pipetting enough
solution to give a final concentration of 4% (approximately 1:10 dilution). This fixative contains
methanol, which assist in cell membrane permeabilisation. In some experiments, the co-culture was
assessed by fluorescence microscopy of live cells. Live co-culture was immediately assessed
microscopically after addition of Hoechst 33342 (lpg/ml) and propidium iodide (l|ig/ml) to
differentiate apoptotic cells by their differential ability to exclude dyes from the cytoplasm. When the
co-culture was assessed by flow cytometry, live co-culture was trypsinised using lx trypsin-EDTA.
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The cells were then centrifuged and resuspended in ice-cold 70% ethanol in PBS overnight prior to
analysis.
2.6.9 Tri-culture
In some experiments, it was necessary to interact the co-culture with cell populations containing
apoptotic cells. Apoptotic rat MC and apoptotic leucocytes were prepared as described in Chapter 2.4.
Cell populations that were 100% apoptotic were incubated with the co-culture based on 5 cells for
every 1 M<)> in the co-culture. Apoptotic cells that were 30-60% apoptotic were incubated based on 10
cells for every 1 M<)) in the co-culture.
The co-culture was established as described (Chapter 2.6.1). Pre-prepared apoptotic cells were
resuspended in full DMEM/F12 at 20 x 106 cells/ml if 30-60% apoptotic or 10 x 106/ml if 100%
apoptotic. Ten microlitres of apoptotic cells was then added to wells of 96-well plate containing the co-
culture. In some experiments, 10pm latex beads (5 x 107 /ml in ddH20) (Polysciences) were added.
This required 2pl per well of 96-well plate to achieve 5 beads for every 1M(|>.
For most experiments, apoptotic cells were incubated for 6h with the co-culture. Non-adherent cells
were then washed away by agitation of the medium using a plastic Pasteur pipette, followed by
aspiration of medium (see Figure 2-6). Aliquots of medium replaced that which had been aspirated and
the washing procedure was repeated. After the second wash, activating cytokines, where appropriate,
were added. Experimental plates were incubated for 8h and 24h before fixation (Chapter 2.6.8).
Some wells were fixed using 2% glutaraldehyde solution for 5min. The wells were washed again with
PBS x2 to remove any remaining aldehyde and left dry. These wells were subsequently used to assess
the percentage of cells that had phagocytosed apoptotic cells.
These wells were assessed for ingestion of apoptotic cells by staining apoptotic neutrophils for the
presence of myeloperoxidase (Appendix 1). The fixed well was immersed in a substrate solution
containing o-dianisidine (DMB) with hydrogen peroxide. After 10-30min, the location of PMN was
seen as a brown homogenous pigment. The interaction was stopped by washing the wells with
water/PBS and wells were assessed for ingestion with the aid of Nomarski optics to visualise the M())
cell membrane. Wells were assessed for percentage M<|> ingesting apoptotic cells by counting five
fields per well (see Chapter 2.7.2). Ingestion of apoptotic thymocytes and rat MC was assessed using
Nomarski optics without the aid of a cell specific dye.
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Figure 2-6: Diagram indicating schedule for preparation and execution of co-culture of mesangial cells
with macrophages. Note insert for experiments involving triculture (addition of pre-prepared apoptotic cells).
2.7 ASSESSMENT OF MESANGIAL CELL APOPTOSIS
2.7.1 Fluorescence microscopy
Previous studies of MC apoptosis in the group had relied on fluorescent microscopical counting of live
cells in wells after staining with acridine orange (AO), a fluorescent dye that labels RNA and DNA of
live cells. Unfortunately, this method was limited since it did not allow MC and M(|> to be
distinguished. Also, AO was toxic to cells after 30 min, and it resulted in high background
fluorescence in the medium. Propidium iodide (5pg/ml) fluoresced red with 450-490 nm excitation at
the same time that CMFDA labelled cells fluoresced green. Propidium iodide labelled the DNA and
RNA enabling simultaneous detection of condensed nuclear material within green cells and detection
of M<|> nucleus and cytosol. Microscopically, the MC undergoing apoptosis were distinct in that they
had obvious nuclear condensation, often displayed marked cytoplasmic blebbing, apoptotic bodies and
cells shrinkage (Figure 2-7). To aid diagnosis (particularly when assessing human MC) Hoechst 33342
(l|Lig/ml) was also used to stain fixed cells. When the co-culture was excited at 365nm, cell nuclei












Figure 2-7: Mesangial cells undergoing apoptosis. (A) Four apoptotic rat MC surrounding three M<|> in
fixed co-culture. Note characteristic nuclear condensation of green MC (B) Single green rat MC (thick arrow)
adjacent to M<|> (thin arrow) in fixed co-culture. Note characteristic cytoplasmic blebbing. (C) In live co-culture,
live green spindle shaped MCs. Four rounded up green cells can be seen excluding PI (lpg/ml) (thick arrow).
Two similar cells admitting PI can be seen (thin arrow). (D) Same image of live co-culture showing Hoechst
admission into rounded green cells confirming apoptosis. (E) Fixed rat MC exposed to IFN-y/TNF-a showing
many apoptotic nuclei. (F) Human fixed co-culture showing three green apoptotic MC (arrows) adjacent to a M<|>.
of assessment also enabled easy detection of cells in the different phases of mitosis; metaphase,





Figure 2-8: Mesangial cells in different stages of mitosis (anaphase, telophase, metaphase). (A-C) Rat
mesangial cells (X320, X200) in various stages of mitosis stained with PI after fixation. (D) Human MC in
unactivated co-culture with CMFDA-labelled MC counterstained with PI in mitosis.
To achieve this labelling with fluorophores the fixed co-culture plates were left for at least 48h at 4°C
to allow firm fixation to the monolayer of loosely adherent MC. Medium was gently tipped off the
wells and a solution of PI (5pg/ml) and Hoechst 33342 (lpg/ml) in PBS was added to each well using
a transfer plastic pipette. After 5min, the solution was aspirated to dryness and immediately replaced
with a fluorescent-quenching mountant containing 90% glycerol, 10% PBS pH 8.6 and 1-4-
diazabicyclo-2-2-2-octane (DABCO) at 5mg/ml.
2.7.2 Blinded microscopical counting
One fundamental problem with microscopical counting of apoptotic cells is observer bias. It is not
feasible for one person to perform the experiments, and another person to count them. To obviate
observer bias, the observer should be blinded as to the nature of the experiment in each well assessed.
In addition a fixed routine for assessment of microscopical fields should be maintained; that is wells
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should be counted in a stereotyped manner, and each well should be assessed in exactly the same way
as the previous well. Since it is not possible to blind the observer completely as to the nature of the
experimental conditions in each well (e.g. co-culture vs. MC control where in the former M(J> are
visibly present and in the latter M<j) are not), it is mandatory that each well be assessed in an unbiased
way. To achieve these maxims and avoid bias:
• All experimental plates were set up in a symmetrical fashion, with different experimental
conditions occurring in a different order on separate plates.
• Once plates were processed with fluorophore labelling, plates were coded and lids were removed.
• Plates were then counted from top left (position Al) in columns and records maintained by the
well code stamped on the plate. Once all wells had been counted, the lids were matched with the
plates to reveal experimental conditions.
• Each well was assessed by x 32 objective for rodent studies and x 15 objective for human studies.
• Five fields were chosen for assessment from each well.
• Fields were chosen without viewing the well whilst selecting the field. The position of viewing
followed from 12 o'clock to 3 o'clock to 6 o'clock to 9 o'clock, and finally a central position.
• If a selected field included the edge of the well it was reselected without being assessed
• Each field was scored regardless of whether it was devoid of cells or overcrowded with cells.
• Each condition was in triplicate wells.
2.7.3 Hoechst and PI staining of live cells
To further verify the nature of the cells which appear apoptotic morphologically, it was necessary to
assess them functionally. Apoptotic cells but not necrotic (or secondary necrotic) cells are impermeable
to propidium iodide (lpg/ml). On the other hand, live cells but not apoptotic (or necrotic) cells are
impermeable to Hoechst 33342 (lpg/ml). Unlike assessment of the fixed, permeabilised cells, this
assessment is a measure of membrane function. To assess the co-culture further at 24h live co-culture
was exposed to the two fluorophores simultaneously. After 5min incubation at 37°C, wells were scored
microscopically for Hoechst positive and PI positive cells. Both green mesangial cells and non-green
(Mc|>) were assessed in this way (Figure 3-5).
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2.7.4 Trypan blue staining
A further dye for assessing cells is trypan blue. This dye is excluded from all but necrotic cells. Co-
culture at 24h was removed from wells by trypsinisation and an aliquot placed in a haemocytometer.
An equal volume of 0.4% trypan blue was added to the haemocytometer, and the percentage of blue
cells was assessed by counting.
2.7.5 Flow cytometric analysis of MC apoptosis in co-culture
Much time and effort was spent during this thesis to develop a successful flow cytometric based assay
of MC apoptosis in co-culture. Unfortunately, many of the flow cytometric based assays that work well
with leucocytes (Sun et al., 1992; Brown & Savill 1999) did not work well with the myofibroblast
mesangial cell. FITC-conjugated Annexin V, which binds to phosphatidylserine (PS) exposed on the
outer lipid bi-layer of plasma membrane of apoptotic cells, did not provide enough shift of
fluorescence to be a sensitive marker of apoptotic cells. Furthermore, often the range of fluorescence of
the MC was over several log orders, rendering sensitive assays impossible by this method. Other
studies such as a colour shift using JC-1 (Macho et al., 1996) were also of low sensitivity.
After much work, the flow-based assay for hypodiploidy (as assessed on RNase treated ethanol fixed
cells) was found to be reproducible, though reliably less sensitive than microscopical counting.
Co-culture was performed in 6-well plates. Other assays of MC alone that were induced into apoptosis
were performed in 6-well plates or T25 flasks. Supernatants were removed by pipetting and placed
flow cytometric polystyrene tubes (Falcon) on ice. Cells were washed with PBS, the washings kept in
the chilled polystyrene tube. Adherent cells were trypsinised and all placed in the FACS tube. FACS
tubes were centrifuged at 190g forlOmin to pellet all cells. Supernatant was aspirated and the pellet
resuspended gently in ice cold 70% ethanol, 30%PBS. Tubes were covered and stored at 4°C for 16h.
Tubes were centrifuged at 190g for 5min and aspirated. After washing with 5mls PBS, and further
centrifugation (190g for lOmin), cells were resuspended in 200pl of PBS containing PI at 200pg/ml
and RNase A at 500pg/ml, and incubated at 37°C for lh. Cells were then assessed by flow cytometry
(excitation 488nm) for DNA content.
Apoptotic MC due to their size are fragile and it was necessary to find a balance between preferentially
losing apoptotic cells during centrifugation (due to smaller size) and not destroying the apoptotic cells
by exerting excess force on them.
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2.7.6 Terminal deoxy-uridine nick end labelling (T.U.N.E.L.) and DNA fragmentation assays
Co-culture was also assessed using TUNEL staining to highlight apoptotic cells by virtue of
fragmented DNA. This assay was used with success on tissue sections. However, due to the large
number of washing steps involved, in cell culture, the majority of apoptotic cells were washed away.
The assay was therefore of no use.
Tritiated thymidine labelling of MC DNA was carried out, and after 24h of activated co-culture cell
lysis was attempted with an alkaline buffer and Protease K digestion of the nuclear membrane.
Unfortunately by virtue of the FCS present in the vast majority of experiments, the proteinase K digest
was inhibited. This assay was therefore abandoned. However, should future experiments be performed
in serum free conditions it could be used as it reliably indicated fragmented DNA which can be
collected on separate filter papers from non-fragmented chromosomal DNA (Mooney et al„ 1997).
2.8 SEMIQUANTITATIVE COLORIMETRIC ASSAYS
2.8.1 Griess assay
This assay measures nitrite concentration in a solution, and can be an indirect assay for nitric oxide
generation as this is the major stable metabolic product. The acidic Griess reagent reacts to produce a
deep purple colour whose absorbency is best measured at 540nm (DeShan et al„ 1966; Thomsen et al.,
1990). The Griess reagent is unstable and has two components, Sulfanilic acid and N-ethelenediamine.
Each solution is stored separately in the dark at 4°C and mixed in equal volumes immediately prior to
use.
Due to the colorimetric nature of the assay, initially medium containing no-phenol red was used.
However, due to the acidic nature of the Griess reagent, medium with no nitrite appears pale yellow
and does not interfere with 540nm absorbency.
The reagent is sensitive over concentration of lpM to lOOpM, therefore standard curves using sodium
nitrite solution were generated. A typical standard curve is shown (Figure 2-9). Samples were assayed




Figure 2-9: Standard curve of A560 against concentration of sodium nitrite dissolved in DMEM/F12
(without phenol red).
2.8.2 Nitrite plus nitrate
For some experiments it was important to assay nitrite plus nitrate as nitric oxide can be converted to
nitrate particularly in the presence of oxygen radicals. An enzyme purified from liver, nitrate reductase
enables reduction of nitrate to nitrite so that it is detectable by the Griess reagent. The enzyme utilises
NADPH as a cofactor. NADPH interferes with the Griess reagent when in high concentration therefore
to keep [NADPH] low, the addition of glucose-6-phosphate and glucose-6-phosphate dehydrogenase
permitted cycling of NADP back to NADPH (Granger et al., 1996; Giovannoni et al., 1997).
Immediately before reduction of samples an enzyme mastermix was prepared (Appendix 1) containing
these enzymes and substrates in a phosphate buffer. It was found that 8()jul of sample incubated with
25|0.1 of enzyme master-mix for one hour enabled complete reduction as assessed by reduction of
standard concentrations of sodium nitrate solution.
2.8.3 Tumour necrosis factor ELISA (murine)
Attempts were made to generate our own ELISA from polyclonal antibodies, in-house biotinylation
and in-house generation of peroxidase based substrates. However, the assay was unreliable with a low
sensitivity. It was therefore decided to utilise the Quantikine ELISA system from R&D Systems. This
kit, whilst expensive was very sensitive and reproducible. Therefore, all data utilised this system.
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2.8.4 Assays for estimating protein concentration
For some studies, Bradford reagent was utilised. This reagent (brown) turns blue when interacting with
proteins. One part of protein solution is mixed with nine parts Bradford reagent and absorbance
measured at 340nm. The effective protein concentration was obtained from a protein standard curve.
This assay is limited in that SDS interferes with the assay. Therefore, in some studies, a kit based, one
step solution was utilised (Biorad) and absorbencies were read in the same fashion as for the Bradford
Reagent.
2.8.5 Hydrogen peroxide assay
The colorimetric reagent contained a saline/glucose buffer, with phenol red and horse radish
peroxidase. This reaction mix (Appendix 1) was mixed with an equal volume (100|LLl) of fresh cultures
supernatant that had been clarified by centrifugation (lOOOg, 3min, 4°C). The mix was incubated for
60min at 37°C, 5% C02. Five microlitres of IN sodium hydroxide was added and the sample measured
by absorbency at 610nm. Standard curves were performed revealing linearity between 5jj,M and
200|aM hydrogen peroxide.
2.9 WESTERN BLOTTING
2.9.1 Preparation of cellular proteins
For collection of cellular proteins, a hypotonic lysis buffer was used. When collecting cellular proteins
from MC for Fas and FasL analysis a Hepes based buffer was used (Appendix 1). To this lysis buffer
was added Nonidet P40 (or Ipegal) (0.2%) to dissolve proteins out of membranes.
Cells in T75 flasks at sub -confluent density were transferred to ice. Medium was removed and cells
were scraped in ice cold PBS. Once scraped cells were pelletted by centrifugation (250g, 5min, 4°C),
the pellet was then resuspended through a fine (23G) needle in 1ml ice cold lysis buffer with detergent.
The resuspended cell pellet was incubated on ice for lOmin, then centrifuged (10,000g, lOmin, 4°C).
Protein concentration was then calculated using the Bradford reagent (see Chapter 2.8.4).
An aliquot of cell lysate was then mixed in a 3:1 ratio with Laemmli buffer (Appendix 1), and boiled
for 3min to break disulphide bridges in the proteins.
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When cellular proteins were collected from M(J) the procedure was different. Due to limited numbers of
M<j), 1 x 106 cells were seeded into each well of 6-well plates and after 16h, experiments were
performed. To collect proteins, medium was aspirated away and plate placed on ice. To each plate
500pl of hypotonic lysis buffer was added. For these experiments, a different, Hepes-based buffer was
used (Appendix 1). In some experiments the detergent Triton-X 100 (0.2%) was added.
Cells were incubated for 10 min on ice and scraped with a pipette tip until all cells were detached. The
aliquots were placed in chilled 1.5 ml Eppendorf tubes. In the case where Triton-X 100 was added,
cells were centrifuged at 10,000g, lOmin 4°C, to remove cell nuclear material and insoluble cell debris.
The supernatants with the addition of 0.1% SDS were then lyophilised at 10°C. At this stage samples
were resuspended and boiled for 3min in Laemmli buffer. Cell number was utilised as a surrogate for
protein estimation, since wells contained equivalent cell numbers. In other experiments, membrane
proteins were separated from cytosolic proteins. To achieve this, once cells were loosened from the
plates, they were subjected to freeze-thaw cycles x 2 in liquid nitrogen. After sonication (4 x 5s), nuclei
were then pelletted at 10,000g 10 min 4°C. The supernatant was then transferred to fresh Eppendorf
tubes and centrifuged at 100,000g 10 min 4°C. The pellet now contained membranes, whereas the
supernatant contained cytosolic proteins. On ice the pellets were resuspended in Laemmli buffer and
boiled for 3 min.
2.9.2 Preparation of soluble supernatant proteins
For some experiments it was necessary to analyse secreted proteins by western blotting. It is possible
to lyophilise supernatants but the high salt concentration remaining prevents acceptable running of
proteins in acrylamide. It was therefore decided to precipitate proteins from the supernatants.
Supernatants from M(|) in 6 well plates were collected into tubes on ice. Samples were centrifuged at
10,000g lOmin 4°C to remove cell debris. The supernatant was then mixed with ice-cold isopropanol
(60% isopropanol, 40% sample by volume). Samples were then incubated in a -20°C freezer for
15min, then centrifuged again at 10,000g for 15min OoC to pellet precipitated proteins, remaining
supernatant was aspirated and the pellets were resuspended in Laemmli buffer and boiled for 3min.
2.9.3 Preparation of SDS-PAGE




For large gels a BioRad assembly was used. The clean glass plates were 15x15 cm2 and separated by
1.5mm spacers. For small gels a BioRad mini-gel system was used. Clean glass plates were 7x7 cm2
and separated by 0.75mm spacers. The plate assembly was sealed using a sealing gel (Appenidx 1).
Running gels were prepared as described in Protein Electrophoresis Applications Guide (Hoefer). The
proportions of constituents for different gel types can be found in Appendix 1.
Monomer acrylamide (30%) / bis-acrylamide (0.5%) solution was purchased from Sigma pre-prepared
and filtered. Other constituents were prepared and stored at 4°C (Appendix 1)
Once plates were assembled, sealing gel was added to ensure sealing of the bottom of the gel plates but
also the sides with the spacers. Once polymerised, running gel was added to within 2-3cm of the base
of the toothed comb where samples will be loaded. The top of this gel was gently covered with 0.1%
SDS solution or water saturated n-butanol to ensure even polymerisation of the top of the running gel.
Once polymerised, the 0.1% SDS or butanol was poured away and allowed to evaporate. The stacking
gel was poured and the toothed comb inserted. Once polymerised the gel could be used immediately or
stored overnight at 4°C, in Cling-Film.
The gel(s) was transferred to the gel tank, the comb gently removed so as not to disturb the sample
wells and buffer placed in top and bottom tanks (Appendix 1). Samples boiled in Laemmli buffer could
now be loaded into each well.
Once loaded the gel was exposed to a current. For the large gel system, which lacked a cooling system,
the gel was run for 16h on ice at 10-15mA per gel. For the mini gels with better cooling of the plates,
gels were run faster (over 2-3h) at 15-20mA per gel.
2.9.4 Wet transfer of proteins
Once electrophoresed proteins were transferred to either nitro-cellulose or PVDF paper. The former
required to be wetted with dH20, the latter required to be wetted with 100% methanol before usage. The
membrane was cut to size taking care not to transfer any proteins (such as that on one's hands-gloves
were used), and equilibrated in Towbin transfer buffer. A transfer sandwich was made using cassette
with sponges, two pieces of pre-wetted blotting paper and the membrane. The gel was removed from
the glass plates, stacking gel and excess gel trimmed away and transferred by means of a stream of
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dH20 into a tray containing transfer buffer with transfer sandwich. The gel was placed carefully in
apposition with the membrane taking care to remove all air bubbles. As a general rule proteins are
bound to SDS are negatively charged and will therefore move towards the anode (red) in an electrical
field. It should be noted however, that some proteins are positively charged and will move in the
opposite direction. The sandwich is then sealed and placed in the transfer tank which is filled with
transfer buffer.
Proteins were transferred using BioRad system. Proteins were transferred at 1mA per cm2 of transfer
membrane for 6h on ice.
Upon completion of transfer, the gel was inspected for transfer of pre-stained markers to the paper.
Confirmation of transfer could be obtained by transiently staining the membrane with Ponceau S and
staining the gel with Coomassie brilliant blue. The membrane was not allowed to dry out but usually
placed in PBS.
2.9.4 Incubation with antibodies
Membranes were placed in cylindrical tubes (sealed with Parafilm) and incubated at room temperature
with blocking solution by rolling. Usually, this solution was 4% Marvel in PBS or 4% Marvel, 0.05%
Tween 20 in PBS. The Marvel solution was centrifuged (200g 5min) to remove any insoluble debris.
Primary antibodies stored as recommended at 4°C or -20°C, were diluted in blocking solution and
incubated with the membrane by rolling in the cylindrical tube. This was usually at 4°C overnight,
though in some instances binding required 48h (see results).
After incubation membranes were washed with PBS (sometimes including 0.05% Tween 20) three
times for 5min each wash and rolled to assist washing. Secondary horseradish peroxidase (HRP)-
conjugated antibodies were incubated at manufacturer's recommended dilution unless other dilutions
were found superior. Sometimes further layers of secondary antibody were required. Between each
layer of antibody, three washes were carried out as described above.
2.9.6 Detection of antibody binding
To achieve this, two methods were employed. Firstly, 4-chloro-l-naphthol was used as a substrate and




Using the former, 20mg of 4-chloro-l-naphthol were dissolved in 500p.l of methanol/ethanol and
mixed with 50ml of 2mM Tris, 200mM NaCl pH 8.0. To this was added 600p,l of 6% hydrogen
peroxide. The solution was incubated at room temperature with the membrane on a rocking platform.
Colour change was observed and when adequate the reaction stopped by washing with PBS.
Using chemiluminescence, the solution was purchased from Amersham and prepared according to
manufacturers instructions. The wet membrane was placed in a plastic sheath and the solution poured
over the surface to obtain an even thin film. The top of the plastic sheath was placed over the blot, and
in a dark room photographic paper (Kodak) was placed over the blot in a cassette and exposed. To start
this was usually 30s. After development, a second exposure was made as necessary.
2.9.7 Immunoprecipitation and detection of cell surface proteins
Cell surface proteins of live cells were biotinylated using 5mls PBS with 0.5mg NHS-Biotin. 10 x 106
mesangial cells were incubated with the solution at 4°C for 30 min. After washing x 3 in ice cold PBS,
cells were scraped, washed by centrifugation at 250g 5min in PBS, and resuspended in 1ml hypotonic
lysis buffer (Hepes buffered, not Tris buffered). Effective lysis of cells was performed by freeze thaw
cycles x 2 in liquid nitrogen. Cell membrane was separated from cytosol by centrifugation (14000g
lOmin). The supernatant was separated and the pellet resuspended in Hepes/buffer now containing
Triton-X 100 0.2%. The protein solution was incubated at 4°C for 30min with lpg of rabbit IgG and
4p.l of protein A sepharose beads. After separation of the beads by centrifugation primary rabbit IgG
was added (1 pg/mg of protein) and incubated for 16h at 4°C. Now 4|il of Protein A sepharose beads
were added and agitated for 30 min in ice. Positive and negative control antibodies were utilised and
pre-cleared beads were kept for additional controls.
Beads, maintained on ice were washed x 3 in lysis buffer (no inhibitors) and then washed xl in 0.5%
SDS in 25mM Tris pH 7.4. The beads were now resuspended on 30(il of Laemmli buffer, and applied
to gel electrophoresis.
2.9.8 Estimating protein concentration
To estimate protein concentration, protein solution was mixed with a colorimetric substrate. Most
analysis used the Bradford reagent. This however has its weakness in that not all proteins are detected
by this reagent equally and also in the presence of detergent such as SDS, the assay is unreliable. Given
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those findings, in some experiments a commercial colorimetric assay was used. However, in the
majority of cases the Bradford reagent was sufficient (see Chapter 2.8.4).
2.9.8 Staining of membranes and gels
To view proteins in gels several methods are available including Silver stain and Coomassie brilliant
blue R-250 stain. The former is more sensitive but is labour intensive. The latter is quick, simple, and
particularly useful when looking for protein loading of lanes in the gel or transfer of proteins to a
membrane. Gels were stained by immersing in the staining solution and covering to minimise methanol
and acetic acid vapour. The gel was agitated for 4h. The stain was then replaced with destain and
shaken slowly for 30min. Destain was replaced every 12h until background of the gel was clear.
The membrane itself can be stained either reversibly or permanently. The former was found to be
useful as a quick test to assess whether proteins had transferred and whether loading was even.
Ponceau S staining was rapidly reversible by immersing the membrane in ddH20. To achieve staining,
the membrane was incubated with Ponceau S solution for 15min and briefly destained by washing in
water. Complete destining was carried out by further washing with ddH20.
2.10 ELECTROMOBILITY SHIFT ASSAY
2.10.1 Preparation of nuclear proteins
Sub-confluent mesangial cells growing in T162 (lOxlO6) flasks were exposed to experimental
conditions. At the end of the experiment, flasks were placed on ice and the medium replaced with 10ml
of chilled PBS. After scraping with a cell scraper, cells were placed in a universal container and
centrifuged (250g, 5min 4°C). After decanting, the pellet was washed and resuspended with 1 OOOpl of
chilled lysis buffer A (Appendix 1). The cells were centrifuged (10,000g, 5min 4°C). After decanting,
the pellet was resuspended in lOOpl of buffer A containing 0.2% v/v NP 40 using a 23G needle, and
incubated on ice for lOmin. After centrifugation (10,000g, lOmin 4°C) the supernatant was removed
and stored. The pellet contained crude nuclear preparation. This was resuspended in 50-100(4.1 of Buffer
C (Appendix 1) using a 23G needle and incubated for 15min in the fridge door (>5°C). The sample was
centrifuged (10,000g, lOmin 4°C). The supernatant now contained soluble nuclear protein and was
stored at -70°C for EMSA.
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Protein concentration was calculated using the Bradford reagent in order that equal loading could be
established.
15|_Lg of nuclear protein was required for each incubation with oligonucleotide
2.10.2 Generating labelled oligonucleotides
Complementary sequences of ssDNA were prepared according to published sequences with
3Voverhangs for a known restriction enzyme. To anneal ssDNA each ssDNA oligonucleotide was
diluted with ddH20 to a final concentration of 1.75pmol/(il. The oligonucleotides were mixed and
boiled in a water bath (lOmin). The water bath was allowed to cool to room temperature. Samples were
then frozen (-20°C).
To radio-label the annealed probe (sufficient for 50 lanes) 7.0 pmole (4pl) of oligonucleotide was
mixed with lpl of lOx kinase buffer (Promega), 10U of T4 kinase and 4pl of 32P-ATP (9.25mBq in
25pl Amersham). This mixture was incubated 37°C for 30min, then diluted with ljul 0.5M EDTA and
89pl of Tris-EDTA (TE buffer Appendix 1). The final hot probe was frozen at -20°C until use in a lead
lined container.
2.10.3 Binding reaction
This reaction needed to be optimised for each oligonucleotide used. Binding reaction buffer, therefore
may be required to vary in its composition. The buffer used for NFkB and IRF-1 studies is shown
(Appendix 1). 15|ig of nuclear extract (usually in 2-3|il of buffer) was made up to 10|il with ddH20,
then mixed with 1.5p.l oflOx reaction buffer, l,5pl of PolydldC (2pg/pl Promega). Finally, 2.0|J.l of
labelled probe (10,000-100,000 cpm). The incubation was for 15min RT. In my experience nuclear
protein < 1 jj.g/jj.1 does not bind well to the oligonucleotide in vitro. Therefore choosing whether to
resuspend nuclear proteins in 50|il or 100|il of Buffer C will be crucial to the outcome. 3jil of xylene
cyanol/bromophenol blue loading dye (Appendix 1) was added to each incubation.
2.10.4 Gel electrophoresis




Gels were prepared in 15 x 15 cm2 plates (1.5mm spacers) with a sealing gel nut no stacking gel. Once
prepared and placed in the electrophoresis apparatus, top and bottom tanks were filled with 0.25 x
TBE. Behind a Perspex shield, samples were loaded with appropriate care and handling of
radioactivity. Once loaded into the glass plates the gel was electrophoresed at 180V (1 plate or 2plates)
for 60-75min. Care was taken to keep the free, labelled oligonucleotide within the gel to minimise
contamination.
2.10.5 Visualisation of radioactive gel
Once electrophoresed gels were placed on blotting paper and dried using a gel dryer. Free, labelled
oligonucleotide in the bottom of the gel was removed and discarded appropriately. The dried gel was
now exposed using photographic paper in a cassette for 16h at -70°C. Films were then developed using
standard techniques.
2.10.6 Super-shift and cold-competition assays
For cold-competition assay, the nuclear protein extract was incubated overnight with a 50 fold excess
of unlabelled oligonucleotide. Following this incubation the labelled oligonucleotide was added and
incubated as described in Chapter 2.10.3. The completed reaction was then electrophoresed as
described. For super-shift assays, the nuclear protein extract was incubated for 16h at 4°C with the
antibody of choice and as a control a non-specific antibody was incubated with another aliquot of
nuclear protein. The nuclear protein was then incubated with labelled oligonucleotide as described
(Chapter 2.10.3).
2.11 MOLECULAR BIOLOGICAL TECHNIQUES
2.11.1 Preparation of agar plates
Bacterial grade sterile petri dishes were assembled close to a Bunsen flame. LB agar was prepared
(Appendix 1) and autoclaved. When cooled to < 55°C the appropriate antibiotic was added (Appendix
1) and the agar poured into plates. Petri dish lids were replaced to allow ventilation and when set
condensation was allowed to evaporate (37°C oven or laminar flow hood). Plates were stored wrapped
in Cling Film until usage.
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2.11.2 Preparation of broth
LB broth and Terrific broth were prepared (Appendix 1) and autoclaved. The addition of antibiotics
was made with the broth at room temperature
2.11.3 Preparation of agarose gels
Agarose gels were prepared with Tris-Borate-EDTA (TBE) (Appendix 1) buffer. The alternative Tris-
acetate-EDTA (TAE) was not regularly used. Typically percentage agarose varied from 0.7% to 1.5%
depending on the size of DNA under analysis (higher % gel for smaller DNA). Gels were usually
prepared in the upturned lids of microwell plates. Once the agarose had boiled, ethidium bromide was
added to the gel (10(ig/ml final concentration). Once the gel cooled (hand held) it was poured. Clean
gel tanks were filled with 1 x TBE and regularly replaced.
2.11.4 Generation of competent bacteria
DH5a competent bacteria were generated were generated from DH5oc cells. Cells were streaked onto a
plate containing LB agar. Sixteen hours later, 10-15 colonies were selected and placed in 250ml of
SOC medium (Appendix 1). Cells were incubated in the medium for 16h at 18-25°C with agitation at
200-250rpm, until the ODWX) was 0.6 (0.4-0.8). The culture was spun to pellet the cells (3000rpm, 4°C).
The pellet was then re-suspended in 84ml of Transformation buffer (Appendix 1), on ice. This
suspension was incubated for lOmin on ice, then spun again (3000rpm, 4°C). The pellet was
resuspended in 20ml of chilled transformation buffer and 1.5ml of DMSO was added, and again
incubated on ice for lOmin. The suspension was then frozen in liquid N2 in 500fxl aliquots.
2.11.5 Transformation of competent bacteria by heat shock
DH5a E. coli were routinely used in these studies. E. coli were stored at -70°C in 80pl aliquots.
Bacteria were thawed on wet ice and incubated with the DNA sample (typically >10ng) for 20min on
ice. They were then incubated in a block at 42°C for lmin followed by 2min on ice. 900|il of LB broth
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was added and bacteria shaken and incubated at 37°C for lh. After centrifugation (5000g 5min RT),
the pellet was resuspended in 200|il of broth and applied evenly to the surface of an agar plate.
2.11.6 Selection of resistant clones
Transformed DH5a bacteria were plated onto agar plates containing antibiotics. Only those bacteria
expressing the appropriate bacterial resistance gene would survive and grow as colonies. Successful
transformation would result in many single colonies growing on an agar plate for 16h at 37°C. Single
colonies could be picked using a flamed wire loop and transferred to bijous bottles containing 2 or
3.5ml of LB broth with appropriate antibiotics present. Bijous were shaken (200/min) for 16h. A
second agar plate with a grid reference was used to streak a defined area of the agar with the picked
colony so that a second population of the clone could be maintained.
2.11.7 Screening of colonies by STET preparation
Often it is necessary to screen many clones when searching for successful insertion of the gene of
interest. A cheap and simple way of screening is to isolate plasmid DNA from the bacterial clonal
population by lysosyme assisted hypertonic lysis.
1.5ml of bacteria in broth (or 3.0ml) was pelleted by centrifugation (5000g, 5min RT). The pellet was
resuspended in 600(j,l of STET solution (Sucrose, Tris, EDTA, Triton X 100) (Appendix 1) and 50p.l of
lysosyme (lOmg/ml in dH20). Samples were then boiled in a heating block (100°C) for l-5min until a
dense white precipitate formed. Samples were centrifuged (10,000g, lOmin RT). The pellet (white) was
then discarded (usually by removing using a 200pl pipette tip). 600pl of isopropanol (RT) was mixed
with the supernatant and inverted to mix. Samples were again centrifuged (10,000g, 15min, RT).
Supernatants were discarded and samples dried by patting on blotting paper. Samples were inverted
and left to dry for 5-10min. To each sample 50pl of dH20 (pH 8.0) was added (if pH of dH20 is < 7.4
consider using lOmM Tris pH 8.0) to resuspend DNA. This may require agitation and incubation at
37°C for a few min. RNase A was added (200pg/ml final concentration) and samples incubated for
15min at 37°C.
Aliquots of DNA solution (typically 5-lOp.l) were electrophoresed to look for gene insertion.
Alternatively, diagnostic digests were made on the DNA prior to electrophoresis.
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2.11.8 Purification of DNA for transfection
In the majority of cases purification of plasmid DNA was carried out using the Qiagen Tip-100 kit and
lysis of pelletted bacteria was carried out according to manufacturers instructions.
However, it was not possible to obtain sufficient plasmid DNA from DH5a bacteria transformed with
the 767 (see Figure 2-10) or 776 IRF-1 containing plasmids. These plasmids were very low copy
number, and processing of larger volumes of broth did not improve the yield much above 2pg of DNA.







































































Figure 2-10 The 767 vector with restriction sites demonstrated. This vector was supplied from Prof. Hauser
at the Gesellschaft fur Biotechnologische Forschung. It comprises a colEl bacterial promoter, with an ampicillin
resistance gene. The fusion gene IRF-1 with HER is shown. This gene construct is under the MPSV promoter
which crosses the Hpa\ restriction site (480).
One litre of Terrific broth was inoculated and incubated with 767 plasmid and incubated until
absorbency, A^o was 0.4-0.6. The bacteria were pelletted in 300ml flasks in a Beckman centrifuge
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(4000g, 10°C, 30min). The pellet (from 1 litre) was resuspended in 50ml glucose buffer. Once
resuspended 100ml of lysis buffer was added and mixed by inversion, followed by incubation on ice
for 5min. Subsequently, 150ml of high salt buffer was added and mixed by rapid inversion of the tube
until a well-dispersed SDS/protein precipitate had formed. The mixture was incubated on ice for
lOmin. The mixture was aliquoted into 50ml tubes and centrifuged (4,000g, lOmin 4°C). The
supernatant was passed though a gauze to remove particulate matter and 100ml of isopropanol was
added to the supernatant to precipitate nucleic acids. After further centrifugation (4,000g, 15min 4°C),
the supernatant was drained completely leaving a pellet of small nucleic acids. After drying the tube,
the pellet was resuspended in 10ml of dH20.
To precipitate RNA an equal volume of LiCl solution (5M) was added and after mixing was incubated
on ace for 30min. After centrifugation (he supernatant centrifugation (4,000g, 5min 4°C), the
supernatant containing plasmid DNA was collected.
Further purification was made by mixing an equal volume of phenol rchloroform with the supernatant.
After mixing and centrifugation, the upper layer containing DNA was separated and DNA precipitated
using 2.5 volumes of 100% ethanol. After mixing the DNA solution/ethanol was incubated at -20°C
for lh to maximise precipitation. After centrifugation (4,000g, 15min 4°C), the pellet was washed with
70% ethanol and then resuspended dH20 containing RNase A at 15pg/ml for lh. After a further
phenol :chloroform extraction, plasmid DNA was precipitated by adding 1/10 volume of 3M sodium
acetate pH5.2 and 2.2 volumes of 100% ethanol. The DNA precipitated immediately and after further
centrifugation (4,000g, 15min RT) and washing with 70% ethanol, removal of all ethanol by drying,
the final pellet was resuspended in 10ml of lOmM Tris pH 8.0).
Purity and quantification of plasmid DNA was achieved by gel electrophoresis of dilutions of the stock
DNA. The aliquots were run against a marker of known quantity/DNA concentration standard such as
Hindlll cutX,. Alternatively, an aliquot of DNA solution was checked by assessing absorbency A280 and
A260- The A260 value was used to estimate DNA concentration.
2.11.9 Precipitation of DNA in solution
If DNA was soluble in a low salt solution, 0.1 volumes of 3M sodium acetate pH5.2 was added, mixed
followed by the addition of 2.2 volumes of ethanol. The mixture was incubated at room temperature for
l-2h and then centrifuged at 10,000g for 15 min at room temperature. The supernatant was then
decanted from the pellet and the pellet washed in 500 |il of ice-cold 70% ethanol to remove salts. After
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further centrifugation at lOOOOg, 5min the pellet was air dried and re-dissolved on dH20 or 0.1 M Tris
pH 8.0.
If DNA was already dissolved in a high salt solution, precipitation was achieved by adding 2 volumes
of isopropanol and incubating at room temperature for 1 -2h. Precipitated nucleic acids were pelletted,
washed and resuspended as described for precipitation of DNA from low salt solutions.
2.11.10 Gel purification of DNA
Gel containing DNA was excised under UV visualisation and placed in a clean Eppendorf tube. After
heating to 65°C to melt the gel it was mixed with binding buffer (Qiagen) and passed through an
equilibrated Tip-100 ion exchange column according to manufacturer's instructions.
After elution in a high salt buffer, DNA was precipitated as described above (Chapter 2.11.9).
2.11.11 Ligation of insert DNA and plasmid vector
DNA was prepared and digested to generate insert DNA and vector DNA with compatible ends (either
sticky-sticky or blunt-sticky). DNA was prepared by phenokchoroform purification followed by
precipitation by gel purification followed by precipitation and resuspension. Vector and insert DNA
concentrations were estimated by running a known concentration on a gel against 500ng of Hindlll cut
X (Appendix I). DNA was ligated at 1:3 vector:insert molar ratio. lOOng of vector DNA was used with
the appropriate mass of insert DNA mixed. 1U of T4 DNA ligase with lpl of lOx ligase buffer. The
total volume of ligation was lOpl. The ligation was carried out in a PCR heating block. The
temperature was varied every 30s from 14°C to 24°C over 100 cycles to maximise efficiency of
ligation.
2.11.12 GENERATION OF A VECTOR FOR STABLE TRANSFECTION OF HERIRF-1
UNDER THE CMV PROMOTER
Previous studies of transfection of MC have indicated that the CMV promoter reliably resulted in
adequate transcription of exogenous genes (Stylainou et al„ 1999). Further evidence for this came from
the GFP fluorescence study (Figure 2-14); the eGFP gene was linked to a CMV promoter. It was
decided therefore to link the IRFHER gene to a CMV promoter. The eGFP vector contained a selection












Figure 2-11: Diagram showing insertion of the IRFHER gene into the EGFP-N1 vector at the Sad
restriction site in the multiple cloning site of the vector. Note the position of Bgll 1 in the MCS of the vector and
insert which was used to determine correct orientation of the insert in the vector.
Furthermore, comparison of restriction-digest sites between GFP and 767 indicated that the IRFHER
with its stop codon could be inserted between the CMV promoter and eGFP gene (Figure 2-11).
To achieve that, 15(ig of 767 purified DNA was digested for 4h with the enzyme Sacl in the presence
of multicore buffer followed by 15 min heat inactivation of the enzyme at 65°C. This step generated
two fragments, one 2065bp (2kb), the other 2780bp (3kb) (Figure 2-13). According to the restriction
map, the 2kb fragment would contain the IRFHER gene. This 2kb fragment was gel purified and an
aliquot of DNA was underwent a diagnostic digest with BamHl, which as expected revealed all 16bp
and a 953bp fragment (Figure 2-13), confirming the nature of the purified fragment. The uncut 2kb
DNA was quantified by running ljxl of pure DNA along-side a lOObp ladder of known quantity. 1 jllI
The 2kb fragment of 767 DNA was 75ng/|al. 5|ig of the eGFP vector was digested with Sacl in
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multicore buffer for 6h. The vector was seen to be linearised by the single site digest (Figure 2-12).
The free ends of the digested DNA were de-phosphorylated to prevent re-ligation of vector alone
during insertion of IRFHER. The vector was then purified by phenol/chloroform extraction and DNA








Figure 2-12: (A) Agarose gel (0.8%) showing DNA (Ethidium bromide). Lane 1, uncut 767 vector showing
whole plasmid plus supercoiled form. Lane 2, lOmg of 767 vector digested with Sad for 6h producing two
fragments. Lane 3 vector linearised with ECoRl indicating its size (approaching 5kb). (B) Agarose gel (1.0%).
Lane 1 purified 2kb fragment from Sad digest of 767 vector. Lane 2 diagnostic digest of that fragment with
BamHl to reveal two fragments (1116bp & 953bp). Lane 3 eGFP vector. Lane 4 eGFP vector linearised with Sad
digest.
Ligation was set up with insert : vector in a 3:1 molar ratio, using T4 ligase. Control ligation was set up
with no insert. Ligation was carried out alternating between 14°C and 24°C for 30s at each temperature
for 200 cycles, then was maintained for 8h at 16.5°C. This procedure was used to balance the enzyme
activity against the need to DNA free ends to come into close apposition.
DH5a competent E. coli were transformed with half of the ligation product. The bacteria were plated
onto agar plates containing the antibiotic kanamicin.
After incubation overnight, the plates from vector alone ligation contained few colonies, but the plates
from vector plus insert ligation contained many colonies. 32 colonies were selected, isolated on a
kanamicin agar plate and grown in broth. After 16h incubation, plasmid DNA was isolated from
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bacteria by STET procedure. After RNAse treatment plasmid DNA was run on an agar gel to screen
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Figure 2-13: (A) Agarose gel (1.0%) showing plasmid DNA from colonies selected for insertion of the
IRFHER cDNA. Note two of these plasmids travel more slowly than the others indicating inserted DNA. (B)
Vectors selected for retardation in (A) were digested with BgZII. Correct insertion of the cDNA results in a 5.2kb
and 1.5kb fragment after digestion as in lanes 1,7,8.
From this initial screen, 9 colonies were selected on the basis of obvious retardation of DNA in the gel
indicating insertion.
DNA (5pl of 50|xl) from these clones was digested with Bglll. Since both ends of the insert were cut to
leave a SacI site, it would be possible for the insert to be inserted in either orientation. The new vector
would only produce IRFHER mRNA if the insert was in the correct orientation. In this correct
orientation, this digest would generate a 1552bp and a 5.2kb fragment. In the incorrect orientation,
527bp and 6.2kb fragments would be generated (Figure 2-13, Figure 2-11). Following this digest three
colonies were identified as containing the inserted gene in the correct orientation (clones 5,25,29).
Clone 5 was selected (eGFP/IRFHER(5)). 200mls of LB broth were incubated to achieve absorbencies
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of 0.4. The plasmid DNA was purified by Qiagen Tip 100 columns and purity confirmed by relative
absorbance (900ng/jnl).
2.11.13 Generation of stably transfected rat mesangial cells
Prior to transfection, mesangial cells were treated for one week with G418 antibiotic to produce a does
response curve. Every 48h the medium containing antibiotic in medium was removed from the cells
and replaced with fresh medium plus antibiotic. Cell growth and cell loss were assessed
microscopically every 48h. Doses of G418 ranged from lOOng/ml to lOOOng/ml. It was found that at
day 3 lOOng/ml inhibited cell proliferation, 250ng induced cell death but that doses of 5oong/ml and
greater resulted in almost complete cell loss. At day 6, lOOng/ml induced widespread cell death and
viable cell loss. 250ng/ml of G418 resulted in virtually complete cell loss.
Prior to stable transfection, transient transfection of mesangial cells using different transfection
techniques was employed to maximise transfection efficiency. A lipid transfection agent (Transfast,
Promega) was compared with electroporation (Equibio) using the eGFP vector which, when expressed
under the CMV promoter, the protein product fluoresces green in the cytoplasm. A series of studies
were set up varying the parameters to maximise transfection. For the lipid reagent, this included cell
density, amount of DNA duration of interaction, centrifuging the lipid vesicles onto the cells, and
duration before assay. For electroporation, this included cell density, amount of DNA, voltage,
impedance and time of electric current. At 48h cells were washed, trypsinised and assessed by flow
cytometry (Figure 2-14). The histograms indicate that electroporation appeared to give more
favourable results in terms of transfection efficiency.
T75 flasks of sub-confluent MC grown in medium with 10% FCS (5x10 6 cells), were trypsinised, and
after neutralisation of trypsin-EDTA with full medium, pelletted (250g, 5min 4°C), then resuspended in
800pl of full medium containing 20|ig of purified eGFP plasmid DNA (0.1M Tris pH 8.0). The cell
suspension was placed in a sterile electroporation cuvette on ice and exposed to electric shock: 280V,
1500|J,F. Pulse time was calculated by the electroporator according to impedance. The pulse time was
typically 20-30ms.
Immediately following electroporation, cells were resuspended in lOmls of chilled medium and
returned to a T75 flask and returned to the incubator. Typically, more than 50% of cells survived and




Figure 2-14: Fluorescence histograms of rat mesangial cells transfected with eGFP by electroporation (A) or
lipid transfection reagent, transfast (B). Cells were transfected, then cultured for 24h. They were trypsinised and
assessed by flow cytometry directly (C) Fluoresecent micrograph (X200) of confluent rat mesangial cells Pll
transfected with the eGFP vector by electroporation. Note intensely positive green fluorescent cells.
The vectors eGFP and eGFP/IRFHER(5) were linearised with the restriction enzyme AseI
Confirmation that the vectors were linearised was obtained by gel electrophoresis (not shown). Rat
MC, passage, 11 were transfected with 20|Lig of eGFP or eGFP/IRFHER(5). After 48h, there were 20%
of fluorescent cells in the control transfection (cells transfected with eGFP/IRFHER(5) were not
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expected to fluoresce). Cells were now exposed to G418 at 250ng/ml and cultured for a further week,
replacing the medium every third day. After 7d, colonies derived from single cells were seen. In the
control wells, only 20% of these colonies fluoresced however. This suggested that in the non-
fluorescing colonies either the eGFP expression was very low or that the eGFP gene had been switched
off or deleted, whereas the neomycin resistance gene was being transcribed. This might suggest that a
proportion of the colonies from the eGFP/IRFHER(5) transfected cells would also not significantly
transcribe the IRFHER gene. Two approaches were made here. In one case, all cells from in excess of
10 colonies were 'lumped' together to generate a polyclonal stable line. Clearly all cells would have
the neomycin gene, but many cells would not have expressed the IRFHER gene or the eGFP gene.
The other approach involved picking colonies. In the tissue culture hood, colonies were picked with
sterile pipette tips and transferred to 96-well plates where they were trypsinised and re-plated into
wells. Single colonies were expanded and then selected on the basis of green fluorescence or increased
levels of spontaneous apoptosis as seen in the HERIRF-1 clones but not in the eGFP clones. Also some
IRFHER clones that grew normally were selected. These clones were maintained in G418 at lOOng/ml,
a dose sufficient to prevent growth of cells without the neomycin resistance gene.
2.11.14 Polymerase chain reaction methods for genomic DNA
When assessing gld/gld mice for a point mutation in the Fas gene, suitable primers were designed
around the mutation. Primers were selected to maximise binding of primer, maximise specificity and
minimise the possibility of the primer binding to itself.
To achieve this, certain maxims were observed (The Source of Discovery Protocols and Applications
Guide. Third Edition. Promega). Primers should be 15-30bp. They should contain 40-60% G+C and
care should be taken to avoid the possibility of a secondary structure. 3" ends of primers should not be
complementary to avoid dimerisation. Three G's or three C's should be avoided near the 3" end.
Ideally both primers should anneal at the same temperature which is dependent on the primer with the
lowest melting temperature (Tm). The latter can be estimated:
Tm = 81.5 + 16.6 * (log10[Na+]) + 0.41 * (%G+C) -675/n
[Na+] = molar salt concentration, n = number of bases in the oligonucleotide
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Genomic DNA was prepared isolated from M(|) from wild type or gld/gld mice using a eukaryotic DNA
extraction system from Qiagen. Following analysis of the published gene and mutation (Takahashi et
al., 1994), a 31 lbp segment, covering the predicted mutation site of the gene, was amplified by PCR
using the primers 5' -GTGGCCTTGTGATCAACG-3' and 5' -CTCTGGAGTGAAGTATAAG-3'
These primers were generated at Oswel laboratories.
Due to the low G+C content of the primers, it was determined that a low annealing temperature would
be required.
The PCR reaction was prepared:
5|il of DNA solution, 5 (J.1 lOx PCR reaction buffer (Appendix 1), 2 pi dNTPs (5mM of each), 1.5 pi
MgCl2 (50mM) final concentration 1.5mM, 5pl Forward primer (lOOpmoles), 5pl Reverse primer
(lOOpmoles), made up to 49pl with dH20.
After mixing and centrifuging, then allowing the primers to anneal 1U (lpl of Taq polymerase was
added).
The following conditions were found to be optimal:
95°C, 5min, 55°C 90s followed by addition of Taq, 72°C 90s, 95°C 90s, 55°C 90s for 36 cycles.
2.11.15 Purification of mRNA from eukaryotic cells
The method used in this thesis involved extraction of total RNA which contains ribosomal as well as
messenger RNA. All solutions prepared were fresh-opened, guaranteed RNase free or DEPC treated
prior to usage (0.01% diethyl pyrocarbonate was added to water in RNase free glass ware and left to
stand overnight, before autoclaving. Sub-confluent mesangial cells growing in a monolayer in T75
flasks were separated from overlying medium on ice, then trizol (Gibco 15596) was added to the cells
using appropriate caution for phenol containing compounds. 1ml of trizol was used for each 10cm2 of
cells. After scraping, the cell suspension on ice was passed through a pipette several times. This cell
suspension was frozen (-80°C) until required.
The suspension was incubated at room temperature for 5min, then 0.2ml of chloroform was added per
ml of trizol. Tubes containing the mixture were shaken and incubated for 2/3min at room temperature.
This was then centrifuged at 10000# for 15min, 4°C. The top, aqueous phase now containing RNA was
separated from the lower layer containing DNA and protein and RNA was precipitated by adding
0.5ml of isopropanol per 1ml of trizol. The mix was incubated for lOmin room temperature, then spun
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12,000g, 10 min 4°C. The supernatant was discarded, the pellet washed with 75% ethanol and spun at
7,500g for 5min, 4°C. The pellet was air dried for 5 min then dissolved in RNase free water or TE
(20(xl/lml of trizol, and incubated at 55°C for lOmin. The RNA was then frozen (-80°C) for storage.
RNA was quantified using A260. Absorbance of 1.0 represents 40pg/ml of single stranded RNA. Purity
(A260/A280) should be 2.0. Purity was also demonstrated using gel electrophoresis (Figure 2-15)




Figure 2-15: Agarose gel electrophoresis of RNA extracted from rat mesangial cells. Note distinct bands of
rRNA (28s and 18s).
2.11.16 Polymerase chain reaction methods for mRNA
Moloney murine leukaemia virus reverse transcriptase (Superscript II-Gibco 18064-022) was used to
produce cDNA from the mesangial cell RNA preparation. To initiate reverse transcription an oligo dT
(12-14) primer was used which binds to the poly-A tail of mRNA.
In some experiments total RNA was treated with RNase free DNase (Promega) for 30min to remove
any stray plasmid DNA.
l|Xg of total RNA was added to the oligo dT primer (0.5p.g/pg RNA) The total volume was made up to
1 2|ll1 with nuclease free water. This mix was heated to 70°C for 5min in a heating block, then chilled on
ice to achieve annealing. To this was added:
2|xl 0.1M DTT, 1 (0.1 dNTP mix (lOmM of each), 4pl of 5x Superscript II buffer (250mM Tris-HCl
pH8.3, 375mM KC1, 15mM MgCl2)
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The reaction mixture was incubated at 42°C for lh and stopped by heating to 70°C for 15min.
Murine IRF-1 primers were designed based on the cDNA sequence for murine IRF-1 and expected to
give a 477bp product in a PCR reaction (Appendix 1). In preliminary experiments, using these primers
with aliquots of plasmid DNA containing the IRFHER gene, PCR was maximised. The following
maximised PCR system was used thereafter.
The PCR reaction was set up on ice:
2.5|xl of 10X PCR reaction buffer (200mM Tris pH 8.4, 500mM KC1) was mixed with 4(il (20%) of the
cDNA derived from one T75 flask of cells, 2 x lpl of primer solutions at 10pM, made up to 25JJ.1 with
water.. For negative controls lp.1 of RNA solution was used in place of cDNA. The mix was heated to
95°C for 2min then held at 80°C.
In a separate tube:
2.5(11 oflOX PCR reaction buffer (200mM Tris pH 8.4, 500mM KC1) was mixed with 1.5(tl of MgCl2
(50mM stock) to give a final concentration of 1.5mM, 0.5(xl of dNTP (20mM of each stock), Taq
polymerase 0.2(tl and made up to 25(0.1 with water.
The contents of the second tube were combined with the first at 80°C and 35 cycles of PCR were
initiated at 96°C (30s) followed by 60°C, (30s), followed by 74°C (45s). After these cycles the product
was heated to 74°C for 5min then returned to room temperature.
2.12 IMMUNOHISTOCHEMISTRY
2.12.1 Proliferating cell nuclear antigen
Assessment of mitosis was made by specific identification of proliferating cell nuclear antigen (PCNA)
in mesangial cells using PC10 antibody (DAKO) in fixed wells of 96-well plates. Briefly, following
quenching of endogenous peroxidases with 3% hydrogen peroxide in methanol (5min, 20°C), and
permeabilisation with 0.1% Triton-X 100, 0.1% sodium citrate in PBS (5min, 20°C), the cell
monolayer was blocked for 30min at room temperature with 10% new-born calf serum (NBCS) in
PBS. The primary antibody was then applied 1:50 in PBS, 10% NBCS (4h, 20°C) or the appropriate
irrelevant control. After washing wells x3 with PBS containing 0.05% Tween 20, specific localisation
was assured incubating with biotinylated anti-immunoglobulin (1:1000) in PBS/NBCS). After further
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washing steps x 3, streptavidin-peroxidase was added at 1:10000 (Sigma) in PBS, followed by the
addition of the substrate AEC (Vector).
2.12.2 Anti-a-smooth muscle actin
Human, rat and mouse mesangial cells were all labelled with anti-a-smooth muscle actin (Sigma). Sub-
confluent cells in wells were fixed with formaldehyde (4% in PBS) and permeablilised with ice-cold
methanol (5min). After drying, wells were blocked for 30min at room temperature with 10% new-born
calf serum (NBCS) in PBS. After removing, the primary antibody (1:400) in PBS/NBCS, or the
appropriate irrelevant control, was applied overnight at 4°C. After washing x 3 with PBS and 0.05%
Tween 20, a secondary FITC-conjugated anti-mouse IgG was applied at 1:1000, again in PBS/NBCS.
After lh, room temperature, wells were washed x 3 in PBS and then mounted with DABCO-based
fluorescent mountant for viewing (Chapter 2.7.1).
2.12.3 Anti-ED-1
Rat macrophages in culture and early cultures of mesangial cells from whole glomerular outgrowths
were assessed for ED-1 positive cells (macrophages). The primary antibody was anti CD 120 (Serotec).
Wells containing cells were fixed and permeabilised as in Chapter 2.12.2. After blocking with
PBS/NBCS for 30 min room temperature the primary antibody, or the appropriate irrelevant control,
was added in blocking solution (1:50) and cells were incubated overnight at 4°C. After washing steps,
secondary antibody, either FITC-conjugated or TRITC-conjugated anti-mouse immunoglobulins
(1:1000) was applied for lh at room temperature. Following further washing x 3, cells were mounted
as above for viewing.
2.12.4 Anti-Thyl.l
Rat mesangial cells were labelled with this antibody (Serotec) as confirmation of their phenotype. Cells
were prepared as described above. However, these cells were not permeabilised due to the cell-surface
location of the antigen. After blocking, cells were incubated with the antibody or appropriate control
diluted 1:100 overnight at 4°C. After washing x 3 as above cells were labelled with FITC-conjugated
anti mouse immunoglobulin (1:1000) in PBS/NBCS for lh at room temperature. After further washing




Mesangial cell cultures (human and rat) were labelled with this antibody (Sigma) Cells were labelled as
described above using primary antibody at 1:300. Cos cells (monkey kidney tubular epithelial cells)
were used as a positive control. After washing and labelling with the secondary antibody, there was no
evidence of specific binding to any cells in the mesangial cell population.
2.12.6 Anti iNOS-haem
Both macrophages and mesangial cells were labelled with this antibody. Fixed, permeabilsed cells in
wells were blocked with PBS/NBCS blocking solution for 30min room temperature. The rabbit anti
serum was diluted 1:400 and applied in blocking solution to the cells overnight 4°C. After washing x 3
with PBS/Tween 20, cells were incubated with FITC or TRITC-conjugated anti rabbit
immunoglobulins (DAKO) (1:40) diluted in blocking solution for lh. After further washing (PBS) cells
were mounted with the DABCO-based mountant.
13. FLOW CYTOMETRIC IMMUNOFLUORESCENCE
2.13.1 Anti-Fas
Human mesangial cells were grown to 80-90% confluence in 6-well plates, then trypsinised using
standard TE. Immediately after loosening the cells were placed into polystyrene flow cytometry tubes
(Falcon) in 50% medium containing FCS to neutralise the trypsin and EDTA effect, on ice. Suspended
cells were centrifuged (200g, 5min, 4°C), and the medium overlying aspirated. The cells were then
suspended in 200(xl of PBS containing 10% NBCS. After 20min on ice, the primary monoclonal
antibody, CH11 (TCS laboratories) was added (l|ig/ml, 1:500). Appropriate IgM control was added.
After incubating the live cells for lh on ice, the polystyrene tubes were filled with 3ml of ice-cold PBS
to wash, then centrifuged again as above. After gentle aspiration of medium cells were resuspended in
200|il of PBS/NBCS containing FITC-conjugated anti IgM X at 1:1000. After 30 min on ice cells were




As a control for the effect of trypsin on Fas cleavage, Jurkat cells, known to express Fas on the cell
surface treated in the same way and used as a positive control.
2.13.2 Anti TNFR1
Sub-confluent human MC proliferating in T75 flasks were trypsinised and centrifuged as described
above (Chapter 2.13.1). For these experiments, cells were resuspended in ice-cold FACS flow solution
This solution is PBS, filter-sterilised containing bovine serum albumin (5%) and NaN3 (0.1%). This
solution was used in preference to the PBS/NBCS in an attempt to reduce background auto-
fluorescence. Cells were re-suspended in 200pl of the FACS flow containing 10% mouse serum, on
ice. The mouse serum was utilised to specifically block Ig receptors on the surface of mesangial cells
which might compete with the primary antibody binding.
After 20 min blocking on ice, the primary antibody (1:200, 5|0.g/ml) or irrelevant control mouse IgG^
After lh incubation on ice, cells were washed by adding 3ml of ice-cold FACS flow to each
polystyrene tube, followed by centrifugation (200g, 5min, 4°C). Cells were resuspended in 200|il of
FACS flow containing FITC-labelled secondary anti mouse IgG (DAKO 1:1000) and after 30 min
washed again followed by centrifugation. The cells were again resuspended and analysed by flow
cytometry.
2.13.3 Anti F480
Mouse bone marrow-derived macrophages were phenotypically defined by expression of cell surface
staining for the protein antigen F480. Live cells were prepared as described for cell surface labelling of
mesangial cells (Chapter 2.13.2). After preparation, cells were suspended in FACS flow solution and
incubated with anti-F480-FITC (Serotec) or irrelevant rat IgG at 1:50 dilution in FACS flow containing
10% rat serum. After lh, cells in polystyrene tubes were washed with FACS flow (3mls per tube) and
re-pelleted (220g, 5min, 4°C). Since the antibody was directly conjugated cells were resuspended and
assessed by flow cytometry. A one log10 order shift in green fluorescence was seen in the whole cell




2.14 ACCELERATED NEPHROTOXIC NEPHRITIS IN THE RAT
2.14.1 Induction of accelerated nephritis
Male Sprague-Dawley rats (weight 180-200g) were immunised by injection of lmg normal rabbit IgG,
in Freund's complete adjuvant (Difco) subcutaneously in the flanks.. After seven days, the rats were
injected with 1ml of nephrotoxic serum intravenously. Nephrotoxic serum was generated by repeated
(x 3) injections subcutaneously of 5mg of crude extract of rat glomerular basement membrane, into
rabbits. The initial dose and boosters were given at monthly intervals. The rabbits were sacrificed and
serum obtained by exsanguination. The serum was pre-absorbed against rat red cells obtained from SD
rats. Briefly, the serum was incubated overnight at 4°C with whole red cells, before centrifugal
separation. Dilutions of serum were assayed with red cells at 37°C to determine whether anti-red cell
antibodies remained. If significant red cell lysis occurred at dilutions greater than 1:3, the serum was
absorbed again with rat whole red cells.
2.14.2 Assessment of proteinuria and renal function
The night prior to experimental time point, animals were placed in individual metabolic cages. Urine
was collected in metabolic cages for 18h and frozen. At a later time point albuminuria was confirmed
by rocket immuno-electrophoresis (performed by hospital laboratory).
2.14.3 Histology
Animals were killed, and cortical biopsies were taken for histology (paraffin sections), standard
haematoxylin and eosin staining which confirmed severe proliferative glomerulonephritis. Biopsies
were placed in Methyl Carnoy's fixative and stored at -80°C, and also were placed in mountant and
frozen directly in liquid nitrogen, before being transferred to -80°C for storage prior to preparation of
fresh-frozen sections.
2.15 ANALYSIS OF DATA
Experimental data were expressed descriptively as mean values with standard error of mean
demonstrated using error bars or preceded by ± symbol.
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Experimental data were compared using student's t test for comparison of two variables. In cases
where multiple variables were tested, ANOVA was utilised.
Significance P < 0.05 was denoted by *, P < 0.01 by ** and P < 0.001 by ***.
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3.1 QUIESCENT OR UNACTIVATED RODENT MACROPHAGES DO NOT INFLUENCE
RAT MESANGIAL CELL APOPTOSIS
Twenty thousand, seven day rat bone-marrow-derived (BMD) macrophages (M(|>) were plated into
wells of 0.3cm2 (96 well plate) overnight in full (i.e. containing 10% FCS) DMEM/F12 and left to
spread for 16h. Rat mesangial cells (MC), pre-labelled with green CMFDA were trypsinised. Twelve
thousand were added to wells containing in 200|Lil of medium, or to adjacent control wells
containing medium with no M(|). Once adherent (2-3h) wells were washed, and 200(il of full
DMEM/F12 medium replaced. Cells were incubated at 37°C, then either fixed at 8h and 24h or
assessed live at 24h. Later time-points were hindered by overgrowth of MC when contact inhibition
lead to a reduction in mitotic figures seen.
Experiments carried out in this manner were assessed for apoptotic and mitotic MC by inverted
fluorescence microscopy of both live cultures and formaldehyde fixed cultures by counterstaining with
both propidium iodide which binds to DNA and RNA and fluoresces red, and Hoechst 33342 which
binds to DNA and fluoresces blue (Figure 3-1, Figure 3-2). Mesangial cells were discernible from M(j)
due to their green fluorescence from the CMFDA.
j!
Figure 3-1: Fluorescent photomicrograph (X 200) showing fixed co-culture of CMFDA green-labelled rat
MC co-cultured with rat BMD M(|> (appearing red/orange due to PI staining of cytoplasmic RNA. Note
presence of MC undergoing mitosis (arrow) and an absence of apoptotic cells
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Figure 3-2: M(|> do not influence apoptosis or mitosis of proliferating MC in co-culture. Rat BMD M(|>
(2xl04 per well) were co-cultured with CMFDA-labelled rat MC (1.2 x 104 per well) in the presence of full
DMEM/F12, and compared with 1.2 x 104 MC per well growing alone without M<|). (A) At 8h and 24h live co-
culture was assessed by Hoechst and PI staining by fluorescence microscopy for apoptotic green MC. After
fixation with formaldehyde solution and counter staining with PI and Hoechst, co-culture was scored
morphologically for (B) MC apoptosis and (C) MC mitosis. Note no significant difference between co-culture
and MC alone (n=4).
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Performing the co-culture in 8.0cm2 wells (6-well-plate) without pre-labelling mesangial cells with
CMFDA enabled the whole co-culture to be assessed by flow cytometry once the cells in the well were
trypsinised. It was found that the best flow cytometric assessment for mitotic and apoptotic cells was
propidium iodide (PI) staining of RNAse treated, ethanol fixed cells. This labelled the nuclei of cells
which the cytometer could detect by nuclear size, n = cells in Gq/Gx of the cell cycle. 2n = cells in
G2/M of the cell cycle and < n = hypodiploid cells, representing those undergoing apoptosis (Figure 3-
3). Other flow cytometric assays of MC apoptosis such as Annexin-V detection of phosphatidyl-serine
exposure on the outer membrane was unsuccessful largely due to the high auto-fluorescence of cells







Figure 3-3: Assessment of co-culture by flow cytometry. 6 x 105 mouse were co-cultured with 3.5 x 105
unlabelled rat MC in full DMEM/F12 according to Methods. After trypsinising the whole co-culture, processing
and labelling nuclei with PI they were analysed by flow cytometry (A). The co-culture was compared to 3.5 x 105
MC growing alone (B). Note there was no difference in the population of cells in G2M nor hypodiploid cells.
Note two diploid peaks representing rat and mouse nuclei.
Data from microscopical assessment of co-culture compared with MC growing alone, and also data
from flow cytometric analysis indicated that there was no evidence of significant difference in the
appearance mitotic or apoptotic MC. Therefore, quiescent M<|> did not appear to have any effect on
MC (Figure 3-2, Table 3-1).
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Experiments were repeated, but after washing the established co-culture, medium was replaced with
DMEM/F12 containing 1% FCS. At 24h, although the background level of apoptosis in control wells
had increased, there still did not appear to be any difference between co-culture and MC growing alone
in the occurrence of these parameters (Table 3-2).
Table 3-1: Flow cytometric analysis of cellular DNA content in unactivated rodent co-culture
Unstimulated Unstimulated Unstimulated
co-culture MC alone M(|) alone
% G2/M-phase cells 18.1±1.5% 19.4±1.1% 2.7±1.4%
% hypodiploidy 0.6±0.3% 0.7±0.2% 0.3±0.1%




3.2 CYTOKINE ACTIVATED RODENT M(j) INDUCE APOPTOSIS AND CELL CYCLE
ARREST OF RAT MC
Having established the co-culture assay, attempts were made to activate M<|) to determine whether
activated M<|> had any effect on rat MC. Initially, rat recombinant IFN-y was applied. Since in the
inflamed kidney, MC adjacent to M<|) would be exposed to the same cytokines, the whole co-culture
was exposed to the cytokines. This meant that controls of M0 alone and MC alone, exposed to the
same cytokines would have to be assessed.
Initial pilot studies involved priming BMD M<)) for 16h with IFN-y rat once they were seeded into
wells. One hundred U/ml and 500U/ml were tested. Once the co-culture was established and washed,
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the IFN-y was replaced. The co-culture was assessed microscopically at 8 and 24h. There appeared to
be a small effect: at 24h there was a decrease in the appearance of mitotic figures. However, this effect
was not uniformly reproducible. When mouse (C57B16) BMD M<|> were used in the same numbers in
co-culture with the rat MC there was no effect from IFN-y (rat IFN-y is equally efficacious when
binding to the murine IFN-y receptor). Given the variability of this effect, it was possible that some of
the IFN-y effect seen with rat M(J> might be due to low grade LPS contamination (Erwig et al., 1999)
acquired during collection of bone marrow.
Studies suggested that IFN-y priming of M<f> switched the phenotype enabling other signalling
molecules to activate the cell (Riches 1995; Erwig etal., 1999). To obtain full activation therefore, M(J)
were primed as described above. Once the co-culture was established IFN-y was replaced with IFN-y
plus TNF-a, IFN-y plus lipopolysaccharide (LPS-from Escherichia coli serotype 026:B6) or IFN-y plus
CD40L. As controls, LPS, TNF-a and CD40L were assessed in co-culture alone without IFN-y
priming. In addition, MC growing alone, without M<)> were exposed to the activating cytokines. A
variety of doses were assessed and it was determined that maximum effects of TNF-a were seen at
lOOU/ml, and for LPS this was 500ng/ml-1 fig/ml. of this particular preparation. lOOng/ml of LPS had
approximately 20% of the effect of lpg/ml and lng/ml had no discernible effect over IFN-y alone.
CD40L worked at lOng/ml.
The activated co-culture was assessed at 8h, 16h, and 24h by fluorescence microscopy initially and
later by flow cytometric analysis. At 8h there was suppression of MC mitosis, at 16h, there was
additionally the appearance of apoptotic MC, which was more striking at 24h (Figure 3-4, Figure 3-5).
Control wells showed no significant increase in MC apoptosis over this time-period. LPS alone
activating co-culture suppressed mitosis and weakly induced apoptosis (not shown).
Assurance that the cells seen microscopically after fixation with formaldehyde and counter-staining
with propidium iodide were truly apoptotic was concluded from studying live co-culture at 24h, when
small rounded-up cells, loosely adherent to the monolayer were seen. In live co-culture, the rounded up
cells appeared intensely green due to the presence of CMFDA. Addition of propidium iodide (PI)
(l|j.g/ml) and Hoechst 33342 (lp.g/ml) to individual wells enabled further assessment of these cells
after a five minute period to allow diffusion of the reagents. Hoechst can be used to label DNA of fixed
cells as it intercalates with DNA but not RNA. However, it has another property: live cells are able to
exclude it from the cytosol by means of membrane pumps (Sun et al., 1992), whereas apoptotic cells
(and necrotic cells) cannot. Therefore after 5min exposure, apoptotic DNA will fluoresce brilliantly
(365nm excitation) but live and mitotic cells will scarcely fluoresce. PI, on the other hand, is excluded
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from both live and apoptotic cells but can enter post apoptotic or necrotic cells due to increase
membrane permeability. The results of such studies revealed three important pieces of data:
The vast majority of green rounded-up cells seen in live co-culture were able to exclude PI, but they all
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Figure 3-4: Activated co-culture leads to MC apoptosis and suppression of mitosis. Rat BMD M<j) were co-
cultured with CMFDA-labelled rat MC in a 1.5 : 1.0 ratio (Methods). Once established the co-culture was
activated with IFN-y (lOOU/ml) plus LPS (lpg/ml). (A) The effect of M({> on MC apoptosis at 8h and 24h. Note
induction of apoptosis at 24h. (B) The percentage of mitosis at 8h and 24h, note suppression of mitosis at both
time points. (C) The effect of activated M<{> on MC number. Note a decrease in mesangial cells during the
time points assayed compared with the expected increase. * P < 0.01 vs. control MC alone (n=4).
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After fixation of the same wells with formaldehyde and counter-staining with PI (now all cells
admitted PI which binds to both DNA and RNA) the same cells that appeared apoptotic when assessed
morphologically (fixed experiments), were scored as apoptotic when assessed functionally in the live
culture (Table 3-3, Figure 3-6).
There was no difference in counting total apoptotic cells as assessed by Hoechst when compared with
counting apoptotic MC only demonstrating that M<|> do not undergo apoptosis in this assay (Table 3-3).
Assessment of the whole co-culture by flow cytometry again using PI to bind DNA only, revealed an
increase in hypodiploid cells that was attributable to apoptotic mesangial cells alone (since there was
no evidence of M<)) apoptosis in wells of activated M<j) alone or M<|> apoptosis in co-culture when
assessed microscopically). Although not all M<|> in wells were loosened when the co-culture is
trypsinised for this assay, their presence is seen by the double G[ peak. These M<(> diluted the absolute
level of MC apoptosis as assessed by this method (Figure 3-7, Table 3-4).
Table 3-3: Percentage apoptotic rat MC in live co-culture by exclusion of propidium iodide but not
Hoechst 33342
Hoechst +ve cells PI +ve cells Apoptotic MC in
fixed co-culture
Activated co-culture 17.9±1.4% 2.7±1.4% 16.0±2.6%
Several other methods were assessed for measuring apoptosis of mesangial cells in co-culture. These
included TUNEL staining (Gorczyca et al., 1993), JC-1 labelling (Macho et al., 1996), apo-3 staining
and assessing cells for DNA fragmentation using a thymidine labelling, glass fibre method
(Erusalimsky et al., 1996). However, these assays either did not work (apo-3 assay, and fragmentation
assay due to presence of FCS) or were insensitive due to loss of delicate apoptotic cells during
processing (TUNEL and JC 1). It was found that the most sensitive assay was blinded microscopical
counting of live/fixed wells with verification from the hypodiploid study (which also had the advantage
of assessing cells in G2/M.
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Figure 3-5: Fluorescent micrograph of activated rat co-culture of BMD with CMFDA-labelled MC.
(A) At 24h of co-culture, after fixation and counter-staining with PI, the co-culture shows many green rounded-
up cells with evidence of red nuclear condensation (X200). (B), A Mc|> adjacent to a green MC showing
cytoplasmic blebbing, characteristic of early apoptosis (XI000).
100
Chapter 3: Results 1. Inflammatory macrophages induce apoptosis of mesangial cells
Table 3-4: The effect of activated rodent co-culture on percentage G2M and hypodiploid MC
unstimulated activated
co-culture co-culture
% G2/M-phase cells 18.1±1.5 10.4±1.4*
% hypodiploidy 0.6±0.3 6.2±2.2*
Activated MC alone showed 0.6±0.3% hypodiploidy and 18.1±1.5% G2/M cells. M(|) alone showed 0.3+0.1%
hypodiploidy, with out cells in G2/M
For further verification of the suppression of mitosis, co-cultures were stained immuno-histochemically
for the proliferating-cell nuclear antigen (PCNA). The staining procedure results in loss of apoptotic
cells from the wells. However, counter-labelling with and a-smooth muscle actin to distinguish MC
from M<|> enabled scoring rat MC for PCNA positivity. The results confirmed a reduction in PCNA
positive MC in co-culture (Table 3-5). However, this was only seen at 24h, not 8h, which may reflect
the duration of PCNA activity during the cell cycle. Assessment was made by microscopical counting
of fixed, labelled wells for PCNA-positive MC. Interestingly, M<|>, which were not seen to undergo
mitosis in activated co-cultures, though an occasional mitosis was observed in quiescent co-cultures,
were uniformly PCNA positive. This observation may be relevant to findings of PCNA positive M<j)
(by dual labelling in sections from patients with human glomerulonephritis (Lan et al., 1995). Thus
PCNA M<() might not necessarily be proliferating. The three assays of MC proliferation described, all
indicate that in co-culture with activated M<|> MC are prevented from proliferating.
Table 3-5: The effect of co-culture on PCNA-positivity of rat MC at 8h and 24h
unactivated activated activated
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One important observation throughout was the lack of M<|> apoptosis. Observations of the development
of BMD M(|> in wells showed a proliferative burst from days 2-4 of differentiation. Thereafter, there
was a steady decline in M<|> numbers. These cells were lost by low-grade apoptosis (Mangkornkanok et
al., 1975; Daems et al., 1976). Similar loss of human monocytes during differentiation to M<|) can be
seen and similar observations have been made by others (Flad et al., 1999; Kiener et al., 1997). There
are publications (Lan et al., 1997; Nitsch et al., 1997) indicating the activated M(j) can undergo
apoptosis, which may be TNF-mediated. However, when M<|) alone were seeded to wells, washed and
activated (IFN-y plus LPS), then assessed for apoptosis at 24h, by fluorescence microscopy, there was
consistently <0.5% apoptosis. In co-culture, assessment of total apoptotic cells in live co-culture (by
Hoechst staining) showed no significant difference when compared to apoptotic MC as assessed by
morphological assessment of fixed wells (Table 3-3). Together these results indicated that the cell type
undergoing apoptosis was almost exclusively the MC.
The MC used in this assay were derived as outgrowths from whole rat glomeruli from the Sprague
Dawley rat. To be sure that the effect of M({> on MC seen was not simply an artefact of this particular
cellular outgrowth, two other outgrowths were derived; one from the Sprague Dawley rat and the other
from the Wistar rat. Initially, these cells grew very slowly but after the fourth passage they grew much
quicker and were duly used in the co-culture assay, as described above. On this occasion, the rat M(|)
were primed for 16h with IFN-y, then activated using IFN-y and LPS once the co-culture was
established (Table 3-6). Both these rat MC types were induced into cell cycle arrest and apoptosis by
co-culture with M<(), confirming this as a general effect.
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Figure 3-6: Confirmation of MC apoptosis in live co-culture at 24h. (A) (X 500) green rounded up MC
exclude PI (i), but do not exclude Hoechst 33342 (ii), characteristic of apoptosis. After fixation and counter-
staining the same cells reveal the morphological criteria of apoptosis (iii). Note some rotation of apoptotic cells
during fixation. (B) At lower power (X 320) one can clearly see apoptotic cells (Hoechst positive only) but they
exclude PI (i). After fixation and counter-staining the apoptotic green MC can be seen amongst live
(appearing orange post apoptotic cells (ii)).
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Figure 3-7: Fluorescence intensity histograms showing Gq/Gj, G2/M and hypodiploid cell DNA content in
(A) quiescent co-culture, and (B) activated co-culture. In activated co-culture, the percentage of hypodiploid cells
(Ml) was 9.1% compared with 0.47% in quiescent cultures. These figures correlated well with percentage
apoptotic cells as assessed by fluorescent microscopy of live cultures. UV induction of MC apoptosis was used as
a positive control (not shown).
Table 3-6: The effect of activated co-culture on apoptosis of primary polyclonal rat MC at 24h
Unactivated co-culture activated co-culture
Co-culture
% MC apoptosis 1.2±1.0% 7.9±1.2%*
% MC mitosis 2.0±0.6% 0.1±0.1%**
MC growing alone
% MC apoptosis 1.2±0.5% 1.0±0.3%
% MC mitosis 1.8±0.7% 2.5±0.4%
* P < 0.05 **P<0.01 (n=6) ~
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3.3 SUPERNATANTS FROM ACTIVATED RODENT M<|> HAVE NO EFFECT ON RAT
MESANGIAL CELL CYCLE OR APOPTOSIS
In order to determine the mechanism by which M<(> were inducing apoptosis and cell cycle arrest of MC
initial studies focussed on whether supernatants from activated M<|) could 'carry over' the effectors
from M<j) to MC. That is, whether the effectors were soluble (as opposed to membrane bound) and
stable.
1.5 x 105 M(|) in culture in wells of 24-well plates (2.0cm2) were cultured in 500|J.l of full DMEM/F12
for 24h either with IFN-y/LPS activation or without (carriage medium only).
After 18h, the supernatants were collected, centrifuged (4°C 5min 4000g) to remove any cell debris.
200(il was transferred to rat MC that had been seeded into wells of 96-well-plates at a 70% density.
Cultures were continued for 24h, and as controls fresh medium containing IFN-y/LPS were placed on
adjacent MC. At 24h, wells were fixed and assessed for MC apoptosis (Table 3-7). Supernatants
transferred from Mc|> to MC did not have the ability to induce MC apoptosis or cell cycle arrest over
24h, indicating the need for close apposition or contact between the two cell types.
Table 3-7: The effect of supernatant transfer from IFN-y/LPS activated rat M<|) to rat MC on MC apoptosis
















Note relatively high background levels of apoptosis. No significant differences
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3.4 M<|> INDUCTION OF BOTH CELL CYCLE ARREST AND APOPTOSIS IS BLOCKED BY
INHIBITORS OF NITRIC OXIDE GENERATION
Given the necessity for co-culture rather than supernatant transfer, it was decided to use simple soluble
inhibitors of candidate effectors, which could be added to the co-culture at the time of activation. In the
literature, there are reports of nitric oxide inducing cell cycle arrest and apoptosis of mesangial cells
(Muhl et al., 1996). This was obviously a candidate. Furthermore, activated M(|) are known to undergo
a respiratory burst in certain circumstances (Johnson et al., 1987) and both Cook et al and Johnson et al
have noted a potential role for oxygen radicals as M<|) effectors in glomerulonephritis (Cook et al.,
1989; Johnson, Guggenheim et al., 1988). Initially blocking studies were set up adding L-monomethyl
arginine, a competitive nitric oxide synthase inhibitor at 500|J.M (as suggested by Mannick et al., 1994;
Waddington et al., 1996), using D-monomethyl arginine as a control (inactive) amino acid. Enzymes,
degrading oxygen radical effectors, super oxide dismutase and catalase were also added at 500U/ml
(effective concentrations suggested by Sugiyama et al (Sugiyama et al., 1996)) (Table 3-8). These
initial studies indicated a potent effect of L-NMMA on MC apoptosis in co-culture.
Table 3-8: The effect of nitric oxide and super-oxide radical inhibitors on induction of rat MC apoptosis in
co-culture with M(J> at 24h
Percentage apoptosis at 24h
Activated co-culture Activated MC control
Inhibitor:
None 12.4±2.4% 1.2±1.4%
L-NMMA (500pM) 2.2±2.1%* 1.6+1.5%
D-NMMA (500pM) 13.4±1.9% 1.9±2.5%
S.O.D. (500U/ml) 11.9±3.1% 0.9+1.1%
Catalase (500U/ml) 13.1+1.2% 1.3±0.3%
S.O.D. plus catalase (500U/ml) 14.1±2.1% 1.2±0.9%
*P<0.01 (n=4)
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Figure 3-8: Dose response curve showing the dose of L-NMMA required to inhibit rat MC apoptosis in
activated co-culture at 24h (IC50 5.1 ±3.6|iM) (n=4).
To determine the effective concentration of L-NMMA activated co-cultures were set up with a range of
doses of the inhibitor (Figure 3-8). This shows an IC50 of 5.1±3.6|xM and total inhibition of M(|) killing
of MC with 100p,M of inhibitor. At 24h the NOS inhibitor L-NMMA (100pM), but not its inactive
analogue D-NMMA was able to almost completely reverse the M(j) effects on MC apoptosis and
mitosis. In fact, MC grew as though M(|) were not present (Table 3-9).
Table 3-9: The effect of L-NMMA and D-NMMA on activated M<)>-induced induction of rat MC apoptosis
and suppression of mitosis in co-culture at 24h.
L-NMMA D-NMMA
Co-culture Control Co-culture Control
% Apoptosis 2.6 ± 1.2 2.9 ± 1.9 16.3 ±4.3* 3.5 ±2.1
% Mitosis 2.9 ± 0.2 2.3 ±0.1 0.2 ± 0.2* 2.6 ± 0.2
Cell number 908 ± 104 911 ±86 549 ± 78* 820 ± 19
After pre treating with ylFN (lOOU/ml 16h), M(J) were activated using ylFN (lOOU/ml) and TNFa (lOOU/ml).
Either D-NMMA (lOOpM) or L-NMMA (lOOpM) was added to wells. * P < 0.05 compared with co-culture in
the presence of L-NMMA (n=4).
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L-NMMA is a non-specific NOS inhibitor. There are three NOS enzymes, recently renamed NOS1
(nNOS or neuronal), NOS2 (iNOS or inducible), and NOS3 (eNOS or endothelial). To be more
specific a NOS2 selective inhibitor L-N6-(l-iminoethyl) lysine dihdrochloride (L-NIL) was added to
co-culture at the same time as activation. This inhibitor behaved similarly to L-NMMA in that it almost
completely blocked the M<() effects on MC mitosis and apoptosis in the co-culture assay (Figure 3-9). A
dose response curve for this drug gave an ED50 of 0.33±0.40pM. Ten micromolar was sufficient to
maximally block the M<j)-derived effects. Note however, in these studies, there remained (not
significant) a small induction of apoptosis and inhibition of mitosis.
3.5 CYTOKINE-ACTIVATED RODENT M(J> INDUCE NITRIC OXIDE SYNTHASE 2 AND
ABUNDANTLY PRODUCE NO
One hundred thousand 7day BMD rat M<|) were seeded into wells of 24-well plates overnight. After
16h, M(|) were washed and 400|il of full DMEM/F12 (without phenol red) or DMEM/F12 containing
no FCS was added. M<|> were activated with cytokines (Figure 3-10) and cultured for 24h. At this stage,
supernatants were collected, centrifuged to removed cell debris (4000g, 5min). An equal volume of
Griess reagent was added at room temperature for 5min before the sample was assessed by photo-
spectrometry at 540nm (OD540). Purple coloration indicated nitrite, the major stable product of NO
release.
Analysis of NO generation by rat M<j> indicated abundant release within 24h by activated M<|) but not
quiescent M(|) (Figure 3-10A). Further, IFN-y alone was a weak inducer of NO generation, but was
necessary in switching M<|) to become sensitive to other cytokines. Indeed, in murine studies, IFN-y
alone did not bring about NO generation (Table 3-10). Thus low grade LPS contamination in the rat
cultures might explain why IFN-y alone was able to induce nitrite production. These data are in
keeping with many published reports about the generation of NO by rodent M(|) (Fournier et al., 1995;
Erwig et al., 1999). Mouse M<|) similarly produced abundant nitrite in supernatants using a similar
experimental protocol (Table 3-10).
When M(|) were activated in the presence of the inhibitors L-NMMA and L-NIL there was a 50-60%
reduction in nitrite production at inhibitor concentrations sufficient to block M(|) killing of MC (Figure
3-10B,C.). Furthermore, in prolonged culture, M<|) produced most nitrite during the first 24h, less in the
next 24h and thereafter produce no more nitrite. This occurred despite replenishing medium and
cytokines every 24h (Figure 3-11).
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Figure 3-9: The effect of activated M<|> on rat MC apoptosis and mitosis is largely abrogated by the addition
of the NOS 2 inhibitor L-NIL. Rat BMD M<|), primed ylFN for 12h, then activated with ylFN (lOOU/ml) and LPS
(lpg/ml) were cultured with mesangial cells as described in Methods. L-NIL (30pM) or carriage medium was
added once the co-culture was established. (A). The effect of L-NIL on activated M(J)-induced apoptosis of
mesangial cells at 24h. L-NIL almost completely abrogates the effect of co-culture on MC apoptosis. (B) The
effect of L-NIL on activated M(|)-induced suppression of mitosis at 24h. L-NIL restores mesangial cell mitosis.
(C) L-NIL in the co-culture enables MC to increase in number similarly to controls. * P <0.05 vs. co-culture in
the presence of carriage medium (n=4).
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Figure 3-10: Nitrite generation in the supernatants of activated rat BMD M((>, cultured in full DMEM/F12,
expressed as nmole of nitrite per 106 cells per 24h. (A) A comparison of pro-inflammatory cytokines. (B) The
effect of iNOS inhibitors in IFN-y/LPS induced NO generation. (C) The effect of iNOS inhibition on IFN-y/TNF-
a induced NO generation (IFN-y lOOU/ml, TNF-a lOOU/ml, LPS lpg/ml, L-NMMA lOOpM, L-NIL 10(iM)
(n=4).
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Table 3-10: Generation of nitrite in supernatant of 1.0 x 105 murine M(|> in 400pl full DMEM/F12
Nitrite produced over 24h
Control IFN-y ylFN/LPS ylFN/TNFa
Mouse BMD M<|>














Figure 3-11: Accumulation of nitrite in supernatants of cultures of activated rat BMD M<(> with time. Fresh
medium with cytokines was replaced every 24h. There was no significant loss of M(|) over the period of study.
Cultures were activated with IFN-y (lOOU/ml) /LPS (lpg/ml). In some cultures L-NMMA (lOOpM) was also
added (n=4).
By indirect immunofluorescence, M<|) in 24-well plates as described above, homogeneously induce
cytoplasmic iNOS, whereas unactivated or quiescent BMD M<|> do not have cytoplasmic iNOS (Figure
3-12).
Ill
Chapter 3: Results 1. Inflammatory macrophages induce apoptosis of mesangial cells
Figure 3-12: Immunofluorescent micrograph (X 200) of iNOS in activated rat BMD M<|) at 6h after
activation with IFN-y and LPS. The cultures were fixed with ice cold methanol, then labelled with anti-iNOS
specific polyclonal antibody followed by the appropriate FITC-conjugated secondary antibody. Negative control
rabbit pre-immune serum (not shown) did not reveal specific binding. Note unactivated M(|) (not shown) showed
no specific binding of anti-iNOS antibody.
3.6 CYTOKINE-ACTIVATED RODENT MC INDUCE NOS 2 AND PRODUCE LOW
LEVELS OF NITRIC OXIDE
The data presented so far lead one to hypothesise that activated M<|> by their release of NO directly
induce cell death and cell cycle arrest of rat MC. However, there are other possible explanations for the
data. One possibility is that NO feeds back on the M<j) to maintain activation in a similar way that
Riches' group suggested TNF-a dependent feedback to maintain activation of M<|> (Lake et al., 1994).
Other factors released by the M<|> would actually be the effectors. Another possibility is that MC also
produce NO (perhaps to protect from M(|) mediated damage), and NO blockade selectively blocks this
generation and renders the MC susceptible to other factors. Indeed, there is significant literature on the
ability of rodent MC to produce NO (Nitsch et al., 1997; Shultz et al., 1994; Waddington et al., 1998;
Mohaupt et al., 1994).
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To test this, 0.6 x 105 rat MC were cultured in wells of 24-well plates overnight, washed and 400|li1 of
full DMEM/F12 or DMEM/F12 without FCS, was replaced. MC were then activated with a variety of
cytokines to induce nitrite production in the supernatant. Supernatants were analysed 24h later after
centrifugation (4000g, 5min) to remove debris.
Initial results showed no evidence of NO generation (data not shown). However, the sensitivity of the
Griess assay is approximately l|iM (lower limit of assay). Following consultation with both Prof. J.
Pfielschifter (Frankfurt) and Dr. V. Cattell (Imperial College, London) the three rat MC clones used in
these studies were assessed more thoroughly for NO generation. Initially, by indirect
immunofluorescence, it became apparent that in the presence of IFN-y together with TNF-a iNOS was
induced (Figure 3-13). Activation of M<|> with IFN-y (lOOU/ml) alone, TNF-a (lOOU/ml) alone, LPS
(l|Lig/ml) with and without IFN-y and IL-lp (40ng/ml) did not induce iNOS.
Figure 3-13: Induction of iNOS in rat MC. 0.6 x 105 rat MC clone (sub-confluent) was cultured in 24-well
plates with 1.0ml full DMEM/F12, and activated with IFN-y (lOOU/ml) with TNF-a (lOOU/ml) or carriage
medium for 24h. After fixation with ice cold methanol, cells were incubated overnight with anti-iNOS specific
polyclonal antibody followed by appropriate secondary antibody. (A) clonal rat MC. (B) polyclonal rat MC. Note
induction of cytoplasmic iNOS in cytokine activated culture. Some cells strongly express iNOS, others weakly
express and others appear negative. Note cells incubated with pre-immune rabbit serum as negative control
showed no specific binding (not shown).
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Culture of large numbers of MC in T75 flasks for 48h confirmed the generation of small quantities of
NO by Griess reagent. However, the MC only produced NO and iNOS in response to IFN-y together
with TNF-a (Figure 3-14). These experiments were performed concurrently with several clones
(Figure 3-14), which showed broadly similar results, i.e. that IL-1 (3 alone had no effect on NO
generation and the IFN-y with TNF-a were the most important cytokines in inducing NO generation.
Indirect immunofluorescence of fixed wells for iNOS (Figure 3-13) showed that more cells were
strongly positive for the enzyme 48h than 24h (4.7% vs. 20.2%) when using lOOU/ml of each cytokine.
Increasing the dose to 300U/ml of each cytokine increased the number of strongly positive cells to
16.8% at 24h and 30.4% at 48h. The remaining cells were weakly positive or and a few were negative,
though this was difficult to score microscopically. The studies therefore were assayed at 48h. However,
despite this result, the nitrite generated in the medium represented 2%-5% the amount of NO generated
by an equal number of rodent M<(). By comparison, similar immunofluorescence of BMD M<|) for iNOS
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Figure 3-14: Nitrite accumulation in supernatants of rat MC growing (clonal P8, polyclonal P6) in T75
flasks over 48h. Aliquots of rat MC (clonal or polyclonal) were seeded into T75 flasks with 5ml full DMEM/F12.
After overnight culture they were activated as indicated. 48h later, supernatants collected and assayed for nitrite.
Cells were trypsinised and counted by using a haemocytometer. Nitrite accumulation was normalised to cell
number (TNF-a 300U/ml, IFN-y 300U/ml, LPS lpg/ml, IL-lp 40ng/ml).
The nitrite and iNOS data were in contrast to published work showing early rat MC primary cultures
(P1-P3) produced NO in response to LPS alone (Shultz et al., 1994; Mohaupt et al., 1994).
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Furthermore, Pfeilschifter's group showed their mesangial cell clone (MZ) (derived from single cell
preparation of rat glomeruli initially cultured at 1 cell per well) abundantly produced NO in response to
IL-lp alone, though not to LPS (Nitsch et al., 1997). Cattell's group had also published work on a rat
MC clone producing abundant NO in response to IL-lp alone (Waddington et al., 1998), though they
have struggled to produce further clones with this phenotype (Personal communication S.
Waddington). Cattell's group demonstrated in the Thy 1.1 model of mesangio-proliferative
glomerulonephritis that NO released from whole glomeruli extracted from kidneys of Lewis rats with
nephritis correlated closely with the presence of M0, not mesangial cell proliferation (Cattell et al.,
1993). Furthermore, when diseased glomeruli were exposed to LPS, they produced more NO.
Exogenous IL-lp also increased NO generation but this again appeared to reflect M<\> infiltration.
(Cattell et al., 1993).
Figure 3-15: Fluorescent micrographs (X200) of confluent monolayers of early passage rat MC cultures (P2)
showing induction of iNOS by LPS in some cells co-localises with ED-1 positive M(j).. 0.6 x 105 rat MC were
cultured in 24-well plates with 1.0ml full DMEM/F12, and activated for 24h with IFN-y (lOOU/ml) and LPS
(ljig/ml). After fixation with ice cold methanol, cells were incubated overnight with (A) anti-iNOS specific
polyclonal antibody followed by phycoerythrin-conjugated secondary antibody or (B) anti-ED-1 monclonal
antibody, followed by FITC-conjugated secondary antibody. Note in the iNOS view a MC (see different
morphology) weakly staining positive next to a M<|> (arrow).
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Staining of glomeruli for iNOS indicated co-localisation with ED-1 positive cells only (T Cook,
Imperial College. Personal communication) These data would seem to suggest, at least in the Thy 1.1
model of nephritis, M((), not MC were the major source of NO.
To investigate these conflicting observations further, early passage rat MC (P1-P3) revealed by
immunofluorescence the presence of strongly iNOS positive cells in response to LPS alone. These
positive cells appeared different from adjacent cells and dual labelling with anti-ED-1 (rat M<|> antigen)
indicated significant numbers of M<|> in the culture (Figure 3-15). They represented up to 5% of cells in
the culture, but were no longer present from P5 onwards. This observation, I believe explains why
early passage rat MC generate low levels of NO in response to LPS (Shultz et al., 1994).
To further clarify the issue of NO generation by MC in culture, P15 MZ cells from Prof. Pfeilschifter
(Nitsch et al., 1997) were obtained. These cells were cytologically a little different from any MC
(human, rat or mouse) cultured in our laboratory before (Figure 3-16). Phase contrast microscopy
indicated them to often lack the characteristic spindle morphology. They were, however, positive for
oc-smooth muscle actin by indirect immunofluorescence (data not shown). Unfortunately, there are no
specific markers for rat mesangial cells as fibroblasts and interstitial myo-fibroblasts share the same
markers (including Thy 1.1).
Figure 3-16: Phase contrast photomicrographs showing (A) rat MC (X 200) cultured in our laboratory, (B)
the same rat MC at higher power (X320) showing spindle morphology. (C) Rat 'MZ' cell provided by Prof.
Pfeilschifter at low power and (D) the same cells at higher power showing a different morphology with less
tendency to form spimdle morphology.
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These MZ cells did indeed produce large amounts of NO in response to IL-ip. They produced much
more in response to IFN-y with TNF-a. LPS was ineffective (Figure 3-17). The NO generated by
equivalent numbers of cells in response to cytokines, was approximately 30% that produced by M(().
When MZ cells were co-cultured for 24h with activated M(J), there was no specific NO-dependent
killing. Indeed supernatants from the co-culture contained large amounts of NO, greater than observed
from an equal number of M<|> alone. This would suggest that pro-inflammatory cytokines released from
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Figure 3-17: Representative study of nitrite generation in the supernatant of MZ mesangial cells growing in
T75 flasks over 48h. Aliquots of rat MC were seeded into T75 flasks with 5ml full DMEM/F12. After overnight
culture, they were activated as indicated. 48h later, supernatants collected and assayed for nitrite. Cells were
trypsinised and counted by haemocytometry. Nitrite accumulation was normalised to cell number (TNF-a
300U/ml, IFN-y 300U/ml, LPS lpg/ml, IL-1P 40ng/ml).
Table 3-11: Induction of apoptosis of MZ rat mesangial cells by rat BMD M()) in activated co-culture
Unactivated Activated
Co-culture Control Co-culture Control
% Apoptosis 2.4 ±1.3 1.8 ±1.2 3.9 ±1.3 1.8 ±1.1
% Mitosis 2.2 ±1.2 1.8 ±0.6 1.3 ±0.6 2.2 ±0.8
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Immunofluorescence of the co-culture using MC from our laboratory indicated that despite induction
of iNOS in some MC, these MC were susceptible to M<J) derived NO killing. That is some of the
apoptotic MC were positive for iNOS. This study was difficult due to loss of apoptotic cells during
washing, however iNOS positive apoptotic cells were seen. Indeed studies detailed in the next section
will highlight that MC that have been treated with IFN-y and TNF-a to produce NO were equally
susceptible to apoptosis induced by exogenous donors of NO.
3.7 RODENT MC UNDERGO CELL CYCLE ARREST AND APOPTOSIS IN RESPONSE TO
HIGH LEVELS OF NO DONORS
To test the susceptibility of MC to nitric oxide, MC were plated into wells at 70% density and allowed
to grow for at least 4h. This duration of growth was important, as Sterzel's group (Yao et al., 1998) had
shown that adhesion protected cells from apoptosis induced by low levels of NO. In preliminary
experiments, MC that had been adherent longer than 4h (not shown) were no less susceptible compared
with those plated for 4h. However, those cells that had been adherent for only lh were much more
susceptible to NO-donors. When cells were seeded into plates containing medium with NO donors
(0.1 mM GSNO) pre-added, they also underwent apoptosis (data not shown). Probably, these data
emphasise the importance of integrin-mediated adhesion in the survival of MC and myofibroblasts in
general. (Singhal et al., 1998; Jobson et al., 1998; Mooney et al., 1999).
Specific nitric oxide donors were chosen because of the availability of non-toxic, control substances:
S-Nitroso glutathione (GSNO), releases glutathione (glu) and NO, S-Nitroso penicillamine (SNAP)
releases penicillamine (NAP) and NO. These breakdown products were therefore used as controls on a
mole for mole basis.
The NO-donors resulted in far more nitrite in the medium at 24h than M<(). When 0.1 mM GSNO was
incubated in solution for 24h the A540 with the Griess reagent was 1.370. Typical A540 of 1.0 x 105 rat
M<|) in incubated in the same conditions was 0.300-0.600. The site of action of the NO donors,
however, is throughout the medium in the well (there is no receptor ligand interaction). This is because
the donors break down spontaneously in solution. NO release from M<)) interacting with MC is at a very
specific point where local concentrations will be much higher.
Cells were exposed to a range of doses of NO donors, or the appropriate control. At 24h plates were
fixed and assayed subsequently using Hoechst and PI to fluorescently label DNA/RNA, and counted
microscopically for apoptosis and mitosis. NO donors but not their controls induced apoptosis in the rat
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MC (Figure 3-18). In this study, 0.5M GSNO at 24h resulted in 0.00% mitosis compared with 2.38%
mitosis in the presence of 0.5M glutathione. A time course for induction of apoptosis and suppression
of mitosis is also shown (Table 3-12). There was a progressive increase in apoptosis over a 24h period
(in keeping with the co-culture data).
0 0.5 2.51 1.5 2
[NO donor] mM
Figure 3-18: Induction of rat MC apoptosis by donors of NO. 70% confluent rat MC clone cultured in full
DMEM/F12 was exposed to 0.5,1.0,1.5, and 2.0mM of the NO-donors GSNO or SNAP, or appropriate control.
Experiments were fixed and assayed after 24h incubation.
Table 3-12: Induction of apoptosis and cell cycle arrest of rat MC by lOmM GSNO with time
8h 16h 24h
NO donor-GSNO l.OmM
% MC apoptosis 5.2±1.4% 13.7±2.0% 16.3±2.3%
% MC mitosis 0.0+0.0% 0.0±0.0% 0.0±0.0%
control glutathione 1 .OmM
% MC apoptosis 1.5±0.5% 1.0±0.5% 0.3+0.1%
% MC mitosis 2.3±0.5% 4.9±1.3% 2.0±0.5%
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Note that even without induction of apoptosis (at lower doses), there was cell cycle arrest. Flow
cytometric data indicated that there was an accumulation of cells in G,/G0. (Data not shown).
Notably, the early passage primary rat MC were less susceptible to apoptosis by NO donors.
Nevertheless, at higher doses the donors did induce apoptosis. This may relate the their lower rate of
proliferation (as reflected by percentage mitosis), compared with later passage cells or the rat MC
clone (Table 3-13).
Table 3-13: Induction of polyclonal rat MC (P5) apoptosis by the NO-donor, GSNO at 24h
Percentage apoptosis
l.OmM 2.0mM 5.0mM
GSNO 6.6±1.4% 11.4+3.0% 19.0±4.9%
glutathione 4.1 ±1.5% 4.9±1.0% 3.8±1.1%
Prof. Pfeilschifter's group had shown that their MZ cells were resistant to NO donors when activated to
produce NO (Muhl et al., 1996). To test this, our MC clone was stimulated for 24h with IFN-y
(300U/ml) plus TNF-a (300U/ml) (or mock-stimulated with carriage medium) to induce iNOS and NO
generation. Activating cytokines were washed away with PBS x 3. Cells were then plated in wells at
equal density, and after 4h of growth, the active NO-donor GSNO was added at a range of
concentrations. Wells were assayed at 16h (Figure 3-19). Note that even after withdrawal of cytokines
from the cells they continue to release NO (nitrite) into the supernatant for 24h. Nitrite in supernatant
in first 24h was 12nmole/106 cell, and during the 24h after cytokine withdrawal was 8nmole/106 cells.
These data indicated no protection of MC from exogenous NO following endogenous production of
low levels of intracellular NO.
Rat MC were primed with IFN-y plus TNF-a for 24h, then treated with IFN-y, TNF-a (to maximise
MC NO generation), and GSNO (ImM) to induce apoptosis. At 24h, 21.2±2.4% of primed cells
compared with 11.9±2.1% of unprimed cells were apoptotic (n=4 P < 0.05). Therefore, more apoptosis
was induced in the cells producing their own NO than cells which had been exposed to GSNO alone
without IFN-y plus TNF-a. This result was in contradiction to that which might be expected. Taken
together with the data above (Figure 3-19), which indicated that rat MC generating their own NO were
not more sensitive to NO donors, other factors must have been inducing apoptosis (Chapter 4).
Corroborating evidence was obtained using the MZ cells. When primed with IL-ip (to generate MZ-
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derived NO), then exposed to GSNO there appeared to be no difference of appearance of mitoses or
apoptotic bodies compared with unprimed cells (contrary to that which was published) (Nitsch et al.,
1997). However when treated with IFN-y plus TNF-a (to generate MZ-derived NO), then exposed to
GSNO there were fewer mitoses and an increase in apoptotic bodies. IFN-y and TNF-a must be
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Figure 3-19: Representative study of induction of apoptosis of unprimed or IFN-y/TNF-a (300U/ml) primed
rat MC by the NO donor GSNO. Rat MC were primed (IFN-y (300U/ml) TNF-a (300U/ml)) or mock-primed for
24h. Cytokines were washed away and cells were seeded into wells. After 4h, concentrations of the NO-donor
GSNO were added. Wells were fixed at 16h and assayed for apoptosis
3.8 NOS 2 KNOCKOUT MURINE M<|> CAN NOT INDUCE CELL CYCLE ARREST OR
APOPTOSIS OF RAT MC
The data presented so far suggested that it was most likely that M(J) induced MC apoptosis in co-culture
by release of nitric oxide. The induction of iNOS and NO generation by MC in response to IFN-y and
TNF-a suggested that the simple explanation might be more complicated. However, there was little
evidence that the iNOS positive MC from our laboratory were resistant, on the contrary they appeared
more susceptible to apoptosis. MZ cells from Prof. Pfeilschifter's group were resistant to M(|) killing. It
remains to be determined how relevant those cells are to in vivo biology given the difficulty in
generating cells from glomeruli that reproduce the phenotype of the MZ cell, and given the pattern of
NO generation in the Thy 1.1 model of glomerulonephritis (Cattell et al., 1993).
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To be clear as to the mechanism of MC killing, BMD M<|> from mice lacking iNOS (or NOS 2) were
utilised. Previous studies had confirmed that mouse BMD M(j) (Chapter 3.2) shared the ability with rat
BMD M<\> to induce apoptosis of rat MC. In collaboration with Prof. Liew at the University of
Glasgow, 129/sv mice lacking a functional iNOS gene were obtained for use (Wei et al., 1995). Bone
marrow was harvested from five gene-targeted animals and five wild-type controls. Following
maturation in Teflon wells, M(|) differentiation was confirmed by cytology (Figure 3-20). Cells were
tested for NO generation by collection of supernatants from wells of 24-well plates (Table 3-14). These
data confirmed a dramatic reduction in NO generation over 24h, compared with same strain wild type
M(|). Interestingly, however, the cells could still be induced to produce some nitrite. There is evidence
that eNOS can also be induced, but that it is less efficient at NO generation (Weiner et al., 1994 Wei et
al., 1995). It may be an adaptive response by the animal that eNOS partially compensates for the lack
of iNOS.
Figure 3-20: Photomicrograph (X 400) of Diff-Quik stained cytospins of murine bone marrow derived M(|)
from iNOS knockout 129/sv mice. Note characteristic morphology of macrophages. There were no
morphological differences compared with the wild type (not shown).
M(|) were co-cultured with rat MC as previously described and assayed at 8h, 24h and 48h. At 24h wild
type M(|) induced apoptosis of rat MC (Figure 3-21), yet the knockout M(|) were incapable of doing so.
This difference was marked and clear. In addition, whilst mitosis was suppressed by wild type M(|), the
knockout M(() did not suppress MC mitosis (Figure 3-21).
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Table 3-14: Nitrite generation by wild type and iNOS knockout murine BMD M(f>
Nitrite produced over 24h
Control ylFN/LPS
129/sv wild type 3.7 ± 0.4 134.2 + 38.2

























Figure 3-21: The effect of M<() from iNOS knockout mice on rat MC apoptosis and mitosis. Co-culture with
CMFDA-labelled MC was establish in a 1.0 MC:1.5 M<|> ratio. After washing some experiments were activated
with IFN-y (lOOU/ml) and LPS lpg/ml. After 24h incubation wells were fixed and scored for (A) MC apoptosis
and (B) MC mitosis. iNOS knockout M<J) were compared with wild type M<|> and MC growing alone (n=4).
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3.9 M<j) FROM INFLAMED RAT GLOMERULI SPONTANEOUSLY PRODUCE
COMMENSURATE AMOUNTS OF NO
Whilst it was clear that M(|) derived from rat or mouse bone marrow induced apoptotic cell death of
MC by release of nitric oxide, it was important to determine how relevant this was to glomerular
inflammation. During the course of the thesis, it has become apparent that the models of
glomerulonephritis available, vary widely in phenotype and presence of cell type, depending on many
factors including strain of animal, specific batch of inducing agent and possible low grade pathogens
harboured by the animals used.
In collaboration with Prof. Rees (University of Aberdeen), the question was asked whether M(|> from
glomeruli of Sprague Dawley rats with a macrophage-rich form of telescoped nephrotoxic nephritis
shared similar properties with activated BMD M<)).
To achieve this telescoped NTN was induced. This particular disease model is believed to be a largely
cell-mediated disease, brought about by cognate and non-cognate CD4 T cells with M<() as the final
effectors (Rosenkranz et al., 2000; Erwig et al., 1999). This disease model results in proteinuria and
diminution of renal function within 48h, and progressive deterioration over succeeding weeks. On day
2, there were 21.4±3.1 M0 per glomerular cross section and by day 4, there were 16.1 ±1.5 M<j) seen
(approximately 80 cells per glomerular cross section).
To isolate M0, disease was induced, upon sacrifice of the animal, kidneys were removed onto ice.
Glomeruli were isolated from kidneys by sieving and then digested using enzymes to a single cell
suspension. The single cell suspension was then plated into wells of 24 well plates, in full DMEM/F12
and washed to remove non-adherent cells after 2h. M(}>, by their adherent properties were selected by
this process with > 90% purity.
To compare the effects of glomerular M(J) with BMD M<|), aliquots of single cell suspension were
placed in wells from control animals, and animals from 2d, 4d and 7d of disease such that equal
numbers of M(|) remained in wells (1.5 x 105), as calculated from previous experiments. 400pl of
medium was placed on the adherent cells and cultured without the addition of cytokines for 24h.
Supernatants were assayed for nitrite generation at 24h (Figure 3-22). It can be seen that M<|) from this
model of NTN spontaneously produced nitric oxide without the addition of activating cytokines. By
comparison, M(|) from control or normal glomeruli did not produce NO spontaneously. When BMD M(|)
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were activated for the 24h period with IFN-y (lOOU/ml) and LPS (1 fig/ml), or IFN-y plus TNF-a they
produced similar amounts of nitrite compared with the glomerular M<|> from diseased animals (Figure
3-22). Further, resident M<j) from normal glomeruli responded similarly to pro-inflammatory stimuli.
These results suggested that M<|> from this model of NTN might induce MC apoptotic death by NO
release in vivo.
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Figure 3-22: Spontaneous nitrite generation by glomerular M(t> from telescoped nephrotoxic nephritis
compared with cytokine-activated resident glomerular and BMD M<(>. 1.5 x 105 M<J) were seeded to wells with
400pl of medium and cultured for 24h. Where indicated exogenous cytokines were added, i. BMD M(|), ii.
activated BMD M<j) (IFN-y lOOU/ml LPS lpg/ml), iii. activated BMD M<j) (IFN-y lOOU/ml TNF-a lOOU/ml), iv.
resident glomerular M<|>, v. activated resident glomerular M(() (IFN-y lOOU/ml TNF-a lOOU/ml), vi. glomerular
M<(> day 2 NTN, vii. glomerular M(|) day 4 NTN (n=5).
3.10 M<]) FROM INFLAMED BUT NOT NORMAL RAT GLOMERULI INDUCE CELL
CYCLE ARREST AND APOPTOSIS OF RAT MC
To determine the role of NO in inducing MC apoptosis in vivo, NO generation by M(J) in the glomeruli
should be specifically blocked in vivo. However, this process is technically very difficult to achieve for
a variety of reasons. Firstly, there are no truly specific inhibitors of iNOS, i.e. all the inhibitors affect
eNOS which plays are major role in vascular tone and local circulation. In inflammation endothelial
cells are induced to express iNOS which plays a major role in modulating vascular tone and local
haemodynamics (Bouloumie et al., 1997; Cooke 1998). Also, iNOS blockade in vitro is followed by
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rebound effect when the drug is removed (data not shown). If local concentrations of iNOS inhibitors
were to decline during an in vivo experiment due to metabolism, then opposite effects might be seen.
Furthermore, as discussed later (see Chapter 8), each published model of nephrotoxic nephritis differs
in the contribution of immune complexes and cell mediated immunity to M(|> activation. At certain time
points in the disease model, neutrophil and M<j) oxygen radical mediated damage might predominate
(see Chapter 5). Since NO can counteract the effects of oxygen radicals, paradoxical effects might be
seen.
To obviate these problems, it was decided to perform an ex vivo co-culture, 1.0 x 105 M()> were isolated
from tNTN glomeruli in wells of 24-well plates. CMFDA pre-labelled MC were added in a IMC: 1.5
M(|> ratio (0.6 x 105 MC), and cultured in 1.0ml of full DMEM/F12 for 8,16, and 24h. Wells were
assayed at this time point for the appearance of apoptotic MC (Figure 3-23).
The data presented indicate that these M<|) spontaneously inhibited MC mitosis and induced apoptosis,
reminiscent of the effect of activated BMD M<j). The combined effects on mitosis and apoptosis might
suggest an NO-dependent effect. However, the data were notably different from the co-cultures with
BMD M<(). Whilst in the BMD co-cultures there was a progressive increase in induction of apoptosis
from 8h to 24h, these experiments showed induction of apoptosis at 8h which increased at 16h, but was
diminished by 24h. Mitosis was suppressed at 8h, and at 16h, but by 24h the effect was diminished.
Importantly, however, M0 from each of the three experimental time points (2d, 4d, and 7d) displayed a
similar pattern of effect on the MC (Table 3-15). By contrast, equal numbers of resident glomerular M(|)
did not significantly induce MC apoptosis or suppress the increase in cell number (Table 3-15). Mitosis
appeared to be suppressed but this did not occur at 8h.
Why should these differences exist? Firstly, the experimental protocol was necessarily different since
the M(|) were already activated in the wells. Therefore when seeded, MC were immediately exposed to
NO (and other cytokines). In the BMD co-cultures, M<|) were not activated, therefore seeded MC would
not be exposed to NO and cytokines prior to adhesion and laying down matrix. The increased
susceptibility of MC to NO when not adherent is described (Chapter 3.7). Furthermore, the co-culture
was not washed after cells were plated. Since there is always some attrition during seeding, these
factors probably explain why there is early appearance of apoptosis and why control wells show
increased apoptosis at 8h than later time points.
Secondly, control wells of glomerular M<j) alone showed that at 24h, the majority of cells appear small
and rounded up rather than adherent and spread out. Unfortunately, Hoechst staining was not available
at the time of completing these experiments, but these cells appeared to spontaneously undergo
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apoptotic cell death at 24h. It remains possible that they were a loosely adherent type of M<|>. However,
my experience has been that activated M(j) adhere better than their quiescent counterparts. (Figure 3-24
M<t> alone and co-culture). Rubin-Kelley's group describe the necessity for CSF-1 to allow glomerular
M<|) survival in early glomerulonephritis seen in the MRL lpr/lpr mouse (Rubin-Kelley et al., 1994).


































Figure 3-23: The effect of M<j) from glomeruli of rats with day 2 telescoped NTN on MC apoptosis and
mitosis. Glomerular single cell suspension and M(j) isolation yielded 50-60% confluent monolayer of M<|>.
Immediately following isolation, co-culture was established with CMFDA labelled MC without the addition of
cytokines. (A) The effect of M<j) on mesangial cell apoptosis at 8h, 16h and 24h. Note induction of apoptosis at
8h, peaking at 16h and much reduced at 24h. (B) The effect of M(|> on mesangial cell mitosis at the same time
points: mesangial cell mitosis was suppressed at 8h and 16h. (C) M<|> suppressed the expected increase in MC
number at 16h. This effect was more marked at 24h.* P < 0.05 compared with control MC (n=3).
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It seemed likely therefore, that the reason that M<{> effects on MC declined at 24h was M<|> death. Since
this occurred in the cultures of M<J) alone, two questions arose; firstly did glomerular M<J> die due to the
enzymatic digest or did they die due to lack of cytokines such as CSF-1? Secondly, was the reason for
poor induction of apoptosis of MC in co-culture, due to death of M<j)?
Table 3-15: The effect of resident glomerular M<J> and diseased glomerular M<|> from rats with NTN at 2d, 4d
and 7d, upon MC apoptosis, mitosis and cell number.
2dM<|> 4dM<|> 7dM<)> resident M<|>
apoptosis at 16h 493 ±23 261 ±11 487 ± 16 58±35
(% of control)
mitosis at 16h 19 ± 12 38 ±60 23 ±29 52±25
(% of control)
MC number at 24h 73±9 85 ±6 81 ± 9 99±8
(% of control)
Control MC apoptosis 0.68% ± 0.04, mitosis 3.8% ± 0.7 and MC number 1729 ± 68.
To answer these questions, 7d BMD rat M(J) in Teflon were activated for 6h with IFN-y (lOOU/ml) and
LPS (lpg/ml). They were washed x 2 and exposed to the same enzymatic digest procedure as used to
extract M([> from glomeruli. These M<() were then plated into wells of 24-well plates at 1.0 x 105,
followed by 0.6 x 105 CMFDA-labelled MC. The experiment was assayed at 8h, 16h and 24h (Figure
3-25.). Mcf) treated with digestive enzymes after activation were less able to induce apoptosis than
BMD M(|) in the co-culture described above. Inhibition of mitosis was present at 8h and 16h, but not at
24h, and MC number was slightly lower than controls at 24h. They therefore behaved similarly to
glomerular M<)>. Furthermore, the cultures at 24h showed many apoptotic M<|), indicating that the
extraction procedure of glomerular M(|) can inflict substantial damage to the M(J) (Figure 3-24).
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Figure 3-24: Fluorescent micrographs (X200) from co-culture using glomerular from NTN. (A) Co-
culture of green-labelled rat MC with rat glomerular from nephrotoxic nephritis (day 4) fixed and
counterstained with PI at 24h. Note apoptotic rat MC (arrows). (B) Similar photomicrograph of glomerular M<|>
growing alone fixed and stained with PI, showing many small rounded cells (suggestive of apoptosis). Rat BMD
M<|> activated with IFN-y and LPS for 4h show very few small rounded cells (C) but if treated with collagenase













Figure 3-25: Induction of rat MC apoptosis by pre-activated rat BMD M<|> that had been pre-treated with a
collagenase digest. M<|> and MC were plated in 24-well plates in a 1.0 MC: 1.5M<|> ratio. No activating cytokines
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3.11 GLOMERULAR M<\> INDUCED DEATH OF RAT MC IS BLOCKED BY INHIBITORS
OF NO GENERATION
To determine the aetiology of the effects of glomerular M<)) on MC in co-culture, L-NMMA or the
inactive isomer D-NMMA was added to wells at 100|iM, at the time of seeding wells. When these
experiments were assayed (Figure 3-26) there appeared to be inhibition of the M<t> effects on MC.
When L-NMMA was applied to 4d-co-culture, results showed a reversal of suppression of mitosis and
mesangial cell number increased in line with control MC growing alone. MC apoptosis was not
different from control wells at any time point, though background levels were elevated. The results for
co-culture with 2d M<|) and 7d M(j) in the presence of L-NMMA were less convincing, though in each
case there appeared to be some suppression of the M(|)-derived effects. It remains unclear whether this
reflects other, non NO-dependent mechanisms, or whether the sensitivity of the assay was insufficient
to indicate differences clearly. Unfortunately, whilst in retrospect it would have been interesting to
look at N02"/N03" ratios and hydrogen peroxide levels in supernatants from the glomerular M<|), these
assays were not performed and no samples remain from those studies. Cook et al (Cook et al., 1989)
and Holdsworth et al (Holdsworth et al., 1988) reported oxygen radical generation in a rabbit models of
tNTN using luminol. NO however, also causes a positive response with luminol (Wang et al., 1991).
3.12 L-ARGININE, THE PRINCIPAL NOS 2 SUBSTRATE IS NECESSARY FOR M<|>-
DEPENDENT EFFECTS ON RAT MC
Albina et al have reported in a model of healing skin wounds in the rat, that the concentration of L-
arginine, the substrate for iNOS, falls to a level well below that found in plasma. This fall occurs
swiftly following the early stages of the wound generation (Albina et al., 1990; Reichner et al., 1999).
The fall in L-arginine is attributed to a rise in arginase levels, another enzyme which utilises L-
arginine. This arginase does not appear to be derived from M(|), though activated M(|> are known to
synthesise a form of arginase, whose activity lags behind iNOS activity. In addition, in low oxygen
tensions as might be found when capillary flow is compromised, iNOS might not function efficiently
since it is also requires 02 as a substrate (Albina et al., 1990) (see Figure 1-2). Indeed activated M<|),
found in the Albina wound model, show iNOS enzyme induction but no evidence of NO generation (as
evidenced by accumulation of L-citruilline (see Figure 1-2)). Unfortunately, this wound-healing model
is artificial in that it involves dramatic disruption of tissue architecture with consequent diminished
local blood flow. This model might more accurately therefore reflect an ischaemic, inflamed tissue.
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When L-arginine levels are low, the enzyme eNOS has been described to generate superoxide radicals








Figure 3-26: The effect of M<J> from glomeruli of rats with day 4 telescoped NTN on MC apoptosis and
mitosis in the presence of L-NMMA. Macrophages from inflamed glomeruli were co-cultured with CMFDA-
labelled rat MC as shown in Figure 3-24. However, during co-culture the medium contained L-NMMA lOOpM.
Apoptosis and mitosis were scored microscopically at 24h (n=3).
131
Chapter 3: Results 1. Inflammatory macrophages induce apoptosis of mesangial cells
Figure 3-27: Cartoon showing (A) inducible NOS with its cofactors and (B) endothelial NOS with cofactors.
Note similar binding sites for NADPH, FAD, FMN and the electron transport chain. Note similar Haem- catalytic
moiety and dependence on tetrahydrobiopterin as a co-factor. The principle difference indicated is that iNOS
binds calcium firmly and is therefore calcium-'independent' whereas eNOS binds the cofactor calcium-
calmodulin reversibly and is therefore calcium dependent
Such dysfunctional eNOS has become a topic of avid research recently in the context of abnormal
vascular relaxation. The role of the highly unstable peroxynitrite, which is said to be toxic to cells, I
believe remains putative (Xia et al., 1997; Bank et al., 1998; Heeringa et al., 2001). Using electron
paramagnetic resonance spin trapping for detecting oxygen radicals and nitric oxide Xia et al (Xia et al
1996; Xia et al., 1997) have suggested that both nNOS and iNOS also can generate super-oxide in low
oxygen tensions. Superoxide generation is inhibitable by both L-NMMA and SOD. They show by
immunostaining activated murine macrophages for nitrityrosine that it nitrosylated tyrosine only occurs
in activated Mc|) in L-arginine depletion. These data suggest the presence of peroxynitrite (Figure 3-27).
Whilst the glomerulus has an extremely good blood flow, during inflammation, there is often capillary
thrombosis and destruction of the normal glomerular capillary bed. It is possible that relative hypoxia
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M(|):MC co-culture was performed in the presence of low levels of L-arginine, achieved by combining
DMEM/F12 containing no L-arginine with 10%FCS that contains low levels of L-arginine (estimated
at 6(iM). The L-arginine levels for these experiments was not measured but one can assume that it is
close to normal calf serum levels as reported previously (Albina et al., 1989). DMEM/F12 medium
normally contains 0.6mM, RPMI contains 1.2mM and normal human plasma contains 0.1 mM.
For these experiments, co-culture was established as described in Methods (Chapter 2.6). After 2-4h,
the co-culture was washed and replaced with full DMEM/F12 (L-arginine deplete). Co-culture was
activated with IFN-y (lOOU/ml) and LPS (lp.g/ml). At 24h experiments were assayed for MC apoptosis
(Figure 3-28). One might have expected MC necrosis or possibly increased MC apoptosis due to
oxygen radical release or peroxynitrite release (Xia et al., 1997; Bank et al., 1998; Albina et al., 1989).
However, in stark contrast, MC apoptosis was markedly decreased to levels just exceeding control
levels. As a positive control for the experiments, adjacent wells prepared identically were executed in
medium containing normal levels of L-arginine. At the same time mitosis was equally suppressed in
the L-arginine deficient experiments compared with the L-arginine replete experiments previously
demonstrated (not shown). To investigate the mechanism further, the absolute level of apoptosis was
enhanced by increasing the ratio of M(j) to MC from 1.5:1 to 3:1 (see next section for details). Inhibitors
of NOS and oxygen radicals were tested to see whether the lower level was inhabitable. The excess
apoptosis was inhibited by the addition of L-NMMA) (Figure 3-29) (albeit higher doses were required
as 100|J,M of L-NMMA had no effect not shown), but not inhibitors of hydrogen peroxide or
superoxide radicals; catalase and SOD. Furthermore, no increased levels of M(|) apoptosis were
observed.
These data would imply that in conditions where the concentration L-arginine was limited, iNOS
expression in M(|> does not necessarily lead to cell death of neighbouring MC. The role of peroxynitrite
is brought into question by these data as one would have expected MC apoptosis or necrosis mediated
by peroxynitrite. This did not happen. Interestingly, when the co-culture was repeated using 1% FCS in
the absence of L-arginine MC apoptosis was induced (17.4+2.4% (normal L-arginine) vs 16.9±2.2%
(L-arginine deplete)) (see Chapter 4).
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Figure 3-28: The effect of low levels of L-arginine on M(|) killing of MC in co-culture. Rat BMD M(|> were
co-cultured with CMFDA green MC. After washing medium was replaced with L-arginine depleted full
DME/F12 medium and activated with IFN-y (lOOU/ml) and LPS (lpg/ml). MC apoptosis was assessed at 24h. As
a positive control, induction of MC apoptosis in adjacent wells using medium with normal (plasma) levels of L-
arginine is shown (n=5).
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Figure 3-29: L-NMMA, but not catalase or superoxide dismutase inhibits M<|> killing of MC in L-arginine
depleted conditions. Activated co-culture was established in low L-arginine tensions. At the time of activation
with IFN-y and LPS soluble inhibitors were added. MC apoptosis was assessed at 24h (n=5).
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3.13 THE RATIO OF RAT M<|> TO RAT MC INFLUENCES Mo DEPENDENT KILLING
To define further the killing effect of M<f> on MC experiments were designed to find the maximum
effect of M<(> on MC. In vivo M<)> may contribute as many as 50% of cells in the glomerulus during
inflammation (Nolasco et al., 1987; Cockwell et al., 1998). However, it is difficult to translate the
interaction of the two cells in vivo (three dimensions, local blood flow, oxygen tension) directly to the
situation in vitro (two dimensions, no blood flow, optimal pH, oxygen tensions). It is clear that close
proximity of cells is required for the killing effect though the co-culture does not directly indicate
whether cell: cell contact is required. The studies reported thus far indicated that over 24h, up to fifteen
percent of MC underwent apoptosis. Were the remaining cells recalcitrant or would an increase in M<J):
MC ratio result in further apoptosis of cells? Series of experiments were initiated to vary the ratio of
cells, but maintain the overall coverage of the well at 90-100% at the start of the co-culture (Figure 3-
30). At higher M<|):MC ratios there was a greater induction of MC apoptosis which reached a plateau at
< 40%. When M<}>: MC ratios were 0.5:1, there was a reduction in killing compared with higher ratios
but this was still greater than control wells. The data suggest that local interactions of M<|> with MC
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Figure 3-30: The effect of increasing M(p to MC ratio on induction of apoptosis of MC in activated co-
culture at 24h. Co-culture was established by altering the ratio of cell types but keeping the total number of cells
constant (3.5 x 104 cells per 0.3cm2 well). Co-culture was assessed 24h after activation. Note that MC apoptosis
rises sharply but plateaux at ratios above 4M(|):1MC with induction of approximately 40% MC apoptosis.
Average MC apoptosis in control wells of MC alone plus cytokines was 1.9±1.1% (n=4).
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3.14 QUIESCENT HUMAN MONOCYTE DERIVED M<p DO NOT INFLUENCE HUMAN MC
APOPTOSIS
The studies so far have described experiments using rodent bone marrow M<)> and rat MC. They have
been very informative in understanding the interaction between activated M(j) and MC. Parallel studies
were carried out using human cells. These were more difficult to achieve satisfactorily, largely because
of the difficulty in reproducibly growing human MC. Many observations made early in the thesis were
not investigated until the latter stages of the thesis due to lack of suitable human MC.
However, in the end a surprisingly coherent pattern developed. Of note, the M(j) used in these
experiments were derived from peripheral blood monocytes from healthy individuals. They were
differentiated in autologous serum (believed to be under the influence of GM-CSF (Daems et al.,
1976)). One must be cautious comparing and contrasting the data obtained from the rodent with the
human. Also, the human MC were obtained from 50y (average) old kidneys. Whilst, the cell doubling
time approached that of rat clonal MC during some stages, that was not sustained and cells did not
grow for more than 13 passages (usually less than 10). The rat cells can grow for more than 100
passages (Personal communication Dr. M Kitamura, Imperial College).
Bearing these differences in mind, 7d monocyte derived M<() (MDM), matured in Teflon wells (purified
by either elutriation or MACS bead column), were plated into wells to cover 50% of the surface (2 x
104) per well of 96-well plate. The M<)) culture medium was Iscove's modified DMEM with 10%
autologous PRPDS. After 4h, medium was removed and replaced with full DMEM/F12. Cells were left
for 12h in wells. Sub-confluent flasks of human MC were labelled with green CMFDA, washed,
trypsinised and added to wells in a 2:1 ratio (small cells) or 2.5:1 ratio (larger cells). After 4h cells
were washed and medium was replaced with full DMEM/F12. Cells were cultured for 8h, 24h and 48h,
and assayed for human MC apoptosis and mitosis
This was assessed by fluorescence microscopy of live and formaldehyde fixed wells using PI (1 pg/ml)
and Hoescht 33342 (lpg/ml). Due to the limited supply of human MC they were used sparingly. Flow
cytometric assays require large numbers of cells that would have precluded many of the experiments
presented being performed. The microscopical assay demonstrated that M<() had no significant effect on
either mitosis or apoptosis over a 48h period (8h, 24h, 48h) (Figure 3-31 Figure 3-32).
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Figure 3-31: The effect of co-culture on human MC mitosis and apoptosis at 24h. Co-culture was established
as described. Here, the assay was fixed and MC apoptosis and mitosis assessed microscopically. Note there was
no induction of MC apoptosis (n=5).
This result is in contrast to data reported by Mene & Cinotti (Mene & Cinotti 1996) where they showed
an early lysis of human MC induced by adhesion of U937 myelomonocytic cells. It is possible that
these U937 cells are activated. Indeed U937 cells have been shown to have cell surface TNFa
suggesting they display an activated phenotype. However, even at 3h after initiation of co-culture in
these studies there was no evidence of induction of cell death by apoptosis nor any evidence of necrotic
cells (as assessed by uptake of PI by live co-culture).
In limited studies, once the co-culture was established, medium was replaced using DMEM/F12
containing only 1% FCS. In these studies, there was no induction of apoptosis of MC. Importantly, MC
mitosis did not appear to differ greatly in co-culture from growing alone (MC apoptosis; co-culture
1.2%, MC alone 1.7%. MC mitosis; co-culture 0.21%, MC alone 0.13%). This result is, perhaps in
contrast to that shown by Singhal (Sharma et al., 1996; Singhal et al., 1996) where supernatants from
M<j) were able to promote thymidine uptake in labelled human MC, suggesting that M<]) might release
growth factors such as PDGF to promote MC growth. There was no obvious indication of this from
these studies, though 1% FCS might surpass any effect from growth factors released from M<|>. Further,
there is good evidence (Abbott et al., 1991; Abbott et al., 1992) that cultured human MC generate their
own growth factors.
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Figure 3-32: Fluorescent micrograph (X 320) of CMFDA green-labelled human MC in co-culture with
quiescent human M<|> seen as red cells due to PI labelling of RNA. Note no apoptosis of MC. Human MC have
paler nuclei than rodent cells (see arrows).
Further, in limited studies, seeding 0.5 x 105 human MC (to achieve 50% covering of the well) onto
confluent monolayers of M(|) (5.0 x 105 M<|) per 1.5cm2), lead to suppression mitosis of MC at 24h
assessed microscopically (Table 3-16). Similar experiments in the rodent system had no effect on MC
mitosis (Chapter 3.1). Note, in the human co-culture, there was also a small induction of apoptosis.
This data might be compared with studies by Bennett et al (Boyle et al., 1998; Bennett 1999) who co-
cultured MDM with human vascular smooth muscle cells (VSMC) and showed over 7d a dramatic loss
of VSMC induced by M<|>. The M<|> were not activated with cytokines. It should be emphasised that
these studies were also carried out on early passage cells (P4-P6) which explains why mitotic levels
were high.
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Table 3-16: The effect of a confluent monolayer of M<(> on human MC proliferation
Confluent M<p plastic well
mitosis 0.62% 3.59%
apoptosis 3.83% 0.83%
3.15 CYTOKINE ACTIVATED HUMAN M<|> INDUCE HUMAN MC APOPTOSIS
Similar co-cultures were prepared to those described in the preceding section. Once established, and
after washing, the co-culture was activated with human IFN-y (500U/ml) and LPS (1 |0,g/ml), after 24h
of co-culture there was an increase in MC apoptosis (Figure 3-33, Figure 3-34) at 24h. In live activated
co-cultures there were 7.2±1.6 cells positive for Hoechst uptake. Only 6.9% of these took-up PI as
well, indicating that the majority of cells were apoptotic as opposed to necrotic. Similar increases in
MC apoptosis were also present at 48h (data not shown). Like the rodent studies, there was a decrease
in human MC mitosis. However, in the control wells (MC alone with activating cytokines IFN-y and
LPS), mitosis was also suppressed. It appeared that IFN-y was a potent suppressor of mitosis in the
human MC, though was not sufficient to induce apoptosis. In limited studies, when co-culture was
activated in DMEM/F12 containing 1% FCS only, there was a small augmentation of apoptosis (9.6%
MC apoptosis at 24h in activated co-culture vs. 2.5% in MC controls) compared with cultures in 10%
FCS. Importantly, in similar co-culture using human MC of earlier passage (P4-P6 compared with P7-
P10) the induction of apoptosis was more impressive. In those studies (n=4) 16.4% of MC were
apoptotic at 24h compared with 2.8% in MC control wells and 4.0% in unactivated co-culture. Since
similar ratios of MC: M<)) were used in all studies, one explanation for this observation is the higher
rate of mitosis of the earlier passage cells (2.3% compared with 1.3%). The relationship between cell
cycle and apoptosis is explored (Chapter 6, Chapter 8) further.
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Figure 3-33: The effect of activation of human co-culture with IFN-y (500U/ml) and LPS (lpg/ml) on MC
mitosis and apoptosis at 24h. Co-culture was established in a 2.5 1.0 (MC) ratio using human MC of
passage 7-10. After 24h incubation cultures were fixed and assayed by fluorescence microscopy for MC mitosis
and apoptosis (n=5).
3.16 HUMAN M<|) KILLING OF HUMAN MC IS NOT BLOCKED BY INHIBITORS OF NO
GENERATION
When L-NMMA (lOOpM) was added to the co-culture at the time of activation there was no effect on
either MC apoptosis or mitosis (Table 3-17), that is L-NMMA was not effective in counteracting the
effects of activated human MDM on human MC











Figure 3-34: Fluorescent micrograph of activated human co-culture. Fixed wells (X 200) showing green MC
and red M(|). Note rounded up green cells with condensed nuclear material, indicative of apoptosis (arrows), (i)
Live co-culture with Hoechst and PI present in the medium (X640) showing a green rounded up cell with
cytoplasmic blebbing (arrow). The same cell fluorescing by different excitation wavelength (ii) shows the green,
rounded cell admitting Hoechst only, not PI and binding to the condensed chromatin, (iii) Fixed co-culture
(X200) with PI and Hoescht. A composite view showing red M<|>, green MC and two apoptotic MC bodies.
Nuclear condensation is seen in the left-hand body
3.17 HUMAN M(|) DO NOT PRODUCE NITRIC OXIDE
To investigate why L-NMMA was ineffective, a search of the literature uncovered many publications
on the relative inability of human to generate NO (Albina 1995; Weinberg et al., 1995). Authors
had published data conclusively showing that human MDM produced iNOS in response to pro-
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inflammatory cytokines such as IFN-y with LPS (Weinberg et al., 1995; Kashem et al., 1996). iNOS
positive M(j) in inflamed human glomeruli have been demonstrated (Kashem et al., 1996; Furusu et al.,
1998; Wang et al., 1997; Heeringa et al., 2001). However, studies of NO release in the form of nitrite
have indicated that human MDM do not produce NO despite induction of iNOS. There are many
possibilities for this (Figure 3-35). For example arginase II which is induced in M(|) might predominate
(Waddington et al., 1998), other co-factors or substrates might be lacking (Albina 1995). However, a
very comprehensive study by Weinberg (Weinberg et al., 1995) indicated that even in vitro enzyme
studies of human MDM iNOS enzyme failed to result in NO production. Furthermore, M(|) derived
from human bone marrow also fail to produce NO (data not shown). It should be noted however, that
U937 cells (human monocytic cell line) which also do not produce NO in response to cytokines, can be






Figure 3-35: Diagram indicating the factors influencing the ability of human iNOS to generate NO in
mesangial cells. The presence of arginase II might deplete intracellular arginine, the availability of oxygen, and
co-factors such as BH4 will influence NO generation, as will the prevailing intracellular and extracellular levels
of ROI.
142
Chapter 3: Results 1. Inflammatory macrophages induce apoptosis of mesangial cells
Using the particular system described for maturing MDM, differentiated M<J> were plated (1.5 x 105)
per well of 24 well plate and once adherent medium was replaced with full DMEM/F12 and cells were
cultured overnight. Pro-inflammatory cytokines were added and cells were incubated for 24h (Table 3-
18). Supernatants were assayed for nitrite using the Griess reagent. In none of these cases was there
release of nitrite into the medium. Interestingly, when human cells ingested opsonised zymosan
particles there was a small release of nitrite (Table 3-18). These levels compared favourably with
nitrite released from rat BMD M(j) when ingesting rat serum-opsonised particles. Clearly human MDM
have the ability to produce some NO in response to the appropriate stimulus.
To investigate this further, M<() were seeded into wells and cultured for protracted periods (72h and 7d)
with a variety of cytokines (LPS, IFN-y/LPS, IL-4, IFN-y/IL-4), which had been reported to induce
substantial nitrite release from MDM (Paul-Eugene et al., 1995; Panaro et al., 1999; Vouldoukis et al.,
1995; Kashem et al., 1996). None of these were able to induce NO release. Furthermore, supernatants
from M<)) cultured in Teflon wells for 7d also did not produce nitrite. This final result is in contrast to
data from Bennett's group who indicated nitrite generation by MDM over 7d in culture (Boyle et al.,
1998).
Table 3-18: Nitrite generation by human monocyte derived M<|) over 24h
NA IFN-y LPS IFN-y IFN-Y/LPS OZ
LPS TNF-a/IL-lp
1.21 2.84 2.14 1.37 1.17 10.36
±1.49 ±1.14 ±1.53 ±1.41 ±1.31 ±2.69
nitrite is expressed as nmoie/106 cells/24h
N/A no additive, IFN=y 500U/ml, LPS lpg/ml, TNF-a 300U/ml, IL-lp lOng/ml, opsonised zymosan (OZ) 25pg
per well.
In concurrent experiments, for comparison rat BMD M<|) stimulated with IFN-y/LPS generated 104.6 units of nitrite,
and stimulated with OZ generated 13.8 units of nitrite
3.18 HUMAN MC DO NOT PRODUCE NITRIC OXIDE
Proliferating human MC (three different growths) were grown to sub-confluence in T75 flasks in full
DMEM/F12, then stimulated with cytokines for 48h. There was no release of nitrite detected by the
Griess assay (Table 3-19). However, workers in Aberdeen had reported three human MC growths to
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release nitrite into supernatants in response to pro-inflammatory cytokines (Nicolson et al., 1993). The
levels of NO reported were in keeping with the data for rat MC (but not MZ cells) (Chapter 3.6). Their
data indicated combinations of IFN-y/TNF-a and LPS did not induce nitrite (as confirmed by Table 3-
19), but in addition, IL-1(3 was necessary. The human MC reported here were not exposed to a similar
cytokine combination. The rat MC studies (Chapter 3.6) would suggest, however that the levels of NO
reported by Nicolson et al would be insufficient to protect human MC from high levels of NO that
could potentially be released from neighbouring cells in vivo. Immunohistochemistry of human IgA
nephritis indicated that both M<() and MC induce iNOS enzyme. In retrospect it would have been useful
to assay supernatants from activated human co-culture for release of MC derived nitrite. Unfortunately,
none were stored in suitable conditions for that purpose.
Table 3-19: Nitrite generation by human MC over 48h
NA IFN-y IFN-y IFN-y/LPS
TNF-a TNF-a
0.25 0.56 0.15 0.57
±0.21 ±0.41 ±0.07 ±0.39
nitrite is expressed as nmole/106 cells/48h
3.19 HUMAN MC UNDERGO CELL CYCLE ARREST AND APOPTOSIS IN RESPONSE TO
HIGH LEVELS OF NO DONORS.
Whilst there is clear evidence above that NO plays no obvious role in human M<[> control of human MC
in vitro, there may be a role for M(|) NO in vivo, that is not manifest in vitro. Unfortunately extraction
of human M(|) from tissue is not possible due to the small amounts of tissue at biopsy and the
uncertainty of M<)) presence at the time of biopsy sampling. Nevertheless, it was relevant to inquire
whether proliferating human MC were susceptible to apoptosis and cell cycle arrest in response to the
NO donor GSNO. Wells of 96-well plates were seeded with human MC (8,000 per well, left overnight,
washed and replaced with full DMEM/F12. GSNO was added over a range of concentrations and the
experiments were fixed and assayed microscopically at 24h (Table 3-20). These data indicate that NO
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donors have similar effects on human MC as those seen on rat MC confirming NO-dependent killing is
a possibility.
Table 3-20: Induction of apoptosis of human MC in response to the NO donor, GSNO
Gutathione GSNO
l.OmM 0.5mM l.OmM 2.0mM
apoptosis 2.1 ±1.6% 2.6±1.8% 5.2±2.1% 14.2±2.1%
mitosis 1.6±0.4% 0.1 ±0.3% 0.0±0.0% 0.0±0.0%
3.20 SUMMARY
• Quiescent rodent and human M<J> do not induce apoptosis of MC
• Cytokine activated rodent and human M<j) induce apoptosis and cell cycle arrest of MC
• In the rodent co-culture, iNOS inhibitors block, and iNOS knockout M<{> are incapable of, induction
of apoptosis and cell-cycle arrest
• M<|> from inflamed glomeruli of rats also induce iNOS-dependent cell-cycle arrest and apoptosis of
MC ex vivo
• Rat MC can also induce iNOS and produce low levels of NO
• In those MC that generate large amounts of NO, there is resistance to M<|)-mediated induction of
apoptosis
• Human M<(> produce little NO
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4.1 IN CYTOKINE-ACTIVATED CO-CULTURE WITH RODENT M<)>, IFN-y PRIMED RAT
MC ARE MORE SUSCEPTIBLE TO APOPTOSIS THAN UNPRIMED CELLS
Both in vitro (Chapter 3) and in vivo, there is evidence that MC produce iNOS (Furusu et al., 1998).
IgA nephropathy, a human glomerular disease can develop into a crescentic glomerulonephritis with
inflammatory infiltrate. Immunohistochemistry of glomeruli from patients with such disease shows the
presence of iNOS in both infiltrating M<|) and in MC, indicating that MC can potentially produce NO.
Experiments initially designed to investigate whether rat MC producing NO after IFN-y plus TNF-a
treatment would be protected from M(|>-derived NO killing, revealed an unexpected observation. Rather
than MC being protected from apoptosis induced by M<|>, on the contrary, MC that were pre-treated
with IFN-y (300U/ml) and TNF-a (300U/ml) for 24h before co-culture underwent more apoptosis than
unprimed cells in concurrent experiments. The increase was approximately a doubling (Figure 4-1).
The presence of mitotic figures in the co-culture was completely suppressed, suggesting that M(j>-
derived NO was still able to act on the NO producing MC (not shown). The observation that MC that
were producing NO themselves were still susceptible to NO released from M(j) was seen in Chapter 3.7















unprimed MC primed MC
Figure 4-1: The effect of priming of rat MC on M(j> induced apoptosis in activated co-culture at 24h. Rat
MC were primed with IFN-y (300U/ml) and TNF-a (300U/ml) for 24h prior to co-culture. After washing they
were labelled with CMFDA and were then cultured in a 1.5 M(|> : 1.0 MC ratio. After washing, the co-culture was
activated (IFN-y lOOU/ml plus LPS lpg/ml) and assayed for MC apoptosis at 24h (n=5 * P < 0.05).
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4.2 L-NMMA PARTIALLY INHIBITS M(j) MEDIATED APOPTOSIS OF PRIMED RAT MC
Mesangial cells primed with IFN-y (300U/ml) plus TNF-a (300U/ml) were co-cultured with rat BMD
M(|) and the co-culture was activated with IFN-y (lOOU/ml) and LPS (1 pg/ml). The NOS competitive
inhibitor L-NMMA or its inactive analogue D-NMMA was added at lOOpM simultaneously with
activation. There was induction of apoptosis by M<J) at 24h. In co-cultures with L-NMMA present, the
percentage MC apoptosis induced was reduced compared with experiments including D-NMMA in the
medium (Figure 4-2). However, unlike co-culture with unprimed MC where L-NMMA completely
blocked killing (Table 3-9), in these experiments, the effect was limited, not exceeding a fifty percent
reduction . Experiments were also performed with L-NMMA at 500|xM. Despite the high dose of NO
competitive inhibitor, the primed MC still underwent apoptosis compared with control wells of primed













unprimed D-NMMA unprimed L-NMMA primed D-NMMA primed L-NMMA
Figure 4-2: The effect of priming rat MC with ylFN plus TNFa on susceptibility to apoptosis by activated
rat BMD Mc|) in the presence of iNOS inhibitors. MC were pre-treated with ylFN (300U/ml) plus TNFa
(300U/ml) (primed), or PBS carriage medium (unprimed), for 36h. BMD M()> were added to wells and primed
with ylFN (lOOU/ml) for 12h. Co-culture was established and M<(> activated with ylFN (lOOU/ml) plus LPS
(lpg/ml) according to Methods. L-NMMA (lOOpM) or D-NMMA (100|iM) was added to the co-culture with the
activating cytokines. At 24h, unprimed MC (left hand columns) underwent apoptosis in the presence of D-
NMMA, but in the presence of L-NMMA this was abrogated. Primed MC (right hand columns) also underwent
apoptosis, but the frequency was increased in the presence of D-NMMA, and L-NMMA was only partially able
to abrogate this effect. * P < 0.01 vs. unprimed co-culture with D-NMMA. ** P < 0.01 vs. control primed MC
with L-NMMA (n=5).
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4.3 BMD M(j) FROM NOS 2 KNOCKOUT MICE CAN INDUCE APOPTOSIS OF PRIMED
MC
The rat co-culture experiments described suggested non-NO dependent killing of MC by M<|) was
occurring when the MC had been exposed to a synergistic combination of IFN-y with TNF-a over the
preceding 24h. However, the generation of NO by both M()> and MC renders this interpretation of the
results complicated. To clarify the mechanism, BMD M<)> from 129s/v iNOS knockout mice were
employed in the co-culture and compared with littermate wild type controls (Figure 4-3). The results
re-iterate the data derived from similar experiments shown above with the iNOS inhibitor L-NMMA
(Chapter 4.2); that is that M(|) can induce apoptosis of MC by a mechanism independent of NO
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Figure 4-3: The effect of activated M(j) from NOS 2 knockout mice on unprimed and primed MC apoptosis.
BMD Mtp from NOS 2 -/- 129/sv and wild type mice were matured as described in Methods. MC were primed or
not primed with IFN-y (300U/ml)/TNF-a(300U/ml), and the co-culture was established and activated as before.
At 24h of co-culture there was induction of MC apoptosis when wild type mouse M(j) were employed. NOS 2 -/-
Mcp had a greatly reduced capacity to induce apoptosis of unprimed cells. Wild type M(j> induced increased
apoptosis of primed MC at 24h. However, NOS 2 -/- M((> were also able to induce a more modest degree of
apoptosis of primed MC. * P < 0.01 vs. NOS 2 -/- M<|) in co-culture with unprimed MC. ** P < 0.001 vs. control
primed MC. n=4.
These experiments were repeated using MC that had been primed with IFN-y alone for 24h prior to co-
culture (Table 4-1). The MC therefore were not generating NO prior to the co-culture (Chapter 3.6.).
MC that had been primed with IFN-y alone were also more susceptible to apoptosis than unprimed
cells and the additional susceptibility was independent of NO generation by M(|> (not shown).
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Table 4-1: Augmented induction of rat MC apoptosis by activated M<(> following MC priming with IFN-y
(300U/ml) alone
Primed MC unprimed MC
% MC apoptosis at 24h
Activated co-culture 28.9±1.6% 18.1±3.1%**
Activated MC alone 4.5±1.5% 2.1±1.4%
**P<0.01 n=5
4.4 SUPERNATANT TRANSFER FROM ACTIVATED M<|> TO PRIMED MC INDICATED
CLOSE APPOSITION OF CELLS IS REQUIRED FOR KILLING
To test whether the additional factor that enabled killing of primed MC (by apoptosis) by cytokine
activated M<|> supernatant transfer experiments were established comparable to those described
(Chapter 3.3).
One hundred and fifty thousand BMD M<(> were cultured in wells of 24-well plates (2.0cm2) in 500(il of
full DMEM/F12 for 24h. They were then activated with either IFN-y (lOOU/ml) plus LPS (lpg/ml), or
with carriage medium only (not activated). After 18h, the supernatants were collected, centrifuged (4°C
5min 4000g) to remove any cell debris. Mesangial cells which had been primed with IFN-y/TNF-a
(300U/ml) for 24h were washed, trypsinised and seeded into wells of 96-well-plates at a 70% density
4h before supernatant transfer. Two hundred microlitres of freshly isolated M(|)-conditioned medium
were transferred to rat MC. Cultures were continued for 8h and 24h. As controls, fresh medium
containing IFN-y/LPS was placed on adjacent MC. At 8h, and 24h, wells were fixed and assessed for
MC apoptosis.
Conditioned medium containing 10% FCS did not induce apoptosis of MC (0.85% vs control 1.05%
(fresh full medium with IFN-y plus LPS), nor was there any effect on mitosis. When the experiments
were repeated using DMEM/F12 without FCS (i.e. serum free medium) the conditioned media from
activated M<j) now induced apoptosis over and above controls (Table 4-2). This data suggests the need
for close apposition in the NO-independent induction of apoptosis. However, it is possible that since
the effective dose of this apoptosis-inducing reagent will be much lower in a supernatant than at the co-
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culture monolayer, it will be ineffective and therefore an artefact of cell culture. In low FCS conditions
soluble factors might be more effective (see Chapter 8).
Table 4-2: The effect of conditioned medium from activated M(J) on MC apoptosis and mitosis in the
absence of FCS at 24h
Unactivated M<|> Activated M(p
apoptosis 3.7±1.0% 10.4±0.9%*
mitosis 1.8±0.3% 1.6±0.2%
Control medium with activating cytokines (IFN-y lOOU/ml plus LPS lgg/ml) induced 5.7% apoptosis. Mitosis
was 1.4% (* P < 0.05 n=4).
4.5 RAT MC PRIMED WITH IFN-y PLUS TNF-a ARE SUSCEPTIBLE TO APOPTOSIS BY
SOLUBLE RECOMBINANT FAS LIGAND
Rat MC were plated into wells at 70% density and exposed to soluble human recombinant Fas ligand
(sFasL). There was no effect on MC apoptosis at 24h as assessed by Hoechst and PI staining of fixed
wells. However, when rat MC that had been primed for 24h with IFN-y and TNF-a in combination,
prior to plating into wells for experimentation, sFasL (lOOng/ml) induced apoptosis of MC (Figure 4-
4). To be sure this observation was not an artefact of the clonal cells, other polyclonal cells were
compared (Figure 4-4) and showed similar induction of apoptosis after similar priming. Further, other
rat MC clones were susceptible to sFasL only after IFN-y/TNF-a priming, as was the MZ clone from
Prof. Pfeilschifter's group (18.0% vs 0.7% at 16h). Priming with IFN-y alone resulted in 0.5%
apoptosis vs. 0.0% (control), and after IL-1P priming 0.4% vs. 0.0% (control).
The pattern of induction of apoptosis by FasL was different from that induced by NO; firstly, mitotic
cells were observed in wells where apoptosis was induced (though this was reduced compared with
control wells). Secondly, induction of apoptosis occurred earlier and peaked (Table 4-3) earlier than
induction of apoptosis in co-culture (Chapter 3.2) or upon administration of exogenous GSNO
(Chapter 3.7). Peak apoptosis with FasL occurred at 16h.
Using human MC, Gomez (Gonzalez-Cuadrado et al., 1996) reported that IFN-y priming alone of
human MC was sufficient to augment susceptibility of these cells to apoptosis by the agonistic anti-Fas
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antibody CH11. The experiments reported in this thesis indicated that rat M<(> primed with IFN-y alone
were not rendered susceptible to apoptosis by sFasL. However, 24h of priming with TNF-a (300U/ml)
alone did render cells slightly susceptible (Figure 4-5). This difference between human and rat cells
might relate to activation of the IRF-1 (interferon regulatory factor-1) promoter which is investigated
in Chapter 6. As a positive control, Jurkat cells (a T cell lymphocytic leukaemia cell line), with known
susceptibility to Fas-mediated apoptosis were cultured with sFasL at lOOng/ml. At 15h, there was
31±1.7% apoptosis vs 3.9+0.2% in controls without sFasL. Apoptotic morphology was assessed by
cytospin following Diff Quik staining. This result is in keeping with reports from Jurg Tschopp's group
(Schneider et al., 1998). Interestingly when CH11 anti-Fas IgM antibody at 50ng/ml was applied to
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Figure 4-4: The effect of priming rat MC with ylFN plus TNFa for 24h on susceptibility to Fas ligand
(Apo-1 ligand) and expression of Fas protein. These studies employed both cloned primary MC (filled bars) and
conventional multiclonal primary cultures (unfilled bars). Apoptosis assessed at 16h. Note that unprimed MC
(two sets of bars on the left) were not susceptible to soluble FasL at lOOng/ml) (NA = no additives). However
note a significant increase in apoptosis after exposure of cytokine primed MC to FasL. Note also similar results
using cloned MC or primary cultures * P < 0.01 vs unprimed with FasL (n=3).
During the course of this work, Schlondorff s group in Germany demonstrated identical findings using
an SV40 transformed mouse mesangial cell line: the agonising anti-Fas antibody, Jo-1, had no effect
on the mouse MC. However, when primed with IFN-y plus TNF-a the cells were now sensitised to
Fas-mediated apoptosis (Berger et al., 1998).
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Table 4-3: Time course for induction of apoptosis of primed rat MC by soluble Fas ligand at lOOng/ml
8h 16h 24h
FasL
apoptosis 21.1±3.7% 40.5±4.4% 15.0+5.3%
mitosis 0.5±0.3% 1.2±0.8% 1.9±0.7%
Control
apoptosis 1.5±0.5% 1.0±0.5% 0.3+0.1%
mitosis 2.3±.5% 4.9±1.3% 2.0±0.5%
Concentration of sFasL
Figure 4-5: Dose response curve for induction of apoptosis by sFasL on IFN-y/TNF-a primed rat MC. Rat
MC were primed for 24h with either IFN-y (300U/ml) with TNF-a (300U/ml) or TNF-a alone. Cells were
washed, trypsinised and re-plated at 70% confluency. After 4h FasL was added. Cells were fixed and scored for
apoptosis at 16h. Note priming with IFN-y alone had no effect. Note, FasL at 200ng/ml was no more effective
than lOOng/ml.
To determine the efficacy of sFasL a dose response profile was generated using primed rat MC cells
(Figure 4-5). This study indicates the relatively high concentrations of FasL required for induction of
apoptosis compared with the actions of other cytokines (such as TNF-a). The dependency on high
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concentrations of sFasL may reflect the need for trimerization of the molecule for it to be effective at
activating Fas (Schneider et al., 1998). There is a wealth of literature on the role of soluble versus
membrane-bound Fas ligand in bringing about apoptosis. Much of this data has been published during
the generation of this thesis. The debate has hinged on whether FasL released from the surface of
leucocytes can effectively trimerize the receptor Fas (Schneider et al., 1998; Cheng et al., 1994; Serrao
et al., 2001; Brown & Savill 1999). Flowever, recent data from cells multiply transfected with cDNA
for Fas-tagged with different fluorophores, indicates that Fas (and other death receptors) exist as pre¬
formed trimers in the plasma membrane as do their ligands. The possible role of multiple trimeric
receptor clustering might therefore be more important in death signalling. Data from our laboratory
suggest that sFasL released from human M<|) can kill human neutrophils (Brown & Savill 1999),
probably in conjunction with other cytokines, The data are supported by others (Kiener et al., 1997;
Mangan et al., 1991). However, there are significant data suggesting other roles for sFasL such as
blockade of Fas-induced apoptosis (Schneider et al., 1998; Cheng et al., 1994 Tanaka et al., 1998), or
as a neutrophil chemokine (Allison et al., 1997; Seino et al., 1997; Kang et al., 1997; Chen et al.,
1998). It is possible that soluble recombinant FasL is better able to self trimerize/induced receptor
clustering at high concentrations that endogenous sFasL which is cleaved from eukaryotic cells.
When experiments on rat MC were repeated in serum free conditions, cells were marginally susceptible
to apoptosis by sFasL, above control levels (control 6.1% vs sFasL 13.7% at 16h). When TNFa was
also added there was a dramatic induction of apoptosis that was not mediated by TNF-a alone (TNF-a
9.8% vs TNF-a plus sFasL 20.8% at 16h), indicating synergy. The fact that TNF-a signalling through
TNFR1 recruits DISC proteins might allow cross-talk with Fas, since Fas utilises the same DISC
proteins (Varfolomeev et al., 1996).
These data indicate that in some way priming renders cells more susceptible to Fas ligand.
4.6 PRIMED RAT MC INCREASE EXPRESSION OF THE DEATH RECEPTOR FAS
Numerous regulatory steps in caspase 8-dependent signalling and DAXX-dependent signalling
following Fas trimerization have now been described, principally in lymphocytes (Holler et al., 2000;
Yanagisawa et al., 1997; Ungefroren et al., 1998; Boise et al., 1997; Duckett et al., 1998) (Figure 1.8).
These factors seem to regulate a cell's susceptibility to death. It appears that Fas (and FasL) are fairly
ubiquitous, so clearly Fas mediated apoptosis must depend on other factors rendering cells susceptible.
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One factor might simply be the density of cell surface receptors since trimerization of Fas is required
for signalling, another might be cell to cell receptor-ligand co-factors.
To investigate further, antibodies were selected to assess cell-surface Fas expression in rat mesangial
cells. Unfortunately, no commercially available antibodies have been raised against rat Fas, they are all
against human and mouse Fas, with some reported to display cross-reactivity. The most widely used
human (CHI 1, ZB4) and mouse (Jol) antibodies do not cross-react with rat Fas. Two antibodies were
selected for flow cytometry (Transduction labs F22120, Pharmingen). In repeated studies, however
neither showed selective binding to unprimed or primed rat cells (data not shown). Instead, membrane
fraction lysates from primed and unprimed rat mesangial cells were prepared. Using the AB-1 anti-Fas
antibody (Calbiochem) which recognises the trans-membrane domain of rat Fas (Kimura et al„ 1997) a
band at 45kD was faintly present in unprimed cells and increased in primed cells (Figure 4-6). Equal
loading was ensured by Coomassie staining of the polyacrylamide gel. Since the ubiquitous actin also
lies at about 45kD, adjacent lanes containing the same amount of protein were blotted for P-actin.
Clearly this intense band migrates slightly further than the Fas band. The results suggest therefore that







Figure 4-6: Immunoblot showing increased expression of the Fas protein with IFN-y/TNF-a priming of rat
MC for 24h. Whole cell Triton-X 100 lysates were prepared from unprimed cells (Lanes 1 & 3) or cells primed
with IFN-y/TNF-a (Lanes 2 & 4). After normalisation for protein loading, the gel was electrophoresed, and
blotted. The membrane was incubated with AB-1 (1:40) anti-Fas antibody overnight. Visualisation used a
peroxidase conjugated secondary antibody and enhance chemiluminescence. Adjacent lanes with the same
loading were separated and incubated for pactin to demonstrate a different migratory pattern. The blot indicates
increased Fas expression after priming.
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4.7 RED-OX POTENTIAL AND FAS-MEDIATED KILLING
There has been significant interest in the red-ox potential of cells in regulating susceptibility to Fas
mediated killing. Human lymphocytes that are induced to express iNOS and release of low levels of
NO are rendered susceptible to Fas-mediated killing (Mannick et al., 1997; Sciorati et al., 1997). This
susceptibility is blocked by the NOS inhibitor L-NMMA. Indeed, unpublished data from our laboratory
indicates that in the presence of the iNOS inhibitor L-NIL, human PMN are protected from apoptosis
induced by the agonistic anti-Fas antibody, CH11 (Dimmeler et al., 1998; S. Brown Personal
Communication). It has been reported conversely that superoxide radicals also can protect cells from
Fas mediated death (Clement et al., 1996). Human monocytes, activated with IL-lf5 or TNF-a
however, undergo apoptosis upon Fas ligation using anti-Fas CHI 1 antibody. This effect is abrogated
using N-acetylcysteine or glutathione (Um et al., 1996). The MC used here, when primed with IFN-y
and TNF-a became susceptible to apoptosis by sFasL. However, they also produced NO through
iNOS. Experiments were designed to block NO generation to determine whether Fas-mediated killing
could be suppressed. Rat MC were primed with IFN-y and TNF-a for 24h in the presence of L-NIL
(30|jM). Cells were transferred to wells and exposed to sFasL in the continued presence of L-NIL
30pM. There was no difference in the ability of sFasL to induce apoptosis at 16h (28.4±4.6% vs
30.2±3.9%) after 16h. There was also no difference at 8h and 24h (not shown).
4.8 IFN-y PLUS TNF-a TREATED HUMAN MC ARE ALSO SUSCEPTIBLE TO FAS-
MEDIATED APOPTOSIS
Gonzalez-Cuadrado (Gonzalez-Cuadrado et al., 1996) had reported that human MC can undergo
apoptosis after exposure to high doses of the agonistic IgM anti-Fas antibody CH11. The percentage
apoptosis increased after treatment with IFN-y. The same group went on to study (Gonzalez-Cuadrado
et al., 1997) the fate of mesangial cells in vivo mice after bolus of the agonistic anti-Fas antibody Jol.
The treated mice underwent a very rapid mesangiolysis (presumably by apoptosis), suggesting that in
vivo MC apoptosis by Fas might be biologically important. Of note, however, similar studies by
Nagata's group (Ogasawara et al., 1993; Lacronique et al., 1996) confirmed hepato-cellular death after
bolus administration of the Jo 1 antibody but did not report pathology in the kidney.
Since the rat MC in vitro required priming with a combination of cytokines to render them susceptible,
human MC were primed with IFN-y plus TNF-a for 24h. After trypsinising, re-plating and washing,
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either sFasL (lOOng/ml) or the agonistic antibody CH11 (500ng/ml) was added to wells which were
assayed at 16h for apoptosis (Figure 4-7). It was evident that the priming step rendered these cells very
sensitive to apoptosis by CH11, but in adjacent wells sFasL at lOOng/ml was ineffective. Isotype
control mouse IgM had no effect. Even at 500ng/ml human sFasL induced only 0.9±1.1% apoptosis of
IFN-y/TNF-a primed cells by 24h. Whilst sFasL was ineffective on human MC, concurrent
experiments with the MZ rat MC clone confirmed the bioactivity of this agent.
The data indicated that unlike the rat cells, human MC that had been primed with IFN-y alone or IFN-y
plus LPS were also susceptible to CHI 1 mediated apoptosis. TNF-a priming and IL-1 (3 priming were
ineffective at inducing susceptibility in human MC (Figure 4-7).
Further evidence that red-ox potential is not involved in regulating MC Fas-mediated apoptosis can be
implied from these data. Human MC treated with the cytokines in Figure 4-7. did not produce
measurable NO (unlike the rat MC) (Chapter 3.19). Therefore low level NO generation does not
regulate Fas susceptibility in MC unlike that shown for human lymphocytes (Mannick et al., 1994).
40.0%
30.0%
IgM control IFN- IFN/LPS IFN/TNF
Priming cytokines
Figure 4-7: Induction of apoptosis by CH11 anti-Fas antibody after priming of human MC. Proliferating
human MC were primed with cytokines as shown (IFN-y 500U/ml, TNF-a 300U/ml, LPS lpg/ml) for 24h. They
were trypsinised seeded in full medium into wells at 70% confluence. After 4h they were exposed to CH11
500ng/ml or IgM control and assayed for MC apoptosis at 24h. Note IgM control did not exceed 0.9±1.1%
apoptosis (n=3).
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4.9 PRIMED HUMAN MC HAVE INCREASED EXPRESSION OF CELL SURFACE FAS
Proliferating human MC (P5-7) growing in six-well plates were primed with IFN-y and TNF-a for 24h,
or primed with carriage medium only (unprimed). Cells were trypsinised and placed on ice with the
anti-Fas antibody CH11 at 500ng/ml. An isotype control of mouse IgM was used on some cells. As a
positive control, Jurkat cells were exposed to trypsin and after neutralisation were also incubated with
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Figure 4-8: Immunofluorescence flow cytometry histograms showing induction of Fas on the cell surface
of human MC following priming with IFN-y plus TNF-a. Proliferating human MC were trypsinised, pelleted and
resuspended in blocking buffer alone (red), with the addition of CH11 at 2pg/ml (green) or IgM control (black).
After lh on ice, cells were washed, and a secondary FITC-conjugated antibody added. After 30min on ice cells
were assessed by flow cytometry. (A) unprimed MC, (B) MC that had been primed with IFN-y (500U/ml) plus
TNF-a (300U/ml) for 24h and (C) trypsinised Jurkat cells as a positive control. #
158
Chapter 4: Results 2. The regulation of mesangial cell apoptosis in co-culture by interferon-y
After washing and addition of FITC-conjugated anti-mouse IgM antibody (1:400), samples were
analysed by flow cytometry (Figure 4-8). The data indicate the presence of Fas on human MC. The
expression is markedly increased by priming.
4.10 HUMAN AND RAT M(J) HAVE FAS LIGAND, BUT ONLY PARTICULATE
PHAGOCYTOSIS RESULTS IN RELEASE OF SOLUBLE FAS LIGAND
It has been reported that M<j) can utilise FasL/Fas interaction to induce cell death of neighbouring cells
(Badley et al., 1997; Brown & Savill 1999; Hughes et al., 1999). This interaction is well-established in
lymphocyte interactions (Takahashi et al., 1994; Ashany et al., 1995; Waldner et al., 1997), though the
role of FasL in M<)> cell mediated toxicity is more controversial. Clearly for M(f> in the co-culture (and
also in vivo) to induce MC apoptosis by Fas/FasL interaction, they must express FasL at the cell
surface. Reports of FasL expression by flow cytometry (Badley et al., 1997; Kiener et al., 1997)
indicate both very low levels which require biotinylation of the primary antibody to achieve a
detectable signal and large intracellular stores which are readily mobilised. In our own laboratory,
mature human MDM have been shown to have cell surface FasL only using the anti FasL antibody,
clone 33 (Pharmingen) (S. Brown unpublished observations). These discrepancies may relate to the use
of antibodies which had been reported to detect Fas ligand (Santa Cruz) (Smith et al., 1998; Restifo
2000) have been shown to cross react with other cell surface proteins.
Given these difficulties in detection, a western blot approach was chosen using the clone 33 antibody.
To clarify the presence of Fas ligand in/on macrophages a western blot approach was taken since the
clone 33 antibody has been used successfully in the department with Jurkat cell controls (Brown &
Savill 1999).
Whole cell Triton-X 100 lysates were prepared from human monocyte derived and rat BMD Mc()
cultured in 6 well plates (approximately 1 x 106 cells per well). M(|) had been cultured in Teflon for 7d
and seeded into wells 16h earlier. Cells were activated with IFN-y/TNF-a, IFN-y/LPS or opsonised
zymosan particles for 16h. Supernatants were collected on ice and simultaneously M(j> in wells were
lysed with a Triton-X 100 lysis buffer (Chapter 2). Soluble cellular proteins were isolated by
centrifugation of lysate at 10,000g for lOmin (4°C). Supernatants were centrifuged at lOOOg for lOmin
(4°C) to remove cell debris and then mixed with an equal volume of ice cold ethanol. The mixture was
incubated at minus 20°C for 15min and then centrifuged at 0°C for 20min 15,000g. The protein
precipitate was removed from the supernatant by decanting and resuspended in Laemmli buffer.
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The whole cell lystaes were boiled with 0.1% SDS, then lyophilised at 4°C and resuspended in
Laemmli buffer. Samples were run on a 12.5% SDS PAGE, transferred onto PVDF membrane and,
after blocking with 5% marvel in PBS with 0.05% Tween 20, the membrane was incubated at 4°C for
48h with Clone 33 anti-human FasL antibody (1:200). After washing and the addition of secondary
peroxidase-conjugated antibodies the membrane was developed with 4-chloro-l-naphthol. The
membrane (Figure 4-9) indicates that both human and rat M(|> have membrane bound FasL. The amount
of protein does not appear to increase with cytokine activation. Rather, M(f) that have ingested
opsonised zymosan particles may have less membrane bound protein. The blot was re-incubated with
anti p-actin to show protein loading. The blot would suggest that rat M<|) produce rather less FasL than
human M<|>, though that might reflect a greater avidity of the antibody for human FasL over rat FasL.
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Figure 4-9: Immunoblot for Fas ligand from Triton-X soluble extracts from human (lanes 1-3) and rat M<j)
(lanes 4-8). 1 x 106 cells in wells were incubated with cytokines for 16h. Cellular proteins were isolated and after
denaturing were electrophoresed. Proteins were transferred to PVDF and incubated with clone 33 anti FasL
antibody (1:200). After the addition of secondary peroxidase-conjugated antibodies proteins were visualised
using the substrate 4-chloro-l-naphthol. The blot was also incubated with anti P actin antibody (1:400) to indicate
loading of samples. Lanes 1: human M<|> NA, 2: IFN-y/TNF-a, 3: opsonised zymosan. Rat M<(>, 16h after
treatment 4: NA, 5: IFN- y (300U/ml) plus TNF- a (300U/ml)„ 6: IFN- y (300U/ml) plus LPS (lpg/ml), 7:
zymosan or 8: opsonised zymosan. Note there were no increases in FasL with cytokines. Discrete bands at 37kDa
confirm the presence of FasL.
The blot of soluble protein isolated from supernatants (Figure 4-10) indicates that M<{) release soluble
FasL which is augmented in response to ingestion of opsonised zymosan particles. Cytokine
stimulation did not promote sFasL release. Despite centrifugation the blots indicate significant
membrane bound FasL was found in the supernatant. The amount of mFasL in supernatant might be
increased following M(j) ingestion of opsonised zymosan. This might reflect release of micro vesicles
by the M(|). These vesicles have been shown to have biological effects on neighbouring cells including
induction of apoptosis (Martinez-Lorenzo et al., 1999). The rat M<|) did not appear to release any
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soluble FasL. This may reflect a true biological difference or might simply indicate a lower affinity of











Figure 4-10: Immunoblots of soluble FasL in protein extracts from supernatants of 1 x 106 macrophages. At
16h supernatants were harvested and soluble proteins were precipitated (see Methods). After electrophoresis and
transfer of proteins Fas L was visualised with anti-FasL antibody (clone 33 1:200) (A) Supernatants from human
MDM 16h after treatment with no agent (lane 1), IFN-y (500U/ml) plus TNF-a (300U/ml) (lane 2), or opsonised
zymosan (lane 3). (B) Supematants from rat BMD macrophages 16h after treatment with no agent (lane 1), IFN-
y (300U/ml) plus TNF- oc (300U/ml) (lane 2), IFN- y (300U/ml) plus LPS (lpg/ml) (lane 3) zymosan (lane 4) or
opsonised zymosan (lane 5). Note human MDM release the 27kDa sFasL spontaneously and this is augmented
by opsonised zymosan. Rat M<j) do not release sFasL in this assay. Note release of mFasL.
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4.11 RAT MC EXPRESS FAS LIGAND
During the course of this study, several groups (Hughes et al., 1999; Koide et al., 1999) indicated that
proximal tubular cells of the kidney produced both in vitro and in vivo Fas ligand. This observation
appeared surprising given the known pro-apoptotic effects of this cytokine. It was suggested that
tubular cells might regulate their population by 'fratricide' i.e. neighbouring cells might induce death
on others by Fas/FasL interactions. Others had shown increases in Fas protein during stresses such as
hypoxia (Tanaka et al., 1994; Khan et al., 1999) in tubular cells but also in cardiac myocytes, and
indicated that Fas/FasL interactions might regulate hypoxia-induced apoptosis. These ideas were
expanded on by Bennett using vascular smooth muscle cells suggesting Fas/FasL cell surface
interactions might be important in P53-apoptosis (Bennett et al., 1998). Indeed, work from our own
group using gld/gld mice indicated that Fas/FasL interactions did play a role in induction of apoptosis
of distal tubular cells during the inflammatory response to acute ureteric obstruction (Hughes et al.,
1999).
It was therefore of interest to ascertain whether MC might also express FasL. Rat MC were cultured in
T75 flasks and primed with IFN-y/TNF-a for 24h, or left unprimed. At 80% confluence cells were
lysed with a NP-40 lysis buffer on ice, and scraped from the flasks. Soluble proteins were isolated in
the supernatant after centrifugation and after re-suspending and boiling in Laemmli buffer were
analysed by SDS-PAGE. After incubating with the clone 33 antibody, discrete bands were visualised
after peroxide-conjugated secondary antibody binding (Figure 4-11). The blot clearly indicates specific
binding at 33kD indicating the presence of FasL.
Figure 4-11: Immunoblot for Fas ligand in rat MC. Rat MC were unstimulated or stimulated with IFN-
y/TNF-a for 24h. Soluble proteins were extracted in a buffer containing a detergent NP40. After electrophoresis
(12% PA gel) and transfer of proteins, the PVDF membrane was incubated with clone 33 mAb (1:200), followed
by 2° peroxidase antibody. This membrane was visualised with enhanced chemiluminescence. Discrete 37kDa
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4.12 FAS LIGATION IS NOT RESPONSIBLE FOR M<)> MEDIATED KILLING OF PRIMED
RAT MC
One attractive hypothesis for the increased killing by M(|) of MC that have been primed, is that M<j)
induce MC apoptosis by ligating Fas either by release of sFasL or by membrane interactions. In
support of this, evidence of FasL/Fas interactions inducing target cell apoptosis by M<]> is provided
from (Brown & Savill 1999; Badley et al., 1997). Further, it is clear that mouse MC can undergo
apoptosis through Fas ligation in vivo (Hughes et al., 1999). However, against this hypothesis is that
Triton-X 100 lysates showed that unactivated M<f) also have FasL, whereas unactivated M<|> do not have
TNF-a for example. Also the target cells (MC) have FasL as well as Fas. To investigate further BMD
M(J) were developed from gld/gld mice on the C3H/HEJ background. This spontaneous point mutation
renders FasL unable to bind to Fas (Takahashi et al., 1994) and the mice susceptible to the lupus
syndrome. However, on the C3H/HEJ background the organs are normal (i.e., there is no
inflammation). The M(|> were assessed for NO production in response to IFN-y/LPS; gld/gld M<|)
produced 85.6±4.4 nmole/24h/106 cells, wild type Mtj) produced 103.7±9.9nmole/24h/106 cells.
Co-cultures were performed using the mutated mouse M(|) and the wild type littermate M<|). The co-
cultures were performed with primed and unprimed cells (Figure 4-12) and assayed at 24h. The data
indicated that both primed and unprimed rat MC were induced into apoptosis to the same degree
whether the M<|) can produce functional FasL or not. It is obviously possible that due to the species
heterogeneity (mouse and rat) that mouse FasL might not bind well to rat Fas. However, the
observations of increased killing of rat MC that had been primed occurred whether the M(|) were
derived from rat or mouse (Chapter 4.2, 4.3). The animals used were purchased from Jackson
Laboratories USA. They were not routinely genetically screened. Given the lack of histology to
identify clearly the mice as mutated, it was important to be certain of the mice were indeed gld/gld. To
this end, DNA was isolated from M(|) from the knockout and wild type animals. A 31 lbp segment,
covering the predicted mutation site of the gene (Takahashi et al., 1994), was determined to be
amplified by PCR using the primers 5'-GTGGCCTTGTGATCAACG-3' and 5'-
CTCTGGAGTGAAGTATAAG-3' which were designed around the point mutation. Purified genomic
DNA was then subjected to PCR (Chapter 2). The products were sequenced by a fluorescent dideoxy
method. The sequence analysis (Figure 4-13) indicates the published point mutation in this animal was
indeed present in the animals used for these experiments, but not present in the wild type controls.
These data indicate that at least in the co-culture system M0 do not employ Fas ligand in inducing
target cell death. Interestingly, Rubin-Kelley's group published experiments (Wada et al., 1999) where
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kidneys from wild type MRL mice had been transplanted into lpr/lpr MRL mice (i.e. a Fas mutated
mouse that develops glomerulonephritis). The transplanted kidneys were not rejected (consanguineous)
but the non-mutated kidneys developed glomerulonephritis and renal damage at the same rate as
mutated kidneys. This result supports the data shown that suggest that Fas/FasL interactions are not
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Figure 4-12: The effect of murine BMD M0 with mutated, non-functional Fas ligand (,gld/gld) in co-culture
with unprimed and primed MC. BMD Mc|) from the CH3/HEJ mouse were matured according to Methods. MC
were primed or unprimed, and the co-culture was established and activated as described. At 24h, activated wild
type and gld/gld M(|) induced similar amounts of apoptosis in unprimed MC. Primed MC were more susceptible
to the apoptosis-inducing effects of these M(|>. However the gld/gld M<|) were not significantly different (n=5).
Figure 4-13: Fluorescent dideoxy sequencing of PCR products from genomic DNA from gld/gld and wild
type macrophages using primers for the murine FasL gene. Genomic DNA was subjected to PCR using primers
designed to incorporate the published point mutation. Excerpts from the gld/gld (1) and wild type (2) sequences
confirm the published mutation resulting in phenylalanine to leucine conversion.
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4.13 IN CYTOKINE ACTIVATED RODENT CO-CULTURE WITH IFN-y PRIMED MC,
BLOCKADE OF TUMOUR NECROSIS FACTOR RECEPTOR 1 INHIBITS MC APOPTOSIS
The investigation of the NO-independent, M<|>-mediated induction of apoptosis, had not found an
explanation in Fas ligand. However, one piece of evidence perhaps held an important clue. When M<{)
were primed with IFN-y alone (without co-incubation with TNF-a) the extra apoptosis seen in co-
culture was still present. A number of other death receptors and their ligands are found on M<J) and
peripheral cells. One common feature for some death receptors been that IFN-y treatment of a variety
of tumour cells renders them susceptible to apoptosis by ligation of these death receptors whereas
otherwise the tumour cells would be resistant (see Chapter 1). Since the co-culture indicated a role for
IFN-y alone in modulating susceptibility of the MC it seemed logical to investigate other receptors and
ligand in more detail. These receptors and their ligands are stylised in cartoon form (Figure 1.12).
Although not included in this study, TRAIL, another TNF family of death ligands can ligate TR2 on
target cells. The latter has been found on proximal tubular cells of the kidney (Choi et al., 2000). All
these receptors can activate NFkB pathway and/or activate the caspase pathway.
To determine their role in M(|):MC interactions, in collaboration with Carl Ware (La Jolla, USA) we
were able to use chimeric soluble receptors as blocking agents in the co-culture. These proteins were
generated by isolation of cDNA (Crowe et al., 1994), then fusion to the Fc portion of human IgG,. The
proteins were expressed in a baculovirus expression system and secreted by insect cells. They were
purified from cell culture supernatants by Protein A sepharose columns. Proteins were provided in
serum-free Hanks solution.
In the presence of competitive inhibitors of NO generation in the co-culture of activated M(|) with IFN-
y primed MC, the remaining kill would be due to factors other than NO. This model was used for
addition of soluble receptors.
Co-culture was established and at the time of activation with IFN-y and LPS L-NIL (30pM) and the
soluble receptor (lOpg/ml) was added. As controls human IgGt or no receptor were used. Experiments
were assayed at 24h, though some experiments were extended to 48h, when the results were very
similar (Figure 4-14). The results showed that TNFR1 blockade was effective at reducing the ability of
M<|) to kill MC. The inhibition was not complete however, so a dose response curve was generated to
determine whether higher concentrations of TNFRl-Fc would increase inhibition further (Figure 4-14).
Whilst 50|J.g/ml of TNFRl-Fc was slightly more potent than lOpg/ml, the effect was still not complete
inhibition. It remained possible that other receptor ligand interactions were relevant. However,
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blockade of LTPR and HVEM (or both together (not shown) did not have any effect at 24h or 48h,
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Figure 4-14: Soluble tumour necrosis factor receptor 1 inhibits M<j> killing of primed rat MC. (A) Murine
BMD M<|> were co-cultured with MC as described in Methods, Experiments were activated with IFN-y and LPS
as described, but in addition L-NIL (30pM) was added to block NOS 2-mediated killing, and were assayed at
24h. Additionally, soluble Fc-fusion proteins TNFRl-Fc, LTPR-Fc, HVEM-Fc, or isotype control IgG, were
added in culture medium at lOpg/ml. Control wells containing MC but no M(|) received all reagents. Note a
reduction in the capacity of M(j) to induce apoptosis in the presence of TNFRl-Fc. * P < 0.05 by single factor
ANOVA (n=3). (B) Using the same co-culture assay of MC apoptosis, a range of doses of TNFRl-Fc was added
to wells and apoptosis quantified, compared with 50pg/ml of IgGi control shown as zeropg/ml of TNFRl-Fc on
the curve (n=3).
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4.14 TNF-o/TNF-p DOUBLE KNOCKOUT MOUSE M<J) SHOW IMPAIRED ABILITY TO
INDUCE APOPTOSIS OF IFN-y PRIMED MC
The fusion protein studies did not definitively determine the precise role of TNF in regulating MC
apoptosis. They did however point to TNFR1 ligation as the likely candidate in bringing about MC
apoptosis. In collaboration with Prof. Ryffel at University of Cape Town, murine BMD M<j), deficient
in TNF were derived. Because of the ability of M<|> to produce lymphotoxin (TNFp) in addition to
TNFa (Yoshioka et al., 1993; Takemura et al., 1994) and because TNFfJ has a similar affinity for
TNFR1 as TNFa, mice deficient in both gene products were used (Rudin et al., 1997). Preliminary
studies showed both knockout and wild type M(|> produced similar amounts of NO (nitrite) in response
to IFN-y with LPS (50.0±4.6 [WT] compared with 47.0±3.3 [TNF KO] measured in nmoles per 106
cells per 24h). In co-culture, both wild type and knockout M<)> had similar capacity to induce apoptosis
of unprimed or quiescent MC at 24h. MC apoptosis was 20.6%±1.0 at 24h induced by wild type M(j)
and 18.1%±3.1 induced by knockout M(j).
However, in co-culture with primed MC the knockout M(|> were significantly less able to induce









Figure 4-15: The comparative effect of activated wild type and TNFa/TNFP knockout murine M(|> on
apoptosis of MC primed with IFN-y. MC were primed as described for 24h in the presence of IFN-y (300U/ml).
Co-culture was established using BMD M<)> from either TNFa/p knockout mice or WT littermate controls and
activated according to Materials and Methods. Experiments were assayed after 24h. Note that the knockout M(|)
were less able to induce MC apoptosis than the WT controls. * P < 0.05 vs WT co-culture (n=5).
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To determine further whether the additional 'kill' of MC was solely due to TNF release similar
experiments were performed in the presence of L-NIL 30|xM. In these experiments induction of MC
apoptosis by knockout M<j) was no different from control MC alone with activating cytokines, implying
the NO and TNF alone account for all the killing effect of M<}> on MC (Figure 4-16).
Supernatants from activated M<{> (IFN-y plus LPS) cultured in 24-well plates, confirmed that the
knockout M(|> were completely unable to produce TNF-a as assessed by ELISA (WT M<|> 3982 pg/ml
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Figure 4-16: M<|) directed killing in the absence of NO is TNF restricted. In a separate series of experiments
to those in 2.14.1, co-culture was established with primed MC in co-culture with wild type and TNF-a/TNF-p
knockout M(j). In addition to activation, L-NIL (30pM) was added to wells to block NOS 2 mediated killing.
Again, MC apoptosis was assayed at 24h. In these conditions, whilst the WT M<J> were able to induce MC
apoptosis, the knock out animals incapable of inducing apoptosis greater than that seen in control wells. ** P <
0.01 vs WT co-culture (n=5).
4.15 IN LOWER SERUM CONDITIONS, TNF-DIRECTED KILLING OF RAT MC
PREDOMINATES OVER NITRIC OXIDE.
All the co-culture experiments had been performed withl0% FCS in the medium (i.e. full
DMEM/F12). This was in keeping with a model of glomerular inflammation where it is known that
there can be an abundance of growth factors and the mesangium is exposed to plasma proteins.
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However, when co-culture of BMD M(() and unprimed MC was carried out in medium containing 1%
FCS, there was a substantial increase in the ability of wild type activated M(|> to induce apoptosis
compared with the TNF knockout M(J) (Figure 4-17). This was not due to different NO release since in
DMEM/F12 without FCS wild type and TNF KO M<j) produced similar amounts of nitrite (40.6±8.2
[WT] compared with 35.4±1.6 [TNF KO] measured in nmoles per 106 cells per 24h).
These data contrast sharply with similar experiments carried out in the presence of 10% FCS where
there was no such difference (see above). It seems likely therefore that in conditions of low FCS, the





















Figure 4-17: The effect of wild type and TNF-a/TNF-p knockout M(j) on unprimed MC in low-serum
conditions. Co-culture was established as described in Methods using BMD M()> derived from WT or TNF-
oc/TNF-p knockout animals. Once established medium was removed and replaced with similar medium
containing only 1% FCS. Cultures were activated as described with IFN-y (lOOU/ml) and LPS (lgg/ml) and were
assayed at 24h. WT M(p were more potent in their ability to induce MC apoptosis. ** P < 0.01 vs WT co-culture
(n=5).
4.16 IN CYTOKINE-ACTIVATED CO-CULTURE WITH HUMAN M<j>, IFN-y PRIMED
HUMAN MC ARE MORE SUSCEPTIBLE TO APOPTOSIS THAN UNPRIMED CELLS
In Chapter 4.8, it was shown that human MC that were primed were susceptible to Fas mediated
induction of apoptosis. The data indicated that IFN-y priming alone seemed to be sufficient to enable
Fas mediated killing though this was augmented by priming with both IFN-y with TNF-a. The results
of co-culture of cytokine activated human M<]) with unprimed human MC also demonstrated M(j)-
dependent killing that was independent of NO generation. Despite the results in rat co-culture
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indicating no role for FasL/Fas interactions, Fas mediated killing of human MC seemed to be a
possible candidate. Furthermore, given that data on co-culture of rodent cells, TNFR1 ligation also
seemed a strong candidate.
Initially human MC were primed for 24h with human IFN-y (500U/ml) or left unprimed and then
established in co-culture. The co-culture was activated with IFN-yand LPS and assayed at 24 and 48h.
MC apoptosis at 24h was increased in those experiments using primed MC, again indicating that









Figure 4-18: Interferon-y augments killing of MC by apoptosis in activated human co-culture. Human MC
were either primed with IFN-y (500U/ml) for 24h or left unprimed. Co-culture was established with human MDM
after labelling MC with green CMFDA. After 4h to allow firm adhesion of cells cultures were washed, activated
with IFN-y (500U/ml) plus LPS (lpg/ml), then incubated for 24h. Note that activated M(j) induce apoptosis of
MC but the absolute percentage of apoptosis is increased significantly (* P < 0.05, n=5) in cultures with primed
human MC.
4.17 TNFR1 BLOCKADE RATHER THAN FAS BLOCKADE INHIBITS HUMAN M<|>-
DERIVED KILLING OF BOTH PRIMED AND UNPRIMED HUMAN MC
Since no patients with Fas deficiency were available (Wu et al., 1996) it was decided to test whether
human M<() utilise FasL to induce MC apoptosis by blocking studies using the anti-Fas blocking
antibody, ZB4. Unfortunately, in preliminary cultures of human MC alone, this antibody induced
apoptosis of IFN-y/TNF-a primed human MC. It was equally efficacious as CHI 1, the agonist anti-Fas
antibody (see Chapter 4.8). This paradox might be explained by the possibility of immunoglobulin
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aggregates forming in the antibody stock, since ZB4 and CH11 bind the same epitope on human Fas
(Fadeel et al., 1997; Komada et al., 1999). However, their difference in function has been attributed to
CH11 polymerising Fas whereas the IgG, ZB4 prevents polymerisation. After consultation with Prof.
Nagata (Osaka Bioscience Institute, Japan), it was decided to use the blocking anti-Fas ligand antibody
which has been shown to be at least ten fold more potent than soluble Fas-Fc fusion proteins.
Unfortunately, the isotype of type of hamster anti-FasL IgG produced by the clone is not known.
Therefore, no isotype control antibody was used in these studies.
Concurrent experiments using TNFRl-Fc, LTPR-Fc and HVEM-Fc along with human IgG, isotype
control were carried out to try to elucidate the mechanism of M<j) killing of primed human MC.
At 24h ((Figure 4-19), anti FasL IgG (lpg/ml) had no effect on human MC apoptosis. HVEM-Fc and
LTpR-Fc at 1 0|ig/ml were also without effect. However, TNFRl-Fc (lOpg/ml) inhibited killing by
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Figure 4-19: Induction of apoptosis of human mesangial cells by human monocyte-derived M<)> is inhibitable
by TNF receptor 1 blockade. Co-culture was established using primed human MC and M<j>. Upon activation with
IFN-y plus LPS, soluble Fc-fusion proteins TNFRl-Fc, LTPR-Fc, HVEM-Fc, or isotype control IgG[ (10pg/ml)
were added in culture medium at lOpg/ml. Also, the blocking anti-Fas ligand antibody (lpg/ml) was applied to
adjacent wells. Control wells containing human MC but no M<|) received all reagents. Note a reduction in the
capacity of M<|> to induce apoptosis in the presence of TNFRl-Fc, but not in the presence of any of the other
reagents (** P < 0.01 vs activated co-culture plus IgG[ (n=4)).
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Studies of cytokine activated co-culture with unprimed cells showed that TNFR1 was effective at
blocking MC apoptosis without the need for priming (Table 4-5).
Table 4-4: Inhibition of primed human MC apoptosis induced by activated human M<J) at 48h
MC apoptosis at 24h
Activated plus IgG Activated plus TNFRl-Fc
co-culture control co-culture control
10% FCS 12.4±% 2.7±% 4.1±%** 1.8±%
(**/>< 0.01 n=5)
Table 4-5: Inhibition of the induction of unprimed human MC apoptosis by human M<|> at 24h by TNFR1-
Fc
MC apoptosis at 24h
Activated plus IgG Activated plus TNFRl-Fc
co-culture control co-culture control
10% FCS 7.2±0.4% 2.5±0.8'% 4.1±0.9%** 1.8±1.0%
(**/>< 0.01 n=5)
Whilst these studies did not show complete blockade of MC apoptosis, limited mesangial cell tissue
and blocking agents rendered further experiments not possible. However, the rodent studies (Chapter
4.13, 4.14) indicated that whilst TNFRl-Fc brought about 50% blockade, when knockout M(J) were
utilised complete blockade was seen. The data suggest therefore that at least over 48h, TNF signalling
to cells that have also exposed to IFN-y is responsible for human MC apoptosis.
4.18 LOW SERUM CONDITIONS DO NOT AUGMENT HUMAN M(|>-DERIVED KILLING
OF HUMAN MC
Studies of rat co-culture indicated that low serum conditions rendered MC more susceptible to TNF
mediated apoptosis. It is note worthy that background (controls) levels of apoptosis was also elevated
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in those experiments, indicating the dependence on serum factors for survival (Mooney et al., 1997).
However, when human co-cultures both primed and unprimed, were performed in low serum (1%)
conditions there did not appear to be an augmented effect, nor did baseline levels of apoptosis increase
(Table 4-6). This was regardless of whether the cells had been primed.
Table 4-6: Induction of human MC apoptosis in the presence of 10% FCS compared with 1% FCS
MC apoptosis at 24h
Unprimed MC IFN-y primed MC
co-culture control co-culture control
1% FCS 7.1 ±0.4% 2.5±0.8<7o 10.4±2.8% 3.1±1.1%
10% FCS 6.7±1.6% 1.8±0.4 11.0±2.9 3.1 ±0.9%
n=4
4.19 TNFR1 CELL SURFACE EXPRESSION IS NOT INCREASED BY IFN-y PRIMING OF
HUMAN MC
Since IFN-y/TNF-a priming of mesangial cells renders cells susceptible to death by Fas ligation and
increases cell surface expression of the receptor, it seemed important and logical to ask whether IFN-y
priming alone of MC increased TNFR1 expression, since IFN-y renders MC more susceptible to TNF-
a mediated apoptosis. Unfortunately, due to a lack of specific antibodies against rat TNFR1, the
studies were performed on human MC (127). T75 flasks of proliferating MC were either unprimed or
primed for 24h with human IFN-y for 24h. After trypsinisation, 1x10s cells were incubated at on ice for
lh with no antibody, mouse IgG! control or mouse anti human TNFR1 antibody. Cells were washed xl
and incubated for 30min. with a FITC conjugated Fab of goat anti human IgG. After a further wash,
cells were analysed by flow cytometry (Figure 4-20). The histograms highlight the difficulties in
studying these cells by flow cytometry due to the four log10 order spread of auto-fluorescence.
However, the results demonstrate specific binding of TNFR1 antibody which is not augmented by IFN-
y treatment.
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Figure 4-20: Fluorescence histogram of human MC showing TNF receptor 1 expression on unprimed and
primed cells. (A) Unprimed cells, showing autofluorescence (black curve), murine IgG! plus FITC goat anti
mouse IgG (red curve), and specific binding of mouse anti human TNFR1 plus secondary anti-IgG (green curve).
(B) Cells were primed with IFN-y (500U/ml) for 24h prior to analysis. Coloured curves represent the same
conditions as in (A). Note there is low level expression of TNFR1. P < 0.001 (K-S statistics anti-TNFRl vs.
irrelevant IgG), but this is not increased after priming.
4.20 SUMMARY
• IFN-y is able to augment the susceptibility of MC to killing by M(j) whether the cells are rodent or
human
• MC treated with IFN-y (plus TNF-a in rodents) are susceptible to Fas mediated killing, M(j> did not
induce Fas-mediated death of MC despite the presence of ligands and receptors
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• Blocking studies in co-culture showed that TNFR1 ligation was important in rodent co-culture and
fundamental in human co-culture.
• In the absence of NO generation (with iNOS inhibition or iNOS knockout mice for rodents) TNF
mediated signalling from M<)> results in MC apoptosis in both humans and rodents
• The data point to a pivotal role of IFN-y in controlling M<|>:MC interactions.
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Chapter 5: Results 3
Triggering of mesangial cell apoptosis by macrophages
ingesting opsonised particles
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5.1 opsonised zymosan-activated rodent m<|> induce apoptosis but not
cell cycle arrest of rat mc
Co-cultures of rat BMD M(|) and rat CMFDA-labelled MC in a 1.5:1.0 ratio were established in wells
of 96-well plates in full medium for 4h. As a model of particulate immune complex activation of the
co-culture, zymosan pre-opsonised with pooled rat sera was added (0.5mg/ml; O.lmg per well) (see
Chapter 1.7). Careful attention to elimination of contaminating LPS was made during the preparation
of the opsonised zymosan (Chapter 2.6.7) (Johnston et al., 1985). Twenty-four hours later, the co-
cultures were assayed for MC apoptosis both in live co-culture using Hoechst with propidium iodide
and after fixation and counter-staining (Figure 5-1). As controls, wells containing MC alone with
opsonised particles were assayed. In these studies, M<J) readily ingested the opsonised zymosan (OZ). It
was unclear whether MC also ingested particles. They developed large numbers of intracellular
vesicles in the proximity of the Golgi apparatus, but it was not obvious that these contained OZ, unlike
obvious particles seen within the M<|>.
The results demonstrated that co-culture, activated by OZ, induced M0 to bring about apoptotic cell
death of MC. (Figure 5-2). Furthermore, unlike the cytokine activated rodent co-culture, mitoses were
still observed (Figure 5-1, Figure 5-2), albeit the frequency was reduced, suggesting that nitric oxide
might not be abundant.
When rat M(|> were replaced in co-culture with mouse bone marrow-derived M<]> and the zymosan was
opsonised with mouse serum, similar effects were observed at 24h of co-culture (not shown).
5.2. oz activated rodent m<> release little no but abundantly release
h2o2
To investigate this killing mechanism further, OZ-activated rat M(j) were assayed for NO production
(Table 5-1). The Griess reaction indicated much lower release of NO in the form of nitrite, than that
released from cytokine activated M(j). The assay was repeated, following nitrate reduction of samples,
which indicated that a proportion of the NO had been converted to nitrate (Table 5-1), indicative of an
environment rich in oxygen radicals (Waddington et al., 1996; Sandau et al., 1997).
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Figure 5-1: Co-culture of CMFDA- labelled rat mesangial cells with rat bone marrow-derived M<|> 24h
following exposure to opsonised zymosan. (A) In co-culture of unprimed MC with M<|) there is induction of
apoptosis of MC apoptosis (X200). (B) Co-culture of IFN-y/TNF-a primed MC with M<t>, there is still MC
apoptosis but this is reduced. (C) In unprimed co-culture exposed to opsonised zymosan in the presence of
catalase (lOOU/ml) killing of MC is abrogated (X320). (D) High power view of MC apoptosis (E) Mitotic MC
(telophase) in activated co-culture.
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Figure 5-2: The effect of opsonised zymosan activated rat M<(> on mesangial cell (A) apoptosis and (B)
mitosis. Co-culture of CMFDA-labelled rat MC and rat M(j) in a 1.5:1,0 ratio was established. The co-culture was
activated with rat serum-opsonised zymosan (0.5mg/ml). The culture was incubated for 24h, fixed, then assayed
for MC apoptosis and mitosis (** P <0.01 vs MC alone n=5)




Ops. zym. 2.5 10
nmol/24h/106 cells
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After accounting for the additional NO that had been converted to nitrate, the OZ-activated M(|>
generated much less NO than cytokine activated cells, however.
To investigate further the mechanism of M(j) killing, supernatants were assayed for hydrogen peroxide
(H202) generation (Table 5-2). In contrast to cytokine-activated M((), OZ-activated M(j) produced large
quantities of H202. Evidence in the literature of H202-generating M(J> in glomerular disease can be seen
in work by Cook (Cook et al., 1989), Johnston (Johnson et al., 1987, Johnson et al., 1995) and
Holdsworth (Holdswroth et al., 1985), where in both rabbit NTN and Thy 1.1 nephritis there is
evidence of M<|> derived H202. However, these data should be interpreted cautiously since NO can
produced false positive results in luminol assays (Kikuchi et al., 1993). However, Waddington and
colleagues (Waddington et al., 1996) augmented injury in early heterologous phase NTN with arginase
therapy, which blocks NO production. One interpretation of this result is that inhibiting NO production
results in less quenching of ROI. Together with the earlier reports, this information would be
supportive of a role for oxygen radical production by M<)) in vivo at least in the early stages of
glomerular inflammation.
Table 5-2: Peroxide generation by activated macrophages
N/A IFN-y/LPS PMA OZ
No priming of M<j> 1.6 0.1 7.4 10.6
IFN-y prime - - - 23.2
LPS prime - - - 16.9
Hydrogen peroxide (nmolar) assayed at lh (PMA lOng/ml, OZ 0.5mg/ml.)
In some experiments the M<)) were primed with cytokines prior to activation with OZ
5.3. INHIBITORS OF H202 RELEASE, BLOCK OZ-ACTIVATED M<j)-DEPENDENT
KILLING OF RAT MC
Apoptosis seen in the co-culture assay at 24h was subjected to inhibition by L-NMMA (not shown),
catalase and super oxide dismutase (SOD) (Figure 5-3). L-NMMA was ineffective at 500pM, as was
SOD (500U/ml), but catalase abrogated M(|> killing of MC. Sugiyama (Sugiyama et al., 1996) was able
to induce apoptosis of human MC by addition of exogenous H202 to cultures growing in full medium.
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In his experiments, exogenous H202-mediated killing was blocked with catalase at 500U/ml; SOD was
without effect. Here, lOOU/ml of catalase was sufficient to block M<j)-mediated killing of rat MC, and
500U/ml showed no additional effect. The data clearly indicate a major role for H202 in bringing about
apoptosis of rat MC. Of note, SOD did not appear to play any significant role in inhibiting apoptosis
either alone or in conjunction with catalase (not shown). Rehan (Rehan et al., 1985) showed a role for
hydrogen peroxide in the genesis of NTN in the rat, rather than other oxygen radicals. Catalase blocked
generation of the disease whilst SOD had no effect. This inhibition was believed to be due to blockade
of neutrophil mediated damage to endothelial cells at the onset of disease (Rehan et al., 1985 Johnson
et al., 1987). However, as described in the preceding section, there is no reason to suppose that M<j),
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Figure 5-3: Induction of MC apoptosis by M(|) in opsonised zymosan activated co-culture is inhibitable by
catalase. Co-culture was established as before and activated with opsonised zymosan. At 24h co-culture was
fixed and after counterstaining was scored for MC apoptosis. In some wells the inhibitors S.O.D or catalase were
added. These enzymes were suspended in PBS (** P<0.01 n=4).
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5.4. RAT MC, PRIMED WITH IFN-y PLUS TNF-a ARE RESISTANT TO H202 MEDIATED
INDUCTION OF APOPTOSIS
This experiment was initially designed to test whether Fas ligand release from M(() might induce
mesangial cell death. M(|) that ingest OZ release FasL (see Chapter 4.10 and Brown & Savill 1999),
which in some circumstances induces apoptosis of target cells. Rat MC that have been primed with
IFN-y and TNF-a are susceptible to apoptosis induced by FasL (see Chapter 4.5). Thus, it seemed
plausible that Fas/FasL interaction might be responsible for MC death under these experimental
conditions. Therefore one might have expected to observe increased MC apoptosis compared with
unprimed cells due to an additional Fas mediated death signal.
Rat BMD M(|) were co-cultured with rat MC that had been primed with IFN-y (300U/ml) plus TNF-a
(300U/ml). The priming cytokines, TNF-a/IFN-y were removed by washing. The co-culture was
exposed to OZ (0.5mg/ml). Apoptosis was assessed at 24h.
Rather than demonstrate any additional role for M<|)-derived FasL in killing of MC by apoptosis, the rat
MC primed with IFN-y plus TNF-a for 24h prior to co-culture were more resistant to apoptosis (Figure
5-4). This result was opposite to that seen in the cytokine activated co-culture (Chapter 4.1) where
priming of mesangial cells was able to augment M(j) directed killing. Blockade of the killing effect seen
in Figure 5-4 with catalase, SOD or L-NMMA had no effect (Table 5-3). Thus the MC were rendered
resistant to peroxide mediated apoptosis by priming.
Importantly, when MC were primed with IFN-y alone (i.e. priming without TNF-a) they were no
longer protected from peroxide mediated death (not shown). Thus, cells were only rendered resistant to
H202-mediated apoptosis by priming with both IFN-y plus TNF-a. These unexpected results might be
explained by the generation of NO by mesangial cells primed with IFN-y with TNF-a (see Chapter
3.6). As well as being cytotoxic, NO can be protective due to its ability to quench oxygen radicals,
resulting in nitrate production. Evidence for this cytoprotective role can be seen in atherosclerosis, and
UV damage of keratinocytes in the skin (Cooke et al., 1998; Bauersachs et al., 1999; Yamaoka et al.,
2000). It seems therefore that in rodents, whilst IFN-y/TNF-a primed cells are protected from peroxide
mediated cell death, they remain susceptible to NO mediated death (Chapter 4), and are rendered
susceptible to TNF-mediated death.
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40.0%
unprimed primed
Figure 5-4: The effect of priming rat MC with IFN-y and TNF-a for 24h prior to co-culture on the
susceptibility of MC to killing by opsonised zymosan activated M<j>. Co-culture was established as before. MC
were primed with IFN-y (300U/ml) plus TNF-a (300U/ml) for 24h prior to co-culture (primed) or with carriage
medium alone (unprimed). After 24h of co-culture MC apoptosis in co-culture and control wells was assessed (*
P <0.05 n=5).
Table 5-3: The effect, in rodent co-culture of oxygen radical scavengers on OZ-activated macrophage-
mediated killing of IFN-Y/TNF-a primed rat MC at 24h
N/A ops zym + catalase +SOD
Co-culture 1.4±1.0% 12.9+2.2% 14.2±0.9% 12.2±2.4%
Control 0.9±0.7% 1.4±1.0% 1.0±1.2% 1.1 ±0.8%
n=4
Activated neutrophils undergo a respiratory burst and rapidly induce MC apoptosis by a catalase
inhibitable mechanism (Table 5-4). MC that generate NO after priming are protected from this
neutrophil mediated death. Clearly, it might be advantageous for MC to be protected from excessive
cell death brought about by M<)> or neutrophil interactions.
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Table 5-4: Catalase inhibitable induction of MC apoptosis by activated neutrophils
% apoptosis
LPS activated LPS plus catalase
Unprimed MC 24.7±3.2% 3.4±1.8%
Primed MC 4.1±1.4% ND
Co-culture was established in 96-well plates by seeding 1.2x10" CMFDA-labelled rat MC into wells. MC had
been primed with IFN-y (300U/ml) plus TNF-a (300U/ml) for 24h or left unprimed. An equal number of human
blood-derived neutrophils was added to wells, then activated with LPS (lpg/ml) with or without catalase
(500U/ml). The experiment was fixed with 4% formaldehyde then counter-stained with PI and apoptosis scored
morphologically.
5.5 OZ ACTIVATED M<|> FROM GLD/GLD AND WILD TYPE MICE INDUCE CELL DEATH
OF PRIMED RAT MC EQUALLY
When M<j) are activated by binding and ingestion of OZ, they release soluble FasL (see Chapter 5.4).
The data above indicate that whilst IFN-y/TNF-a primed MC were resistant to H202-mediated
apoptosis they were still induced to die by M<f> through another mechanism. To test whether M(j) release
of FasL had any role in this killing of MC, MC were rendered susceptible by priming with IFN-y plus
TNF-a for 24h. Wild type mouse M(j) and FasL deficient, gldUgld M0 (described in Chapter 4.12) were
prepared. Co-culture was established with IFN-y/TNF-a primed rat MC and either WT or gldJgld M(J)
in the presence of OZ (0.5mg/ml). These mesangial cells previously confirmed as susceptible to
apoptosis by recombinant sFasL (Chapter 4.5). At 24h, MC apoptosis was assessed. The level of
apoptosis was no different in wild type compared with knockout M<]> (Table 5-5). Adjacent wells of
primed MC alone with exogenous sFasL (lOOng/ml) displayed 13.4% apoptosis at 24h whilst primed
cells without sFasL displayed 1 % apoptosis.
These results indicate that whilst recombinant human sFasL can induce apoptosis in susceptible cells,
when it is released from M<j> it is not effective as a pro-apoptotic agent.
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5.6 KILLING OF PRIMED RAT MC BY OZ-ACTIVATED M(J) DERIVED FROM TNF-a/p
DEFICIENT MICE IS ATTENUATED.
Co-culture of mouse M<}> (derived from c57/bl6 mouse) and IFN-y/TNF-a primed rat MC was
established as before. Simultaneously with activation, either human IgGl or TNFRl-Fc at 10|4g/ml
was added to wells. Apoptosis of MC was assessed at 24h and compared with controls of M(|> growing
alone, but exposed to the same reagents. Table 5-6 indicates that killing of IFN-y/TNF-a primed MC
by M(j), activated with OZ, was partially inhibitable by TNFRl-Fc.
Table 5-6: Inhibition of opsonised zymosan killing of primed rat MC by soluble TNF receptor 1
Co-culture MC control
IgGl control TNFRl-Fc





TNFRl-Fc or IgGl used at lOpg/ml
* P < 0.01 n=4
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To better define the mechanism of killing, co-culture, activated by OZ, was performed with BMD M<(>
from either TNFa/p KO mice or WT littermates and assayed for MC apoptosis in fixed wells after 24h
incubation. As in the equivalent co-culture studies using cytokine activated M(|) (Results 4.2), the TNF
KO M(() were much less able to induce apoptosis of the mesangial cells (Figure 5-5), confirming a
predominant role for TNF signalling apoptosis. Interestingly, there was residual killing at 24h
compared with MC growing alone. The aetiology of this residual kill was not investigated.
wild type TNF KO
Figure 5-5: The effect of TNF-a/p knockout or wild type mouse BMD-M(|) activated by opsonised
zymosan on the killing of IFN-y/TNF-a primed MC in co-culture at 24h. Co-culture with primed MC was
established as before. Murine BMD-M(|> were utilised from either TNF-a/p KO or wild type (C57bl6/129/sv)
mice. After 24h of activated co-culture, MC apoptosis was scored microscopically (P<0.01 vs wild type co-
culture. n=5)
5.7 OZ-ACTIVATED HUMAN M<> INDUCE APOPTOSIS OF HUMAN MC THROUGH
RELEASE OF H202 BUT NOT FAS LIGAND
Given the observed differences between human and rodent cytokine-activated co-culture (Chapter 4), it
was necessary to investigate OZ-activated human co-culture further. Human MDM were cultured and
matured for 7d in Teflon. Initially in culture, they were assessed for NO generation (Chapter 3) and
hydrogen peroxide generation. The human MDM behaved similarly to rodent BMD M(J) in peroxide
generation and NO generation in response to OZ. Human co-culture was then assessed. Mature MDM
were seeded into wells for 16h (2 x 104 per well of 96-well plate). 1 x 104 CMFDA green labelled
human MC were added into full DMEM/F12 medium. After 4h, wells were washed and human-
opsonised zymosan was added (0.5mg per well). Wells were assayed at 24h and 48h for human MC
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apoptosis (Figure 5-6). Human M<|> induced human MC apoptosis in OZ-activated co-culture. Data
from 48h studies provided similar results to those seen at 24h (not shown). To investigate the
mechanism, inhibitors of H202 generation, and blocking antibodies to Fas ligation were added to the
co-culture. The induction of apoptosis was inhibited by catalase (Figure 5-6), but not by blocking
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N/A ops zym +S.O.D. +catalase +anti-FasL
Figure 5-6: The effect of inhibitors of Fas ligation and oxygen radical release on opsonised zymosan-
activated human M<p killing of human mesangial cells. Catalase and SOD were used at lOOU/ml, and anti FasL at
lpg/ml. Opsonised zymosan was added at 0.5mg/ml to co-cultures. (* P<0.05 compared with no inhibitor. n=3)
5.8 IFN-Y PRIMED HUMAN MC UNDERGO APOPTOSIS IN CO-CULTURE WITH OZ-
ACTIVATED HUMAN Mc)> BY A TNF-INHIBITABLE MECHANISM
When human MC were primed with IFN-y (500U/ml) alone for 24h, then co-cultured there was
induction of MC apoptosis. This induction was not inhibited by catalase, suggesting that these cells
were now resistant to peroxide mediated apoptosis (Table 5-7). However, the killing observed was
partially inhibited by TNFRl-Fc at 24h (Table 5-7), but not by anti-human FasL antibody. These data
indicate that primed human mesangial cells are relatively resistant to peroxide mediated apoptosis, but
are susceptible to TNF-mediated apoptosis. The data mirror those described above when using rodent
cells in co-culture.
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Table 5-7: The effect of candidate inhibitors on OZ-activated macrophage-mediated killing of IFN-y
primed human MC at 24h of co-culture
N/A OZ +catalase +antiFasL +TNFR1
Co-culture 3.1±1.1% 9.5±2.1% 7.8±1.9% 10.2±2.4% *5.6±1.1%
Control 1.6±0.4% 1.9±1.4% 1.8±0.9% 2.1 ±0.6% 2.1 ±0.8%
Catalase 500U/ml, anti FasL antibody lpg/ml, TNFRl-Fc 10|ig/ml
*P< 0.05 ANOVA n=3
5.9 SUMMARY
To model activation by Fc receptor/complement receptor phagocytosis by M(j), co-culture was devised
with mesangial cells and activated with OZ particles.
• Killing of MC by M<|) was observed in both rodent and human systems
• Catalase-inhibitable, H202-dependent killing was observed. No role for NO was found
• When rat or human MC were primed with IFN-y/TNF-a (IFN-y alone for human MC), killing was
diminished and catalase independent
• The persistent killing was not caused by Fas ligation
• The persistent killing was inhibitable by TNF-Rl/TNF-a/p KO M<j> in rodents and humans
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6.1 INTRODUCTION
The co-culture data described in Chapter 4 indicated that M<)) directed killing of MC involved TNFR1
ligation, but that IFN-y was a co-factor. Indeed, in circumstances where TNF release by M<|) occurred
without IFN-y rendering the target rat MC susceptible, the cells were resistant to apoptosis in response
to this cytokine. In the human studies, MC were susceptible to TNF-a mediated killing in co-culture
without priming of MC with IFN-y, but this killing was augmented following priming with IFN-y. The
data suggest that IFN-y might somehow alter TNFR1 signalling to enable initiation of the death
programme. Importantly, supernatant transfer experiments indicated that soluble TNF-a from M<|> was
not effective at inducing death, implying that close cell-cell contact was required, possibly indicating a
role for mTNF-a.
6.2 IFN-y ENABLES TNF INDUCTION OF APOPTOSIS IN RAT MC
To confirm this interpretation of the data, experiments were designed to investigate the role of synergy
of IFN-y and TNF-a. Rat MC, 70% confluent in 96-well plates, were exposed to recombinant IFN-y,
TNF-a or both for up to 36h, in the presence of 0% FCS, 1% FCS or 10% FCS. They were assayed at
8, 16, 24 and 36h for MC apoptosis (Table 6-1, Figure 6-1, Figure 6-2). IFN-y alone had no effect on
the rat MC apoptosis or mitosis with time (not shown). This observation was reproduced using the
other rat MC growths available (not shown). TNF-a alone had no effect on rat MC apoptosis in 10%
FCS, but in 0% FCS there was a small increase in apoptosis at 16h (8.6±3.5%). This result is similar to
that shown by Sugiyama and colleagues (Sugiyama et al., 1999) utilising the same cells.
Flowever when cells were treated with IFN-y and TNF-a there was clear synergy. Indeed, even in
medium with 10% FCS there was still induction of apoptosis, albeit delayed. This delay was not simply
due to the period required to metabolise FCS-derived growth factors since, replacing the medium at
24h, did not further retard the induction of death. One interpretation is that in the presence of FCS
growth factors, the modulating effect of IFN-y is hindered/retarded.
These data contrast with the supernatant transfer experiments (Chapter 4.4) where transfer of
supernatants from activated (IFN-y/LPS) M<J) did not induce apoptosis of primed MC, yet the
supernatants contained several ng/ml of TNF-a when assessed by ELISA (Chapter 4.14). Notably,
whilst the recombinant TNF-a shown here could only induce 7.8% apoptosis at 36h, in co-culture with
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activated M(j), the TNF-dependent kill was often in excess of 20% at 24h (Chapter 4). It appears
therefore that soluble native TNF-a is without potency, recombinant TNF-a has some potency, when
close cell contact is achieved the TNF-dependent induction of apoptosis is much greater.
Table 6-1: The synergistic effect of IFN-y on recombinant TNF-a-induced apoptosis of rat MC
Percentage apoptosis of MC
8h 16h 24h 36h
experimental 0% FCS 5.7±2.7 20.9±4.8 NA 38.1±5.0
control 1.4±0.9 1.9±0.2 NA 5.3±2.3
experimental 1%FCS 1.0±0.8 3.5±1.6 22.2±2.8 NA
control 0.6±0.9 NA 2.2±1.6 NA
experimental 10%FCS 0.9±1.1 1.1 ±0.6 2.1±0.6 7.8±0.5
control 1.0±0.7 0.9±0.2 0.7±0.9 0.2±0.2
experimental = IFN-y 300U/ml plus TNF-a 300U/ml. Control = carriage medium only
TNF-a alone had did not induce apoptosis after 36h in 10%FCS cultures, but induced 8.6±3.5% apoptosis at 16h
in 0%FCS. IFN-y alone had no effect on apoptosis
Figure 6-1: Fluorescent photomicrograph (X200) showing apoptotic rat MC due to the synergistic effect of
IFN-y plus TNF-a. MC were cultured with IFN-y (300U/ml) plus TNF-a (300U/ml) for 16h in medium withl%
FCS. After fixing and staining with propidium iodide, cells were visualised. Note condensed nuclei of apoptotic
cells (arrows) and a cell in early apoptosis (with cytoplasmic blebbing) following aborted mitosis (block arrow).
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The appearance of mitotic figures was also reduced when IFN-y and TNF-a synergised; at 36h in the
presence of IFN-y plus TNF-a, mitotic figures were 4.1% (control) compared with 1.9%
(experimental). Data drawn from different experiments suggested that this may be because cells in
G2M phase of the cell cycle were more susceptible to TNF-a mediated apoptosis than cells in other
stages of the cycle. When studying the cell cycle by flow cytometry, rat MC that were treated with
IFN-y and TNF-a exhibited a clear reduction of the proportion of cells in G2M (Figure 6-2). This was
in keeping with the qualitative microscopical data where some apoptotic cells appeared to be cells
which had aborted mitosis (Figure 6-1). Furthermore, similar studies on human MC (Table 6-2), which
showed similar synergy of IFN-y with TNF-a, indicated that when the cells were proliferating well (in
the early passages), there was more TNF dependent induction of apoptosis than when they were
proliferating slowly (see Chapter 3.15). When the mitotic rate of HMC growing alone was 2.3+0.8%,
cytokine-activated human M<|) co-cultured with human MC induced 16.4±2.9% apoptosis. When the
mitotic rate was 1.8±0.1%, the induction of apoptosis in co-culture was 6.9±0.3%. Further evidence of
a link between cell cycle and TNF-mediated apoptosis came from mouse MC cultures. Mouse MC
divide very slowly in culture and do not undergo apoptosis in response to IFN-y with TNF-a despite
evidence of intracellular signalling (induction of iNOS). This negative result was seen whether
experiments were performed in 0% FCS or 10% FCS, over a 36h period (Chapter 6.7).
Table 6-2: The effect of recombinant IFN-y plus TNF-a on IFN-y primed and unprimed rat and human MC at
24h
Percentage apoptosis of MC
Unprimed Primed
Control IFN/TNF Control IFN/TNF
Rat mesangial cells 0.9±0.4% 1.1+0.4% 0.2±0.2% 7.8±0.5%
Human mesangial cells 1.3±1.0% 2.8±0.8% 0.4±1.1% 7.3±1.9%
IFN/TNF = IFN-y 300U/ml plus TNF-a 300U/ml. cont = control
IFN-y plus TNF(3 (300U/ml) induced 8.1±2.0% apoptosis of primed rat MC at 24h.
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6.3 INHIBITORS OF NITRIC OXIDE GENERATION DO NOT BLOCK IFN-y/TNF-a
INDUCTION OF MC APOPTOSIS
The role of MC-derived NO was investigated in either induction of apoptosis of MC or protection from
M(|)-derived NO (Chapter 3.6). NO generated by rat MC, did not protect the MC from M<|)-derived NO.
However, in this study, MC were cultured with IFN-y and TNF-a for 48h to allow induction of MC
apoptosis. Adjacent wells also contained high concentration NO inhibitors, L-NMMA (500pM) or L-
NIL (30pM). MC apoptosis was assessed by fluorescent microscopy (Figure 6-3). These results
suggest that NO had no role in regulating TNF-a mediated apoptosis of rat MC.
i
i
Figure 6-2: Fluorescent histograms of PI stained RNAse treated rat MC indicating DNA content. (A) In
untreated cells there were 19.2% in G2/M of the cell cycle and 2.5% of hypodiploid cells whereas (B) in cells
stimulated with IFN-y plus TNF-a for 24h, there were 12.7% of cells in G2/M and 22.5% of hypodiploid cells.
Note that DNA content apparently greater than 2n represents cellular aggregates.
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N/A IFN/TNF plus LNMMA plus LNIL
Figure 6-3: Induction of apoptosis by IFN-y/TNF-a in rat MC is not suppressed by iNOS inhibitors. In full
medium, 70% confluent MC were treated with IFN-y plus TNF-a and assayed for apoptosis after 24h. In some
wells, iNOS inhibitors were added in addition to cytokines, in high concentration in an attempt to block mediated
TNF-killing. (IFN-y [300U/ml], TNF-a [300U/ml], L-NMMA [500gM], L-NIL [50pM]).
6.4 INHIBITORS OF INTRACELLULAR OXYGEN RADICAL GENERATION DO NOT
INHIBIT TNF-MEDIATED KILLING OF IFN-y PRIMED RAT MC
As with Fas signalling, there is evidence that intracellular red-ox potential is important in modulating
TNFR1 signalling (Kim et al., 1997; Sidoti-de Fraisse et al., 1998; Spanaus et al., 1998; Bradham et
al., 1998). Indeed, there appear to be two, sequential mitochondrial-derived oxygen radical bursts in
some cells after TNFR1 ligation. In some studies, intracellular blockade of the oxygen burst inhibits
TNFR1 induction of apoptosis (Um et al., 1996; Sidoti-de Fraisse et al., 1998). The oxygen radical
inhibitors, catalase and SOD, only act extracellularly. Therefore, N-acetyl cysteine, reduced
glutathione and a synthetic inhibitor BHA were all utilised to block the intracellular oxygen spike.
None of these inhibitors had any effect on blocking TNFR1 mediated apoptosis of MC (Figure 6-4)
either in 10% FCS or 1% FCS. There are reports that cell surface glutathione pumps may determine
whether this oxygen spike can be blocked with such quenching agents. In the case of high pump
activity, red-ox status in such cells will not be determined by application of exogenous agents (de
Bittencourt Junior et al., 1998; Hampton et al., 1998; van den Dobbelsteen et al., 1998).
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6.5 IFN-y PRIMED MC TRANSLOCATE MORE NFKB TO THE NUCLEUS THAN
UNPRIMED CELLS UPON EXPOSURE TO TNF-a
Flow cytometric analysis of human MC suggested that unlike Fas, TNFR1 was not upregulated on the
cell surface in cells susceptible to undergo apoptosis (Chapter 4.19). Early work on TNFR1 signalling
into the caspase pathway had suggested that there was a dichotomy in signalling either into the NFkB
pro-inflammatory pathway or into the caspase pathway (Hsu, Huang et al., 1996; Hsu, Shu et al., 1996;
Liu et al., 1996; Wang et al., 1998). This is of course an oversimplification since TNFR1 ligation
appears to signal into many pathways (Liu et al., 1996). However, studies in which TNFR1 induction
of NFkB activity was blocked (Beg et al., 1995; Beg et al., 1996; Brown et al., 1995; Liu et al., 1996;
Hirahashi et al., 2000) indicated that TNFR1 then signalled predominantly to induce apoptosis. Indeed
studies from our own group (Sugiyama et al., 1999) on rat MC using an IkB over-expressing stable cell
line confirmed just that; TNFR1 ligation alone, readily induced MC apoptosis, even in the presence of
10% FCS. Whether this observation reflects inhibition of the survival factors such as the IAPs or
whether it alters the red-ox potential of the cell is unclear (Schreck et al., 1991).
Given the observations above, one might expect that IFN-y treatment would inhibit NFkB signalling by
TNFR1 ligation in MC, thereby 'encouraging' signalling from TNFR1 into the death pathway. Indeed,
Manna and colleagues (Manna et al., 2000) showed that interferon-a down regulates NFkB in Jurkat T
cells, enabling TNF-mediated apoptosis.
To investigate further, nuclear proteins were collected from rat MC, which had been primed with IFN-y
(300U/ml) for 24h, and then treated with TNF-a for 30min, 6h or 24h. This was compared with cells
treated with TNF-a but not primed with IFN-y. The nuclear proteins were then incubated with a short
P32-congugated sequence of dsDNA, the sequence of which corresponded to the NFkB binding site for
the human IL-6 gene (Stylainou et al., 1999). The nuclear proteins were also incubated with a similar
consensus oligomer (Sugiyama et al., 1999; Stylianou et al., 1999). Once incubated the DNA protein
mix was electrophoresed through a non-denaturing polyacrylamide. Retardation of the oligomer
running in the gel indicated binding of nuclear protein and therefore nuclear protein activity. This is the
basis for the Electromobility Shift Assay (EMSA).
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n/a ifn/tnf +gsh +nac +bha
Figure 6-4: Induction of apoptosis and suppression of mitosis by IFN-y/TNF-a in rat MC is not suppressed
by intracellular oxygen radical scavengers. (A) rat MC were cultured for 36h in full DMEM/F12 with IFN-
y/TNF-a (300U/ml) in the presence of free radical scavengers, reduced glutathione (10pM), N-acetyl cysteine
(10pM) and BHA (lOOpM). (B) A similar experiment was carried out in DMEM/F12 and 1% FCS. Apoptosis
was scored at 24h.
A representative mobility shift assay (Figure 6-5) demonstrated that IFN-y treatment alone did not lead
to induction of NFkB activity. TNF-a treatment however led to a rapid recruitment of a proabaly two
NFkB species. Supershift studies (using the NFkB consensus) suggested P65 induction without
obviously P50, though the two induced bands are likely to be (P65)2, and P65/P50. (Figure 6-6). This
induction was sustained for at least 36h. However, when MC had been primed with IFN-y, TNF-a
treatment led to a much greater translocation of NFkB to the nucleus. Supershift studies, and studies
using mutated sequences (Sugiyama et al., 1999) indicated that the proteins were specifically binding
the NFkB sequences.
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Figure 6-5: Representative band shift assay for nuclear NFkB species using the human IL-6 DNA binding
sequence. Arrows indicated specific NFkB bands. Lanes 1-4 represent nuclear proteins from unprimed cells
treated with no treatment (1), TNF-a (300U/ml) for 30min (2), TNF-a for 6h (3), and TNF-a for 24h (4). Lanes
5-8 represent nuclear proteins form rat MC primed with IFN-y (300U/ml) for 24h before treatment with no
treatment (5), TNF-a (300U/ml) for 30min (6), TNF-a for 6h (7), and TNF-a for 24h (8). Note induction of the
NFkB activity in the nucleus with TNF-a. However, note how this is augmented after priming with IFN-y.
This observation is contrary to that which one might expect from previous studies since NFkB has
been shown to protect many cells from apoptosis. Although one explanation for augmented (P65)2
translocation to the nucleus might be increased TNFR1 expression on the cell surface, no evidence for
this was found. Unfortunately, the commercially available anti rat TNFR1 antibodies employed in flow
cytometry and western blotting did not specifically locate TNFR1 (not shown). However, flow studies
of human MC which behaved similarly to rat MC, showed no evidence of increased TNFR1 expression
following IFN-y priming (Chapter 4.19).
6.6 INTERFERON REGULATORY FACTOR 1 IS TRANSLOCATED TO THE NUCLEUS
UNDER THE INFLUENCE OF IFN-y WITH TNF-a
This surprising result required some explanation. Contrary to much published work, rat MC undergo
TNFR1-apoptosis in the face of increased NFkB activity as well as when NFkB activity is blocked.
Studies (albeit on human MC) showed that IFN-y did not render cells susceptible to TNF-mediated
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apoptosis by increasing TNFR1 expression. Was it possible therefore that TNFR1 was signalling
apoptosis by another mechanism?
Antibody :
A
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Figure 6-6: EMSA for NFkB using nuclear extract from TNF-a (300U/ml) (4h) stimulated rat MC. The
nuclear extracts were pre-incubated with antibodies against candidate NFkB species (Santa Cruz Biotechnology)
and the nuclear factor AP-1. Note absence of the specific induced band when nuclear extracts were incubated
with and P65 (Produced in conjunction with Dr. Hitoshi Sugiyama).
Studies in other cell types for many years have observed the anti-proliferative effects of IFN-y, and
have commented that it has been augmented by TNF-a (Kirchkoff et al., 1993; Pine 1997; Ossina et
al., 1997; Spanaus et al., 1998; Burke et al., 1999; Ohta et al., 2000). Many of these studies just looked
at cell counts or H3-thymidine incorporation and did not look for apoptosis to explain a lack of growth.
However, it was highlighted more than a decade ago that interferon regulatory factor-1 (IRF-1) might
be an important nuclear factor in determining this synergistic effect of IFN-y with TNF-a. This nuclear
factor is under the regulation of several nuclear proteins, including NFkB family and STAT la, a
nuclear protein translocated by IFN-y receptor ligation (Pine 1997; Gupta et al 1998).
Early studies indicated that when myeloid tumour cells over-expressed IRF-1 in the nucleus, the cells
did not grow (Kirchkoff et al., 1993). Indeed, in a transgenic mouse where IRF-1 was linked to the
immunoglobulin promoter, the animals were grossly deficient in the B cell lineage (Yamada et al.,
1991).
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Renewed interest has developed recently since it has been found that the NFkB binding site in the IRF-
1 promoter is a novel binding site that synergistically binds NFkB proteins only when STAT la is also
present (Pine 1997; Gupta et al., 1998). Furthermore, many pro-inflammatory genes require IRF-1 to
bind to their promoters (such as iNOS (Martin et al., 1994; Kamijo et al., 1994) in addition to NFkB
species for efficient transcription.
To determine whether IRF-1 was relevant in the rat MC, nuclear proteins were isolated from cells
exposed to IFN-y, TNF-a or both. EMSAs were performed using a IRF-1 consensus dsDNA binding
sequence (Kamijo et al., 1994) and another IRF-1 binding sequence from the protein ISG-15 (Pine
1997), a protein of unknown function that is induced by IFNy.
The shift assay using ISG15 IRF-1 binding sequence (Figure 6-7) indicates that in this cell-type, IRF-1
is synergistically active in the nucleus under the influence of IFN-y and TNF-a. Note that IFN-y alone
was able to weakly induce IRF-1 activity, but TNF-a was completely unable to. Together, induction of
the nuclear protein was augmented.
Using 50X excess cold oligonucleotide almost totally prevented specific binding (Figure 6-8).
Furthermore, rabbit polyclonal anti-IRF-1 IgG but not anti-IRF-2 IgG was able to inhibit specifically
binding of IRF-1 to the oligonucleotide. A scrambled sequence of the ISG15 did not bind IRF-1 in
induced cell extracts. Similar studies to those shown (Figure 6-7 and 6-8.) were performed using the
IRF-1 consensus sequence and confirmed the results (not shown).
6.7 WILD TYPE AND IRF-1 KNOCKOUT CULTURED MOUSE MESANGIAL CELLS DO
NOT UNDERGO APOPTOSIS IN RESPONSE TO IFN-y AND TNF-a
To investigate the pro-apoptotic role of IRF-1 further, glomeruli were isolated from IRF-1 KO mice
and wild type littermates, and mesangial cells were cultured from these glomeruli (see Chapter 2). The
hypothesis was that the knockout cells might be resistant to TNF-a mediated apoptosis following
treatment with IFN-y. The wild type cells would be susceptible to TNF-mediated apoptosis much like
the rat and human MC.
Once cells were established, it was noted that they proliferated very slowly, more slowly than both
human and rat MC. The doubling time was in the order of 96h compared with less than 24h for rat and
human MC. When wild type cells were treated with rat IFN-y and human TNF-a there was no
induction of apoptosis, nor was there suppression of mitosis nor alteration of the G2/M population by
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flow cytometry (not shown). Induction of iNOS however was readily detected in the supernatant as
nitrite, thus confirming that the cytokines were active. There were several possibilities for this
observation. Firstly, human recombinant TNF-a is said not to bind to murine TNFR-2 and TNFR-2
may be important in apoptosis signalling (Chan et al., 2000). Secondly, the cell cycle might be too
slow if the only cells which undergo TNF-dependent apoptosis are the cells which are cycling into
G2/M (see Chapter 3.15). Finally, if membrane bound TNF-a is the most potent form for inducing
apoptosis, the mouse MC might be resistant to recombinant TNF-a, which tends to be mainly in
soluble trimeric form. It was not possible therefore to show that IRF-1 was necessary for TNF




Figure 6-7: Representative band shift using the ISG15 promoter IRF-1 binding sequence. Lanes 2-4 from
cells treated for 30 min. Lane 1 nuclear extract from unstimulated cells. Lane 2 from cells treated with IFN-y
(300U/ml). Lane 3 cells treated with TNF- (300U/ml). Lane 4 cells treated with both IFN-y and TNF-a. Lanes
5-7 cells were treated for 6h. Lane 5 from cells treated with IFN-y (300U/ml). Lane 6 cells treated with TNF-
(300U/ml). Lane 7 cells treated with both IFN-y and TNF-a. Note synergistic induction of IRF-1 activity with
the combination of cytokines.
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6.8 TRANSIENT TRANSFECTION OF RAT MC WITH IRF-1 UNDER THE CMV
PROMOTER RESULTS IN EXPRESSION OF IRF-1 mRNA
Since the mouse cells did not display IFN-y/TNF-a synergism in apoptosis induction, it was decided to
employ an over-expression system to investigate the role of IRF-1 in rat MC apoptosis. In
collaboration with Prof. H. Hauser (Germany) vectors containing the mouse cDNA for IRF-1 were
obtained. This gene was fused with the 3" end of the human oestrogen receptor (HER), under control of
the myeloproliferative sarcoma virus (MPSV) promoter, which had been shown in myeloid cells to
achieve high levels of transcription. The fusion protein IRFHER had been shown to reside in the
cytosol (in myeloid cell lines), but on application of an oestrogen, be translocated to the nucleus where
the IRF-1 bound to DNA and was functionally active (Kirchkoff et al., 1993) (vector 767 Figure 2-10).
A similar vector containing the oestrogen gene but without the IRF-1 cDNA was provided as a
negative control (vector 776).
Unfortunately, no simple assay for IRF-1 activity in transfected cells, such as a luciferase linked IRF-1





Figure 6-8: Representative band shift using the ISG15 promoter sequence for IRF-1 binding. Lane NS
contains no nuclear protein extract, 'u' = nuclear extract from unstimulated cells and, 'a' = nuclear extract from
cells activated with IFN-y (300U/ml) plus TNF-a (300U/ml) for 4h. Lanes 1, extract was incubated with cold
probe. Lanes 2, extract was incubated with hot probe. Lanes 3, hot probe was competed out with 50X excess of
cold probe. Lanes 4, nuclear extract was incubated overnight with polyclonal anti-IRF-1 antibodies, lanes 5
nuclear extract was incubated with anti-IRF-2 antibody. Lanes 6, a mutated probe sequence was employed.
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The rat MC were normally cultured in 10% FCS. However, FCS contains oestrogens. To perform
experiments on rat MC in FCS using this construct it was necessary to deplete all FCS of oestrogens
(Chapter 2.2.9). All experiments utilising transfected cells were cultured in medium supplemented with
depleted FCS.
Rat MC were now transfected with vectors 767 and 776. EGFP-N1 (vector containing the green
fluorescent protein gene under the CMV promoter) was utilised as a control for transfection efficiency.
At 48h, by flow cytometry, 32% of cells were fluorescent. The 767-transfected MC appeared to be
growing as well as the 776 transfected cells. These cells did not undergo apoptosis in response to
estradiol at 5pM (an oestrogen), TNF-a (300U/ml) nor a combination of both (1.33% compared with
1.28% for untreated cells).
To determine why the transiently transfected cells did not undergo apoptosis, mRNA was extracted
from the cells, RT-PCR was performed for IRF-1 cDNA and analysed on a 1.5% agarose gel (Figure 6-
9 lane 3). These data clearly indicated that the transfected cells did not contain any IRF-1 mRNA. The







Figure 6-9: Agarose gel (1.0%) showing PCR products from cDNA from transiently transfected rat MC
when using IRF-1 primers (top panel) and actin primers (bottom panel). Lanes 1 cells transfected with
eGFP/IRFHER, lanes 2 with EGFP-N1, lanes 3 with 767 vector, lanes 4 with 776 vector. Lane 5 shows PCR
products from eGFP/IRFHER vector alone. NS -no DNA sample, 'a' denotes omission of reverse transcriptase.






The HERIRF-1 gene construct was therefore excised from the 767 vector and inserted into the EGFP-
N1 vector under the control of a CMV promoter. Previous studies of transfection of mesangial cells
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have indicated that the CMV promoter reliably resulted in adequate transcription of exogenous genes
(Stylianou et al., 1999). Also, the EGFP-N1 vector resulted in strong green fluorescence in the rat MC,
confirming CMV promoter activity.
After generation and purification of the new vector (Chapter 2.11), 5x 106 rat MC were transiently
transfected with 20|ig of eGFP/IRFHER(5), or 20pg of control EGFP-N1 vector by electroporation.
At 48h, RNA was purified and after reverse transcription, PCR was performed. This study now
confirmed production of mRNA for IRF-1 (Figure 6-9 lane 1). Furthermore, in preliminary studies of
the transiently transfected cells, those with IRFHER appeared to undergo apoptosis in the presence of
estradiol (an oestrogen) and TNF-a whereas the eGFP-transfected cells did not (not shown).
6.9 OVER-EXPRESSION OF IRF-1 IN RAT MC RENDERS THEM SUSCEPTIBLE TO TNF-
MEDIATED APOPTOSIS WITHOUT THE REQUIREMENT FOR IFN-y
Following stable transfection of rat MC with the new vector and the control EGFP-N1 vector,
polyclonal (>10 colonies) and monoclonal cell cultures were generated. Initial observations suggested
that the polyclonal cell cultures appeared to grow normally, but some of the single colony cultures
grew abnormally: IRFHER clones 8,23,25,27,33 all showed increased levels of spontaneous apoptosis.
Whereas, IRFHER clones, 6,11,16,17,18 showed normal growth. The high-expressing eGFP colonies
were maintained (6,5,3,7) and all showed normal growth with normal low levels of spontaneous
apoptosis. From the cells transfected with EGFP-N1, seven other clones were derived that produced no
detectable GFP.
Study of the polyclonal cell lines by morphology and flow cytometry of fixed, PI stained cells,
revealed firstly that the cells exhibited increased levels of spontaneous apoptosis (Table 6-3, Figure 6-
10). Secondly, estradiol alone (5pM) had no marked effect. However, TNF-a alone was able to induce
apoptosis of the polyclonal cells without the necessity for IFN-y. (Table 6-3 shows this most clearly).
When estradiol and TNF-a were applied together, there appeared to be a small increase in the
induction of apoptosis. Note, the control eGFP-expressing polyclonal cells exhibited no more than
0.9% hypodiploidy even in the presence of TNF-a plus estradiol (5|xM).
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Table 6-3: Polyclonal IRFHER expressing MC are susceptible to TNF-a mediated apoptosis when
assessed microscopically at 24h.
N/A estradiol TNF-a estradiol +TNF-a
PolylRFHER(l) 2.1±1.1% 2.3±0.9% 8.4±1.5% 10.7±2.1%
PolyIRFHER(2) 1.6±0.9% 2.4±1.5% 3.5±1.7% 5.6±2.2%
PolyeGFP(l) 0.6±1.0% 0.7±0.3% 0.9±0.9% 0.7±1.2%
Estradiol 5|_iM, TNF-a 300U/ml, N/A = estradiol carriage medium
iif.a^ppolytfpLOQO
Figure 6-10: Polyclonal HERIRF-1 stably transfected rat mesangial cells undergo increased apoptosis in
response to tumour necrosis factor alone (A) Unstimulated cells after 24h in culture as assessed by flow
cytometry of Pi-stained fixed cells and showed 2.1% hypodiploidy. (B) cells were exposed to estradiol (5pM) for
24h resulting in 2.6% hypodiploidy. (C) Cells were treated with TNF-a (300U/ml) which alone induced 6.8%
hypodiploidy and (D) when cells were treated with estradiol and TNF-a in combination hypodiploidy increased
to 8.1%.
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The individual clones were now assessed for apoptosis. All the clones which displayed increased
spontaneous apoptosis, also exhibited TNF-a but not estradiol induced apoptosis (Table 6-4). The
clones that did not exhibit increased spontaneous apoptosis were resistant to the effects of TNF-a
(6,11,16,17,18), and behaved similarly to the stable eGFP-expressing clones (6,5,3,7). Importantly,
when the IRFHER clones that were sensitive to TNF-a were studied by flow cytometry, some of the
clones had abnormalities of cell cycle progression (Figure 6-11). Unfortunately, these clones were not
assessed for IRF-1 expression either quantitatively or by intracellular compartment. Further, no studies
were performed to determine the effect of exogenous estradiol on IRF-1 location within the mesangial
cells.
Table 6-4: IRFHER transfected MC clones are susceptible to TNF-a mediated apoptosis when assessed
microscopically
N/A estradiol TNF-a estradiol +TNF-a
Clone 27 0.6±0.6% 0.6±1.0% 4.9±0.5% 5.2±1.3%
Clone 25 2.1 ±1.4% 2.6±1.4% 12.4±2.4% 12.9±1.8%
Clone 33 5.5±1.4% 4.9±2.2% 8.9±1.0% 9.4±1.2%
Clone 23 2.4±1.1% 1.9±0.6% 6.6±1.2% 7.4+1.2%
Clone 8 1.6±0.3% 1.4±1.0% 4.8±1.6% 5.7±1.6%
Estradiol 5pM, TNF-a 300U/ml, N/A = estradiol carriage medium
6.10 CASPASE INHIBITORS DO NOT BLOCK TNF-MEDIATED KILLING OF IFN-y
PRIMED RAT MC
Rat MC, 70% confluent, primed with IFN-y (300U/ml) for 24h, were then cultured with lOOpM of
DEVD or LEHD (Nicholson et al., 1995; Garcia-Calvo et al., 1998) caspase inhibitors at the same time
as addition of recombinant TNF-a. After 24h there was induction of similar apoptosis in cells that had
and had not been treated with the caspase inhibitors (8.4% LEHD, 7.9% DEVD, 8.9% no inhibitor). In
control wells without TNF-a, there was no difference in background mitosis/ apoptosis levels when the
inhibitors were present. Unfortunately, no suitable positive control was used.
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To determine whether caspase 3 was cleaved, western blots were performed with two different
antibodies, one polyclonal, the other monoclonal (Figure 6-12). The former did not give significant
bands for the protein. The latter (anti-mouse) gave a sharp band for the positive control, but the rat MC
did not appear to have detectable caspase 3. Whilst neither of these two pieces of data were definitive,
they do suggest that rat MC do not have caspase 3.
Figure 6-11: Rat MC clones over-expressing IRF-1 have abnormalities of cell cycle progression as seen by
flow cytometry for DNA content. The four clones shown (25,33,23,8) all exhibit increased levels of spontaneous
hypodiploid cells compared with the control eGFP expressing cells (e7). Furthermore, the IRF-1 expressing cells
all have an accumulation of cells in G2M phase of the cell cycle and a relative loss of cell in the G,/G, phase of
the cycle. This is most prominent in the clone 23.
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1 2
Figure 6-12: Rat MC do not obviously have Caspase 3 in the cytosol. Rat MC were treated for 24h with
IFN-y and TNF-a, then cytosolic proteins were harvested in lysis buffer with NP-40 (lane 1). lOOpg of soluble
protein was electrophoresed in a 10% gel along with (lane 2) 10pg protein extract from murine RZW-3T3 cells,
stably over-expressing caspase 3. The subsequent blot was incubated with anti-mouse caspase 3 antibody C76920
(Transduction labs), which cross reacts with rat caspase 3. After secondary antibody, the blot was visualised
using ECL. Note the non-specific bands at around 40 and 65kDa.
6.11 SUMMARY
• TNF-a mediated apoptosis of mesangial cells is regulated by IFN-y.
• Soft evidence indicates that cells moving into G2M are more susceptible to TNF-a killing than
cells in Go/G^
• The mechanism of TNF-a intracellular signalling appears to be nitric oxide and ROI independent
• IFN-y priming of mesangial cells augments NFkB induction upon TNFR1 ligation.
• IRF-1 is synergistically induced by IFN-y/TNFa
• Over-expression of this IRF-1 alone, appears to be sufficient to induce low level apoptosis of
mesangial cells and block their cell-cycle progression
• IRF-1 appears to permit TNF-a signalling apoptosis without the requirement for IFN-y
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• The role of caspases in TNF-a induced apoptosis of rat MC remains unclear and requires further
work.
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7.1 IN CO-CULTURE, ACTIVATED M<t> PHAGOCYTOSE MC THAT HAVE BEEN
INDUCED INTO APOPTOSIS
From the co-culture studies reported in Chapters 3,4, and 5, it was notable that a proportion of the MC
induced into apoptosis by M<]) were subsequently phagocytosed by the M<|). The proportion of MC that
had been phagocytosed at 24h was variable, but in studies where this was assessed semiquantitatively,
it amounted to around 10%. This proportion is low given the known avidity of macrophages for
ingestion of apoptotic cells (Savill et al., 1989). However, in vitro studies where the proportion of McJ)
that have phagocytosed is much higher (30-40% of M<|) containing at least one apoptotic cell) have
experimental designs that maximise the chance of phagocytosis. In vivo also, where M(J) are believed to
avidly phagocytose, there is much greater cell to cell contact, thereby maximising phagocytic
recognition (Baker et al., 1994). In the 2D co-culture monolayer the majority of apoptotic MC were not
ingested by M0, but remained loosely adherent to the monolayer, often microscopically in a focal plane
just above the live, adherent cells. For stoichiometric reasons, therefore, the assay was not best
designed to promote binding and phagocytosis of such apoptotic cells.
7.2 INGESTION OF APOPTOTIC MC BY M<> IN CO-CULTURE INHIBITS FURTHER
INDUCTION OF MC APOPTOSIS
To address the hypothesis that, in the co-culture model of glomerular inflammation, macrophages that
have ingested apoptotic cells are no longer able to kill live cells, the co-culture was redesigned to
augment or maximise M(|)-phagocytosis of apoptotic MC. This was achieved by overlaying established
co-culture of CMFDA-green labelled rat MC and BMD-M(|) with a confluent layer of pre-formed
(unlabelled) apoptotic MC (Chapter 2.6). For this, large numbers of apoptotic MC were required, and
were generated by UV induction of confluent monolayers. Care was taken to promote apoptosis rather
than necrosis. In all experiments, fewer than 10% of such apoptotic MC admitted propidium iodide and
none admitted trypan blue (Chapter 2.4).
The rodent co-culture was established as previously described in 96-well plates, using primed rat MC
(since these were susceptible to both NO and TNF killing). At the start of the experiment tat the same
time as activation with IFN-y and LPS'), apoptotic rat MC were added such that there were 5x the
number of apoptotic MC as M<|) in the well (total 1 x 105). Live MC were labelled green with CMFDA
and were therefore easily distinguishable from the UV induced apoptotic MC. As a control for the
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apoptotic cells, an aliquot of inert latex beads (10pm) diameter was added to separate wells of co-
culture. In other wells of co-culture and M(j) alone, to which aliquots of apoptotic cells and latex beads
had been added, the experiment was stopped by fixation at 4h. These wells were assessed for ingestion
of apoptotic MC using Nomarski optics. Assessing ingestion in this way revealed that many pre¬
formed apoptotic MC had been ingested, and that 30±6.7% of M(J) had ingested at least one apoptotic
MC. Many M(|) had ingested two or more apoptotic MC (In the co-culture, the majority of
phagocytosing cells were M(J) though some CMFDA-labelled MC also ingested apoptotic MC).
Further, 67±8.4% of M(J) had ingested latex beads. Again, in co-culture, M(J) were the predominant cell-
type to phagocytose the beads. When pre-formed apoptotic MC were added to established quiescent
co-culture and incubated for 4h, 27±9.4% of M(J) ingested apoptotic cells.
The co-culture was incubated for 24h, then fixed and assessed microscopically for green CMFDA MC
apoptosis (Figure 7-1). There was little difference between the proportion of apoptotic rat MC in co-
cultures when M<)) had not ingested, compared with when they ingested latex beads and when they
ingested apoptotic MC.
no ingestion ingestion beads ingestion apoptotic
cells
Figure 7-1: Ingestion of apoptotic MC by activated M<J> does not prevent Mp induced killing of live primed
MC in co-culture. Activated co-culture with IFN-y primed MC was established and activated with IFN-y and
LPS. A five-fold excess of pre-formed apoptotic MC was added to the co-culture at the time of activation,
Control latex beads were added to other wells. Co-culture where M([> had ingested the apoptotic cells showed a
small reduction in M(|)-derived killing but this was not significant (n=5).
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However, when the experiments were repeated in the presence of L-NMMA at 200pM (added
simultaneously with activating cytokines to block the NO-induced killing), wells with M<J) that had











no ingestion ingestion beads ingestion apoptotic
cells
Figure 7-2: Ingestion of apoptotic MC by activated M<j> blocks TNF-dependent killing of live MC in co-
culture. Activated co-culture was established and activated in the presence of L-NMMA (200pM). A five-fold
excess of pre-formed apoptotic MC was added to the co-culture at the time of activation, Control latex beads
were added to other wells. Co-culture where M0 had ingested the apoptotic cells showed no evidence of Mcp-
derived killing (n=5 *** P<0.001).
The experimental design was modified in order that Mtj) could ingest apoptotic cells prior to activation
with IFN-y plus LPS. The co-culture was established, then covered with aliquots of pre-formed
apoptotic MC or beads as above. After 4h, the co-culture was then gently washed to remove any
apoptotic MC or beads that had not been ingested. After washing and replacing full medium, the co-
culture was activated with IFN-y and LPS and, in half the experiments, L-NMMA (200pM) was added.
In these experiments, TNF-dependent killing of live CMFDA-green MC by activated M<J) was still
inhibited by prior ingestion of apoptotic cells (Table 7-1).
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Table 7-1: The effect of ingestion of apoptotic MC by M(|) in co-culture with IFN-y primed MC on M<]>-
induction of MC apoptosis at 24h
% mesangial cell apoptosis
No L-NMMA L-NMMA
no <|> <l> no <)> <t>
Particle ingested
apoptotic mesangial cell (UV) 17.9+2.2 18.510.8 10.712.1 3.311.0**
latex beads (10pm) 20.911.8 22.211.6 15.5.11.3 16.812.5
UV = ultraviolet, (]) = phagocytosis
Rodent co-culture with IFN-y primed CMFDA-labelled MC was established as described in Chapter 2.
Apoptotic cells were incubated with the co-culture for 4h. M<J) were activated with IFN-y plus LPS in the
presence of L-NMMA 200pM after washing away non-ingested cells. Note that control cultures of MC alone
exposed to apoptotic cells followed by activating cytokines underwent no greater than 3.4210.2% apoptosis.
** P < 0.01, compared with no phagocytosis
7.3 INGESTION OF APOPTOTIC LEUCOCYTES BY M<> IN ACTIVATED CO-CULTURE
INHIBITS THE INDUCTION OF MC APOPTOSIS BY M<|>.
To investigate whether selective inhibition of M(|)-derived, TNF-dependent killing following ingestion
of apoptotic MC, was an effect unique to apoptotic MC, apoptotic neutrophils (PMN) and lymphocytes
(thymocytes) were prepared. Rodent neutrophils were difficult to obtain but human PMN were
plentiful from peripheral blood donation. Neutrophils undergo spontaneous apoptosis. Alternatively,
they can be induced by UV irradiation into apoptosis. The thymus of mice represented an easy source
of large numbers of murine single cells that were easily induced into apoptosis by steroids or UV
irradiation. As a control particle in these experiments, live thymocytes were utilised. Both lymphocytes
and neutrophils are cells found in the glomerulus during nephritis.
Neutrophils were incubated either for 16h in full DMEM/F12 or for 6h in Dulbecco's PBS (containing
Ca++ and Mg++). Both treatments typically yielded 30-50% apoptosis when assessed by light
microscopy (see Figure 2-4). Care was taken to make sure that the population did not contain necrotic
cells. To that end, cells were always assessed for trypan blue positivity and in some experiments
assessed by two colour flow cytometry for FITC-conjugated Annexin V binding and PI positivity. PI
positive cells did not exceed 5% (not shown).
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Thymocytes were cultured in full medium and treated with UV irradiation, or dexamethasone. Those
cells that were not treated, progressively became apoptotic such that at 16h there were 14% apoptotic.
However, after 4h incubation, apoptosis was less than 5% when assessed by flow cytometry (Figure 2-
5). Six hours of culture with dexamethasone and 4h culture after UV irradiation yielded apoptotic cells
without significant numbers of post-apoptotic cells.
Live neutrophils exposed to LPS undergo a brisk respiratory burst and can induce bystander MC
apoptosis by a catalase inhibitable mechanism (see Chapter 5.4). It was therefore important that no live
neutrophils remained in the co-culture as this would affect the killing of MC by M<)). In the case of
thymocytes, theoretically live cells might interact with activated M(|) and modulate their response,
though these studies showed no evidence of this being the case. Given these potential problems, the co-
culture was established and apoptotic cells were added (5 x the number of McJ>) for 4h. At this point
non-adherent, non-ingested cells were washed away by very gentle pipetting to leave only the adherent
co-culture, with ingested or bound apoptotic cells. The co-culture was assessed for uptake of apoptotic
leucocytes. This indicated 35±8.1% of had ingested neutrophils (Figure 7-3), and 31.8±6.4% of
M<|) had ingested apoptotic thymocytes. Some M(|) had ingested up to 10 thymocytes (smaller than
neutrophils). Live thymocytes were not obviously ingested by M(|). Non-ingested apoptotic and live
thymocytes were readily washed away. However, it was not possible to wash away all neutrophils. It
appeared that some of the live neutrophils remained adherent to the co-culture. Thus it was necessary
to purify the apoptotic PMN from the live PMN, since the apoptotic PMN were not able to generate a
respiratory burst (personal communication Dr. A Rossi, University of Edinburgh). To achieve this,
aged or UV-induced apoptotic PMN were incubated with magnetic beads bearing anti CD16. Live but
not apoptotic PMN have cell-surface CD 16. By this method live and apoptotic cells could be separated
(Chapter 2.4). Effective separation was ensured by flow-cytometry and morphology (Figure 2-4).
Now CD16-purified apoptotic PMN, live and apoptotic thymocytes were added to the established co-
culture to enable phagocytosis by M<(). After washing, the co-cultures were activated by IFN-y/LPS
and, after 24h, were assessed for green CMFDA labelled apoptotic MC (Figure 7-4). All the studies
with apoptotic PMN and thymocytes suggested a reduction in MC apoptosis, but none of the results
was significant. However, in the presence of L-NMMA (200pM) (Figure 7-5), interaction with
apoptotic cells but not live thymocytes blocked induction of MC apoptosis. The method of induction of
apoptosis did not have bearing on the suppression of M<() in co-culture. Thus, there was no difference
between UV-induced and dexamethasone induced thymocytes, and there was no difference between
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aged and UV induced apoptotic PMN. Furthermore, PMN that were aged in PBS only, induced similar
reductions to those aged in medium with FCS, or human serum (not shown).
Figure 7-3: Ingestion of apoptotic neutrophils by quiescent BMD M<|> viewed by phase contrast microscopy
(X400). A sub-confluent layer of M<|> was interacted with a confluent monolayer of aged human PMN for 2h.
After incubation, cells were washed and the remaining, adherent cells were fixed with glutaraldehyde (0.5%).
After washing with PBS the cells were incubated with DMB and H202. Myeloperoxidase activity (in PMN)
results in brown staining.
7.4 NITRIC OXIDE RELEASE BY ACTIVATED M<|> IS AUGMENTED BY INGESTION OF
APOPTOTIC CELLS BUT NOT LATEX BEADS
The data from co-culture indicated that the inhibition of M0 killing of MC was best achieved in the
presence of L-NMMA. To determine further the mechanism, supernatants were collected from wells of
M<() (24-well plates) that had first ingested apoptotic cells, then been activated with IFN-y (lOOU/ml)
and LPS (lpg/ml). Care was taken to ensure that equal numbers of M<|> were in each well, an equal
volume of medium was applied, and washing of control wells (with latex beads or no apoptotic cells)
was the same as wells with apoptotic cells. All conditions were prepared in triplicate and each
experimental condition was compared with wells of M(|) that had not phagocytosed, on the same plate.
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Reiter and colleagues (Reiter et al.,1999) showed that when LPS-activated murine M(j> ingested
apoptotic tumour cells, there was a small reduction in NO release as assessed by nitrite generation.
Similar reductions in NO release were reported from trypanosome (Protozoan) infected peritoneal
mouse M<j) following ingestion of lymphocytes (Freire-de-Lima et al., 2000) induced into 'apoptosis'
by heating (note that heating would normally induce a non-apoptotic phenotype and is used elsewhere
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Figure 7-4: In activated co-culture, prior ingestion of apoptotic leucocytes by M(|) does not inhibit M<|>
induction of MC apoptosis. Co-culture of murine M(p and CMFDA-labelled, IFN-y primed rat MC was
established. A monolayer of apoptotic leucocytes was added (A) thymocytes, or (B) neutrophils. After 4h
incubation, the co-culture was washed to removed non- ingested cells and then activated with IFN-<)> lOOU/ml)
and LPS (lpg/ml). CMFDA-labelled MC apoptosis was assessed at 24h. Co-culture was compared with
CMFDA-labelled MC cultured without M<t» but exposed to the same apoptotic cell monolayer, washing and
activating cytokines. There was no significant difference in MC apoptosis when M<J) were interacted with
apoptotic cells.
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Figure 7-5: In activated co-culture, prior ingestion of apoptotic leucocytes by M<|> inhibits TNF-restricted
M<|) induction of MC apoptosis. Co-culture of murine M<|> and CMFDA-labelled, IFN-y primed rat MC was
established. A monolayer of apoptotic leucocytes was added (A) thymocytes, or (B) neutrophils. After 4h
incubation, the co-culture was washed to removed non- ingested cells and then activated with IFN-(|> lOOU/ml)
and LPS (lpg/ml) plus the NOS inhibitor L-NMMA at 200pM. CMFDA-labelled MC apoptosis was assessed at
24h. Co-culture was compared with CMFDA-labelled MC cultured without Mt)> but exposed to the same
apoptotic cell monolayer, washing and activating cytokines. When M([> had ingested apoptotic cells there was a
reduction in induction MC apoptosis by the M<|> (P < 0.001 vs no cells. P < 0.05 vs no ingestion).
Since any live PMN that might contaminate the culture (after interaction of apoptotic PMN with M(|))
would produce oxygen radicals after LPS treatment, it was decided to analyse NO release from all
cultures by assessing nitrite plus nitrate (since oxygen radicals promote oxidation of NO2" to NO3"). To
achieve this, once harvested supernatants had been clarified by centrifugation, they were reduced by
nitrite reductase (see Chapter 2.8). To ensure all nitrate was reduced to nitrite, assay plates had sodium
nitrate controls. Before reduction nitrate does not effect colour change in the Griess reaction. By
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comparing equimolar concentrations of sodium nitrite, one could be sure of complete reduction. Total
nitrite was then assayed by Griess reaction and absorbance at 540nm.
When NO was assayed from quiescent M(J) that had ingested apoptotic rat MC there was no significant
generation of NO. Also, apoptotic rat MC, in the presence of IFN-y/LPS did not generate NO.
However, surprisingly, when M<|) had ingested apoptotic rat MC and were then activated there was an
augmented release of NO compared with M(j) that had not phagocytosed (assessed at 24h) (Figure 7-6).
When apoptotic thymocytes were ingested by M(j), there was a similar pattern. That is, ingestion of
apoptotic cells did not activate M<|) per se, and apoptotic thymocytes in the presence of IFN-y and LPS
did not lead to NO generation. However, when M<|) ingested apoptotic thymocytes (induced by
dexamethasone, or UV irradiation), and were then activated, there was augmentation of NO release
(Figure 7-6). As a control, fresh thymocytes (at 2h incubation) which contained few apoptotic cells, did
not have this effect. However, aged thymocytes that had been cultured for 16h displayed up to 20%
apoptosis (see Chapter 2.4). When these cells were incubated with M<|) prior to activation, there was a
22.4±5.6% increase in NO generation.
0% 25% 50% 75% 100% 125% 150% 175%
percentage NO release
Figure 7-6: M(]) that have ingested apoptotic cell produce more NO when activated by IFN-y/LPS than M<|>
which have ingested inert particles or have not ingested any particle. M<|> were exposed to a five fold excess of
pre-formed apoptotic leucocytes or apoptotic MC for 4h in culture. Wells were washed to remove non-ingested
apoptotic cells, medium replaced, then activated with IFN-y (lOOU/ml) plus LPS (lpg/ml). At 24h, medium was
aspirated, clarified and assayed for [nitrate] plus [nitrite] (n=5 ** P < 0.01).
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Human neutrophils (PMN) when aged in Dulbecco's-PBS for 6h or overnight in full DMEM/F12 were
also phagocytosed. Apoptotic PMN alone, treated with IFN-y plus LPS did not induced NO generation.
Phagocytosis of apoptotic PMN by M<() did not activate the M(f> to produce NO (Figure 7-6). However,
M(j) that had phagocytosed apoptotic PMN, upon activation with IFN-y plus LPS, exhibited augmented
release of NO. The method of induction of PMN apoptosis and the type of medium the PMN were
cultured in during induction of apoptosis did not significantly influence these results.
Ten micrometre latex beads did not induce NO release by quiescent M<j) but significantly, after
ingestion, did not influence the generation of NO release by M(J) following activation with IFNy plus
LPS.
7.5 TNF-a RELEASE BY ACTIVATED M<|> IS INHIBITED BY INGESTION OF APOPTOTIC
CELLS, BUT NOT LATEX BEADS
Diminution of soluble TNF-a release has been reported from LPS-activated human MDM (and murine
J774 M<J> cell line) in response to ingestion of apoptotic peripheral blood lymphocytes or human UV
induced PMN (Fadok et al., 1998; McDonald et al., 1999). It seemed likely that since NO release was
not inhibited by ingestion of apoptotic cells, it was likely that the other ligand identified as important in
M(|)-directed MC apoptosis, TNF-a, would be inhibited. The same supernatants assayed for NO release
were also assayed for murine TNF-a by sandwich ELISA.
The same supernatants, analysed in Figure 7-6, were also analysed for TNF-a (Figure 7-7).
Phagocytosis of apoptotic cells, latex beads and necrotic cells did not increase TNF-a release from
quiescent M(J) (open bars in Figure 7-7). None of the apoptotic cell types (alone) treated with IFN-y and
LPS caused TNF-a release into the supernatant (not shown). However, ingestion of apoptotic cells by
M<[>, followed by activation of M<|> with IFN-y plus LPS led to decreases in TNF-a release assessed at
24h. Latex beads did not influence activated M<|) TNF-a release. Furthermore, all apoptotic cells
studied were able to decrease TNF-a release.
Interestingly, though release was diminished by ingestion of apoptotic rat MC, it was not completely
blocked, yet in co-culture M(J) that had ingested apoptotic rat MC were unable to kill live MC by TNF-
dependent mechanisms. One explanation for this is the predominant role of membrane bound TNF-a in
killing by apoptosis. Indeed, there is evidence from M<|) cytolysis of tumour cells that membrane-bound
TNF-a is more potent than the predominant soluble form (Decker et al., 1987; Peck et al., 1989; Perez
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et al., 1990; Duerksen-Hughes et al., 1992; Day et al., 1994; Lazidins et al., 1997; Kusters et al., 1997;
Weiss et al., 1998). Preliminary flow-cytometric based studies of murine BMD-Mc[) have located low
levels of mTNF-a on the cell surface of activated cells (Lynda Stuart personal communication) and
mTNF-oc has been clearly demonstrated by western blotting techniques (Jue et al., 1990). Further work
is required to elucidate whether ingestion of apoptotic cells down-regulates mTNF-a expression on
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Figure 7-7: M<J) that have ingested apoptotic cell release less TNF-a when activated by IFN-y/LPS than M<J)
which have ingested inert particles or have not ingested any particle. M(p were exposed to a five fold excess of
pre-formed apoptotic leucocytes or apoptotic MC for 4h in culture. Wells were washed to remove non-ingested
apoptotic cells, medium replaced, then activated with IFN-y (lOOU/ml) plus LPS (lpg/ml). At 24h, medium was
aspirated, clarified and by ELISA for TNF-a (n=5 * P < 0.05, ** P < 0.01).
7.6 TRANSFORMING GROWTH FACTOR-(3 RELEASE IS AUGMENTED BY M0 AFTER
INGESTION OF APOPTOTIC CELLS
Although, only one third of M(|) in these studies ingested apoptotic cells, the effect of binding/ingestion
of apoptotic cells by M(j) appeared to be able to influence all M([>, given the complete suppression of
TNF-dependent killing. This observation might suggest the role of soluble or paracrine factors. In
limited studies, the cytokine transforming growth factor beta (TGFf5) was assessed in the supernatants
from M(J) that had ingested apoptotic cells, since active TGF|3 is a candidate cytokine responsible for
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inhibiting pro-inflammatory responses following IFN-y/LPS activation. Further, Fadok and colleagues
showed that this cytokine could be released from M(J> upon ingestion of apoptotic neutrophils (Fadok et
al., 1998; McDonald et ah, 1999). Because FCS contains large amounts of inactive bovine TGFP,
which would interfere with an ELISA assay, experiments were performed as described in Chapter 7-4,
except that the medium used contained no FCS. In parallel studies to those described in Chapter 7-4,
M()) that had ingested apoptotic cells were studied for TGF-P release. McDonald and colleagues
(McDonald et ah, 1999) suggested that when J774 cells (M<J> cell line) ingested apoptotic neutrophils
all TGFp was released within 2h of interaction, therefore in these studies M(|> were not washed to
remove non-phagocytosed cells after the interaction period.
Table 7-2 documents TGF-P release into culture supernatants from murine BMD M<j) following
ingestion of apoptotic cells or beads. It indicates that there were small increases in TGF-P release by
the BMD M(j) used in this study. Flowever, non-activated and IFN-y LPS activated M<j) produced TGF-
P without ingestion. It is clear however, that the percentage increase in TGFP release corresponded
closely with the degree of TNF-a decrease and NO increase documented in the parallel studies of
Chapter 7.4 and 7.5. Whether these small increases in cytokine release have functional paracrine or
autocrine effects remains to be explored by blocking studies.
Table 7-2: Release of TGFP (pg/ml) by M(j) following ingestion of apoptotic cells
Ingestion
None apop. PMN apop. Thym. beads
Unactivated 18.210.8 32.5111.1 33.817.4 12.515.4
Activated 23.214.3 45.4110.4 37.216.4 17.615.8
PMN were induced into apoptosis by ageing, thymocytes by UV treatment.
Apoptotic cells alone did not produce significant levels of TGFP
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7.7 SUMMARY
• As well as induction of apoptosis of neighbouring MC, the same M<|> are able to phagocytose the
MC induced into death
• In the presence of the NOS inhibitor L-NMMA, activated rodent M<|> that have ingested apoptotic
MC (or leucocytes) are unable to induce TNF-dependent killing of further MC
• Ingestion of apoptotic cells augments NO release by activated rodent M(])
• Ingestion of apoptotic cells inhibits sTNF-a release by activated rodent M(|)








The data demonstrate in vitro that macrophages activated by pro-inflammatory cytokines and
opsonised particles can induce proliferating MC from the glomerulus of the kidney into apoptosis. This
provides a crucial link between the occurrence of apoptosis in inflammation with presence of
infiltrating M(J). Secondly the data indicate for the first time that ingestion of cells that have undergone
apoptosis can regulate the capacity of macrophage populations to induce apoptosis; a form of negative
feedback built into the inflammatory response. Thirdly, the studies have attempted to delineate the
mechanisms involved in bringing about the Mc)> effects on MC. Amongst the myriad of cell surface and
soluble ligands generated by M<(), the studies demonstrate roles for nitric oxide, tumour necrosis factors
alpha and possibly beta, and also a potential role for hydrogen peroxide. Investigation of these factors
has revealed complex interplay between NO released from both M<|) and MC, and the potential
neutralising effects of NO by oxygen radicals. Further, a striking and potentially important absence of
NO release from human M<j> was shown, compared with equivalent rodent M(|>. Studies of TNF have
indicated subtle synergy between this ligand and the lymphokine IFN-y, a cytokine that may be a
crucial regulator of M<)> directed manifestations of the inflammatory process. Furthermore, the data
point to a predominant role of membrane bound TNF over soluble TNF in bringing about mesangial
cell killing. Cell signalling of apoptosis by TNF-a is at least in part dependent on the nuclear factor
IRF-1. Finally, Fas ligand has no role in macrophage effects upon mesangial cell death or cell cycle.
The data have many implications for understanding inflammation in the kidney, but striking
similarities in inflammatory settings suggest many of the findings here are relevant to the inflammatory
process per se and reveal new findings about M<j) biology.
8.2 MACROPHAGES KILL RESIDENT CELLS; A SPECIFIC OR GENERAL
PHENOMENON?
The thesis demonstrates that inflammatory M<j) can kill proliferating resident cells of the glomerulus in
an ex vivo environment (Figure 8-1). The role of M<j) in the sterile inflammatory setting has attracted
relatively little scrutiny. Inflammation leading to pathology is often predominated by lymphocytes, the
paradigmatic example being acute allograft rejection. However, as described in the introduction, the
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normal resolving inflammatory infiltrate is characterised by neutrophils, followed by M<|>, with only
Figure 8-1: Schematic of the mechanisms by which M<|> induce apoptosis of MC
few lymphocytes influxing. If one considers the normal, resolving inflammatory process as the first
building block of the pathological inflammatory response, M(|> become key players. Pathological
inflammation in the kidney and in particular the glomerulus is characterised by a relative paucity of
lymphocytes and an abundance of M0, and scrutiny of inflammation elsewhere reveals as an
abundant cell type. This is evident in autoimmune diabetes where M(|> comprise a major cell type in the
pancreatic islets (Jun, Santamaria et al., 1999; Jun, Yoon et al., 1999; Suk et al., 2001; Suarez-Pinzon
et al., 2000; Thomas et al., 2000; Liu et al., 2000), and during relapsing and remitting multiple sclerosis
where both BMD M<|> and oligodendrocytes, which are of the M(|> lineage, are major contributors
(Okuda et al., 1997; Tada et al., 1997). Progressive studies of atherosclerotic plaques have confirmed
the inflammatory nature of this disease and confirmed monocyte derived as crucial players in
disease progression (Szabo et al., 1996; Boyle et al., 1998; Bennett 1999). Ongoing studies of resolving
liver fibrosis have shown a striking correlation between the presence of activated M(|> in the resolving




However, the presence of such M<() does not necessarily equate with a killing capacity. Indeed, it may
be that Mc|) are crucial to the survival of certain cell types (Chang et al., 2001; Reveneau et al., 1999).
As well as death inducing factors, M<|> can release a host of pro-survival cytokines. This is well-
illustrated in M(|)-lymphocyte interactions. In the diabetes mellitus mouse model, there is evidence that
local M(|) producing IL-12 are crucial for survival and proliferation of cytotoxic T lymphocytes. In
addition the M(j) release NO and TNF-a, both of which have been shown to be crucial factors in
inducing cell death of pancreatic (3 cells (Jun, Yoon et al., 1999). Whether the same individual M<|) cells
are responsible for both effects is unclear. In atherosclerosis, M<j) plus platelet knockout studies in mice
prone to atherosclerosis (Apo E mice) suggest controversially that M<|) in the plaque are at least partly
responsible for pro-proliferative signals encouraging smooth muscle cells (myofibroblasts known as
VSMCs) to grow (Ross et al., 1990; Wilcox et al., 1994). However, in vitro, monocyte derived M<|>
cultured with VSMCs induce apoptosis of the latter (Boyle et al., 1998; Wilcox et al., 1994; Szabo et
al., 1996). Whether the conflicting nature of M<|) in plaques reflects different populations or different
types of disease activity in the plaques is unclear.
Very recently, in elegant ex vivo co-cultures Meszaros and colleagues (Meszaros et al., 2000) have
demonstrated that wound M()) not only phagocytose wound neutrophils, but they also induce neutrophil
apoptosis by a contact dependent mechanism. In the kidney, in a mouse model of glomerulonephritis
with associated tubulo-interstitial nephritis, M(J> can be clearly localised to tubular cells undergoing
apoptosis. The cells undergoing apoptosis are MCP-1 expressing. In the MCP-1 knockout mouse,
many fewer cells undergo apoptosis and there are many fewer M<|) localised to the tubular cells.
Clearly, in this model M<|) are inducing apoptosis of tubular cells (Tesch et al., 1999). However, in the
glomerulus, there is evidence in other disease models that M(f) can induce proliferation of MC (Oldroyd
et al., 1999). The studies presented here indicate that even the presence of low levels of serum growth
factors M<j> have no additive pro-proliferative effect on MC. This might be because MC produce their
own growth factors which act in an autocrine fashion (Mene & Cinotti 1989; Abbott et al., 1992;
Floege et al., 1994).
Further afield, tumour biology showed initially in vitro but later in vivo that M<j> can induce (Hajri et
al., 1998; Nishikawa et al., 1998; Gal et al., 1997) tumour cell apoptosis by a variety of mechanisms
including nitric oxide, TNF, TRAIL and Fas ligation. The immune response against tumour cells
shares many features with that described in inflammation in the kidney.
These studies taken together with the work presented in this thesis and the work of Lang and
colleagues (Lang & Bishop 1993; Lang 1997) showing the necessity in vivo for M<J) in deleting excess
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cells in the developing eye would indicate that a major role of M(|> is in the regulation of cell
populations.
8.3 THE INTERPLAY OF CELL CYCLE AND APOPTOSIS
Throughout this study, apoptosis of MC has been linked to cell cycle. Firstly MC interacting with
activated rodent M(j) are prevented from entering mitosis, described here as cell cycle arrest. DNA
studies indicate this to be a G,/S arrest. Secondly, many rat MC undergoing apoptosis by TNF-a
appear microscopically to be cells that had attempted mitosis, but had aborted part-way through,
suggesting that the cells were more susceptible to apoptosis in G2/M of the cell cycle. The DNA
content data is difficult to interpret for IFN-y/TNF-a mediated MC apoptosis but would be compatible
with cell death occurring at G2/M. However, cells over-expressing IRF-1, which appears to be
important in TNF-signalling of apoptosis, show an unequivocal G2/M block, evidenced by
accumulation of cells in with 2n DNA content. During experiments with human MC, IFN-y alone
appeared to block MC mitosis. This was not seen with the rat or mouse MC. The effect was seen with
different growths of MC suggesting a true species difference rather than a heterotypic difference. The
anti-proliferative effects of IFN-y are well-described (Kano et al., 1999; Burke et al., 1999). Indeed
there is evidence of this cytokine playing such a role in models of glomerular disease (Johnson et al.,
1995; Oldroyd et al., 1999). There is clear evidence elsewhere that IRF-1 is important in both 'stress'
induced and cytokine induced cell cycle arrest and apoptosis (Tamura et al., 1995; Prost et al., 1998;
Kano et al., 1999). The data shown here for MC confirm that IRF-1 does play a role in both these
functions and for the first time is shown to play a role at the G2/M checkpoint (Figure 8.2).
One other striking correlation in all the studies presented here was that the more cells proliferated, the
greater their tendency to undergo apoptosis in the presence of activated M<|). This observation might
also indicate the role of cell cycle in susceptibility to apoptosis. It is backed up in vivo, in the model of
Thy 1.1 nephritis, and elsewhere, where there was a correlation between number of apoptotic and
mitotic cells in individual glomeruli (Baker et al., 1994; Ophascharoensuk et al., 1998; Hiromura et al.,
1999). It may be that there are checkpoints in the cell cycle at both the G^S border and the G2/M
border (Shankland 2000; Doostzadeh-Cizeron et al., 2001) in mesangial cells that regulate apoptosis.
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Figure 8-2: Simplified schematic showing cell cycle proteins, their interactions at different stages of the
cell-cycle and the checkpoints. Also shown are regulatory proteins P21 and P27, and their possible regulation by
P53 and IRF-1
P53, a nuclear factor important in regulating the cell cycle has also been shown to be important in
regulating cell death by apoptosis in the presence of DNA damage. Prior to DNA synthesis (S phase)
damaged DNA must be repaired. Agents such as NO and oxygen radicals can induce direct DNA
damage. P53 regulates this process by inducing blockade of cell cycle progression prior to new
synthesis. If, after a given period, repair is unsuccessful, apoptosis is triggered (Mercer 1998; Schwarz
& Rotter 1998). One can imagine how important this is in the prevention of propagation of mutations
and the development of carcinomata. However, this pattern of mitotic blockade followed by apoptosis
is that which one sees in M(|)-derived iNOS mediated death in co-culture and the NO-induced G! block
is well described in the literature (Messmer & Brune 1996; Sandau et al., 1997; Schwarz & Rotter
1998). Interestingly, hydrogen peroxide mediated death as described in Chapter 5 is described to
induce P53 but does not lead to cell cycle arrest suggesting a different intracellular process at work.
Again, frequently these apoptotic cells appear to be mitotic cells that have defaulted into apoptosis,
possibly at the G2/M border. Whilst not investigated in this thesis, it is noteworthy that P53 also exerts
a G2/M checkpoint (Taylor et al., 2001; Bache et al., 1999; Chien et al., 2000). The role of the G2/M
checkpoint in peroxide mediated cell death by apoptosis should be sought.
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Bcl-2, is an intracellular protein that is the archetypal family member of a series of proteins that
regulate susceptibility to apoptosis (Korsmeyer 1992). Recent data indicate that Bcl-2 family proteins
are important in regulating cytochrome C release from the mitochondria (Yang et al., 1997). Bcl-2 is a
pro-survival factor that hinders successful signalling through the caspase pathway in certain cell types.
It is de-activated when phosphorylated, thereby tendering the cell more susceptible to apoptosis. In
Jurkat T cells Bcl-2 is phosphorylated during G2/M, and these cells are more susceptible to a variety of
pro-apoptotic physiological stimuli at this time. Inhibition of phosphorylation renders the cells more
resistant to apoptosis (Yamamoto et al., 1999). This makes biological sense since damage to DNA
during mitosis would render progeny mutated without opportunity for repair since the condensed
chromatin is inaccessible to nuclear enzymes (see Figure 1.4).
Studies of y irradiation induced apoptosis of mouse thymocytes indicated apoptosis occurred following
the G2/M checkpoint. In these cells however, when Cyclin B, a regulator of mitosis along with cdc2
kinase, is prevented from accumulating, y irradiation induced apoptosis is prevented. Conversely over-
expression of Cyclin B induces apoptosis (Porter et al., 2000) (Figure 8-2) It appears that the proteins
regulating the cell cycle can now be directly linked to those involved in apoptosis.
Thus, one can see that proliferating cells have a variety of checkpoints where they are susceptible to
apoptosis, as a way of preventing mutation of the genome. Toxic factors such as NO and H202 can
impinge on these checkpoints and death receptor signalling may be most influential at these phases of
the cycle. It seems likely that cells can die by apoptosis at any stage of the cycle, but that susceptibility
varies with cell cycle progression. Experiments to test whether MC have differential susceptibility to
apoptotic stimuli at stages of cell cycle progression were sought by synchronising MC with a double
thymidine block. However, time constraints have prevented their completion.
8.4 NITRIC OXIDE IN INFLAMMATION - JANUS
This study has identified NO in M<))-derived induction of cell cycle arrest and apoptosis of MC in the
rodent system. It seems plausible that M(|)-derived NO will be important in vivo in the inflamed
glomerulus; NO only acts over short distances, both proliferating MC and M(J) are found in close
apposition in glomerular inflammation (see Figure 1.10). There are now clear examples in vivo of NO-
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directed killing of cells. However, these have been a long time coming (Okuda et al., 1997; Hajri et al.,
1998; Nishikawa et al., 1998; Koglin et al., 1999; Cobb et al., 1999).
However, studies using iNOS knockout mice or competitive inhibitors of iNOS, in in vivo models of
glomerular inflammation have not provided a clear picture:
In a mouse model of NTN using the iNOS mouse over the first 48h of disease, there was no difference
in disease parameters compared with control (Cattell et al., 1998). However, this disease appeared
mild, heterologous phase disease, with some neutrophil influx, but only occasional M(|) (Figure 8-3). In
addition, apoptosis was not assessed. Unfortunately, the limited tissue remaining from that study was






Figure 8-3: Schematic showing predicted roles of in heterologous and autologous phases of the animal
model of anti-GBM nephritis, NTN. Note M(|) and neutrophils together in the complement-dependent
heterologous phase, later dominated by cytokine activated M<|) in the autologous phase of disease
Other studies have looked at NTN in the rat, where significant influx is readily achievable. The use
of L-NIL as an inhibitor of NO generation had no real effect on histological parameters, but augmented
proteinuria (Lianos et al., 1998). In this study, Mc() influx was not quantified. However, it is likely that
there were significant M(|) present. Three issues are raised by this study however; firstly, the disease
model is initiated by immune complex and complement deposition in the glomerular basement
membrane. In vitro studies from Chapter 5 indicate these to be potential ligands for ROI release from
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M<(). Investigation of heterologous phase NTN has shown the importance of hydrogen peroxide in
initiation of the disease by neutrophil damage to the endothelium (Johnson et al., 1987; Rehan et al.,
1984; Cook et al., 1989). Secondly, from the data in Chapter 3, it is likely that during the switch from
heterologous to autologous phase disease glomerular M(J) populations switch from producers of oxygen
radicals to generators of NO. Further supportive evidence of this comes from studies by Waddington
who specifically examined the role of iNOS-derived NO in heterologous phase NTN (Waddington et
al., 1996). iNOS inhibitors tend to lack specificity, but are selectively dependent on extracellular L-
arginine concentrations. By inhibiting arginase (the other metabolic pathway for L-arginine (see Figure
1.2)) or by infusing L-arginine, he was able to regulate arginine availability at the site of inflammation.
The studies suggested that NO had little effect on histological parameters. There appeared to be
increases in proteinuria when L-arginine availability was limited, suggesting that NO might be
protective, or anti-inflammatory in some way. Proliferation and apoptosis were not assessed. One
might interpret these observations in two ways; firstly, (assuming that NO-mediated apoptosis of
resident cells is occurring) that NO-induced apoptosis is protective. Secondly, that NO might be
nullifying the effect of neutrophil and M(() release of oxygen radicals.
In favour of the latter is a wealth of evidence that eNOS-derived NO is important in protecting the
endothelium from oxidative stress damage. These observations indicate that NO reacts with radicals to
produce stable, inert nitrate. The eNOS studies however indicate that in conditions of L-arginine
depletion eNOS can paradoxically generate 02- itself, and in addition, a putative compound
peroxynitrite (Xia et al., 1996; Xia & Zweier 1997; Xia et al 1998). Sandau and colleagues (Sandau et
al., 1997) showed that oxygen radicals and NO donors 'cancel each other out' when applied
concurrently to rat MC cultures and MC apoptosis was assessed. Waddington's studies might be best
explained by hypothesising that early oxidative damage from principally neutrophils was being
counteracted by NO generation from both neutrophils and Mcj).
The role of iNOS-derived NO at the site of inflammation is complicated by two further observations:
Firstly, Albina's group indicated that tissue L-arginine concentrations are very low in a model of a skin
wound and also in samples of muscle injected with sterile irritants (Albina et al., 1990; Reichner et al.,
1999). It is conceivable that L-arginine levels are low in glomerular inflammation, though high
capillary blood flow might counteract arginine depletion. Using the in vitro model, M(j) killing of MC
by NO was inhibited by reducing L-arginine in the culture medium (Chapter 3.12). Rather than
generating 'toxic' oxygen radicals and peroxynitrite as suggested by Xia and colleagues (Xia et al.,
1998), there was no evidence of MC necrosis and both apoptosis and cell cycle arrest were diminished.
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The remaining induction of apoptosis was inhibited by L-NMMA, not SOD or catalase, suggesting that
the remaining kill was still mediated by lower levels of NO release. These data suggest that unlike
eNOS, iNOS does not appear to induce oxygen radical and peroxynitrite generation or that
peroxynitrite does not kill mesangial cells (Bank et al., 1998; Heeringa et ah, 2001).
Secondly, it appears that during inflammation, endothelial cells induce iNOS and this enzyme can 'take
over from eNOS' in regulating vascular tone (Cadogan et ah, 1999; Heeringa et ah, 2001). Thus, any
attempt to modulate iNOS release of NO will necessarily influence local blood flow and local
haemodynamics. If iNOS is inhibited, arterioles will vasoconstrict, and may contribute to ischaemia
and hypoxia, which are undoubtedly factors in glomerular scarring in their own right (Shanley 1996).
Therefore, in vivo studies of the role of NO in regulating MC proliferation and apoptosis will probably
prove impossible to interpret unless iNOS can be selectively regulated in the M<j).
Yet we know that M(|) in the glomerulus produce iNOS and (in rodents ex vivo) nitric oxide (Cattell et
ah, 1993; Kashem et ah, 1996; Furusu et ah, 1998; Heeringa et ah, 2001), and detailed studies in Class
IV human lupus glomerulonephritis have indicated close correlation between iNOS and neighbouring
apoptosis (Wang et ah, 1997). We now also know that M0 ex vivo from the rat tNTN model can induce
MC apoptosis by iNOS dependent mechanisms. Further Weinberg (Weinberg et ah, 1994) has
indicated that NO must have a role in development of nephritis since the MRL Ipr/lpr, lupus nephritis
prone mouse, did not develop nephritis when fed L-NMMA in the diet. Noble's group have indicated
that iNOS is crucial in the initial mesangial apoptosis seen in their model of Thy 1.1 nephritis (Narita et
ah, 1995), but this work has not been reproduced successfully (K Mosely presonal communication and
Mosely et ah, 1999).
One possible future avenue is the iNOS knockout mouse. In studies of transplanted cardiac rejection,
the iNOS knockout mouse shows less apoptosis of cardiomyocytes than wild type controls, indicating
an unequivocal for M(|>-derived NO in inducing resident cell apoptosis (Koglin et ah, 1997). However,
Weinberg (Gilkeson et ah, 1997) crossed the MRL Ipr/lpr with the iNOS KO mouse, to find that
progression of spontaneous glomerular disease (which does have glomerular inflammatory M<])) was
not different from controls. Vasculitic lesions in the animals that lacked iNOS did not develop,
however. This disappointing result is hard to reconcile with the earlier work using L-NMMA
(Weinberg et ah, 1994) and might suggest that if iNOS is important in determining glomerular disease
progression that in the knockout animal other, non-NO pathways can take its place (redundancy).
Furthermore, there is evidence that during ontogeny NO (like Fas, TNF-a, LT-a) is important in
regulating lymphocyte subset proliferation rendering the knockouts prone to more vigorous TH1
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responses. Therefore studying this role of iNOS in M<J) in vivo might require conditional cell-specific
knockout animals.
To conclude, iNOS derived NO at the site of glomerular inflammation can theoretically have the
following, often opposing influences:
1) induction of apoptosis and cell cycle arrest of resident cells
2) Negating the effect of oxygen radicals released from neutrophils and M(J)
3) Regulating microvascular tone
One can see from in vivo glomerulonephritis studies that often the disease comprises different phases
of immune activation whereby high levels of oxygen radicals might be released and only later high
levels of NO would be generated. It also appears that each model of nephrotoxic nephritis has different
characteristics perhaps dependent on the different severity and duration of the heterologous phase of
disease compared with autologous phase.
Finally, evidence from Chapter 3 indicates that MC can also generate NO. It is possible that high levels
can be generated, by some MC in some circumstances, enough to protect that MC from NO-mediated
damage. However, more likely is the somewhat lower level of MC NO generation as demonstrated
from MC from our laboratory. In studies of co-culture where MC were primed to generate their own
NO and M<|) were activated by opsonised particles to generate oxygen radicals, the MC were relatively
protected from peroxide mediated apoptosis. This observation has been mirrored in the vascular
endothelium and in UV-induced inflammation in the skin (Yamaoko et al., 2000; Cooke 1998).
Thus, NO is a molecule with diverse biological effects, which may be both protective and inductive in
immune mediated apoptosis.
8.5 FAS AND ITS ROLE IN APOPTOSIS
Fas/FasL interactions have been recognised in regulating lymphocyte populations for some years. This
is most clearly seen in the MRL Ipr/lpr or gld/gld mice which have non-functional mutations in Fas
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and FasL respectively. These animals are characterised by a generalised lymphoproliferative disease
with excess CD4-, CD8- lymphocytes, cells which are normally deleted (Takahashi et al., 1994). One
characteristic of the Fas/FasL deficient animals is the development of glomerulonephritis. The animals
have a lupus-like syndrome with auto-antibodies including anti dsDNA antibodies.
The glomerulonephritis is similar to that seen in human lupus, with linear immune complex deposition
on the glomerular basement membrane, mesangial proliferation and influx of M<|) mainly and some
lymphocytes. Often there is intense focal lymphocyte infiltration to areas of the interstitium also.
This disease brings into question the role of Fas/FasL signalling apoptosis in development and
progression of glomerular disease. Since the early-1990's it was recognised that in addition to
lymphocyte regulating properties of Fas/FasL signalling ligation of Fas on resident hepatocytes could
induce widespread apoptosis (Ogasawara et al., 1993). Gonzalez-Cuadrado first showed that Fas
ligation with agonistic antibodies could induce apoptosis of human mesangial cells in the presence of
IFN-y. They went on to describe mesangial lysis (due to mesangial cell apoptosis) in mice after
administration of systemic agonistic anti-Fas antibodies (Gonzalez-Cuadrado et al., 1996; Gonzalez-
Cuadrado et al., 1997). In addition there was widespread hepatocyte apoptosis. This glomerular
observation was not reported in earlier, similar studies showing similar hepatic cell apoptosis to that
noted in the Gonzalez-Cuadrado study. However, given this result and the observations reported in
Chapter 4.5-4.10 it seemed likely that not only was Fas important in lymphocyte regulation but also in
resident tissue regulation in inflammation.
In the MRL Ipr/lpr mouse model of spontaneous progressive glomerulonephritis, Rubin-Kelley's group
highlighted the importance of CSF-1 (M<|) survival and differentiation cytokine) and the chemokine
MCP-1 (monocyte chemo-attractant protein) in glomerular disease progression (Rubin-Kelley et al.,
1994; Wada et al., 1997; Tesch et al., 1999). These data heavily implicate the M(|) as the key mediator
in disease progression in this model.
The data from Chapter 4 confirm that in vitro, MC primed with IFN-y plus TNF-a (in rodents) and
primed with IFN-y alone (humans) was sufficient to enable Fas-mediated apoptosis of proliferating
cells. This feature of myofibroblast-like MC is echoed in similar studies of other myofibroblasts such
as human vascular smooth muscle cells (VSMC) (Bennett et al., 1998) where Fas ligation also
mediates apoptosis in primed cells. Furthermore, Fas induced apoptosis of tubular epithelial cells of the
kidney has been widely reported (Schelling et al., 1998; Lorz et al., 2000; Hughes et al., 2000). Thus




In 1997, Badley and colleagues (Badley et al., 1997) using ex vivo modelling, indicated that human
M<|> could utilise FasL to bring about apoptosis of bystander CD4+ lymphocytes, providing a model of
CD4+ cell loss in HIV disease by HIV infected M<|>. TNF-a was also implicated as a factor in bringing
about this apoptosis. Studies from our own group also indicated that supernatants from Mc)> activated by
opsonised particles were able to bring about neutrophil apoptosis by a mechanism inhibitable by
blockade of Fas binding (Brown & Savill 1999). Thus, it seemed plausible that activated M({> might
regulate MC populations utilising FasL.
The co-cultures shown in this thesis (Chapter 4, Chapter 5) indicate that whilst M<J) are known to have
FasL both on the plasma membrane (Dr. S. Brown-personal communication) (Bennett 1999) and
released into the supernatant, following cleavage, they do not appear to utilise it in inducing apoptosis
of susceptible MC. More curiously is that MC themselves (Chapter 4.11), VSMC and tubular epithelial
cells of the kidney also have FasL, yet there is no in vitro evidence of an apoptosis inducing role for
this ligand.
This lack of M(f> killing by apoptosis is in contrast to in vivo studies by Hughes & Johnson (Hughes &
Johnson 1999) where inflammatory M(|> influx induced by ureteric ligation appears to be a factor
responsible for induction of apoptosis of distal tubular cells. When experiments were performed in Ipr/
Ipr mice (C3H/HEJ background which lacks glomerulonephritis), there were fewer apoptotic distal
tubular cells, though this did not affect other disease parameters.
However, in keeping with the negative data presented in this thesis, Rubin-Kelley's group were able to
transplant kidneys from MRL Ipr +/+ mice into MRL Ipr -/- mice and show that the onset and
progression of glomerulonephritis was no different from the native kidneys over a 12 wk period (there
was no rejection). This would indicate that in a Mt|>-rich progressive disease, FasL had no bearing on
disease outcome.
The role of FasL in vivo appears complicated. There is very good evidence that FasL is a neutrophil
chemokine (Kang et al., 1997, Otonello et al., 1999, Suarez-Pinzon et al., 2000, O'Connell 2000). It
may be that expression of FasL by resident cells in culture (activated de-differentiated phenotype) has
more to do with chemokine function than apoptosis. Indeed MC in culture are known to release an
array of chemokines (Banas et al., 1999). Unfortunately, in the studies in this thesis, soluble FasL
released by MC was not assessed.
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Notably, Rubin-Kelly's group purified lymph node lymphocytes from diseased (Ipr/lpr) animals and
found that renal proximal tubular cells underwent apoptosis in co-culture, indicating that FasL was not
crucial for lymphocyte mediated induction of apoptosis (Schwarting et al., 1998).
There has been some debate about the respective roles of soluble over membrane bound FasL in
bringing about apoptosis. This will be explored elsewhere (Chapter 8.6).
Pancreatic p cells in the islets of Langerhans in the pancreas are a target for immune mediated
destruction by apoptosis in type 1 diabetes mellitus and in the spontaneously diabetic (non-obese
diabetic) mouse. A role for Fas/FasL has been postulated with significant in vivo evidence from the
Ipr/lpr mouse crossed with the NOD mouse since these mice do not develop disease (Signore et al.,
1998; Thomas et al., 2000). Pancreatic P cells are rendered susceptible to FasL by similar cytokine
administration to that shown in this thesis for mesangial cells. However, despite intense influx of M<))
and cytotoxic lymphocytes in this disease model, it appears that in Fas deficient NOD mice, the
attenuated disease phenotype is due impaired proliferation of cytotoxic and effector T cells, not due to
impaired apoptosis of P cells (Kim et al., 1999; Kim et al., 2000). Like the situation for kidney disease
whilst Fas/FasL appeared an attractive target for manipulating disease progression through regulating
target cell death, it appears that in the pancreas Fas/FasL plays no role clear role in apoptosis of target
cells, but may regulate lymphocyte populations.
In contrast, Hughes and Johnson (Hughes 1999) have confirmed a small but definitive role for M(j)
derived FasL in inducing distal tubular cell apoptosis in kidney inflammation induced by ureteric
obstruction. Also, the Con A model of hepatitis is clearly inhibitable by anti-FasL antibodies (Kim et
al., 1999). Whether this is due to down-regulation of the immune response or blockage of target cell
killing is unclear (Ogasawara et al., 1993). However, more detailed studies of hepatocyte injury
indicate IFN-y and TNF-a to be indispensable whereas absence of Fas had no bearing on the disease
process (Ohta et al., 2000).
Thus whilst there are clear in vitro examples of M<)> killing target cells by FasL/Fas ligation, there was
no in vitro evidence from this thesis of M(p killing MC by this mechanism. The in vivo data would
suggest that Fas/FasL is an important regulator of lymphocyte populations but it has little role in
regulation of resident cell apoptosis in inflammation.
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8.6 TUMOUR NECROSIS FACTOR AS A GENERAL REGULATOR OF CELL
POPULATIONS
Despite clear evidence in vivo and in vitro of FasL regulating lymphocyte populations, the evidence of
regulation of resident cell populations is limited. The data presented here indicate that MC apoptosis
can be mediated by TNFR1 ligation. In the case of human MC, it appears to be the major mechanism
of M<j)-directed MC apoptosis in the absence of NO release by M(|>. The rodent and human data indicate
a role for IFN-y in modulating MC susceptibility to apoptosis by TNF signalling. Thus TNF alone
appears insufficient to induce cell death; rather cells require prior exposure to IFN-y in order that TNF
can successfully trigger apoptosis.
As stated in Chapter 8.5, there is clear evidence for an in vivo role for TNF-a in directing target cell
apoptosis in models of viral induced hepatitis (Ohta et al., 2000). TNF-a is also strongly implicated in
immune destruction of the pancreas in the NOD mouse (Suk et al., 2001). There is an abundance of
evidence that TNF-a has an important role in the immune response to tumour cells (see Chapter 8.7).
In vitro studies have also indicated TNF-a to have a role in endothelial cell apoptosis and CD4
lymphocyte apoptosis in models of HIV disease (Lindner et al., 1997; Badley et al., 1997).
Unfortunately, like studies of NO in vivo, the disease outcome following modulation of the
TNF/TNFR1 axis is complicated by the pleiotropic effects of TNF in the inflammatory response. For
example, there are unequivocal studies showing NTN in rats and mice is markedly abrogated in TNF-a
KO mice or in rats concurrently treated with anti-TNF-a antibodies (Le Hir et al., 1998; Karkar et al.,
2001). However, the authors suggest that the major reason for this is that TNF-a is crucial in disease
initiation through either platelet activation and degranulation or its role in upregulation of integrins on
the endothelium, which enable leucocyte diapedesis.. This being the case it is not possible to comment
on whether TNF in vivo is playing a role in resident cell apoptosis. Conditional knockout animals
might be required to identify the role of TNF at different stages of the inflammatory process in vivo,
given that its requirement early in inflammation prevents testing its function in later inflammation in
knockout models.
The TNF-a knockout mouse exhibits significant abnormalities of lymph node development with
certain cell types being under-represented or absent (Eugster et al., 1996). It appears that TNF-a/p
have roles in regulating lymphocyte populations.
237
Chapter 8. Discussion
8.7 MEMBRANE OR SOLUBLE TNF?
The co-culture studies in this thesis show that whilst MC death in humans and rodents is TNF-
dependent, transfer of clarified supernatants from activated M(j) has no killing effect on susceptible
mesangial cells, despite the presence of micromolar quantities when assessed by ELISA. The TNF-
dependent killing in co-culture amounted to up to 20% of MC at 24h. Notably, recombinant TNF-a
(rTNF-a) in susceptible cells had some killing effect but it did not match the direct M(|)-co-culture
effect. Thus in a hierarchy of killing mTNF > rTNF > sTNF. There is evidence that rTNF-a can exist
in polymeric form. Interestingly, the studies of the killing effect of FasL in this thesis would indicate
that CHI 1 IgM antibody > rFasL > endogenous sFasL in killing of MC, and studies of other cell types
would confirm that mFasL » sFasL in inducing apoptosis (Schneider et al., 1998). Again there is
evidence that the recombinant sFasL can exist in a polymeric form in solution. This potency for
mTNF-a in inducing apoptosis has recently been highlighted in studies from Albina's group of wound
Mtj) inducing apoptosis of wound inflammatory neutrophils by a TNF-dependent mechanism. This
killing effect was contact dependent, soluble TNF-a was ineffective (Meszaros et ah, 2000). Other
studies of peripheral blood neutrophils has indicated their selective susceptibility to apoptosis by
mTNF-a (Murray et ah, 1997).
There is however, a president for mTNF-a having a more potent role in killing of target cells in other
in vitro and in vivo studies (Decker et ah, 1987; Peck et ah, 1989; Perez et ah, 1990; Duerksen-Hughes
et ah, 1992; Day et ah, 1994; Lazidins et ah, 1997; Kusters et ah, 1997; Weiss et ah, 1998). The data of
FasL seem to reiterate this paradigm. Importantly, in studies of the killing effect of both mTNF-a and
mFasL there is evidence of a synergistic role for adhesion molecules ICAM-1, av(53 and CD36.
Whether they act purely as functional anchors or whether they provide co-stimulation has not been
investigated (Meszaros et ah, 2000; Seig et ah, 1998).
In the studies of Chapter 7, it was notable that it was possible to abrogate completely, TNF-dependent
killing of MC following M(|>-ingestion of apoptotic MC. At the same time, sTNF-a release by the same
M<t> was only partially inhibited. This paradox would fit well with the hypothesis that M<j>-membrane
TNF was dependent for killing. Further studies should be directed at understanding co-factors in
mTNF killing such as integrins as suggested by Meszaros and Seig.
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8.8 INTERFERON-y; A CONTROLLING CYTOKINE
Throughout this thesis, IFN-y can be viewed as a fundamental co-factor in M(j) activation, as a
modulator of M(() activation states, and importantly as a crucial factor controlling both MC
susceptibility to apoptosis and cell cycle progression. It can be seen that for effective M((> activation to
stimuli such as TNF-a, CD40L and LPS (and IL-1P), IFN-y was a crucial co-factor. When M<|> were
exposed to immune complexes (opsonised zymosan), they responded with a brisk respiratory burst.
However, IFN-y pre-treatment in rodent M<j) modulated this response (Chapter 5.2 and Johnston et al.,
1985). When, proliferating MC had been exposed to IFN-y there was augmentation of M(|)-dependent
killing, which in both humans and rodents was TNF-dependent. IFN-y was therefore important in TNF-
dependent apoptosis. Interestingly, IFN-y was crucial in protection of MC from peroxide-dependent
killing of MC, possibly by the induction of MC to produce low levels of NO.
IFN-y is the archetypal lymphokine, and certainly there is much evidence in vivo of the presence of
activated lymphocytes in glomerular inflammation. There is evidence in telescoped nephrotoxic
nephritis (Huang et al., 1997; Kitching et al., 1999; Cunningham et al., 1999; Rosenkranz et al., 2000)
and the diffuse proliferative glomerulonephritis of Ipr/lpr MRL mice (Schwarting et al., 1998) of IFN-y
secreting, proliferating lymphocytes. However, there is also now substantial evidence of IFN-y release
by activated M(|) (Schindler et al., 2001). Whether the M<|> used in the experiments shown in this thesis
were producing IFN-y was not tested, but the efficacy of adding IFN-y to these cultures suggests M<j>-
derived IFN-y levels was low, if present at all. The reports of M(|)-derived IFN-y at least suggest that
IFN-y secreting T cells/ NK cells might not be necessary at the site of inflammation for the effects
observed in these studies.
Interestingly, two groups reported opposite effects from IFN-y blockage in nephrotoxic nephritis in
mice. In one, from Tipping's group (Kitching et al., 1999) telescoped NTN was compared in IFN-y
C57B16 KO mice and wild type mice. This intense crescentic glomerulonephritis, which the group
have shown to be Thl cell-mediated disease, was dramatically abrogated in the IFN-y KO mice. The
data indicated a requirement for locally produced IFN-y in the glomerulus for disease progression. This
result can be readily explained from the models in this thesis whereby glomerular M(j) are activated
largely by lymphokines from antigen specific T cells. Excessive M(j) number and activation would lead
to excessive mesangial cell loss, through the mechanisms delineated in this thesis, scarring and
glomerular injury, whereas the KO mice would be much less able to activate M<J) thereby limiting
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damage. Similar studies of the lupus like GN seen in the lpr/lpr mice have shown dependence on IFN-y
locally produced in the glomeruli as crucial for disease progression.
Another group (Ring et al., 1999), also induced telescoped NTN in C57bl6 mice, compared disease in
WT animals, WT treated with anti-IFN-y antibodies, or disease in IFN-y KO mice. When IFN-y was
deficient or blocked, there was augmentation of disease, the opposite of that reported above. On further
examination of the disease model, it could be seen that the disease was mild, with marked immune
complex formation, and a mild M(|> and neutrophil influx suggestive of a humoral-mediated disease.
From the models developed in this thesis, one might anticipate that many of the M(() in the inflamed
tissue might be activated by immune complexes, not lymphokines. It would therefore follow that IFN-y
acting on proliferating MC might protect them from peroxide mediated injury derived from neutrophils
and M(j). Thus blockade of IFN-y would lead to failed MC protection and therefore, excessive
apoptosis, scarring and damage to glomeruli.
8.9 HYDROGEN PEROXIDE, A FACTOR IN MACROPHAGE-DIRECTED KILLING?
The data presented here point to a role for hydrogen peroxide in M<|)-mediated deletion of MC by
apoptosis. The importance of hydrogen peroxide in disease initiation in a variety of inflammatory
lesions of the kidney has been demonstrated by others (Holdsworth et al., 1988; Johnson Couser et al.,
1987; 1988, Johnson, 1994; Rehan et al., 1994; Heeringa et al., 2001). It is clear that neutrophil-
mediated endothelial and basement damage is catalase inhibitable in these models. Cabell's group
emphasised the role of hydrogen peroxide (Mosely et al., 1999) in the initial mesangiolysis (mesangial
cell apoptosis) seen in the Thy 1.1 model of mesangioproliferative GN. This is likely to be mediated by
both neutrophils and Mtj) that are rapidly recruited to the mesangium.
That immune complexes are crucial in the early pro-inflammatory stages of the immune response has
been unequivocally demonstrated using Fc-y receptor knockout mice (Suzuki et al., 1998; Wakayama
et al., 2000; Launay et al., 2000; Gomez-Guerrero et al., 2000). However, whether they are important
in the perpetuation of injury or remodelling is much more controversial. Waddington's studies of early,
heterologous rat NTN suggested strongly a predominant role for oxygen radicals in disease
perpetuation at least over the first 24h of disease (Waddington et al., 1996). Furthermore, Johnson has
indicated that a proportion of M<)> in the resolving stages of Thy 1.1 nephritis are myeloperoxidase
positive (Johnson et al., 1995), suggesting that in later, resolving stages of this disease that M<|) may be
generating ROI. However, there is much data that point to the role of cell mediated immunity in
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disease progression in inflammatory models such as nephrotoxic nephritis, possibly without the
requirement for immune-complex activation of the immune system (reviewed by Rosenkranz et al.,
2000). Indeed, the M<j) from day 2 and day 4 of rat telescoped NTN presented here show their
phenotype to be similar to lymphokine activated M<j> rather than immune complex activated cells
(Chapter 3.9). In the telescoped model of NTN used here it appears therefore that the predominating
M<() phenotype is one activated by lymphokines rather than immune complexes (see Figure 8-3). The in
vitro studies here indicated that M()) activated by opsonised particles can abundantly release H202.
However, Albina's group (Nessel et al., 1999) have questioned the ability of wound M<]) to generate a
respiratory burst. Unlike resident peritoneal M<|>, M(|) from wounds were less able to generate peroxide
and radicals in response to PMA or zymosan. It is possible that one explanation for this observation is
that the wound M(|> have already undergone a respiratory burst and are therefore no longer able to
respond.
8.10 IRF-1 APPEARS TO HAVE ROLES IN APOPTOSIS SIGNALLING PER SE, AND ALSO
SUSCEPTIBILITY TO TNF-DIRECTED APOPTOSIS
The data in this thesis point to an important potential role for IRF-1 in kidney disease as a regulator not
only of M<]) activation (such as a co-factor in iNOS gene transcription (Kamijo et al., 1994; Martin et
al., 1994; Tada et al., 1997)), but also a crucial factor in regulating MC progression through the cell-
cycle and susceptibility to apoptosis. There is no published work on the role of IRF-1 in glomerular
injury, but it appears plausible that at least in some MC, TNF-a might regulate the MC population by
activating an IRF-1 dependent check point in the cell cycle and overriding the cell into apoptosis. Most
work on apoptosis has used cell lines and in particular haematopoeic cell lines. Relatively little
attention has been paid to primary tissue-derived cells. However, important studies in the inflamed
endocrine pancreas and in hepatitis point to a role for IRF-1 dependent apoptosis in pancreatic P cells
and hepatocytes (Suk et al., 2001; Pavlovic et al., 1999; Kano et al., 1999). The studies of P cell
apoptosis in endocrine pancreatic inflammation co-localised IRF-1 positive P cells with TUNEL
positivity indicating those cells undergoing apoptosis were IRF-1 expressing. The data in Chapter 6
suggest that the MC did not utilise caspase 3 and possibly other caspases in TNF-dependent death. This
would appear incompatible with the orthodox model of caspase dependent apoptosis shown in Figure
1.4, but increasingly there are many reports of caspase independent death in a variety of cell types
(Green & Kroemer 1998; Hildeman et al., 1999; Huang et al., 2000; Doerfler et al., 2000; Fitch et al.,
2000; Honarpour et al., 2000). It increasingly appears that there is no universal death pathway in
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mammalian cells. The studies in Chapter 6 provide no evidence for an intracellular ROI flux being
important in signalling apoptosis following TNFR1 trimerization, whilst it has been demonstrated to be
important in certain tumour cells, and many other cells investigated. Whether this relates to glutathione
pumps preventing accumulation of ROI quenchers from accumulating intracellularly remains
unanswered (de Bittencourt Junior et al 1998; Hampton et al 1998; van den Dobbelsteen et al 1998). It
is striking that whilst certain cells such as the L929 mouse fibrosarcoma cell line are exquisitely
sensitive to soluble TNF-a, only a proportion of MC undergo apoptosis. I have suggested elsewhere
that in MC it is likely to relate to the number of cells entering the G2/M phase of the cell-cycle. TNF-a
mediated death in L-929 cells, due to its widespread killing effect is unlikely to be cell cycle
dependent, is both caspase and ROI dependent. Could it be that TNF-mediated apoptosis in MC is both
caspase and ROI independent?
The data from the IRF-1 over-expression studies (Chapter 6) show firstly that such over-expressing
cells have an increased rate of spontaneous apoptosis. This would implicate IRF-1 directly in the
apoptotic signalling process. When the IRF-HER gene construct was expressed in myeloid cells,
increased spontaneous loss of these myeloid cells was only reported when estradiol was present
(Kirchoff et al., 1993). This was not the case in the transfected MC. One possibility for this difference
is that the system is 'leaky' in the MC, i.e. active IRF-1 leaks into the nucleus without the need for
estradiol. This could be tested by EMSA, and is required to establish why spontaneous apoptosis is
increased. Providing that is confirmed, one can assume that IRF-1 has a role in apoptosis. Secondly,
many of the clones exhibited retarded progression through G2/M, indicating a G2/M block. Again,
assuming the gene construct in MC is ieaky', this would indicate that IRF-1 does play a role in cell
surveillance at the G2/M checkpoint (Figure 8-2). This has not previously been demonstrated. Thirdly,
when TNF-a was applied to these cells, apoptosis was augmented. It is unlikely that TNF-a
application would significantly augment active IRF-1 levels in the MC. More likely is that IRF-1 has
rendered the MC susceptible to TNF-mediated apoptosis. Thus IRF-1 may well be the pathway
required by IFN-y for achieving susceptibility, as has been reported for hepatocytes (Kano et al., 1999).
These data fit in with evidence that IRF-1 is eesential for some types of apoptosis in lymphocytes
(Yamada et al., 1991; Matsuyama et al., 1993; Tamura, Ishihara et al., 1995) and hepatocytes (Kano et
al., 1999).
Whilst it is purely speculation, and several areas of investigation require clarification, it appears logical
to pursue IRF-1 dependent signalling in the regulation of tissue homeostasis and remodelling in kidney
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disease. Investigation of models of glomerular injury in the IRF-1 KO mouse chimeric for wild type
bone marrow would be a potential mechanism for delineating the role of IRF-1 more clearly.
8.11 MACROPHAGE ACTIVATION STATES
The data from this thesis emphasise that M<j) are not simply 'activated' but that activation can result in
different patterns of cytokine production and toxic metabolite release. These patterns of activation are
clearly seen in M(|> activated by IFN-y plus another pro-inflammatory cytokine such as LPS, compared
with Fc-yR-mediated activation. In the former, NO is abundantly produced, in the latter oxygen
radicals released. Investigations by others of cytokine release from M(|> or array data of mRNA
transcripts demonstrates that different stimulatory factors result in different patterns of cytokine release
such as high IL-12/IL-18 following toxoplasma surface antigen exposure compared with much lower
IL-12 release following IFN-y plus LPS (Yap & Sher 1999). In this thesis M<J) taken directly from
inflamed glomeruli were high NO and high TNF-a producing cells. Whether all Mc|> were producing
NO and TNF-a was not tested. Single cell data were not collected for M(|> cytokine profiles to see
whether there were mixed populations. For example, it would be valuable to know whether they were
individual high H202 producing cells amongst the glomerular M(j) from the rat tNTN model (Chapter
3). Interestingly, immunohistochemical studies of inflamed glomerular M<)) suggest that the glomerular
population of M<|) might be phenotypically diverse (Lan et al., 1995; Furusu et al., 1998; Heeringa et
ah, 2001).
Over recent years it has also been appreciated that naive M(|> can be classically activated and alternately
activated (Goerdt & Orphanos 1999). These latter cells are alternatively activated in that they are
producing an array of cytokines such as IL-10 and TGF-(3, but not pro-inflammatory cytokines such as
IL-1, TNF, IL-12, IL-6. The spectrum of cytokine production is not subtly different, but quite different
from the IFN-y/LPS activated M(j). It is clear that initial cytokine exposure of naive M(|> or monocytes
to cytokines such as IL-4, IL10, IL-13, TGF-(3 or glucocorticoids can induce the alternatively activated
phenotype (Erwig et ah, 1999; Goerdt & Orphanos 1999).
There is increasing evidence from the microbiological field that M(|), potently activated by the adaptive
immune system can be down-regulated by concomitant signalling from receptors ligated by
components of the innate system. This has been elegantly displayed by Mosser's group, whereby M<()
activated by LPS are alternatively activated by Fc-yRI ligation and signalling (Gerber et ah, 2001).
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Rather than release IL-12, they release IL-10, and for that reason might be thought of as alternatively
activated. Others have linked infectious agents which notoriously evade the immune system, such as
the measles virus, with similar activation of innate immune receptors that render the M0 de-activated in
terms of pro-inflammatory cytokine release. This deactivation correlates with disease perpetuation
(Atabani et al., 2001; Karp & Wills-Karp 2001; Braun et al., 2001).
These alternatively activated M0 appear to have different functions. They express preferentially,
receptors of the innate immune system such as mannose receptor, scavenger receptor type 1. They
appear to suppress production of oxygen radicals and are said to predominantly metabolise arginine
through the arginase pathway. They express highly, Class II molecules, but express limited
chemokines. Thus they appear well equipped for anti-inflammatory responses, antigen presentation and
efficient phagocytosis (see Figure 8-4) (Goerdt & Orphanos 1999). The inflammatory process involves
the pro-inflammatory response with positive feedback and local destruction of tissue. However, for
healing and resolution the pro-inflammatory response has to abate. It is possible that alternatively
activated M<j) are an essential component of the normal healing response in any organ, in particular the
kidney. Thus imbalance in the types of Mc|) involved in the inflammatory response might explain
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Figure 8-4: Differentiation of monocytes to classically activated or alternatively activated M<()
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8.12 APOPTOTIC CELLS AS LIGANDS AND MODULATORS OF M<> FUNCTION
For some years, it has been clear that unlike many other particles, when apoptotic cells are
phagocytosed they do not exert a pro-inflammatory response from the phagocytosing cell such as M<j>
(Meagher et al., 1992). The perception has been that apoptotic cells are effete bodies that need to be
removed from the inflammatory site lest they should spill their contents and provoke further
inflammation. This is certainly true for apoptotic granulocytes (Stern et al., 1996). However, that view
does not hold so tight when considering apoptotic resident cells. Firstly, they tend not to contain
granules with potent tissue-destroying enzymes, and secondly in limited experiments (not shown) I
found no evidence that post-apoptotic MC nor necrotic debris incited pro-inflammatory responses in
Mtj> (not shown). More recently data has indicated that binding/phagocytosis of apoptotic cells appears
to alter their function. M<J) have variously been reported to show a decreased capacity to induce
cytolysis of tumour cells, release TGF-p, IL-10, decreased TNF-a, IL-1(3, decreased NO release and
decreased chemokine production. In addition, it appears that other anti-inflammatory factors such as
prostaglandins are upregulated (Voll et al., 1997; Fadok et al., 1998; Reiter et al., 1999; McDonald et
al., 1999; Freire-de-lime et al., 2000). Thus it appears that apoptotic cells are not inert but actually send
signals to the M(f> or non-professional phagocytosing cell, to alter the function. In the case of the M<|)
this signal bears some of the hallmarks of the alternatively activated M<J>. The data presented in Chapter
7 indicate for the first time that M<|) killing MC can be switched off from further killing by ingesting
apoptotic MC. This is a clear case of negative feedback in the inflammatory response; the sort of
process one would expect to see in the normal inflammatory response (Figure 8.5). This new
hypothesis needs to be tested in vivo. For it now provides a novel site for therapeutic intervention.
Clearly, removal of angry M(j) or exogenous agents that alter their function will alter the inflammatory
process (such as corticosteroids). Modulation of TNF signalling of apoptosis (or NO or H202) would
alter the disease, and modulation of the binding of phagocytic cells might alter the disease. Further, it is
clear now that of the increasing cell-surface ligands important in phagocytosis of apoptotic cells (see
Savill and Fadok 2000) some will be important in cell signalling. Exploiting these signal pathways
should reveal new disease modifying and therapeutic targets.
The data from Chapter 7 provide an unexpected observation. Both Reiter and colleagues (Reiter et al.,
1999) and Freire-de-lima and colleagues (Freire-de-lima et al., 2000) show data of modest reductions
in NO release (nitrite) when phagocytes ingest apoptotic cells (in the latter case they might have been
necrotic). The data from Chapter 7.4 show augmented NO release by M(|> following ingestion of
apoptotic cells. This contrary data requires further investigation, but it brings us back to the question of
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whether NO is pro-inflammatory or anti-inflammatory. I have provided much evidence that NO in
inflammation often acts to counteract pro-inflammatory events (Chapter 8.4). It might be entirely
appropriate in vivo in certain situations that the alternatively activated M<|> should have augmented NO
generation.
Figure 8-5: Negative feedback in killing of MC by M<|> by ingestion of apoptotic MC
The question of failed clearance of apoptotic cells enters a new era if it is true that post apoptotic cells
or necrotic cells (apart from granulocytes) are not pro-inflammatory to the M<|>. It is possible that post
apoptotic or necrotic cells fail to deactivate Mc|>, and it is possible that ingestion post apoptotic cells
could lead to inappropriate presentation of self to the immune system (Gallucci et al., 1999). The Clq
knockout mouse exhibits delayed or failed apoptosis and develops autoimmunity (Taylor et al., 2000).





The two main conclusions from this Thesis are firstly that M<j), by a variety of mechanisms are able to
bring about apoptosis of proliferating mesangial cells, and secondly that binding/ingestion of those
cells induced into apoptosis serves as an off signal to the inflammatory M<|>, turning it into a reparative
healing M(().
These observations need to be tested in vivo. The balance between classically activated and reparative
M<)> should be modified and the absolute number of inflammatory M<j) should be selectively modified in
glomerulonephritis to determine the effect on mesangial cells.
I believe that further investigations are warranted into the role of IRF-1 and caspases/ROI signalling of
death. I feel this section of the thesis received unsatisfactory attention, since there appear to be
important signalling pathways controlling MC susceptibility to death.
The roles of mTNF can be clarified further with simple in vitro experiments and there remains the
question of the role of NO which can be tested with the right in vivo experiments.
Finally, a whole new avenue has been opened up by considering modifying phagocytosis of apoptotic
cells. There are now knockout mice with clear defects in clearance of inflammatory apoptotic cells.
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Add components one at a time to 900ml dH20 Adjust pH to 7.4. Make up to l.Olitre







Add components one at a time to 900ml dH20 Adjust pH to 7.4. Make up to l.Olitre
Tris-buffered saline
Dissolve 8g of NaCl, 0.2g of KC1, and 3g of Tris base in 800ml of distilled H20. Add 0.015g of
phenol red (optional). Adjust the pH to 7.4. Make up to 1 litre
lx Trypsin EDTA (supplied by Life Technologies)
0.05% (w/v) trypsin
0.53mM EDTA





0.0013mg CuS04.5H20 3075.4mg HEPES
0.05mg Fe(N03)3.9H20 2.39mg Na hypoxanthine
0.417mg FeS04.7H20 0.042mg Linoleic acid
311.8mg KC1 0.105mg DL-68 Thioctic acid
61mg MgCl2.6H20 8. lmg Phenol red
lOOmg MgS04.7H20 0.081mg Sodium putrescine.2HCl















































1 .Omg glutahione (reduced)
HEPES
5mg Phenol red
240mg L-arginine.HCl 0.3mg D-Ca pantothenate
50mg L-asparagine 3.Omg Choline chloride
20mg L-aspartic acid l.Omg Folic acid
50mg L-cystine 35mg I-inositol
20mg L-glutamic acid 1 .Omg Pyridoxal E1C1
300mg L-glutamine 0.2mg Riboflavin
lOmg Glycine l.Omg Thiamine HC1
15mg L-Histidine 0.2mg Biotin
50mg L-Isoleucine 0.005mg Vitamin B12
50mg L-leucine 1 .Omg para-aminobenzoic






















0.0 lg phenol red
Make up to 1 .Olitre








Make up to 1 .Olitre
Paris buffer
20mM Tris HC1 2.42g
125mM NaCl 7.31g
lOmM KC1 0.74g
lOmM Na acetate 0.82g
5mM glucose 0.9g
Make up to 900ml with dH20
PH to 7.4 with 0.1M HC1, then make up to 1000ml
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Appendix 1
SODIUM DODECYL SULPHATE-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-
PAGE)
Lysis buffers
1) For mesangial cells



























4 x running buffer
36.3g Tris base
Add 150ml ddH20
Adjust to pH 8.0 with HC1
ddH20 make up to 200ml
Store 4°C in the dark (3months)
4 x stacking buffer
3.0g Tris base
Add 40ml ddH20
Adjust to pH 6.8 with HC1
Store 4°C in the dark (3months)
Laemmli buffer
1.0ml 8M urea
250pl 0.5M Tris pH 6.8
200pl glycerol
400pl 10% SDS
100pl 2-mercaptoethanol (can be substitued)
50plddH20


















made up to 1 litre with dH20 (pH should be 8.2-8.4)
Coomassie brilliant blue stain











0.1% (w/v) Ponceau S in 5% acetic acid
l.Og Ponceau S
50ml acetic acid





Running gel final concentration
7.5% 10% 12,5% 15%
Monomer sol". 10ml 15ml 20ml 25ml 30ml
4 x running buffer 15ml 15ml 15ml 15ml 15ml
10% SDS 600pl 600pl 600pl 600pl 600pl
dd H20 34.1ml 29.1ml 24.1ml 19.1ml 14.1ml
10% APS 300pl 300pl 300pl 300pl 300pl
TEMED 20pl 20pl 20pl 20pl 20pl
Stacking gel 4% acrylamide
Monomer sol". 2.66ml







Final conc. Stock conc. volume
lOmM HEPES pH 7.9 1M lOOpl
1.5mM MgC12 1M 15pl
lOmM KC1 1M lOOpl
50pM DTT 1M 5pi
lOOpM phenanthroline lOmM lOOpl
lpg/ml pepstatin lmg/ml lOpl
1 OOjiM 1 -trans-epoxysuccinyl-leucylamide 5mM 200pl
(4-guanido)butane (antipain)
lOOpM 3,4-dichloroisocoumarin (DCI) 30mM 33pl
lOmM sodium fluoride 0.5M 200pl
lOOpM sodium orthovanadate 5mM 200pl





Final conc. Stock conc. volume
20mM Hepes pH 7.9 1M 200pl
420mM NaCl 5M 840pl
1.5mM MgCl2 1M 15jxl
0.2mM EDTA 0.5M 2pl
25% v/v glycerol 100% 2500pl
lOOpM DCI 30mM 33pl
ddH20 6408pl
Tris-EDTA (TE)
lomm Tris-HCl (500jla1 1m Tris pH 7.4)
ImM EDTA (lOOpl 0.5M EDTA)
pH 7.4
make up to 50ml with dH20
Table M2
5% 6% 7%
30%/0.5% acrylamide solution 8.33ml 10.0ml 11.67ml
dH20 38.8ml 37.1ml 35.5ml
5x TBE 2.5ml 2.5ml 2.5ml
10% APS 320pl 320pl 320pl
TEMED 40pl 40pl 40pl
NITRIC OXIDE ASSAYS
Griess Reagent
2% Sulfanilic acid solution:
5% orthophosphoric acid was prepared from 85% orthophosphoric acid ( < 0.0005% nitrite) and
distilled water. 470mls of dH20 was added to 30mls of orthophosphoric acid stock. To this were
dissolved lOg of sulfanilamide. The solution was stored at 4°C.
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0.2% N-(l-naphthyI)ethelendiamide (NED) solution:
1 g of NED was dissolved in 500ml of distilled water and stored at 4°C in the dark.
Nitrate reductase
Phosphate buffer
1 litre of ddH20
8.00g sodium chloride
0.20g Potassium chloride
0.20g Potassium dihydrogen orthophosphate (KH2P04)
1.15g Disodium hydrogen orthophosphate (Na2HP04)
pH 7.4, filter sterilised
Nitrate reducatase and glucose-6-phosphate dehydrogenase were dissolved in 50% glycerol 50%
phosphate buffer and stored at -20°C. NADPH was dissolved in phosphate buffer and stored at -20°C.
Enzyme mastermix
Phosphate buffer 1ml
Nitrate reductase (59U/ml) 1 Opl






























0.17M (2.3 lg) KH2P04
12.54g K2HP04
90ml dH20









Make upto lOOOmls. Autoclave.
Antibiotic concentrations for agar plates and broths
Final concentration for agar plates:




Stock solutions for broths:
Ampicillin lOOmg/ml in dH20 (sterile filtered)
Kanamycin sulphate 30mg/ml in dH20 (sterile filtered)
STET solution
4g Sucrose
1.25ml Tris-HCl 2M pH 8.0
5ml EDTA 0.5M
2.5ml Triton-X 100






Dissolve into 950ml of H20. Adjust pH to 6.7
Add 10.9g of MnC12.4HzO, then make up to 1000ml with H20. Filter with 0.22pm membrane. Store at
4°C.
lOx Tris borate EDTA (TBE)
107.8g Tris base
55g boric acid
7.44g disodium EDTA . 2H20
Add components in order to 800ml of dH20. Use slightly less than full amount of boric acid. Check




Diethyl pyrocarbonate (DEPC) 0.01% in dH20 (note carcinogenic)
Leave overnight at RT
Autoclave for 20min
Gel loading buffer




Plasmid mega (midi) prep
Glucose buffer
1.25ml 2M glucose
1.25ml lMTris pH 8.0
lml 0.5M EDTA




make up to 50ml with dH20
High salt buffer
150ml 5M potassium acetate
28.75ml acetic acid






200ml dHzO adjust pH to 8.0
make up to 250ml
RNAse stock solution
lOOmg pancreatic RNAse A (bovine pancreas)
10ml T10SI5 (pH 7.5)






10ml glacial acetic acid
use within 72h
Apoptotic neutrophil stain
15ml PBS pH 6.2
15ml Hanks w/o
300p.l DMB (o-dianisidine (Sigma) 1.25mg/ml in dH20. Aliquots stored at -20°C)




All tissue culture plastic flasks were from Costar (Cambridge MA)
All tissue culture plates for experiments were from Becton Dickinson (Falcon; Franklin Lakes NJ)
Tissue culture reagents were from Life Technologies (Paisley, Scotland)
Cytokines were from R&D systems unless stated otherwise
All enzymes used in molecular biology were from Promega (Madison WI) unless stated otherwise
Oligonucleotides were from MWG-Biotech AG





F22120 Anti Fas (for rat)
Anti Fas (for rat)
Ab-1 anti Fas (for rat)
4H9 Anti FasL
Clone 33 anti FasL






































Soluble recombinant human Fas ligand
Miscellaneous










Gift from Prof C. Ware
Gift from Prof C. Ware
Gift from Prof C. Ware
Peprotech
Peprotech












Activated Macrophages Direct Apoptosis and Suppress Mitosis
of Mesangial Cells1
Jeremy S. Duffield,2* Lars-Peter Erwig,T Xiao-quing Wei,* Foo Y. Liew,* Andrew J. Rees,+ and
John S. Savill*
During inflammation in the glomerulus, the complement of resident myofibroblast-like mesangial cells is regulated by mitosis and
apoptosis, but the cellular mechanisms controlling the size of mesangial cell populations have remained obscure. Prompted by
studies of development, we sought evidence that macrophages regulate mesangial cell number. Rat bone marrow-derived mac¬
rophages primed with IFN-y then further activated in coculture with LPS or TNF-a elicited a 10-fold induction of rat mesangial
cell apoptosis and complete suppression of mitosis, effects inhibitable by the NO synthase inhibitors L-monomethyl arginine and
L-A^-f 1 -iminoethyl) lysine dihydrochloride. Complete dependence upon macrophage-derived NO was observed in comparable
experiments employing activated bone marrow macrophages from wild-type and NO synthase 1~'~ mice. Nevertheless, when
mesangial cells were primed with IFN-y plus TNF-a, increased induction by activated macrophages of mesangial apoptosis
exhibited a NO-independent element. The use of gld/gld macrophages excluded a role for Fas ligand in this residual kill, despite
increased expression of Fas and increased susceptibility to soluble Fas ligand exhibited by cytokine-primed mesangial cells. Finally,
activated macrophages isolated from the glomeruli of rats with nephrotoxic nephritis also induced apoptosis and suppressed
mitosis in mesangial cells by an L-monomethyl arginine-inhibitable mechanism. These data demonstrate that activated macro¬
phages, via the release of NO and other mediators, regulate mesangial cell populations in vitro and may therefore control the
mesangial cell complement at inflamed sites. The Journal of Immunology, 2000, 164: 2110-2119.
Remodeling of tissues occurs during successful resolutionof the inflammatory response induced by tissue injury.Until recently, the mechanisms involved have been ob¬
scure. Although accumulation of cells with myofibroblast features
is a familiar feature of the response to injury by many tissues, it is
only recently that apoptosis (programmed cell death) has been
identified as the major mechanism by which excess myofibroblast-
like resident cells are eliminated during successful repair of in¬
flammatory injury. We established this concept for myofibroblast-
like mesangial cells (MC)3 in the glomerulus of self-limited
proliferative glomerulonephritis induced by anti-MC Ab (Thy-1.1)
(1). Subsequent reports have confirmed a comparable remodeling
role for myofibroblast apoptosis in the healing of skin wounds (2)
and the resolution of hepatic inflammatory injury (3).
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However, little is understood of the cellular control mechanisms
that regulate apoptosis of myofibroblast-like resident cells during
resolution of inflammation. Given that repair of tissue injury may
reiterate processes involved in tissue development, we have be¬
come interested in the possibility that similar cellular mechanisms
might regulate remodeling by apoptosis in both developmental and
inflammatory contexts. Seminal work by Lang and colleagues (4)
has demonstrated a key role for macrophage (M(j>)-directed apo¬
ptosis in the elimination of unwanted capillaries in neonatal de¬
velopment of the mouse and rat eye (5). Mtj> dock on to the mi¬
crovascular endothelial cells and trigger their apoptosis in this
model of tissue remodeling, but the cell-killing mechanisms de¬
ployed are as yet unclear. The probable relevance of this observa¬
tion to regulation of cell populations at inflamed sites has been
underscored recently by Tesch and colleagues (6), who, using a
nephrotoxic serum model of glomerulonephritis, demonstrated de¬
creased resident tubular cell apoptosis in the monocyte chemoat¬
tractant protein-1 (MCP-1) knockout animal compared with wild
type. During tubular inflammation, there was an MCP-1-directed
influx of M<j> to the interstitium. In the knockout animal, the influx
of M(/> was reduced. It appears, therefore, that M(/> in this model
are inducing tubular cell apoptosis. The killing mechanisms in both
models, however, remain to be defined, although in the tubular
injury model, in vitro experiments suggested that M4> can release
soluble factors capable of triggering tubular cell death.
Furthermore, there have been indications that Mtj) might have
the capacity to direct apoptosis of glomerular MC, which assume
a myofibroblast-like phenotype in situations in which they threaten
to promote the persistence of glomerular inflammation by secre¬
tion of cytokines, or progression to scarring by excess deposition
of abnormal extracellular matrix. First, Mene and colleagues (7)
showed that U937 promonocytic cells were able to induce cytol-
ysis of cultured MC, although it was not determined whether this
represented apoptosis or necrosis. Second, Hruby et al. (8) reported
0022-1767/00/S02.00
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similar findings in cocultures of rat peritoneal M<j> and MC, im¬
plicating NO in the phenomenon by specific inhibition of MC dis¬
integration with l-NMMA. Further evidence that Mtj> might have
the capacity to induce apoptosis in neighboring cells by the release
of NO comes from coculture studies indicating that cytokine-ac-
tivated peritoneal Mcj> can trigger apoptosis in proliferating breast
tumor cells by a mechanism inhibitable by l-NMMA (9, 10). How¬
ever, in no preceding study has there been a direct demonstration
that M(f> can trigger apoptosis in glomerular MC.
In this study, we have tested the hypothesis that M<f> activated to
express inducible NO synthase (also known as NOS-2) can trigger
apoptosis in cultured MC, which are well known to reiterate the
myofibroblast features displayed in the injured glomerulus in vivo.
We report that in contrast to quiescent cells, M<j> activated in vitro
or isolated from inflamed glomeruli not only inhibited MC mitosis,
but did indeed induce apoptosis in MC. Cytokine stimulation of
MC was able to increase the kill. Furthermore, use of specific
NOS-2 inhibitors and NOS-2 knockout M(j> clearly implicated
M(/>-derived NO as a key mediator inducing apoptosis and inhib¬
iting mitosis in glomerular cells. The data establish a new facet to
the multifunctional role of the M$ in inflammation: the capacity to
direct remodeling by coordinate induction of apoptosis and inhi¬
bition of mitosis in resident tissue cells.
Materials and Methods
Materials
Tissue culture reagents were from Life Technologies (Paisley, Scotland),
and tissue culture plastics from Costar (Cambridge, MA). Experimental
culture wells were from Becton Dickinson (Falcon; Franklin Lakes, NJ).
Cytokines were from Genzyme (Cambridge, MA), and all other reagents
were from Sigma-Aldrich (St. Louis, MO), unless otherwise stated.
Preparation of BMD M(f)
Femurs and tibias were removed from 200- to 250-g rats (Wistar). Bone
marrow was isolated from these by standard sterile techniques (11) and
matured for 7 days in Teflon wells in using DME/F12 medium with 10%
FCS, penicillin (100 U/ml), and streptomycin (100 mg/ml), conditioned
with M-CSF from L929 cells. In some experiments, BMD Mtj> were de¬
rived from knockout NOS-2 mice (129/sv-NOS-2~/~) (12) and wild-type
controls (8 wk). In others, BMD Mc(> were obtained from mice bearing an
inactivating point mutation of FasL (C3H/HEJ-gM/gW) and wild-type con¬
trols (8 wk) purchased from The Jackson Laboratory (Bar Harbor, ME).
Establishment of MC cultures
MC were derived by clonal selection from glomerular single cell prepara¬
tion (gift of Dr. M. Kitamura, Department of Medicine, University College,
London, U.K.) and from primary outgrowths from isolated whole glomer¬
uli (13). MC were verified, and purity established, as described (1, 13, 14).
Cells were used from passages 4 to 12. Primary cells were maintained in
DME/F12 medium with 16% heat-inactivated FCS, penicillin (100 U/ml),
and streptomycin (100 mg/ml). Clonal cells were maintained in the same
medium with 10% FCS. MC were maintained in the logarithmic growth
phase.
Mf> coculture with MC
Matured (7-10 day) M<fi were plated in 96-well plates initially at a density
to cover 60-70% of the well surface; typically, this required 2 X 105 cells.
MC were prelabeled with CellTracker Green CMFDA (Molecular Probes,
Eugene, OR): cell cultures, 70-80% confluent, were washed with medium
lacking serum and then incubated for 1 h in serum-free medium containing
CMFDA at 5 ng/ml. Cells were washed in medium containing 10% FCS to
remove any unbound CMFDA, then trypsinized and added to cultured M<p
in a 1.5 M<j>:l MC ratio. Experiments were conducted in DME/F12 me¬
dium containing 10% FCS. Once cells had become adherent, typically 2-4
h, wells were washed to remove nonadherent cells. Preliminary experi¬
ments mixing unlabeled and labeled cells showed no evidence of transfer
of CMFDA from labeled to unlabeled cells (data not shown).
Activation protocols
When desired, M$ were primed for 12 h with IFN-y (100 U/ml) before
coculture. After coculture was established, M<f> were activated using either
IFN-y (100 U/ml) plus LPS (1 /xg/ml), or IFN-y (100 U/ml) plus TNF-a
(100 U/ml). Unactivated or quiescent cells were exposed to carriage me¬
dium only (PBS, 0.1% BSA).
In some experiments, MC were primed in flasks for 36 h with a com¬
bination of IFN-y (300 U/ml) plus TNF-a (300 U/ml). Cells were washed
thoroughly and trypsinized before establishing coculture. Mock-primed
cells were grown in flasks containing carriage medium only (PBS,
0.1% BSA).
Assessment of apoptosis and mitosis
Morphological criteria. At the end of the experiment, wells were fixed
by adding formaldehyde (4% final concentration), stored at 4°C for 48 h to
ensure firm adherence of the fixed apoptotic cells to the monolayer. Sub¬
sequently, medium was removed and propidium iodide (PI) in PBS (5
/xg/ml) was added for 5 min to stain both Mtp and MC. This reagent was
then discarded and wells were covered with a fluorescent mountant. Using
inverted fluorescent microscopy, five fields were randomly and blindly
selected from each well so that at least 300 MC were counted in each well.
Wells were counted nonconsecutively. MC labeled with CellTracker Green
CMFDA were discernible from M<1> by their green fluorescence (M<j> ap¬
peared red due to PI binding to RNA as well as DNA). Apoptotic cells were
clearly distinguishable by characteristic morphology (cytoplasmic bleb-
bing, cell shrinkage, nuclear condensation, and fragmentation); in our pre¬
vious studies of MC apoptosis (1, 14), these morphological criteria have
been extensively validated against quantitative and qualitative measures of
apoptosis. Mitotic cells were easily discernible by characteristic morphol¬
ogy and shape change.
Functional criteria. MC apoptosis was also assayed in live cells by
addition of Hoechst 33342 (bisbenzimidazole dye) to wells at a final con¬
centration of 5 /xg/ml. This dye is actively excreted by live, but not apo¬
ptotic cells (15). After 15 min at 37°C, wells were counted as described
above for apoptotic cells. PI was also added to live wells (1 /xg/ml) to
exclude necrotic cells (see Fig. 1). Furthermore, 99.8% of cells in the live
coculture were able to exclude trypan blue assessed, as previously
described (10).
Flow-cytometric assay. Coculture was performed as described above
in a 1 MC:1.5 Me(> ratio in six-well plates (Becton Dickinson). After 24 h,
the coculture or controls were washed, followed by the application of 1X
trypsin-EDTA. All washings and eluted cells were collected, and after
centrifugation (300 X g), they were permeabilized with 70% ethanol at 4°C
overnight. After washing with PBS, cells were treated with RNase (100
/ug/ml) and PI (40 /xg/ml) for a minimum of 30 min. Cells were then
detected by forward and side scatter, then assessed by excitation at 488 nm
and measuring fluorescence at 639 nm using FACScalibur (Becton Dick¬
inson). The characteristic distribution of DNA content enabled accurate
assessment of diploid, G2/M phase, and hypodiploid populations (14).
Immunohistochemistry. Further assessment of mitosis was made by
specific identification of proliferating cell nuclear Ag (PCNA) in MC using
PC10 Ab (Dako, Carpenteria, CA) in fixed wells. Briefly, following
quenching of endogenous peroxidases with 3% hydrogen peroxide in meth¬
anol (5 min, 20°C), and permeabilization with 0.1% Triton X-100, 0.1%
sodium citrate in PBS (5 min, 20°C), the primary Ab was applied 1:50 in
PBS, 10% NBCS (4 h, 20°C). Specific localization was assured by biotin-
ylated anti-Ig and streptavidin-peroxidase using the substrate AEC (Vec¬
tor). MC were distinguished by the subsequent labeling with FITC-conju-
gated a smooth muscle actin Ab.
All experimental conditions were prepared in triplicate. All experiments
and conditions were observer blinded. Experiments were performed on at
least three separate occasions. M<)> and primary MC cultures were derived
from at least three different animals.
Mcf-conditioned supernatant transfer
A total of 106 mature BMD M<(> was seeded to six-well plates with medium
containing 10% FCS. Cells were activated with IFN-y and LPS, as de¬
scribed in activation protocols. After 16 h, supernatant was removed and
clarified at room temperature by centrifugation at 350 X g for 5 min,
followed by centrifugation at 10,000 X g for 5 min. Two hundred micro¬
liters of supernatant were transferred directly to MC established 24 h pre¬
viously (covering 70-80% of the well surface) in 96-well plates. After 8,
16, and 24 h, apoptosis, mitosis, and cell number were assayed morpho¬
logically by PI staining of fixed monolayers.
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Nitrite assay
Griess reagent was prepared using 0.5% sulfanilamide in 2.5% orthophos-
phoric acid with 0.05% N-ethylenediamine (16). Samples were mixed with
an equal volume of reagent and absorbancy measured after 10 min at 540
nm. Standard curves were prepared using dilutions of sodium nitrite. BMD
M4> and glomerular Mif> were prepared as described. A total of 105 cells
were placed in wells with 400 /ri of full medium (without phenol red).
After 24 h, medium was collected and mixed with an equal volume of
Griess reagent. After 5 min, absorbance at 540 nm was measured. Using
sodium nitrite standard curves, the total nitrite accumulated was calculated
and expressed as nanomoles per 106 cells per 24 h. To assess MC nitrite
production, subconfluent 75-cm2 flasks were cultured for 48 h in 5 ml of
medium. A 400-p.l aliquot was used in the Griess assay, and cell number
was assessed by hemocytometer to give equivalent results expressed as
nanomoles per 106 cells per 48 h.
Western blot analysis
Cytosolic extracts from cells were prepared using a hypotonic lysis buffer
(10 mM HEPES, pH 7.9, 1.5 mM MgC12, 10 mM KC1, 50 pM DTT, 100
pM phenanthroline, 1 pg/ml pepstatin, 100 pM l-tranr-epoxysuccinyl-
leucylamide (4-guanido)butane, 100 pM 3,4-dichloroisocoumarin, 10 mM
NaF, 100 pM sodium orthovanadate, 25 mM ^-glycerophosphate) con¬
taining the detergent (0.2% v/v) Triton X-100, for 10 min on ice, followed
by centrifugation at 10,000 X g for 10 min at 4°C.
Samples were analyzed by SDS-PAGE, followed by Western blotting.
Equal amounts of protein extract were mixed with Laemmli dissolving
buffer (500 mM Tris-HCl pH 6.8, 20% 2-ME, 8% SDS, 30% glycerol, and
bromophenol blue), boiled for 5 min, and electrophoresed in gels contain¬
ing 12.5% acrylamide.
Proteins were electrotransferred to a nitrocellulose membrane in buffer
containing 25 mM Tris base, 192 mM glycine, and 20% methanol (v/v).
Following blocking using 5% milk powder in buffered saline for 1 h at
room temperature, membranes were incubated for 24-48 h with primary
anti-Fas (AB-1; Oncogene Research Products, Cambridge, MA) Ab at 4°C.
After washing in Tris-buflFered saline, membranes were incubated with per¬
oxidase goat anti-rabbit IgG Ab (1:10,000) at room temperature for 1 h.
After further washing, labeled proteins were detected using enhanced
chemiluminescence (Amersham, Arlington Heights, IL). Equal protein
loading was confirmed by staining gels with Coomassie blue. Adjacent
lanes were labeled for /3 actin to confirm the specificity of AB-1 for Fas,
as actin runs at a similar m.w. to Fas by SDS-PAGE.
Sequencing of mouse FasL by PCR
Genomic DNA was prepared isolated from M</> from wild-type or gld/gld
mice. A 311 -bp segment, covering the predicted mutation site of the gene,
was amplified by PCR using the primers 5'-GTGGCCTTGTGAT
CAACG-3' and 5'-CTCTGGAGTGAAGTATAAG-3' (Oswel, Research
Products, Southampton, U.K.). Briefly, 5 p.1 of DNA solution was diluted
with 45 p\ of reaction buffer containing 200 p,M dNTP, 1.5 mM MgCl2,
and primers (100 pmol of each). The reaction mixture was placed in a DNA
thermal cycler (Boimetra, Goettingen, Germany) and the reaction started
by adding 1 U of Taq polymerase (Bioline, London, U.K.). The conditions
of PCR were 95°C, 1.5 min; 55°C, 1.5 min; and 72°C, 1.5 min for 36
cycles. Sequencing, using the fluorescent dideoxy method, confirmed the
gld/gld mutation, resulting in a phenylalanine to leucine conversion at
amino acid position 273 (data not shown).
Induction of accelerated autologous phase of nephrotoxic
nephritis
Nephritis was induced using a standardized protocol (17). Briefly, male
Sprague Dawley rats (weight 180-200 g) were immunized by injection of
1 mg normal rabbit IgG, in Freund's complete adjuvant (Difco, Detroit,
MI). After 7 days, the rats were injected with 1 ml of nephrotoxic serum
i.v. They were sacrificed, and kidneys were prepared as below. Biopsies
were taken for histology, which confirmed severe proliferative glomerulo¬
nephritis (18). Urine was collected in metabolic cages for 18 h, and albu¬
minuria was confirmed by rocket immunoelectrophoresis.
Isolation of single cells from glomeruli
Glomeruli were isolated using a standard sieving technique. Isolated glo¬
meruli were enzymatically digested to single cell suspensions using tryp¬
sin, collagenase, DNase, and EDTA, as described (19, 20). Mtf> were iso¬
lated by adherence in 24-well plates. Aliquots of the single suspension
containing 1 X 105 M<j> were added to wells in full medium with serum.
After 2 h, wells were thoroughly washed to leave adherent Mtjt only. Purity
Table I. Effect of Mf> on the proportion of cells exhibiting DNA
content of G2/M-phase of the cell cycle or hypodiploid DNA content"
Unstimulated Activated Activated
Coculture Coculture Coculture + l-NIL
% G2/M-phase cells 18.1 ± 1.5 10.4 ± 1.4* 20.9 ± 1.5
% Hypodiploidy 0.6 ± 0.3 6.2 ± 2.2* 1.0 ± 0.3
a Cells were prepared and analysed according to Materials and Methods with 1.0
MC:1.5 M<f>. M<f> were primed with IFN-y (100 U/ml), and once coculture was es¬
tablished, activated with IFN-y and LPS (1 /xg/ml). Note data shown refer to whole
coculture. MC controls were activated with the same agents and showed 19.2 ± 0.7%
in G2/M, 0.3 ± 0.1% hypodiploidy. Activated Md> alone demonstrated 0.3 ± 0.1%
hypodiploidy. No M<b had increased DNA content.
*, p < 0.05 compared with unstimulated coculture (n = 3).
of the cells isolated was confirmed by ED-1 immunostaining. Isolation of
resident Mtjt from control kidneys (normal histology) by the same method
required pooling of the single cell suspension from all control animals due
to the scarcity of this cell type (<5% of glomerular cells).
Statistics
The data were expressed as mean values with the SE of mean, and com¬
pared using the paired t test. No multiple comparisons were made.
Results
Activated but not quiescent Mtf coordinately inhibit mitosis and
stimulate apoptosis in MC
Mature rat BMD M<j> were cocultured with rat MC in the presence
of medium containing 10% FCS. Prelabeling of MC with Cell-
Tracker Green CMFDA, and staining of fixed monolayers with PI
enabled selective assessment of MC. Extensive work in our labo¬
ratory has shown that morphological assays of apoptosis on the
basis of typical cell shrinkage and nuclear condensation have ad¬
vantages over other techniques, with which this approach has been
compared and validated (1, 14). First, because apoptotic MC re¬
main intact and closely associated with the monolayer, it is pos¬
sible to assay definitively cell death by apoptosis without disturb¬
ing the culture and risking underestimation of apoptosis due to cell
damage or loss, which we have found to be an inherent problem
with certain assays of apoptosis. Second, microscopical assess¬
ment of the cell culture allows simultaneous detection of cells in
mitosis. Nevertheless, to verify the data, we labeled live cells in
coculture before fixation with Hoechst 33342 and counted cells,
admitting the dye so that nuclei were stained; this fluorescent dye
is excluded by the plasma membrane of healthy but not apoptotic
cells (14). Interestingly, all stained cells demonstrated typical con¬
densed apoptotic nuclei, indicating synchronicity of plasma mem¬
brane and nuclear changes of apoptosis in this cell type. No sig¬
nificant difference between the proportion of cells admitting
Hoechst 33342 and those demonstrating nuclear condensation on
PI staining after fixation of coculture was seen in activated (in one
series at 24 h, there were 35.3 ± 6.2 Hoechst-positive cells per
field compared with 31.5 ± 9 apoptotic MC after fixation and
counterstaining (representing 16.1 ± 2.6% MC per field), n = 9,
p = NS) or unstimulated coculture. To verify further our obser¬
vations, PI was used to label DNA in fixed cells from the coculture
and assess the proportion of cells in G2/M phase or with hypodip¬
loid content of DNA characteristic of apoptosis by flow cytometry
(Table I). Furthermore, confirmatory evidence of suppression of
mitosis was obtained by immunohistochemistry of fixed coculture
for PCNA; the percentage of PCNA-positive MC after 24 h in
quiescent coculture was 88.6 ± 3.7%, but this was markedly re¬
duced to 12.6 ± 4.4% in MC cocultured with M(f> under activating
conditions.
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FIGURE 1. Fluorescence micros
copy of rat BMD M</> and rat MC in
coculture (X200). A, Coculture was
established as described in Materials
and Methods, but was not activated.
At 24 h, after fixation and counter-
staining, green MC with pale red nu¬
clei are easily distinguished from M(p,
which are seen as red cells with red
nuclei. Note mitotic MC (arrow). B,
The coculture was activated by prim¬
ing M(/> with TFN-y (100 U/ml) for
12 h; then once the coculture was es¬
tablished, TFN-y (10(1 I l/ml) plus LPS
(1 jug/ml) were added. At 24 h, note
apoptotic MC with nuclear condensa¬
tion and cell shrinkage (large arrows).
Also note absence of mitotic cells. /,
(X500) Green rounded-up MC can be
seen in live coculture at 24 h. These
cells are excluding PI in the medium
(1 /xg/ml). ii, The same cells are se
1 actively failing to exclude Hoechst
33342 (5 jmg/ml), which simulta¬
neously reveals characteristic apoptotic
nuclei, iii, The same cells after fixation,
pcrmeabilizafiou, and conn I e,rs! Mining
with PI show typical nuclear condensa¬
tion (note thai there has been some ro¬
tation of MC during fixation).
Using these approaches, we found that coculture with unstimu¬
lated rat BMD Mcft had no effect on MC mitosis or apoptosis over
a 24-h period compared with control (Fig. 1A, Table I). However,
when M<fi were primed for 12 h with IFN-y, and then the coculture
was activated with IFN-y plus LPS, suppression of MC mitosis
was observed as early as 8 h (Fig. 2). At 24 h, there was near total
cessation of mitosis compared with control culture of MC growing
alone, stimulated with IFN-y and LPS. In addition, there was al¬
most a 10-fold induction of MC apoptosis (Figs. IB and 2). These
results were supported by flow-cytometric DNA content data (Ta¬
ble I), which showed a 10-fold induction of hypodiploid cells in
the whole coculture when activated, and a 50% reduction of all
cells with double DNA content (G2/M). The combination of these
effects was, as expected, associated with a decrease in MC number
over this time period, whereas when cultured under control con¬
ditions with FCS, MC exhibited the expected increase in number
(Fig. 2). Replacing LPS with TNF-a in the activating regimen in
coculture elicited similar results to those in Fig. 2. Control cultures
of MC alone, stimulated with IFN-y and TNF-a, did not undergo
apoptosis (data not shown). Primary cultures of MC also exhibited
















FIGURE 2. The effect of coculture of rat MC with activated rat BMD
M<£. M<t> were primed with IFN-y (100 U/ml) for 12 h, then coculture was
established (1.5 M<1>: 1 MC) and activated with IFN-y (100 U/ml) plus LPS
(1 jug/ml). A, The effect of activated M<)> on MC apoptosis at 8 and 24 h.
Note induction of MC apoptosis at 24 h. B, The percentage of mitosis at 8
and 24 h. Note the suppression of mitosis at both time points in coculture.
C, The effect of activated M<t> on MC number. Note a decrease in MC
during the time points assayed compared with the expected increase. *,p <
0.01 vs control MC alone (n = 4).
similar responses to coculture with activated M</>. After 24 h of
coculture, MC apoptosis was 7.9% (coculture) compared with
1.2% in controls (p < 0.05), and MC mitosis was 0.1% and 2%,
respectively (p < 0.01). Activated Mt/> underwent very low levels
of apoptosis after 24 h (<0.5%). This low level was seen whether
activated Mt/> were cultured alone or with MC.
By increasing the ratio of Mt/> to MC in coculture, a progres¬
sively greater proportion of MC was apoptotic (39.3 ± 3.5% at
24 h, ratio 10:1). However, at ratios higher than 4:1, a small pro¬
portion of apoptotic cells in live cocultures did not exclude PI. A
3-fold reduction in the number of M<f) in coculture still demon¬
strated significant induction of apoptosis (6.1 ± 2.4% at 24 h MC
control 1.2 ± 0.4%, p < 0.05) and inhibition of mitosis (0.83% ±
0.15 at 24 h MC control 2.3 ± 0.4%, p < 0.05), although this was
reduced compared with 1.5:1 ratio.
NOS-2 mediates inhibition of mitosis and induction of apoptosis
in MC cocultured with activated Mf>
The addition of the nonspecific NOS competitive inhibitor
l-NMMA at 100 ptM was able largely to abrogate the M (^-induced
effects on MC proliferation and apoptosis (IC50 for apoptosis
5.1 ± 3.6 /rM). Higher concentrations (200 and 500 /nM) had no
additional effect. Its inactive analogue (d-NMMA) had no discern¬
ible effect in cocultures with activated BMD M^> at 24 h (Table II).
l-/V6-(l-iminoethyl) lysine dihydrochloride (l-NIL), a specific
competitive inhibitor of NOS-2, was also able largely to abrogate
these M<£ effects at 24 h (IC50 for apoptosis, 0.33 p,M ± 0.40)
(Fig. 3, Table I). Transfer of conditioned supernatants directly
from M(£ (106/ml) activated for 16 h with IFN-y (300 U/ml) plus
LPS (1 p-g/ml) had no effect on apoptosis or mitosis of MC com¬
pared with control (medium containing IFN-y and LPS) (data not
shown). These results are in keeping with NO (a short-lived un¬
stable molecule), signaling apoptosis from the to the MC.
Proinflammatory cytokines increase MC susceptibility to
apoptosis induced by activated M<f or FasL
Using the morphological assay for assessing MC apoptosis, MC
pretreated with IFN-y and TNF-a for 36 h were rendered suscep¬
tible to apoptosis induced by soluble recombinant FasL (Fig. 4A).
This effect was not observed following pretreatment with IFN-y
alone (data not shown). In keeping with previous work on human
MC demonstrating that similar pretreatment increased the expres¬
sion of Fas (Ref. 21 and our unpublished observations), rat MC
Triton X lysates were prepared for Western blot analysis, which
confirmed increased expression of Fas after pretreatment with
IFN-y and TNF-a (Fig. 4B).
To assess whether proinflammatory cytokines also increased
MC susceptibility to Mt/>-induced kill, following pretreatment with
IFN-y and TNF-a for 36 h, MC were washed, trypsinized, and
cocultured with IFN-y-primed rat BMD Mt/> in the presence of
IFN-y plus LPS. After 24 h (Fig. 5), there was a significant in¬
crease in MC apoptosis compared with concurrent experiments
using mock-pretreated MC. This effect was only partially revers¬
ible by adding the NOS-2 competitive inhibitor l-NMMA, sug¬
gesting that mediators other than NO might contribute to the in¬
duction of apoptosis in primed MC. Quiescent M f> had no effect on
primed MC, and the latter were no more susceptible to the sup¬
pression of mitosis by activated Mc|> (see Fig. 6B).
Table II. Effect of l-NMMA and d-NMMA on activated Mf-induced induction of MC apoptosis and
suppression of mitosis in rat MC°
l-NMMA d-NMMA
















a Coculture was established as described in Materials and Methods. After priming with IFN-y, Mifi were activated using
IFN-y (100 U/ml) and TNF-a (100 U/ml). Either d-NMMA (100 /xM) or l-NMMA (100 /xM> was added to wells. Experiments
were assessed at 24 h. Data are given as mean ± SEM.
*, p < 0.05 compared with coculture in the presence of l-NMMA (n — 4).












FIGURE 3. The effect of activated M<f> on MC apoptosis and mitosis is
largely abrogated by the addition of the NOS-2 inhibitor l-NIL. Rat BMD
Mtf>, primed IFN-yfor 12 h, then activated with IFN-y (100 U/ml) and LPS
(1 |Ug/ml) were cultured with MC, as described in Materials and Methods.
l-NIL (30 /xM) or carriage medium was added once the coculture was
established. A, The effect of l-NIL on activated Mc/>-induced apoptosis of
MC at 24 h. l-NIL almost completely abrogates the effect of coculture on
MC apoptosis. B, The effect of l-NIL on activated VIr/j-induccd suppres¬
sion of mitosis at 24 h. l-NIL restores MC mitosis. C, l-NIL in the co-
culture enables MC to increase in number similarly to controls. *,p < 0.05
vs coculture in the presence of carriage medium (« = 4).
M<p expression of NOS-2, but not FasL, determines the capacity
to inhibit mitosis and induce apoptosis in MC
Previous work has indicated that both M<(> and MC produce NO
upon cytokine induction of NOS-2 (22, 23). We confirmed that
rodent BMD Mf> produced NO (as assessed by the use of Griess
reagent to measure accumulated nitrite in culture medium) when
challenged with proinflammatory cytokines (Table III). MC pro¬
duced much smaller amounts of NO in response to IFN-7 plus
TNF-a (Table III). Such cells stained weakly for NOS-2 by indi¬
rect immunofluorescence compared with the bright staining of all
M<£ treated with cytokines (not shown).
These data indicated that competitive NOS-2 inhibitors in the
coculture might therefore have exerted their effects on MC NOS-2,
M</> NOS-2, or both. To differentiate between these possibilities,
BMD M<f> from NOS-2 knockout mice and wild-type control mice
were prepared. The NOS-2_/~ M(/> produced a little NO in re¬
sponse to proinflammatory stimuli (Table III) such as IFN-7 plus
LPS when compared with wild type, in keeping with previous
work suggesting that other NOS may be up-regulated by proin¬
flammatory cytokines (12, 24). Activated 129/sv wild-type mouse
M<f> behaved identically to rat M<|> in the coculture assay, sup¬





















FIGURE 4. The effect of pretreatment of MC with IFN-y and TNF-a in
combination for 36 h upon susceptibility to FasL (Apo-1 ligand) and ex¬
pression of Fas protein. These studies employed both cloned primary MC
(■) and conventional multiclonal primary cultures (M). A, Apoptosis as¬
sessed at 16 h. Note that unprimed MC (two sets of bars on the left) are not
susceptible to soluble FasL at 100 ng/ml (NA = no additives). However,
note a significant increase in apoptosis after exposure of cytokine-primed
MC to FasL. Note also similar results using cloned MC or primary cultures.
*, p < 0.01 (n = 3). B, By immunoblotting, Fas protein is faintly seen at
45 kDa in unprimed MC (left-hand lane). However, after priming, there is
an obvious increase in Fas protein (equal loading of lanes confirmed by
Coomassie staining of the gel). This blot is representative of three separate
experiments.
cytokine-primed or unprimed MC (Fig. 6a). However, activated
NOS-2_/_ 129/sv BMD M<£ exhibited a significantly diminished
capacity to induce MC apoptosis. However, the magnitude of this
reduction was much smaller when MC were primed. This residual
kill did not appear to be due to priming rendering MC susceptible
to the low levels of NO produced by activated NOS-2_/_ M<(>, in
that no further reduction in apoptosis was brought about by adding
l-NMMA to the coculture (up to 500 /xM). The ability to suppress
mitosis was completely absent when activated NOS-2_/_ Mcf>
were cultured with unprimed MC, but by contrast with apoptosis,
there was no residual effect when NOS-2~/_ Mc/> were incubated
with primed MC; there was still no suppression of mitosis (Fig.
6b). These data support the possibility suggested above (Fig. 5)
that M(£-derived mediators in addition to NOS-2-derived NO may
contribute to the killing of primed rather than unprimed MC. Fur¬
thermore, in separate experiments (see Materials and Methods),
clarified supernatants transferred from activated rat M(/> directly to
primed MC demonstrate that this additional factor was soluble and
partially transferable: 24 h after transfer of conditioned supernatant
to primed MC, apoptosis was 10.4 ± 0.9%, control (medium alone
with activating cytokines) 3.7 ± 1% (n = 3).
Given the increased susceptibility of cytokine-primed MC to
FasL-induced apoptosis demonstrated above (Fig. 4a), and the re¬
cently reported capacity of activated human M</> to release FasL
capable of triggering apoptosis in bystander cells (25, 26), we were














FIGURE 5. The effect of priming of MC with IFN-y plus TNF-a on
susceptibility to apoptosis by activated rat BMD M<L MC were pretreated
with IFN-y (300 U/ml) plus TNF-a (300 U/ml) (primed), or PBS carriage
medium (unprimed), for 36 h. BMD M<(> were added to wells and primed
with IFN-y (100 U/ml) for 12 h. Coculture was established and M<j> acti¬
vated with IFN-y (100 U/ml) plus LPS (1 /xg/ml), according to Materials
and Methods. l-NMMA (100 /u,M) or d-NMMA (100 gM) was added to
the coculture with the activating cytokines. At 24 h, unprimed MC (left-
hand columns) underwent apoptosis in the presence of d-NMMA, but in
the presence of l-NMMA this was abrogated. Primed MC (right-hand col¬
umns) also underwent apoptosis, but the frequency was increased in the
presence of d-NMMA, and l-NMMA was only partially able to abrogate
this effect. Higher concentrations of this competitive inhibitor had no fur¬
ther effect (not shown). *, p < 0.01 vs unprimed coculture with d-NMMA.
**, p < 0.01 vs control primed MC with l-NMMA (n = 5).
interested in the possibility that the residual capacity of NOS-2-'-
M(f> for killing of primed MC was mediated by FasL. To assess this
possibility further, we cultured BMD Mr/> from mice homozygous
for a point mutation in the FasL gene, which results in a protein
product unable to ligate Fas such that death signaling ensues (C3H/
HEJ-gld/gld). These M<f> produced similar amounts of NO com¬
pared with their wild-type counterparts (data not shown), and be¬
haved identically, whether cocultured with unprimed or primed
MC (Fig. 7). Nevertheless, the primed MC used in these experi¬
ments were susceptible to apoptosis by soluble FasL (100 ng/ml)
(13.4% at 24 h), whereas unprimed were not (1% at 24 h). The
residual MC apoptosis observed incubating activated NOS-2-'-
M$ with cytokine-primed MC therefore appears most unlikely to
have been mediated by FasL.
Mf> isolated from inflamed glomeruli also inhibit mitosis and
induce apoptosis in cultured MC by an NO-mediated mechanism
To assess the likely in vivo relevance of these observations, tele¬
scoped nephrotoxic nephritis was induced in Sprague Dawley rats.
During the autologous phase, there was predominance of Mc(> in
the mesangium (21.4 ± 3.1 per glomerular cross section on
day 2, 16.1 ± 1.5 on day 4, 1.4 ± 0.6 in controls by ED-1 im-
munohistochemistry). Animals from days 2, 4, and 7 after disease
induction were sacrificed, kidneys were removed, and glomeruli
isolated by sieving. Glomeruli were then exposed to an enzymatic
digest, resulting in a single cell suspension. Mr(> were isolated from
this by rapid adhesion of these cells to plastic wells (>90% purity
by ED-1 immunohistochemistry). M<fi from these diseased glomer¬
uli were immediately cocultured with CellTracker Green-labeled
MC, and the coculture was assessed at 8, 16, and 24 h. Inflamma¬
tory glomerular M$ released similar amounts of NO to activated
rat BMD M<^> (Table III). Resident Mt(> from normal glomeruli
produced little NO, but when challenged with proinflammatory
cytokines, released NO in similar quantities to BMD M<f> treated
with the same cytokines.
unprimed primed
unprimed primed
FIGURE 6. The effect of activated M<(> from NOS-2 knockout mice on
unprimed and primed MC apoptosis. BMD M<£ from NOS-2-'- 129/sv
and wild-type mice were matured according to Materials and Methods. MC
were primed or unprimed as described in Materials and Methods, and the
coculture was established and activated as before. A, At 24 h of coculture,
there was induction of MC apoptosis when wild-type mouse M<(> were
employed. NOS-2-'- M<£ had a greatly reduced capacity to induce apo¬
ptosis of unprimed cells. Wild-type Mtf> induced increased apoptosis of
primed MC at 24 h. However, NOS-2-'- M<j> were also able to induce a
more modest degree of apoptosis of primed MC. *, p < 0.01 vs NOS-2-'-
M<f> in coculture with unprimed MC. **, p < 0.001 vs control primed
MC. n = 4. B. Activated wild-type M<(> suppressed primed and
unprimed MC mitosis similarly. NOS-2-'- M<)> were unable to induce
suppression of MC mitosis (*, p < 0.01).
Mc(> from inflamed glomeruli (activated in vivo) from day 2
of the disease were also able to induce effects comparable with
activated BMD M<|> upon coculture with MC (Fig. 8). Induction
of apoptosis in coculture compared with controls, and suppression
of mitosis was present at 8 and 16 h, but diminished at 24 h.
However, the combination of these effects led to a decrease in cell
number. Results from coculture using M</> isolated from days 4 and
7 of the glomerulonephritis (Table IV) showed similar findings to
M</> from day 2. The addition of l-NMMA was also able to abro¬
gate partially the Mr()-mediated effects (Table IV). d-NMMA had
no effect. At 16 h, there was no significant difference in apoptosis
and mitosis compared with controls.
The difference in tempo and magnitude of effects seen using ex
vivo M(£ appeared likely to be due to two factors. First, the ex vivo
Mc/> were already activated, whereas the BMD Mf> employed
above (Fig. 2) were used under conditions in which full activation
would only have been expected after the coculture had been es¬
tablished. Second, ex vivo M</> underwent programmed cell death
(>70% at 24 h), which appeared to be related to the enzymatic
digest. To investigate these issues further, BMD M$ were acti¬
vated with IFN--y (100 U/ml) and LPS (1 /Ag/ml) for 6 h, then
washed. They were exposed to the same enzyme protocol as glo¬
merular cells, then immediately used in coculture. This approach
N wild type co-culture
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Table III. Both M(j) and MC produce NO in response to proinflammatory stimulia
Cell Type Control
Nitrite Produced Over 24 h
IFN-y/LPS IFN-y/TNF-a 11-1/3
Rat BMD M<j> 5.6 ± 1.1 125.3 ± 10.0 73.5 ± 13.4 ND
Mouse BMD M$
129/sv wild type 3.7 ± 0.4 134.2 ± 38.2 ND ND
NOS-2~/_ 2.4 ± 0.4 32.1 ± 5.6 ND ND
Rat glomerular M<£
Control animals 15.7 ± 4.2 ND 100.7 ± 4.8 ND
Day 2 NTN 154.8 ± 2.5 ND ND ND
Day 4 NTN 109.5 ± 2.3 ND ND ND
Rat mesangial cells
Clonal'' 1.2 ± 1.4 1.6 ± 2.0 23.4 ± 7.6 1.7 ± 2.0
Polyclonal'' 2.7 ± 2.1 4.5 ± 0.4 51.3 ± 15.7 3.9 ± 2.2
a Values are mean ± SE(rc > 4). BMD were either untreated or activated with IFN-y (100 U/ml) plus TNF-a (100 U/ml)
or IFN-y (100 U/ml) plus LPS (1 /xg/ml). Resident rat glomerular M<£ were untreated or activated with IFN-y (100 U/ml) plus
TNF-a (100 U/ml). M(f> from rat glomeruli with nephrotoxic nephritis on days 2 and 4 were untreated. MC were untreated or
activated with IFN-y (100 U/ml) plus TNF-a (100 U/ml), IFN-y (100 U/ml) plus LPS (1 /xg/ml), or 11-1/3 alone (40 ng/ml).
h Nitrite produced over 48 h. ND, not done.
gave comparable results to the ex vivo glomerular Mc/> on MC
(data not shown).
Discussion
In this study, we have demonstrated for the first time that activated
but not quiescent M(/> coordinately induce apoptosis and suppress
mitosis in cultured glomerular MC, which are well known to
exhibit myofibroblast-like features. The use of competitive inhib¬
itors (l-NMMA and l-NIL) and M<£> from gene-targeted animals
lacking NOS-2 provided definitive evidence that M$-derived NO
was critical in both induction of apoptosis and suppression of mi¬
tosis. When MC susceptibility to these M<£-induced effects was
deliberately increased by pretreating MC with proinflammatory
cytokines, a proportion of the M</>-induced kill was independent of
NOS-2. However, despite evidence of sensitization to FasL by
treatment of MC with proinflammatory cytokines, the use of acti¬














unprimed MC primed MC
FIGURE 7. The effect of M<i> with mutated, nonfunctional FasL (gld/
gld) in coculture with unprimed and primed MC. BMD M<£ from the CH3/
HEJ mouse were matured according to Materials and Methods. MC were
primed or unprimed, and the coculture was established and activated as
described before. At 24 h, activated wild-type and gld/gld M4> induced
similar amounts of apoptosis in unprimed MC. Primed MC were more
susceptible to the apoptosis-inducing effects of these M<£. However, the





























8h 16h 24 h
16h 24 h
FIGURE 8. The effect of M<£ from the inflamed glomeruli of rats with
nephrotoxic nephritis (NTN) on MC apoptosis and mitosis. Glomerular
single cell suspension and M<p isolation were carried according to Mate¬
rials and Methods. Immediately following isolation, glomerular M</> from
day 2 of nephrotoxic nephritis were cocultured with MC without the ad¬
dition of cytokines. A, The effect of M<(> on MC apoptosis at 8, 16, and 24 h.
Note induction of apoptosis at 8 h, peaking at 16 h, and much reduced at
24 h. B. The effect of M<|> MC mitosis at the same time points: MC mitosis
was suppressed at 8 and 16 h. C, M<£ suppressed the expected increase in
MC number at 16 h. This effect was more marked at 24 h. *, p < 0.05
compared with control MC (n = 3).
2118 INFLAMMATORY MACROPHAGES DIRECT APOPTOSIS
Table IV. Effect of glomerular Mf> isolated from rats with NTN at days 2, 4, and 7 upon MC apoptosis,
mitosis, and cell numbera
Day 2 Mf
Day 2 Mc/> + l-NMMA Day 4 M4> Day 7
Apoptosis at 16 h 493 ± 23 136 ± 5* 261 ± 11 487 ± 16
(% of control)
Mitosis at 16 h 19 ± 12 83 ± 18* 38 + 60 23 ± 29
(% of control)
MC number at 24 h 73 ± 9 99 ± 10* 85 ± 6 81 ± 9
(% of control)
a Control MC apoptosis 0.68 ± 0.04%, mitosis 3.8 ± 0.7%, and MC number 1729 ± 68%. The addition of l-NMMA (100
p.M) to cocultures with day 2 M$ shows partial abrogation of the M<i>-induced effects on MC. d-NMMA in coculture with day
2 M4> were comparable to no additive and the data have been omitted for clarity.
*, p < 0.05 compared to day 2 M<t> in = 3).
diated by FasL from M<j>. Finally, glomerular M<j> activated in vivo
during experimentally induced glomerulonephritis also induced
apoptosis and suppressed mitosis when cultured ex vivo with MC,
by an L-NMMA-inhibitable mechanism. We conclude that by vir¬
tue of release of NO, activated M(j> can regulate MC number by
both induction of apoptosis and suppression of mitosis.
We believe that these data provide evidence of a new concept in
inflammation: that of M<j)-directed regulation of resident cell pop¬
ulations by the coordinated induction of apoptosis and inhibition of
mitosis. This control may have a pivotal role in the outcome of
acute inflammatory responses, either progression to a hypocellular
scar, or healing by restoration of the normal cell complement and
phenotype. The ex vivo data argue strongly that M(j>-directed reg¬
ulation of MC complement is likely to occur in glomerulonephritis
in vivo, but it is clear that future experiments will need to test the
population-regulating role of Mc/> in greater detail. Evidence of
M<j>-directed tubular cell apoptosis already exists in nephrotoxic
nephritis induced in MCP_/~ and wild-type mice (6), in which
Mcfr accumulation in the tubulointerstitium was much reduced in
the chemokine-deficient mice, and was associated with a marked
decrease in tubular cell apoptosis. Furthermore, consistent with
data suggesting that many cell types exhibit myofibroblast-like
features at sites of tissue injury, preliminary data from Bennett's
group (27) have linked M(j> with apoptosis of vascular smooth
muscle cells in vitro and in atherosclerotic plaques in vivo. There¬
fore, we suggest that M(j>-mediated regulation of resident cell pop¬
ulations should be sought in a wide range of disease settings.
The competitor and knockout M(/> experiments indicated that
M<j>-derived NO plays a major role in inducing apoptosis and sup¬
pressing mitosis in MC. The paucity of NO production by rat MC
compared with M(/> is in keeping with work on whole glomeruli
from rats with Thy-1.1 nephritis, in which NO release correlated
with the presence of M<j> rather than proliferating MC (28). How¬
ever, the only available study of glomerulonephritis in NOS-2_/_
mice was in a model of mild nephrotoxic nephritis with little Mc/>
infiltration of glomeruli (29), and apoptosis was not assessed. Fur¬
thermore, the equivocal data on NO in glomerulonephritis pub¬
lished to date (in which two studies show amelioration of disease
(30, 31): two show no difference (29, 32), and one shows exacer¬
bation (33)) have concentrated on conventional parameters of glo¬
merular injury rather than apoptosis or remodeling. Therefore, ad¬
ditional experiments will be required to confirm a role for M(/>-
derived NO in regulating MC number in glomerulonephritis
models exhibiting degrees of M<j> infiltration comparable with that
observed in human disease (34, 35), in which M</> number may
approach MC number (comparable with the in vitro ratio em¬
ployed in our experiments). It is, however, difficult to extrapolate
directly from in vitro ratios, in which cell interaction is in one
plane, to the in vivo situation. Nevertheless, expression of NOS-2
by Mtj> in human glomerulonephritis (36, 37), despite notorious
difficulties in achieving NO production in vitro (38, 39), suggests
again that NO-mediated apoptosis may be relevant in vivo.
However, the competitor and NOS-2_/_ M<f> studies employing
MC treated with proinflammatory cytokines indicated that, in ad¬
dition to NO, there is at least one other mechanism by which M(j>
can direct MC killing. Despite evidence in human monocyte-de-
rived Mcj) of FasL-dependent killing of neighboring cells (25, 26),
the data from gld/gld mice argue strongly against this subsidiary
M(/>-directed killing mechanism being mediated by rodent M<j>-
derived FasL. To what extent the cytokine-treated or primed in
vitro MC represents a MC in vivo during inflammatory responses
is unclear. In this study, we found that primed cells in vitro were
weakly NOS-2 positive, and produced relatively small amounts of
NO. Immunohistochemistry of glomerular sections from nephro¬
toxic nephritis suggested that Mcj> are the principal cell type ex¬
pressing NOS-2 (40), although similar studies of human disease
demonstrated that some MC in inflamed glomeruli were NOS-2
positive (37). Furthermore, we observed increased rat MC Fas pro¬
tein following cytokine priming, in keeping with studies of human
MC (21). This correlates with work showing that some human MC
during acute glomerular disease have increased Fas protein (41).
Together, these data indicate that at least some MC in vivo share
phenotypic features with cultured MC primed with cytokines in
vitro. Therefore, it would appear desirable for future studies to
investigate further whether such cells are rendered susceptible to
ligation of receptors other than Fas that signal into the caspase
(intracellular death signaling) pathway. Preliminary experiments
(J. Duffield, C. Ware, and J. Savill, unpublished data) employing
TNFRl-Fc chimeras to block TNFR1 on MC point to a role for
M<j>-derived TNF-a/TNF-jS in mediating NO-independent residual
kill of cytokine-primed MC, but a range of ligands for the expand¬
ing TNFR family will need to be assessed before definitive con¬
clusions can be drawn.
The major focus of this study was to determine the potential of
activated M<j> to direct apoptosis of myofibroblast-like MC. How¬
ever, the capacity to limit the growth of MC populations was
clearly enhanced by concomitant suppression of MC mitosis. In¬
deed, exogenous NO donors have been reported to induce DNA
fragmentation and inhibit mitosis in MC (42, 43). It is known that
when MC are treated with the NO donor, 5-nitroso-glutathione, the
nuclear protein p53, whose effects on the cell cycle are well rec¬
ognized, is induced (42). Furthermore, exogenous NO donors ac¬
tivate caspase 8, the most upstream member of the caspase path¬
way, by cleavage, in lymphoid cell lines (44). Future studies
should address the molecular mechanisms by which NO coordi-
nately suppresses mitosis and promotes apoptosis in MC.
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To conclude, this study implicates NO derived from activated
M<j> in regulation of MC populations by induction of apoptosis and
suppression of mitosis in this resident glomerular cell type. We
speculate that this may be a generally relevant mechanism for reg¬
ulation of myofibroblast-like cell populations at sites of tissue
injury.
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Suppression by Apoptotic Cells Defines Tumor
Necrosis Factor-Mediated Induction of Glomerular
Mesangial Cell Apoptosis by Activated
Macrophages
Jeremy S. Duffield,* Carl F. Ware,1"
Bernhardt Fiyffel* and John Savill*
From the Medical Research Council Centre for Inflammation
Research,' University ofEdinburgh, Edinburgh, United Kingdom;
the La Jolla Institute for Allergy and Immunology/ University of
California, San Diego, California; and the Department of
Medicine■* University of Cape Town, Cape Town, South Africa
Activated macrophages isolated from inflamed
glomeruli or generated by interferon--/ and lipopoly-
saccharide treatment in vitro induce glomerular mes¬
angial cell apoptosis by hitherto incompletely under¬
stood mechanisms. In this report we demonstrate
that nitric oxide-independent killing of co-cultured
mesangial cells by interferon-y/lipopolysaccharide-
activated M<f> is suppressed by binding/ingestion of
apoptotic cells and is mediated by tumor necrosis
factor (TNF). Thus, soluble TNF receptor-1 signifi¬
cantly inhibited induction of mesangial cell apoptosis
by 1) rodent M</> in the presence of nitric oxide syn¬
thase inhibitors or 2) human M<f», both situations in
which nitric oxide release was minimal. Further¬
more, murine TNF knockout M <f> were completely
unable to induce mesangial cell apoptosis in the pres¬
ence of nitric oxide synthase inhibitors. We conclude
that TNF-restricted MJj-directed apoptosis of glomer¬
ular mesangial cells can be down-regulated by M<f>
binding/ingestion of apoptotic cells, suggesting a new
mechanism for negative feedback regulation of Mtf>
controls on resident cell number at inflamed sites.
(Am J Pathol 2001, 159:000-000)
Proliferation of resident cells is a prominent feature of
inflammatory responses. In glomerular inflammation there
is typically an increase in number of resident glomerular
mesangial cells that adopt a myofibroblast-like pheno-
type, lay down excess abnormal matrix, and thereby
threaten progression to scarring.1 Plowever, in self-lim¬
ited nephritis excess mesangial cells are deleted by ap¬
optosis and the glomerular cell complement returns to
normal2-3 Until recently the mechanisms mediating de¬
letion of myofibroblast-like mesangial cells have been
obscure. However, we showed that activated macro¬
phages (M<f>) can direct apoptosis of such cells,4 mes¬
angial cell killing being mediated by nitric oxide (in a
rodent cell system) and another unknown factor. Be¬
cause inflammatory M<f> can delete neutrophils5 and a
range of tumor cells6"8 by tumor necrosis factor (TNF)-
mediated mechanisms, there was a strong possibility that
activated M(f> might use TNF to induce mesangial cell Fn1
apoptosis, particularly in human cell systems in which
production of nitric oxide is notoriously difficult to detect.9
Furthermore, the demonstration that activated/inflam¬
matory M4> can kill resident glomerular cells immediately
begs the question as to how the killing capacity of M<f>
might be regulated. Importantly, work from Reiter and
colleagues10 demonstrated that the capacity of rodent
bone marrow-derived M<f> stimulated with interferon
(IFN)-y and lipopolysaccharide (LPS) to induce tumor cell
apoptosis was diminished to —30% of control by inges¬
tion of apoptotic cells. However, although this was asso¬
ciated with a modest reduction in nitric oxide production
to -75% of control, the Mcf> killing mechanism(s) sup¬
pressed by ingestion of apoptotic cells was/were not
characterized further.10
In this study we set out to determine whether activated
Mcf> induction of glomerular mesangial cell apoptosis was
suppressed by M<f> ingestion of apoptotic cells and to
determine which M<)> mechanisms for triggering apopto¬




Media and fetal calf serum (FCS) were purchased from
Life Technologies (Paisley, UK). Tissue culture plastic
was from Falcon (Becton Dickinson, Mountainview, CA)
and Costar (Cambridge, MA) as stated in the text. Cyto-
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kines were purchased from R&D Systems (Minneapolis,
MN) and all other reagents from Sigma (St. Louis, MO)
unless otherwise stated.
Cell Isolation and Preparation
Human mesangial cells were obtained from the cortex of
fresh nephrectomy specimens. Mesangial cells were pu¬
rified from outgrowths of whole, purified glomeruli and
passaged according to standard techniques in full Dul-
becco's modified Eagle's medium (DMEM)/F12 (with
10% FCS, and supplemented with penicillin and strepto¬
mycin (Life Technologies).2 Rat mesangial cells were
derived from outgrowths of whole glomeruli as de¬
scribed.4 They were passaged according to standard
techniques in full DMEM/F12, and were used between
passage 6 and 14. Rodent macrophages were derived
from bone marrow taken from the femur of Wistar rats or
from murine strains (TNFa/j3-/-) and wild-type littermate
controls (C57BL6 x 129sv). In the TNFR1-Fc blockade
studies, they were all C57BL6). Marrow was prepared
and cultured in Teflon bags with murine M-CSF as previ¬
ously described.4 Cells were used after 7 to 10 days, then
were plated into wells 16 hours before experimentation to
ensure adequate adhesion and correct cell number. Hu¬
man macrophages were derived from peripheral blood
monocytes. Briefly, peripheral blood mononuclear cells
were obtained from the buffy coat of fresh peripheral
blood from healthy donors. Red cells were removed by
dextran sedimentation and granulocytes were separated
by centrifugation through a discontinuous Percoll gradi¬
ent.11 The monocytes were then purified using the MACS
monocyte cell isolation system (Miltenyi Biotech). Purity
of monocytes (>95%) was established by flow cytometric
characteristics. Monocytes were then cultured in Teflon
wells (2 x 106/ml) in Iscove's-modified DMEM with 10%
autologous serum. Medium was changed on day 2 and
day 4. Differentiation was confirmed by cytology on cy-
tospins and CD14 immunofluorescence (not shown).
Generation ofApoptotic Cells
Rat mesangial cells were induced into apoptosis by ul¬
traviolet irradiation. Subconfluent monolayers in T75
flasks (Costar) were exposed to UV irradiation (312 nm, 8
W, 3 minutes) followed by incubation for 16 hours. Non¬
adherent (apoptotic) cells were removed by agitation and
collected in the supernatant. After centrifugation, apopto¬
tic cells were further purified by washing with phosphate-
buffered saline (PBS) 1X and centrifugation (190 x g, 5
minutes). Apoptosis was confirmed by histology, selec¬
tive uptake of Hoechst 33342 (1 /j.g/ml), but exclusion of
propidium iodide (PI) (1 jug/ml). Typically, <10% of cells
were Pl-positive and <5% did not exclude trypan blue
(0.2%).
Mouse thymocytes were prepared from 20 g C57/BL6
mice by pressing the thymus through a 50-jxm sieve. The
single cell supernatant was resuspended (2 x 10s cells/
ml) in RPMI supplemented with glutamine and 2-mercap-
toethanol in addition to 10% FCS and antibiotics. Cells
were either exposed to a 5-minute burst of UV irradiation
(312 nm, 8 W) followed by 2.5 hours of culture, or dexa-
methasone (1 /xmol/L) followed by culture for 6 hours.
Typically >50% of induced cells were apoptotic (Annexin
V binding; Boehringer Mannheim. Mannheim, Germany)
and permeable to Hoescht 33342 (1 ^.g/ml)) whereas
<5% of those were positive for the uptake of PI (flow
cytometric analysis, data not shown).
Co-Culture of and Mesangial Cells
For a detailed description, see our earlier work.4 Matured *
rodent bone marrow-derived macrophages were plated
in 96-well plates initially at a density to cover 60 to 70% of AQ: E
the well surface; typically this required 2 x 104cells per
well. Rat mesangial cells were prelabeled with Cell-
Tracker Green CMFDA (Molecular Probes, Eugene, OR):
cell cultures, 70 to 80% confluent, were washed with
medium lacking serum and then incubated for 1 hour in
serum-free medium containing CMFDA at 5 ng/ml. Cells
were washed in medium containing 10% FCS to remove
any unbound CMFDA, then trypsinized and added to
cultured rodent M$ in a 1.5 Mc/>:1.0 mesangial cell ratio,
previously shown to be optimal for demonstration of mac-
rophage-directed mesangial cell apoptosis.4 Experi¬
ments were performed in DMEM/F12 medium containing
10% FCS. Once cells had become adherent, typically 2
to 4 hours, wells were washed to remove nonadherent
cells. In our earlier work4mixing unlabeled and labeled
cells showed no evidence of transfer of CMFDA from
labeled to unlabeled cells. Rodent co-cultures were ac¬
tivated with IFN-y (100 U/ml) plus LPS (1 /xg/ml).
In some experiments, unlabeled apoptotic cells (1 x
10s per well of a 96-well plate) were added to the estab¬
lished co-culture and to the control wells of mesangial
cells alone, at the same time as activating cytokines. As
a control for apoptotic cells, aliquots of 10-ju.m diameter
sterile latex beads (Polysciences, UK) were added to
adjacent co-culture. When thymocytes were used as ap¬
optotic cells, aliquots were added to co-culture for 6
hours, then noningested cells gently washed away, be¬
fore activation. In separate wells containing M</> alone,
apoptotic cells or latex beads were also incubated for 6
hours, then washed off, and wells were fixed for quanti¬
fication of percentage M</> that had phagocytosed apo¬
ptotic cells. This was assessed by phase contrast micros¬
copy. Mcf> (34 ± 5.6%) phagocytosed at least one
apoptotic thymocyte and 30 ± 6.7% phagocytosed ap¬
optotic mesangial cells. M(f> (67 ± 8.4%) ingested latex
beads. By contrast only 1 ±1% of M</> phagocytosed the
population of live thymocytes in this assay.
For human co-culture, human monocyte-derived Mc/>
were plated at 2 x 104 per well as above. Cycling human
mesangial cells were primed with IFN-y (500 U/ml) for 24
hours, then prelabeled with CMFDA as described for rat
mesangial cells. Once washed and trypsinized, they
were added to wells in a 2:1 ratio (because of the larger
size of human mesangial cells). After 4 hours, wells were
washed and replaced with full DMEM/F12. Human co-
cultures were activated with human IFN-y (Peprotech)
(500 U/ml) and LPS (1 jxg/ml).
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Assessment of Mesangial Cell Apoptosis in Co-
Culture
For a detailed description, see our earlier work.4 At the
end of co-culture experiments, wells were either fixed
with formaldehyde (4% final concentration) and stored for
48 hours at 4°C to allow firm adhesion of apoptotic cells
to the plate, or they were assessed live by fluorescence
microscopy after the addition of Hoechst 33342 (1 /xg/ml)
and PI (1 /xg/ml). For assessment of live cells, green
rounded-up cells were scored as apoptotic if they also
were positive for Hoechst uptake, but excluded PI. For
assessment of fixed (and permeabilized) cells by mor¬
phology, plates were first counterstained with PI (1 /xg/ml)
and Hoechst (1 /xg/ml) in PBS for 5 minutes (which stains
both M4> and mesangial cells). After discarding the stain,
wells were covered with a fluorescent mountant. Apopto¬
tic mesangial cells were easily discernible by green flu¬
orescence and characteristic morphology. For both live
and fixed wells, apoptosis of mesangial cells was as¬
sessed blindly and five fields per well were randomly
chosen without observer bias. Each experiment was per¬
formed in triplicate. Previous studies have shown this
method to give similar results to flow cytometric assays.4
However, the microscopical assay is reproducibly more
sensitive because apoptotic mesangial cells tend to dis¬
integrate during centrifugation once they have been
fixed. Note that when exogenous apoptotic cells were
added these were not labeled with fluorescent dyes,
enabling confident identification of apoptosis in the pre¬
viously healthy target mesangial cells.
Assays of TNF-a and Nitric Oxide
Culture supernatants (free from phenol red) were har¬
vested, clarified by centrifugation (4000 x g, 5 minutes)
then stored at -20°C. After complete thawing, 50 /xl of
each sample was assayed by Quantikine mouse TNF-a:
enzyme-linked immunosorbent assay (R&D Systems) ac¬
cording to the manufacturer's instructions. A standard
curve with absorbencies from 0.1 to 1.2 was achieved on
each occasion. Samples (50 /xl) were assayed for nitrite
by mixing with an equal volume of the Griess reagent as
previously described6 and measuring absorbency at 540
nm and comparing with a sodium nitrite standard curve.
Chimeric Soluble Death Receptors
Fusion proteins were constructed using cDNAs for the
extracellular domains of human receptors fused with the
Fc portion of human IgG-,. Proteins were expressed in
insect cells infected with recombinant baculoviruses.
Protein secreted into the culture supernatant was then
purified by protein A-Sepharose column affinity. The pro¬
tein was stored at -20°C in Hanks' salt solution.12
Knockout Mice
TNF-a/TNF-j3 double-knockout mice were generated by
inserting a targeting vector between exon 1 and 2 of the
AQ: F
murine TNF-/3 gene and the middle of exon 4 of the
adjacent murine TNF-a gene of chromosome 17 of GS1
mouse embryonic stem cells. Mutant embryonic stem
cells were selected and injected into C57/BL6 blasto¬
cysts.13
Statistics
All experiments were performed on at least four separate
occasions using at least four animals. The data were
expressed as mean values with the SE of mean. Paired
data were compared using the f-test and multiple com¬
parisons using analysis of variance.
Results
Ingestion ofApoptotic Cells by Activated
Rodent M4> Selectively Suppresses Nitric Oxide-
Independent Induction of Mesangial Cell
Apoptosis
In our previous studies of IFN-y/LPS-activated rodent
bone marrow-derived M<j> killing of rodent mesangial cells
primed with IFN-y (Figure 1) we demonstrated that at
least half of the mesangial cell killing was independent of
M(f>-derived nitric oxide, being unaffected by inhibitors of
inducible nitric oxide synthase (iNOS) such as L-NMMA
at 500 ju,mol/L 4 We also observed that the vast majority of
mesangial cells induced into apoptosis by activated M<f>
were not ingested 4 presumably because of kinetic and
spatial restraints in a two-dimensional culture system in
which IFN-y-primed mesangial cells were added above a
sparse monolayer of Mtf> before the co-culture was acti¬
vated by addition of IFN-y and LPS.
Therefore, to test whether ingestion of apoptotic cells
diminished capacity to trigger apoptosis in mesangial
cells, an established co-culture of IFN-y-primed rat mes¬
angial cells with rat M</> was exposed to a fivefold excess
of mesangial cells induced into apoptosis by UV irradia¬
tion; the apoptotic cells were administered at the same
time as activation of the co-culture with IFN-y and LPS.
Under standard conditions, there was no significant ef¬
fect of apoptotic cells on M(f> induction of mesangial cell
apoptosis. However, in the presence of 200 /xmol/L L- F2
NMMA, apoptotic mesangial cells exerted a dramatic
inhibitory effect on M</> induction of mesangial cell apo¬
ptosis (Figure 2). Addition of the same number (1 x 10s F3
per well) of 10-/xm latex beads, as a control phagocytic
particle, had no inhibitory effect whether L-NMMA was
present or not (Figure 3). Furthermore, suppression of
nitric oxide-independent triggering of apoptosis was ob- T1
served with rodent thymocytes induced into apoptosis by
UV or dexamethasone, but not when freshly isolated no-
napoptotic thymocytes were used as controls (Table 1).
Finally, similar results were observed whether apoptotic
cells were added simultaneously with activation of co-
culture, as above, or if apoptotic cells were administered
to co-culture before activation (Table 1). This indicates
that the suppressive effect was mediated by effects of
4 Duffield et al
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Figure 1. Fluorescent micrograph (original magnification, X320) showing activated co-culture of CMFDA green-labeled mesangial cells with The co-culture
was established according to Materials and Methods and activated with IFN-y (100 U/ml) plus LPS (1 jug/ml) after 4 hours of exposure to preformed unlabeled
apoptotic mesangial cells. At 24 hours, the co-culture was fixed and later counterstained with PI (1 /xg/ml). Apoptotic green mesangial cells are clearly seen with
red/orange pyknotic nuclear material and are readily distinguished from M<£ (arrows). Before fixation, co-culture was exposed to Hoechst 33342 (1 /xg/ml) for
confirmation of apoptosis of the green mesangial cells (see inset). Note inset field and arrow-marked apoptotic cells correspond to central field of main figure.
Note also two apoptotic mesangial cells showing cytoplasmic blebbing (large arrows).
1 15.0%
1 10.C
I DMC alone I
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apoptotic cells apoptotic cells
Figure 2. Induction of rodent mesangial cell apoptosis by activated M</> is
blocked by simultaneous phagocytosis of apoptotic mesangial cells when
• iNOS inhibitors are present. Established co-cultures of rodent M$ and IFN-y
primed, CMFDA-labeled, mesangial cells, or mesangial cells growing alone
(as control), were activated with IFN-y (100 U/ml) and LPS (1 /xg/ml).
Simultaneously to activation, a fivefold excess of unlabeled apoptotic rodent
mesangial cells was added (1 X 105 cells per well). In addition, to some wells
(hatched bars), L-NMMA (200 /xmol/L) was added at the same time as activa¬
tion. After 24 hours of incubation, induction of CMFDA-labeled mesangial
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Figure 3. Induction of rodent mesangial cell apoptosis by activated M<f> is not
blocked by simultaneous phagocytosis of latex beads when iNOS inhibitors
are present. Both established co-cultures of rodent Mcp- and IFN-y-primed,
CMFDA-labeled, mesangial cells, and wells of mesangial cells alone were
activated with IFN-y (100 U/ml) and LPS (1 /xg/ml). Simultaneously a fivefold
excess of unlabeled sterile 10-/xm latex beads was added (IX 105 cells per
well). In addition, to some wells (hatched bars), L-NMMA (200 /xmol/L)
was added. After 24 hours of incubation, induction of CMFDA-labeled mes¬
angial cells was scored (n = 5).
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Table 1. The Effect of Co-Culture with Apoptotic Cells upon
Murine M<p Induction of Apoptosis in IFN-y Primed
Mesangial Cells at 24 Hours in the Presence of




Cell type cells added
Apoptotic mesangial cells (UV) 10.7 ± 2.1 3.3 ± 1.0*
Apoptotic thymocytes (UV) 16.1 ± 1.4 8.2 ± 0.1 +
Apoptotic thymocytes (Dex) 16.1 ± 1.4 8.3 ± 0.51"
Nonapoptotic thymocytes 16.1 ± 1.8 14.2 ± 1.3
UV, Ultraviolet; Dex, dexamethasone.
Rodent co-culture was established as described in Materials and
Methods. Apoptotic cells were incubated with the co-culture for 6
hours. M<#> were activated with IFN-y plus LPS in the presence of L-
NMMA 200 jurmol/L after washing away noningested cells. Note that
control cultures of mesangial cells alone exposed to apoptotic cells
followed by activating cytokines underwent no greater than 3.42 ±
0.2% apoptosis.
"P < 0.01 compared with no added cells.
fP < 0.001 compared with no added cells.
apoptotic cells on the most likely consequent on
ingestion of apoptotic cells, but not excluding an effect of
binding alone.
Blockade of TNFR1 Also Inhibits Nitric Oxide-
Independent Macrophage Induction of
Mesangial Cell Apoptosis
Exposure of activated monocytes/macrophages to apo¬
ptotic cells exerts a well-established inhibitory effect on
secretion of TNF.14,15 It therefore seemed especially
likely that nitric oxide-independent induction of IFN-y-
primed mesangial cell apoptosis by activated Mrf>, which
we had found to be inhibited by apoptotic cells (Figure 2),
was also mediated by M(f>-derived TNF.
To seek a role for TNF in M(f> directed killing of mes¬
angial cells, we examined the effect of soluble chimeric
death receptors (fused with the Fc portion of human
IgG-,) on activated rat macrophage killing of primed rat
mesangial cells in the presence of inhibitors of nitric
oxide synthesis (in these experiments the selective iNOS
inhibitor L-NIL at 30 fj,mol/L, as validated in our earlier
work4). A role for Mcf>-derived FasL had already been
ruled out in rodent co-culture4 by using bone marrow Mcf>
from gld/gld mice (that lack active FasL) and therefore
soluble inhibitors of Fas-FasL interaction were not used.
Induction of rat mesangial cell apoptosis in activated
co-culture was assessed at 24 hours. TNFR1-Fc (10 /xg/
ml) was able to reduce significantly the killing capacity of
M</> in co-culture (Figure 4) whereas lymphotoxin j3-re-
ceptor fusion protein (LT/3R-Fc16) and herpesvirus entry
mediator fusion protein (FIVEM-Fc17,18) had no effect. At
higher concentrations, TNFR1-Fc (50 jxg/ml) was able to
increase further the reduction in killing capacity (14.3 ±
3.3% rat mesangial cell apoptosis in activated co-culture
with IgG! versus 3.9 ± 0.7% mesangial cell apoptosis
with 50 /xg/ml TNFR1-Fc), but the reduction was not
complete. Control rat mesangial cells growing alone with
50 /xg/ml TNFR1-Fc showed 1.3 ± 0.7% apoptosis at 24
15.0% -| ■ co-culture
no blocker IgGl TNFRl-Fc LTbR-Fc HVEM-Fc
blocking agent
Figure 4. Soluble TNFR1 inhibits nitric oxide-independent rodent M<f) killing
of primed rodent mesangial cells. Murine bone marrow-derived M4> were
co-cultured with mesangial cells as described in Materials and Methods.
Experiments were activated with IFN-7 and LPS as described, with L-NIL (30
/amol/L) to block NOS 2-mediated killing, and soluble Fc-fusion proteins
TNFRl-Fc, LT/3R-Fc, HVEM-Fc, or isotype control IgGj were added in culture
medium at 10 /xg/ml. Control wells containing mesangial cells but no M</>
received all reagents. Mesangial cell apoptosis was assessed at 24 hours. Note
a reduction in the capacity of M<£ to induce apoptosis in the presence of
TNFRl-Fc. *, P < 0.05.
hours. The IC50 for this fusion protein was 5.0 ± 1.2 ^g/ml
(Figure 5).
We were also interested in determining whether TNFR1
blockade might similarly inhibit activated human M<f> in¬
duction of mesangial cell apoptosis, because human Mtf>
production of nitric oxide is notoriously difficult to elicit.9
Indeed, we confirmed that the IFN-y/LPS activation reg¬
imen had no significant stimulatory effect on human
monocyte-derived M<f> production of nitric oxide (data not
shown) and that L-NMMA had no effect on activated
human M(f> killing of IFN-y-primed human mesangial cells
(14.7 ± 2.1% apoptosis at 24 hours with 200 ^.mol/L
L-NMMA versus 15.7 ± 1.9% under control conditions). In
this physiologically nitric oxide-independent human cell F6
system, soluble TNFR1 again demonstrated selective in¬




Figure 5. Concentration-dependent inhibition by sTNFRl of nitric oxide
independent of rodent Mc/> induction of rodent mesangial cell apoptosis.
Using the same co-culture assay of mesangial cell apoptosis, a range of
concentrations of TNFRl-Fc was added to wells and apoptosis quantified,
compared with 50 ixg/ml of IgGj control shown as 0 fxg/m\ of TNFRl-Fc on
the curve.
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no act act + IgG + TNFRl-Fc + anti-FasL + LTb-Fc + HVEM-Fc
blocking agent
Figure 6. Induction of apoptosis of human mesangial cells by human mono-
cyte-derived M</> is mediated by TNFR1 ligation. Co-culture was established
using primed human mesangial cells and M<£. On activation with IFN-y plus
LPS, soluble Fc-fusion proteins TNFRl-Fc, LT/3R-FC, HVEM-Fc, or isotype
control IgGx (10 /xg/ml) were added in culture medium at 10 /xg/ml. Also, the
blocking anti-Fas ligand antibody (1 /xg/ml) was applied to adjacent wells.
Control wells containing human mesangial cells but no M(f> received all
reagents. Note a reduction in the capacity of M<f> to induce apoptosis in the
presence of TNFRl-Fc, but not in the presence of any of the other reagents.









wild type TNF KO
Figure 7. The comparative effect of activated wild-type and Tnfa/TnJJi—/-
knockout murine M(/> on apoptosis of mesangial cells primed with IFN-y.
Mesangial cells were primed as described for 24 hours in the presence of
IFN-y (300 U/ml). Co-culture was established using bone marrow-derived
M</> from either Tnfa/Tnjfi—/— knockout mice or wild-type littermate con¬
trols and activated with IFN-y (100 U/ml) plus LPS (1 /xg/ml) in the presence
of L-NIL (30 /xmol/L) to block NOS 2-mediated killing. Experiments were
assayed after 24 hours. Although the wild-type M</> were able to induce
mesangial cell apoptosis, the knockout animals incapable of inducing apo¬
ptosis greater than that seen in control wells. **, P < 0.01 compared with
wild-type co-culture (« = 5).
Nitric Oxide-Independent Induction of Mesangial
Cell Apoptosis Is Restricted by Macrophage
TNF
Although the foregoing studies provided strong evidence
that ligation of TNFR1 played a major role in nitric oxide-
independent M</> killing of mesangial cells, the data did
not provide direct evidence that M</>-derived ligands for
TNFR1 (TNF-a and TNF-/3) were involved. Furthermore,
the failure of sTNFRI to exert complete inhibition of killing
might have reflected its physical exclusion from regions
of close contact between macrophages and mesangial
cells. To examine this question definitively, we prepared
BMD Mcf>from double-knockout Tnfa-/-, Tnff3-/- mice,
and wild-type littermate controls; all animals used were
C57/BL6 x 129sv to ensure that strain differences did not
complicate interpretation.13 Preliminary studies showed
both knockout and wild-type M(f> produced similar
amounts of nitric oxide in response to IFN-7 with LPS
(50 ± 4.6 [wild type] versus 47.0 ± 3.3 [Tnfa/f3-/~] nmol
nitrite per 10s cells per 24 hours) and that this was almost
completely inhibited by the iNOS inhibitor L-NIL at 30
/xmol/L (to 3.7 ± 2.1 and 2.9 ± 1.9 nmol nitrite per 10s
cells per 24 hours, respectively). Supernatants from M(/>
activated with IFN-y and LPS confirmed that the Tnfa/
/?-/- M(/> were completely unable to produce TNF-a, as
assessed by enzyme-linked immunosorbent assay of cul¬
ture supernatants at 24 hours (wild-type M$ 3982 pg/ml
Tnfa/fi-l- M(j)< 0.00 pg/ml). Rat mesangial cells were
primed for 24 hours with IFN-y then co-cultured with
either wild-type M<(> or Tnfa/p-l- M</>. The co-cultures
were activated with IFN-y (100 U/ml) and LPS (1 /u.g/ml) in
the presence of L-NIL (30 /xrmol/L). In these experiments
knockout M</> were completely unable to induce mesan¬
gial cell apoptosis compared with controls of mesangial
cells growing alone in the presence of cytokines (Figure
7). Wild-type M</> induced mesangial cell apoptosis as
expected. These data demonstrate that when nitric oxide
synthesis was inhibited, and therefore used as a model of
human Mt/>-directed apoptosis, M</> production of TNF-
a/0 accounted for all of the killing effect of rodent M(f> on
mesangial cells.
Discussion
Although it has been well documented that Mtf> can kill
tumor cells,6"8 it has only very recently become apparent
that macrophages can also direct tissue remodeling by
inducing physiological cell death, in nontransformed res¬
ident cells.4-19-20 Thus we have shown previously that
activated Mcf>, whether isolated directly from experimen¬
tally inflamed glomeruli or generated by IFN-y/LPS acti¬
vation in vitro can induce apoptosis in cultured primary
mesangial cells.4 In this report, we demonstrate for the
first time that activated M<f> induction of apoptosis in
nontransformed cells can be profoundly inhibited by in¬
teraction of M</> with apoptotic cells. However, in a rodent
system this effect could only be demonstrated when nitric
oxide production was inhibited. Nevertheless, such nitric
oxide-independent direction of mesangial cell apoptosis
was inhibitable by soluble TNF receptor in both a rodent
cell culture system and a physiologically nitric oxide-
independent human cell culture system. Indeed, a major
role for TNF in the rodent system was confirmed by the
failure of knockout Mt/> to induce nitric oxide-independent
mesangial cell apoptosis. Therefore, our key conclusion
is that macrophage-derived TNF may play a major role in
directing apoptosis of primary, nontransformed glomeru¬
lar mesangial cells.
We also regard it as interesting and important that
TNF-restricted Mct> direction of mesangial cell apoptosis
was selectively suppressed by interaction of M</> with
apoptotic cells but not when healthy cells or latex beads
were used as control particles. These data are in keeping
with the marked suppressive effects of apoptotic cells on
activated rodent bone marrow-derived Mc/> killing of tumor
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cells, in which the reported data favor a major role for a
nitric oxide-independent cell killing mechanism because
nitric oxide release was only modestly suppressed.10
Both the latter study and the current work may have
methodological differences from experiments in which
nitric oxide-directed parasite killing was suppressed by
Mcf> binding of apoptotic cells.21 Nevertheless, a second
key conclusion of our work is that interaction with apo¬
ptotic cells can suppress TNF-restricted direction of
mesangial cell apoptosis.
We propose that further work should examine the like¬
lihood that activated Mcf> deletion of resident cells at
inflamed sites may be subject to negative feedback con¬
trol, in which ingestion of apoptotic cells down-regulates
Mcf> capacity to induce apoptosis in resident cells. This
new concept suggests additional deleterious conse¬
quences should M$ clearance of apoptotic cells be de¬
fective. Previously it has been proposed22,23 that re¬
duced M<f> capacity for clearance of leukocytes and other
cells undergoing apoptosis, as now demonstrated in
C7q-/- knockout mice,24 threatens tissue injury be¬
cause of the likelihood that cellular contents escaping
from noningested apoptotic cells undergoing secondary
necrosis will injure tissues directly and indirectly23 by
stimulating Mcf> release of injurious mediators. Our new
data indicate that failure to ingest apoptotic cells might
deprive activated M<f> of a crucial off-signal resulting in
undesirably prolonged capacity to direct death of neigh¬
boring cells by TNF-restricted mechanisms. Neverthe¬
less, it is likely to be some time before this hypothesis can
be tested in vivo, because a growing body of evidence
argues that redundancy in clearance mechanisms may
require that a number are disabled before sustained
defects in clearance of apoptotic cells can be demon¬
strated.25,26
Furthermore, future work will also need to address
whether M<f> ingestion of apoptotic cells down-regulates
M<£ membrane TNF-a cell-surface expression, or whether
integrin co-factors, necessary for successful transduction
of the apoptotic signal, are down-regulated.5 Preliminary
data suggest that membrane-bound rather than soluble
TNF-a is responsible for M^-directed apoptosis of mes¬
angial cells (J. Duffield and J. Savill, unpublished data),
as reported for M (^-directed leukocyte apoptosis.5
To conclude, when macrophage release of nitric oxide
is minimal, as may be expected in human inflammation,
these data demonstrate a major role for TNF in activated
Mcf> killing of cytokine-primed mesangial cells by apopto¬
sis. Furthermore, inhibition of the capacity to direct apo¬
ptosis consequent on Mc£ binding/ingestion of apoptotic
cells reveals a new and potentially important negative
feedback control mechanism in remodeling of the in¬
flamed site.
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